Lens ID,Title,Date Published,Publication Year,Publication Type,Source Title,ISSNs,Publisher,Source Country,Author/s,Abstract,Volume,Issue Number,Start Page,End Page,Fields of Study,Keywords,MeSH Terms,Chemicals,Funding,Source URLs,External URL,PMID,DOI,Microsoft Academic ID,PMCID,Citing Patents Count,References,Citing Works Count
000-141-187-087-774,Nanomaterials and Catalysis,,2011,book chapter,Nanostructured Materials for Engineering Applications,,Springer Berlin Heidelberg,,Annelise Kopp Alves; Felipe Amorim Berutti; Felipe Antonio Lucca Sánchez,"Catalysts are typical nanomaterials, perhaps the first nanomaterials in wide applications. Catalysis is a nanoscale phenomenon that has been the subject of research and development for many years, but only recently has it become a nanoscale science of materials and chemistry involving more investigations on the molecular level. Nanomaterial-based catalysts are usually heterogeneous catalysts. The extremely small size of the particles maximizes surface area exposed to the reactant, allowing more reactions to occur. However, thermal stability of these nanomaterials is limited by their critical sizes; the smaller the crystallite size, the lower the thermal stability. In this chapter the characterization of metal oxides such as CeO2, TiO2, and ZnO and some of their applications as catalysts for methane combustion and photocatalysis is described. The effects of mixed oxides, and mixed phases were investigated.",,,93,117,Crystallite; Nanomaterials; Catalysis; Nanotechnology; Materials science; Catalytic combustion; Characterization (materials science); Nanoscopic scale; Thermal stability; Photocatalysis,,,,,https://rd.springer.com/chapter/10.1007%2F978-3-642-19131-2_7 https://link.springer.com/chapter/10.1007%2F978-3-642-19131-2_7 https://link.springer.com/10.1007/978-3-642-19131-2_7,http://dx.doi.org/10.1007/978-3-642-19131-2_7,,10.1007/978-3-642-19131-2_7,176833334,,0,004-309-913-732-603; 005-643-488-453-231; 007-615-568-063-633; 008-053-058-146-265; 008-587-901-342-873; 008-684-101-599-149; 009-291-359-109-61X; 010-094-466-520-327; 010-470-136-368-584; 011-823-106-894-433; 011-854-504-755-852; 012-656-754-069-627; 013-375-148-749-011; 015-049-031-343-64X; 018-232-090-111-376; 019-660-251-167-985; 019-735-413-819-389; 020-974-799-192-569; 027-180-271-177-280; 029-145-020-220-968; 030-743-042-893-00X; 032-382-361-753-540; 034-780-960-090-837; 037-063-567-284-202; 040-677-505-207-636; 042-346-158-659-502; 042-680-589-441-349; 044-035-949-106-378; 044-292-966-061-543; 050-576-091-808-115; 054-877-267-294-942; 056-891-164-714-098; 058-556-204-940-407; 058-574-777-415-553; 058-585-860-578-795; 059-429-344-440-046; 063-563-123-497-243; 065-125-287-882-802; 067-174-737-555-352; 073-511-680-113-183; 076-670-558-543-283; 080-248-822-554-629; 083-687-387-293-666; 087-453-497-478-462; 088-146-129-383-378; 090-499-078-516-593; 091-016-490-052-61X; 097-119-788-214-415; 098-474-204-886-254; 098-526-874-139-698; 100-919-525-336-180; 105-689-006-940-504; 105-848-345-402-167; 106-376-159-254-731; 111-845-214-178-285; 116-090-461-521-713; 116-487-754-115-458; 117-558-198-207-643; 119-217-858-275-084; 120-866-499-837-414; 132-947-069-286-114; 135-531-419-888-802; 136-170-642-130-258; 138-323-627-601-688; 138-506-147-508-777; 138-789-559-993-521; 140-564-411-117-554; 140-608-676-220-137; 141-861-471-230-089; 143-985-859-734-854; 150-665-205-549-220; 159-749-219-585-092; 161-086-248-475-084; 165-932-655-630-366; 171-094-169-886-89X; 173-537-190-765-374; 175-053-745-559-200; 177-531-502-478-111,3
000-329-230-459-620,Cellular Toxicity and Immunological Effects of Carbon-based Nanomaterials,2019-04-11,2019,journal article,Particle and fibre toxicology,17438977,BioMed Central,United Kingdom,Xia Yuan; Xiangxian Zhang; Lu Sun; Yuquan Wei; Xiawei Wei,"Carbon nanomaterials are a growing family of materials featuring unique physicochemical properties, and their widespread application is accompanied by increasing human exposure. Considerable efforts have been made to characterize the potential toxicity of carbon nanomaterials in vitro and in vivo. Many studies have reported various toxicology profiles of carbon nanomaterials. The different results of the cytotoxicity of the carbon-based materials might be related to the differences in the physicochemical properties or structures of carbon nanomaterials, types of target cells and methods of particle dispersion, etc. The reported cytotoxicity effects mainly included reactive oxygen species generation, DNA damage, lysosomal damage, mitochondrial dysfunction and eventual cell death via apoptosis or necrosis. Despite the cellular toxicity, the immunological effects of the carbon-based nanomaterials, such as the pulmonary macrophage activation and inflammation induced by carbon nanomaterials, have been thoroughly studied. The roles of carbon nanomaterials in activating different immune cells or inducing immunosuppression have also been addressed. Conclusion: Here, we provide a review of the latest research findings on the toxicological profiles of carbon-based nanomaterials, highlighting both the cellular toxicities and immunological effects of carbon nanomaterials. This review provides information on the overall status, trends, and research needs for toxicological studies of carbon nanomaterials.",16,1,1,27,Cytotoxicity; Nanomaterials; DNA damage; Chemistry; Toxicity; Carbon nanomaterials; Carbon based nanomaterials; Programmed cell death; Carbon; Biochemistry,Carbon nanomaterial; Cytotoxicity; Immunological effects; Macrophage,Animals; Apoptosis/drug effects; Carbon/chemistry; Cell Line; Cell Survival/drug effects; Cytokines/metabolism; Humans; Lung/drug effects; Lymphocytes/drug effects; Macrophages/drug effects; Nanostructures/chemistry; Particle Size; Surface Properties,Cytokines; Carbon,the National Natural Science Foundation of China; the National Key Research and Development Program of China,https://link.springer.com/article/10.1186/s12989-019-0299-z https://link.springer.com/content/pdf/10.1186/s12989-019-0299-z.pdf https://doaj.org/article/f5f0148c5ed342a6b3314ad79659a284 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460856 https://pubmed.ncbi.nlm.nih.gov/30975174/ https://particleandfibretoxicology.biomedcentral.com/articles/10.1186/s12989-019-0299-z,http://dx.doi.org/10.1186/s12989-019-0299-z,30975174,10.1186/s12989-019-0299-z,2945964100,PMC6460856,0,000-289-398-938-138; 000-304-942-202-275; 000-408-372-382-839; 000-458-326-685-260; 000-672-679-241-486; 000-722-339-723-983; 001-221-071-682-850; 001-783-499-024-36X; 002-380-466-060-639; 003-354-162-646-523; 004-089-528-905-713; 004-340-429-608-323; 005-054-807-897-409; 005-626-891-111-958; 005-716-268-121-272; 006-096-500-215-575; 006-695-429-395-319; 006-851-651-753-14X; 007-525-528-585-999; 008-026-084-779-329; 009-433-271-836-629; 009-456-342-310-432; 009-826-583-611-258; 009-839-349-649-592; 010-248-044-979-575; 010-937-918-890-314; 011-036-926-787-454; 011-181-272-451-257; 011-275-007-758-407; 011-344-587-439-539; 011-448-803-029-718; 011-789-629-199-839; 012-676-245-361-345; 012-749-102-372-172; 012-781-514-763-428; 012-858-381-884-543; 014-620-138-116-133; 014-851-110-178-090; 016-561-245-840-843; 016-573-632-276-638; 017-186-755-840-24X; 017-602-600-369-051; 018-173-008-558-455; 019-385-187-333-390; 020-058-618-038-199; 020-752-508-998-48X; 020-778-893-407-29X; 021-132-467-762-444; 021-442-133-926-115; 021-496-763-303-40X; 021-557-089-883-508; 021-832-527-337-587; 022-008-026-487-107; 022-089-937-878-931; 022-272-697-530-631; 022-631-097-994-290; 022-646-578-480-145; 024-391-762-181-074; 026-695-118-392-888; 027-414-420-907-638; 027-463-365-947-055; 028-470-973-284-111; 029-035-784-204-442; 029-217-416-387-158; 029-355-468-497-100; 029-485-059-651-328; 030-631-368-010-354; 030-779-488-554-12X; 031-410-368-468-346; 031-478-788-255-022; 032-146-888-430-567; 033-521-373-289-355; 034-591-735-254-900; 034-793-601-225-237; 035-476-252-570-143; 038-798-733-664-483; 038-855-488-498-255; 039-233-671-583-159; 041-300-455-745-140; 041-365-336-589-98X; 041-584-072-733-203; 042-232-815-071-78X; 042-870-359-465-561; 043-485-193-521-820; 043-939-849-770-963; 044-857-228-917-691; 044-865-466-893-672; 045-126-095-812-016; 046-153-688-474-390; 046-847-065-587-168; 047-479-487-714-788; 047-631-147-989-324; 048-784-224-431-919; 048-934-845-045-202; 049-295-741-481-120; 051-032-271-658-987; 051-126-598-938-187; 051-798-691-140-761; 051-859-802-611-076; 052-562-457-476-510; 052-964-239-218-347; 053-080-572-641-336; 053-837-387-381-271; 054-573-623-939-741; 055-165-874-363-170; 055-837-657-785-130; 055-921-408-762-204; 056-394-098-941-833; 056-490-194-990-846; 056-597-043-442-623; 057-198-716-894-105; 057-353-049-934-35X; 058-019-887-379-001; 058-640-350-311-643; 060-301-220-665-473; 060-789-141-965-584; 061-552-924-499-090; 062-322-849-180-911; 062-758-363-264-055; 063-088-966-764-792; 063-312-551-110-109; 064-634-172-146-353; 065-330-154-967-506; 069-553-181-408-009; 072-431-498-996-323; 072-485-598-734-519; 072-849-420-133-710; 073-260-146-068-286; 074-695-049-968-660; 074-718-901-171-93X; 074-728-644-019-708; 076-890-636-537-626; 080-110-418-364-856; 080-180-832-180-773; 081-114-288-967-601; 081-140-447-638-645; 082-512-666-548-499; 083-026-550-466-902; 083-340-158-269-483; 083-385-336-791-928; 083-880-928-070-233; 086-312-117-467-812; 087-159-044-329-07X; 088-398-258-633-258; 088-775-131-610-199; 089-423-508-333-636; 089-816-612-305-35X; 090-045-625-379-502; 090-188-337-776-675; 094-285-767-477-245; 095-363-742-021-054; 097-834-892-758-503; 098-302-321-478-451; 098-499-022-060-786; 099-565-449-408-373; 102-638-965-296-583; 103-994-259-809-115; 104-365-176-016-114; 106-426-894-716-608; 108-827-249-569-860; 111-010-950-042-639; 112-300-100-233-043; 113-599-541-422-398; 115-556-345-915-630; 120-682-080-240-276; 121-076-926-957-585; 121-125-992-064-425; 125-684-388-754-944; 127-515-001-286-847; 127-977-171-290-490; 128-225-825-099-535; 129-210-789-759-739; 130-934-131-000-821; 139-752-283-372-886; 142-923-615-918-315; 144-982-332-920-653; 145-202-591-485-656; 154-172-350-019-744; 176-183-131-995-966; 181-563-722-856-621; 183-576-808-283-743; 191-269-427-049-734; 193-616-090-773-482; 199-277-003-298-412,88
000-451-189-585-914,Effect of irradiation on the properties of nanomaterials,2010-10-12,2010,journal article,The Physics of Metals and Metallography,0031918x; 15556190,Pleiades Publishing Ltd,Russian Federation,R. A. Andrievskii,"Data are generalized on the results of irradiation of nanostructured materials (hereafter, nanomaterials) based on metals, steels, and some compounds (such as oxides, nitrides, carbides, and intermetallic compounds) by metallic and gaseous ions in accelerators and by neutrons under reactor conditions. The effects of the fluence, energy of ions (neutrons), and irradiation temperature on the phase composition, amorphization, nanostructural parameters, impurity segregation, blistering and swelling, electrical and optical properties, hardness, strength, plasticity, fracture toughness, and other characteristics have been considered. Attention is given to the fact that the consolidated (bulk) nanomaterials and isolated nanoparticles behave differently under irradiation. The results of theoretical studies and simulation (by the moleculardynamics method) of the effect of irradiation on the properties of nanomaterials are analyzed.",110,3,229,240,Irradiation; Nanomaterials; Nanoparticle; Metallurgy; Materials science; Fluence; Intermetallic; Chemical engineering; Carbide; Impurity; Fracture toughness,,,,,https://link.springer.com/article/10.1134/S0031918X10090061 https://www.researchgate.net/profile/R_Andrievskii/publication/226977900_Effect_of_irradiation_on_the_properties_of_nanomaterials/links/0deec51f01a6dd0432000000.pdf https://ui.adsabs.harvard.edu/abs/2010PMM...110..229A/abstract,http://dx.doi.org/10.1134/s0031918x10090061,,10.1134/s0031918x10090061,2018817954,,0,002-599-906-761-532; 002-967-298-260-967; 003-617-806-878-963; 006-226-276-516-658; 007-306-715-260-559; 009-046-424-420-684; 009-201-757-544-359; 010-147-109-030-414; 010-895-603-624-027; 012-384-505-262-446; 016-824-067-572-314; 016-856-473-437-042; 018-511-230-167-331; 019-419-000-304-278; 020-923-995-578-784; 023-583-240-939-407; 024-159-059-024-118; 027-227-261-416-087; 028-572-432-602-399; 030-879-571-402-870; 033-131-549-318-92X; 035-242-372-097-192; 036-363-274-156-264; 039-267-214-659-766; 039-421-220-777-745; 040-617-133-448-839; 041-647-365-108-79X; 042-742-250-019-019; 047-506-052-085-821; 051-586-654-562-653; 052-450-730-863-524; 053-841-960-426-885; 056-136-931-879-24X; 058-557-422-843-183; 060-741-001-418-551; 064-485-895-186-977; 069-616-425-137-467; 077-361-237-510-445; 077-927-589-847-455; 079-985-444-203-358; 080-486-830-669-294; 081-753-637-264-420; 082-512-069-265-562; 083-670-635-272-020; 088-872-455-473-244; 089-620-900-562-911; 090-469-377-568-927; 091-524-027-858-305; 092-515-361-185-873; 093-362-668-248-332; 094-269-734-834-963; 097-533-948-103-807; 097-651-413-986-276; 098-779-058-238-503; 102-711-001-418-652; 103-082-573-802-569; 103-693-938-052-530; 104-362-858-494-638; 107-459-148-880-534; 113-108-043-570-540; 114-510-932-755-547; 117-525-748-682-115; 122-447-649-017-136; 126-547-427-243-836; 127-450-594-069-076; 138-400-726-400-714; 139-250-675-669-224; 139-489-340-552-010; 148-188-887-185-012; 148-389-903-234-074; 152-780-500-289-464; 152-909-206-574-963; 155-914-122-598-162; 168-534-692-302-033; 169-304-880-159-126; 180-212-621-826-799; 183-084-302-365-062; 185-966-574-167-892; 187-330-849-958-247; 187-546-651-020-985; 199-348-009-799-731,41
000-839-000-045-086,Nanomaterials: Potential Ecological Uses and Effects,,2011,book chapter,Encyclopedia of Environmental Health,,Elsevier,,M.R. Gwinn,"Engineered nanomaterials are being used in increasing numbers of applications throughout the world. Multiple studies have shown the potential of nanomaterials to lead to adverse human health effects, although the impact on ecological systems has largely remained unexplored. Nanomaterials enter the environment through air, water, and soil. The benefits of nanotechnology to ecology include the use of nanomaterials such as titanium dioxide in water remediation, zero-valent iron in soil remediation, and selenium in mercury adsorption. However, the potential long-term effects of these and other nanomaterials on the environment are unknown. Research into the impact of these materials on ecological systems from the use and disposal of nanomaterials has been limited. This article describes the available literature on the impact of engineered nanomaterials on a variety of ecological systems, including microbial organisms, plants and soil, and aqueous species.",,,1,11,Nanomaterials; Ecology; Materials science; Mercury adsorption; Soil remediation; Engineered nanomaterials; Ecology (disciplines); Groundwater remediation; Environmental remediation; Applications of nanotechnology,,,,,http://www.sciencedirect.com/science/article/pii/B9780444522726005560 https://www.sciencedirect.com/science/article/pii/B9780444522726005560,http://dx.doi.org/10.1016/b978-0-444-52272-6.00556-0,,10.1016/b978-0-444-52272-6.00556-0,193161101,,0,000-411-277-275-661; 000-936-474-539-058; 005-099-502-726-894; 006-742-937-732-720; 009-744-330-100-012; 010-544-724-684-160; 012-433-801-706-708; 013-479-650-333-114; 015-723-245-112-021; 015-746-584-106-605; 018-281-764-592-622; 018-979-482-513-791; 021-186-105-057-67X; 021-909-073-732-007; 025-390-655-868-876; 027-868-323-242-159; 029-324-715-950-178; 029-850-342-521-310; 040-782-969-198-760; 040-894-563-033-073; 040-972-258-639-221; 041-982-242-808-102; 042-447-409-143-053; 042-868-208-408-823; 043-936-210-440-986; 047-370-158-217-167; 047-857-180-956-040; 051-429-846-674-052; 051-768-869-111-865; 053-738-108-802-763; 055-165-874-363-170; 055-921-408-762-204; 058-864-413-632-616; 060-044-968-138-820; 062-330-160-222-157; 063-026-703-144-221; 064-350-642-904-557; 067-961-630-035-210; 074-061-618-403-420; 074-469-111-200-789; 078-012-224-288-751; 083-917-344-900-324; 091-313-014-681-467; 094-970-000-847-023; 095-054-686-640-467; 097-479-417-462-427; 100-592-332-978-089; 100-601-974-641-965; 106-748-773-604-45X; 111-737-115-859-036; 116-283-002-321-705; 135-354-566-194-638; 142-385-948-213-73X; 152-388-990-463-86X; 193-239-380-417-143,2
000-887-296-210-963,Carbon Nanomaterial-Based Biosensing,2013-07-24,2013,,,,,,Yanan Chen,"Carbon nanomaterials, including carbon nanotubes (CNTs) and graphene, are exciting materials that have been the focus of research in recent years. They have unique physical and chemical properties such as high carrier mobility, high surface-to-volume ratio, and robustness, and are thus considered to be ideal candidates to interact with biological systems. However, the pristine carbon nanomaterials usually suffer from the lack of solubility in aqueous systems. Furthermore, these materials are extremely sensitive to any change in their immediate environment, so it is necessary to decorate these materials with receptor molecules to provide specificity. Therefore the chemical functionalizations of carbon nanomaterials are important before such materials can be incorporated into biosensing devices. There are commonly two approaches of functionalizing carbon nanomaterials, namely covalent and noncovalent methods. Covalent functionalization can provide robust chemical groups onto the surface of carbon nanomaterials. However, this method may disrupt the sp2 structure of carbon nanomaterials and affect the electronic properties of these materials. Noncovalent functionalization can bring the desired functionalization while maintaining the intrinsic electronic properties intact, but leaching of the absorbed materials may be a problem. ; In this dissertation, both methods have been used to functionalize carbon nanomaterials towards biosensors. Using noncovalent functionalization scheme, we built two sensing platforms. We used epigallocatechin gallate (EGCG) to noncovalently attach to the surface of single-walled carbon nanotubes (SWNT) and fabricated a resistor-based sensor for hydrogen peroxide. Using porphyrin-based glycoconjugate, we explored the sensitivity of SWNT/glycoconjugate composites towards lectins. Lectins are sugar-binding proteins that exist on the surface of bacteria. Sensing of lectins may lead to the development of bacteria detectors. Furthermore, to explore an optimized system for lectin sensing, we used SWNTs and graphene, as well as different glycoconjugates. It was found out that SWNTs performed better than chemically converted graphene (CCG). Although CCG was not suitable for sensing of lectins using noncovalent functionalization, holey reduced graphene oxide (hRGO), with its interconnected graphene nanoribbon structure and abundant oxygen-containing groups, may be a good platform for biosensing. The functionalization of these groups with antimicrobial peptide can provide specificity to certain bacteria, towards the fabrication of a bacteria detector.",,,,,Surface modification; Biosensor; Nanotechnology; Covalent bond; Materials science; Porphyrin; Oxide; Graphene; Molecule; Carbon nanotube,,,,,http://d-scholarship.pitt.edu/17141/,http://d-scholarship.pitt.edu/17141/,,,93100435,,0,,0
000-934-285-485-696,Radio-nanomaterials for biomedical applications: state of the art.,2016-02-06,2016,journal article,European journal of nanomedicine,16625986; 1662596x,Walter de Gruyter GmbH,Germany,Weifei Lu; Hao Hong; Weibo Cai,"The incorporation of radioactive isotope(s) into conventional nanomaterials can bring extra properties which are not possessed by original materials. The resulting radioactive nanomaterials (radio-nanomaterials), with added physical/chemical properties, can be used as important tools for different biomedical applications. In this review, our goal is to provide an up-to-date overview on these applications using radio-nanomaterials. The first section illustrates the utilization of radionanomaterials for understanding of in vivo kinetics of their parent nano-materials. In the second section, we focus on two primary applications of radio-nanomaterials: imaging and therapeutic delivery. With various methods being used to form radio-nanomaterials, they can be used for positron emission tomography (PET), single-photon emission computed tomography (SPECT), and multimodal imaging. Therapeutic isotopes-loading radio-nanomaterials can possess selective killing efficacy of diseased cells (e.g. tumor cells) and can provide promises for certain isotopes which are not able to be used in a conventional manner. The successful and versatile biomedical applications of radio-nanomaterials warrants further investigations of those materials and their optimizations can pave the way to future imaging guidable, personalized treatments in patients.",8,3,151,170,Nanomaterials; Nanotechnology; Medical physics; Positron emission tomography; Emission computed tomography; Multimodal imaging; In vivo kinetics; In patient; Tumor cells; Computer science,in vivo distribution; positron emission tomography; radiation therapy; radioactive nanomaterials; radiolabel; single-photon emission computed tomography,,,NCI NIH HHS (P30 CA014520) United States; NCI NIH HHS (R01 CA169365) United States,http://europepmc.org/articles/PMC4963156 https://pubmed.ncbi.nlm.nih.gov/27482194/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4963156 https://www.degruyter.com/view/j/ejnm.2016.8.issue-3/ejnm-2016-0011/ejnm-2016-0011.xml,http://dx.doi.org/10.1515/ejnm-2016-0011,27482194,10.1515/ejnm-2016-0011,2410998708,PMC4963156,0,000-023-987-073-963; 000-236-583-812-829; 001-042-480-511-135; 001-832-809-496-986; 003-322-769-371-937; 004-667-169-016-667; 004-922-187-013-676; 005-246-885-866-110; 007-120-073-214-896; 009-963-238-596-772; 011-570-235-855-227; 012-261-607-318-842; 012-308-039-739-512; 013-281-994-083-098; 013-798-434-020-218; 014-449-353-334-152; 015-101-633-031-075; 016-249-722-210-961; 016-263-466-244-177; 016-274-012-122-590; 016-361-280-521-788; 016-640-946-079-095; 018-892-019-699-131; 019-151-085-721-358; 019-166-324-255-115; 020-725-819-922-251; 021-314-023-193-575; 021-419-521-159-979; 023-126-110-445-595; 023-721-376-015-679; 024-098-293-772-96X; 024-345-461-033-505; 024-798-854-791-173; 025-148-194-366-260; 025-324-030-994-682; 026-101-391-277-556; 026-605-223-046-643; 026-922-324-781-056; 027-327-711-212-742; 028-117-822-312-077; 028-255-021-942-47X; 029-679-580-334-927; 030-170-727-313-623; 030-368-913-826-629; 030-626-225-482-358; 030-653-071-493-460; 031-105-105-752-600; 031-348-961-299-841; 031-637-364-703-480; 033-301-751-213-821; 033-423-210-804-341; 033-767-396-385-323; 035-848-075-902-593; 035-902-960-991-191; 035-953-558-953-12X; 039-062-509-960-450; 039-065-487-629-217; 040-225-946-885-355; 041-598-945-869-423; 041-690-052-933-071; 042-762-378-684-69X; 043-133-351-837-822; 043-251-313-533-200; 044-225-701-707-353; 044-233-352-832-85X; 045-124-309-910-756; 045-354-880-624-197; 046-847-487-694-596; 046-877-779-222-352; 047-308-234-601-025; 047-888-598-858-028; 050-787-872-802-656; 051-123-002-811-107; 052-395-730-774-282; 052-777-189-339-234; 053-618-901-631-975; 053-734-854-216-207; 053-821-331-709-235; 054-753-059-017-903; 054-931-604-314-006; 057-402-243-667-337; 059-894-264-715-955; 063-211-034-034-846; 064-831-894-960-843; 065-557-783-965-542; 065-602-059-948-020; 065-720-965-998-131; 066-353-732-426-348; 068-516-196-748-904; 072-754-423-707-036; 073-127-629-820-011; 073-145-489-739-869; 073-192-124-269-19X; 074-398-200-236-155; 081-919-010-091-180; 086-014-928-822-763; 087-404-681-664-15X; 087-819-256-648-700; 091-234-587-034-923; 091-883-075-678-768; 093-191-577-489-84X; 094-807-515-378-078; 096-937-581-635-093; 100-090-972-387-164; 104-584-078-114-28X; 105-980-974-160-269; 106-544-743-661-707; 107-402-159-718-252; 107-657-371-542-199; 108-400-772-053-735; 109-011-887-080-562; 110-980-910-000-689; 124-959-718-305-011; 125-814-115-414-795; 133-040-029-674-498; 133-799-883-039-796; 138-713-074-794-013; 139-195-742-071-929; 146-619-606-555-259; 173-050-719-708-616; 198-808-626-678-343,5
000-961-263-060-64X,Mechanical Properties of Nanomaterials,,2018,book chapter,Physical Fundamentals of Nanomaterials,,Elsevier,,Bangwei Zhang,"Abstract The physical fundament of basic properties of nanomaterials is to investigate the form of motion and the basic regularity for these properties of nanomaterials, the relationship between them and compositions and internal structure of nanomaterials, and the influence of external factors to these properties. Because the grain sizes in nanomaterials are much smaller than those in bulk materials, it is easy to imagine that the properties including some regularities for describing the properties of nanomaterials must be different from those in bulk materials. The experimental and theoretical researches for the properties on nanomaterials in the past more than 10 years have really confirmed this point. This chapter studies the mechanical properties of nanomaterials, which includes elasticity, strength and hardness, fracture and fatigue, creep and superplasticity, and deformation and fracture mechanism. The history of development of a subject, not only the description of experimental data but also the probable explanation for the data, the proposed theory and model, probable existing problem, and the possible way of their solution or direction are all described and discussed.",,,211,250,Elasticity (physics); Nanomaterials; Deformation (engineering); Creep; Nanotechnology; Superplasticity; Materials science; Fracture (geology),,,,,https://www.sciencedirect.com/science/article/pii/B978012410417400006X,http://dx.doi.org/10.1016/b978-0-12-410417-4.00006-x,,10.1016/b978-0-12-410417-4.00006-x,2793413158,,0,000-777-317-101-188; 001-447-677-776-861; 001-824-255-105-153; 002-422-144-366-160; 002-907-056-852-148; 004-104-704-990-906; 004-836-224-067-817; 007-017-819-360-377; 007-509-692-841-704; 009-126-654-375-233; 010-970-632-987-940; 011-577-147-487-729; 011-895-516-749-215; 012-809-708-355-950; 014-224-849-230-800; 014-757-039-385-706; 015-422-403-191-185; 015-839-270-684-034; 016-395-151-498-732; 016-922-403-001-078; 018-068-885-475-972; 018-985-624-750-161; 019-631-686-199-238; 019-736-545-521-677; 023-649-785-065-497; 023-699-133-392-412; 023-979-209-570-622; 024-397-449-007-00X; 025-481-379-196-148; 027-655-013-357-154; 030-627-098-289-209; 030-709-057-467-258; 032-370-184-960-865; 032-917-494-049-969; 033-958-665-334-770; 034-171-847-947-452; 034-461-219-101-62X; 036-164-721-477-616; 038-146-809-843-565; 038-599-298-836-380; 040-124-291-167-607; 040-404-344-638-289; 041-179-740-804-62X; 041-280-120-468-764; 046-577-842-570-890; 049-457-807-395-380; 050-770-603-742-818; 051-291-074-160-027; 051-539-182-102-39X; 051-649-055-030-888; 052-807-326-235-218; 053-495-507-388-738; 054-023-901-798-234; 055-240-073-556-471; 056-359-563-675-742; 057-503-402-766-934; 058-554-724-106-732; 058-684-452-324-853; 059-611-090-091-157; 061-952-845-569-620; 063-220-387-904-186; 063-693-399-907-413; 063-820-249-349-97X; 066-501-081-145-666; 067-691-175-245-592; 070-369-728-209-990; 072-382-249-294-760; 074-379-388-352-671; 077-159-590-983-148; 085-634-162-428-703; 090-857-411-359-673; 090-985-499-431-129; 091-226-247-711-879; 097-507-739-625-482; 098-286-416-383-853; 101-326-270-946-851; 104-223-625-045-233; 104-806-415-661-243; 110-321-142-295-20X; 110-948-821-145-210; 111-543-117-565-466; 135-567-583-451-578; 136-121-115-084-201; 142-621-921-328-694; 148-667-945-034-879; 149-289-244-700-542; 150-656-457-172-568; 151-423-952-848-739; 151-599-431-062-617; 160-276-229-746-345; 162-337-316-330-443; 162-461-835-108-949; 168-775-174-752-875,2
001-097-136-903-429,Upconversion of Rare Earth Nanomaterials,2015-02-02,2015,journal article,Annual review of physical chemistry,15451593; 0066426x,Annual Reviews Inc.,United States,Ling-Dong Sun; Hao Dong; Pei-Zhi Zhang; Chun-Hua Yan,"Rare earth nanomaterials, which feature long-lived intermediate energy levels and intraconfigurational 4f-4f transitions, are promising supporters for photon upconversion. Owing to their unique optical properties, rare earth upconversion nanomaterials have found applications in bioimaging, theranostics, photovoltaic devices, and photochemical reactions. Here, we review recent advances in the photon upconversion processes of these nanomaterials. We start by considering energy transfer models involved in the study of upconversion emissions, as well as well-established synthesis strategies to control the size and shape of rare earth upconversion nanomaterials. Progress in engineering energy transfer pathways, which play a dominant role in determining upconversion emission outputs, is then discussed. Lastly, representative optical applications of these materials are considered. The aim of this review is to provide inspiration for researchers to explore novel upconversion nanomaterials and extended optical applications.",66,1,619,642,Energy transfer; Photon upconversion; Nanomaterials; Nanotechnology; Materials science; Rare earth; Intermediate energy,4f-4f transitions; anti-Stokes emission; energy transfer; nanomaterial; optical application,,,,http://www.ncbi.nlm.nih.gov/pubmed/25648487 https://core.ac.uk/display/155733089 https://www.annualreviews.org/doi/10.1146/annurev-physchem-040214-121344 https://ui.adsabs.harvard.edu/abs/2015ARPC...66..619S,http://dx.doi.org/10.1146/annurev-physchem-040214-121344,25648487,10.1146/annurev-physchem-040214-121344,2113143674,,3,000-122-735-953-773; 000-480-919-841-207; 000-630-992-090-797; 002-264-242-258-728; 002-575-922-682-942; 002-944-935-062-954; 002-991-742-744-846; 003-072-766-474-480; 003-082-693-956-903; 003-949-654-920-384; 004-004-602-432-200; 006-296-648-083-616; 006-579-459-039-421; 006-808-255-140-022; 006-835-413-449-29X; 007-544-169-678-889; 008-732-288-333-175; 010-938-805-920-323; 012-575-432-839-33X; 014-166-375-554-754; 014-888-012-223-782; 014-942-880-411-593; 015-054-918-906-657; 015-401-637-440-321; 015-643-846-437-630; 016-209-907-021-925; 017-492-138-910-033; 018-284-821-192-611; 020-098-284-947-785; 020-171-543-539-830; 020-302-376-900-189; 021-358-391-073-58X; 023-764-284-996-270; 023-784-054-052-918; 023-957-109-807-103; 025-247-214-776-878; 026-110-286-187-326; 026-124-910-034-057; 026-185-497-701-58X; 027-051-004-798-743; 027-278-863-145-579; 029-309-202-545-702; 029-683-973-208-974; 029-693-729-709-67X; 030-439-197-788-240; 031-702-910-786-921; 032-148-465-033-112; 033-207-931-313-079; 034-167-479-184-516; 034-256-545-386-568; 035-813-270-645-588; 035-940-363-200-213; 036-345-555-476-142; 038-314-826-742-395; 038-500-689-150-324; 039-097-730-028-662; 041-877-525-966-632; 042-819-686-758-51X; 043-133-115-699-819; 043-227-535-836-944; 044-329-914-661-21X; 046-954-431-103-260; 047-499-205-512-175; 048-963-116-451-027; 052-492-581-601-082; 052-600-916-480-717; 053-014-084-697-116; 053-624-331-880-769; 055-569-235-312-570; 055-961-009-882-037; 056-136-901-342-003; 056-652-537-775-03X; 057-780-250-173-720; 061-420-667-278-646; 061-852-793-959-513; 062-593-069-103-151; 062-928-679-440-763; 063-779-457-273-218; 066-351-119-530-770; 067-225-103-145-711; 072-401-000-649-360; 072-797-217-131-056; 073-166-439-693-228; 073-424-138-481-36X; 074-504-968-866-011; 075-343-194-353-926; 075-416-438-010-108; 076-387-194-831-028; 077-928-002-218-92X; 079-871-527-421-769; 080-385-718-577-768; 080-826-809-663-662; 080-891-135-680-458; 084-216-399-216-428; 084-424-081-748-076; 086-119-155-104-698; 089-247-147-750-687; 090-971-137-709-157; 091-092-942-930-693; 091-888-002-833-58X; 093-639-672-212-411; 093-852-809-741-625; 094-003-710-338-633; 100-617-430-662-940; 104-001-406-276-732; 106-641-749-355-369; 109-280-162-534-534; 111-233-619-604-177; 113-234-481-014-488; 117-781-148-057-917; 120-532-752-221-921; 122-833-507-264-807; 126-379-117-156-876; 129-635-107-011-154; 130-020-394-348-300; 132-336-306-564-833; 141-176-765-552-600; 157-395-963-519-749; 158-844-032-440-394; 159-949-356-128-003; 188-848-421-144-501; 191-665-280-448-822,68
001-202-985-238-381,A Review on Ternary Vanadate One-Dimensional Nanomaterials,2014-06-18,2014,journal article,Recent patents on nanotechnology,22124020; 18722105,Bentham Science Publishers B.V.,United Arab Emirates,Li Z. Pei; Shuai Wang; Han D. Liu; Yin Q. Pei,"Ternary vanadate one-dimensional nanomaterials exhibit great application potential in the fields of lithium ion batteries, photocatalysis and electrochemical sensors owing to their good electrochemical and photocatalytic properties. The article reviews the recent progress and patents on the vanadate one-dimensional nanomaterials. The synthesis of the vanadate nanorods, nanobelts and nanotubes by hydrothermal method, template method and room temperature wet chemical process is demonstrated. The application of the vanadate one-dimensional nanomaterials for lithium ion batteries, electrochemical sensors and photocatalysis is discussed. The possible development direction of the vanadate one-dimensional nanomaterials for the synthesis and application is also analyzed.",8,2,142,155,Nanorod; Nanomaterials; Nanotechnology; Materials science; Template method pattern; Vanadate; Lithium; Electrochemistry; Ternary operation; Photocatalysis,,,,,https://www.ncbi.nlm.nih.gov/pubmed/24962380 https://pubmed.ncbi.nlm.nih.gov/24962380/ http://www.eurekaselect.com/122828 http://benthamscience.com/journals/recent-patents-on-nanotechnology/volume/8/issue/2/page/142/,http://dx.doi.org/10.2174/187221050802140618144706,24962380,10.2174/187221050802140618144706,2048703545,,0,,11
001-335-088-871-055,Mutagenicity of carbon nanomaterials.,2011-01-01,2011,journal article,Journal of biomedical nanotechnology,15507033,American Scientific Publishers,United States,Håkan Wallin; Nicklas Raun Jacobsen; Paul D. White; John D. Gingerich; Peter Møller; Steffen Loft; Ulla Vogel,"Carbon nanomaterials such carbon nanotubes, graphene and fullerenes are some the most promising nanomaterials. Although carbon nanomaterials have been reported to possess genotoxic potential, it is imperitive to analyse the data on the genotoxicity of carbon nanomaterials in vivo and in vitro and check the validity and predictability of different assays.",7,1,29,29,Nanomaterials; Fullerene; Nanotechnology; Chemistry; Genotoxicity; Carbon nanomaterials; Graphene; Carbon nanotube,,Animals; Carbon/toxicity; Cell Physiological Phenomena/drug effects; DNA Damage; Humans; Mutagenicity Tests; Mutagens/toxicity; Nanostructures/toxicity,Mutagens; Carbon,,https://www.ncbi.nlm.nih.gov/pubmed/21485787 https://www.ingentaconnect.com/content/10.1166/jbn.2011.1185,http://dx.doi.org/10.1166/jbn.2011.1185,21485787,10.1166/jbn.2011.1185,2067648905,,0,,6
001-394-804-146-349,Evaluating Carcinogenic Potential of Carbon Nanomaterials,2019-11-22,2019,book chapter,"Nanotechnology Characterization Tools for Environment, Health, and Safety",,Springer Berlin Heidelberg,,Rajib Ghosh; Yon Rojanasakul,"The goal is to review the adverse health effects, in particular carcinogenic effects, of various carbon-based nanomaterials during their life cycle, including synthesis, utilization, and disposal. Nanomaterials hold great promise for the development of new and better products. However, a number of commercial and biomedical applications of nanomaterials have been reported to have undesirable adverse health effects. Here, we summarize and discuss key findings from recent studies that assess the carcinogenic potential of carbon nanomaterials.",,,103,144,Nanomaterials; Biochemical engineering; Adverse health effect; Carbon nanomaterials; Environmental science,,,,,https://link.springer.com/chapter/10.1007/978-3-662-59600-5_4,http://dx.doi.org/10.1007/978-3-662-59600-5_4,,10.1007/978-3-662-59600-5_4,2991494550,,0,000-138-323-126-794; 000-250-674-780-085; 000-289-398-938-138; 000-672-679-241-486; 000-844-116-539-113; 002-432-568-553-970; 002-508-172-153-645; 003-354-162-646-523; 003-655-028-070-040; 003-676-269-760-950; 004-206-095-128-794; 004-292-836-971-724; 004-929-761-041-13X; 005-835-811-319-865; 005-971-653-926-315; 005-989-525-012-805; 006-304-879-630-709; 006-343-880-502-095; 006-499-704-319-356; 006-659-584-423-887; 007-080-628-665-620; 007-525-528-585-999; 008-132-730-704-495; 008-152-009-712-922; 008-789-583-717-339; 009-433-271-836-629; 009-700-136-837-681; 009-769-880-796-123; 009-833-953-824-898; 010-046-404-466-533; 010-248-044-979-575; 010-464-361-155-189; 010-701-734-883-725; 010-836-694-195-642; 010-925-580-076-13X; 011-764-084-037-555; 012-471-091-553-483; 012-737-508-454-102; 012-749-102-372-172; 012-896-211-245-666; 013-009-137-840-274; 013-745-592-841-557; 015-252-361-674-322; 016-070-529-295-967; 016-110-056-789-492; 016-785-962-917-631; 016-951-550-954-971; 017-251-073-970-686; 017-874-388-852-781; 018-857-272-444-550; 018-973-256-060-002; 019-078-534-185-880; 019-332-716-035-358; 019-596-836-246-757; 019-792-326-750-222; 020-630-515-014-64X; 020-752-508-998-48X; 020-866-916-168-085; 021-015-998-591-557; 021-191-935-214-837; 021-484-622-938-278; 021-653-035-902-697; 022-272-697-530-631; 022-512-082-009-305; 024-236-932-917-356; 024-391-762-181-074; 024-500-553-830-154; 024-741-104-365-426; 025-502-082-988-515; 025-995-879-111-655; 026-115-521-313-787; 026-221-703-324-371; 026-510-532-892-008; 027-393-328-794-116; 027-556-407-570-341; 027-829-096-504-347; 028-822-652-932-858; 029-171-783-312-923; 029-326-764-458-453; 029-773-766-764-58X; 029-826-058-916-905; 030-420-691-099-918; 031-410-368-468-346; 031-651-525-180-782; 032-146-888-430-567; 032-178-078-092-97X; 032-513-446-278-037; 033-028-985-385-947; 033-382-171-363-126; 033-865-566-167-556; 034-793-601-225-237; 035-027-130-485-983; 035-138-225-678-878; 035-539-002-520-552; 035-937-910-425-474; 037-489-783-629-445; 037-517-903-414-074; 037-758-400-304-006; 037-908-672-778-484; 038-855-488-498-255; 038-939-963-003-011; 039-251-131-410-280; 039-752-387-624-018; 039-847-269-524-392; 039-955-655-459-224; 040-425-145-643-811; 040-675-581-571-991; 041-965-842-617-25X; 042-032-699-093-917; 042-656-440-939-667; 043-469-399-097-658; 043-485-193-521-820; 044-862-128-505-83X; 045-021-941-569-086; 045-472-736-572-350; 045-580-248-307-302; 045-874-373-739-87X; 046-177-986-901-051; 046-247-005-960-187; 046-863-899-358-169; 046-911-732-141-674; 047-857-180-956-040; 048-820-718-471-318; 049-085-615-938-542; 049-225-824-803-953; 049-295-741-481-120; 049-494-504-601-805; 051-032-271-658-987; 051-798-691-140-761; 052-521-771-259-273; 052-649-472-691-720; 054-041-211-991-554; 054-527-215-569-019; 055-165-874-363-170; 055-515-986-297-494; 056-189-544-723-439; 056-394-098-941-833; 056-787-269-453-146; 057-592-757-771-422; 057-868-951-855-413; 057-979-575-986-891; 058-742-546-626-96X; 059-067-859-971-940; 062-993-504-443-349; 067-054-473-966-10X; 067-491-905-565-859; 068-144-257-586-773; 068-349-789-402-698; 069-485-262-721-775; 070-187-486-323-389; 070-952-547-039-919; 071-664-660-023-919; 072-042-364-654-214; 072-232-249-974-463; 072-722-881-652-881; 072-969-409-701-234; 074-728-644-019-708; 074-733-616-505-908; 075-251-375-227-621; 076-914-065-657-811; 078-373-817-458-561; 080-211-436-409-23X; 081-537-910-374-385; 082-468-008-022-334; 084-307-092-161-438; 084-366-987-206-06X; 084-811-368-370-269; 086-086-772-752-748; 086-450-310-490-841; 087-644-474-362-063; 088-135-814-991-431; 088-573-504-189-865; 089-779-490-393-039; 090-045-625-379-502; 090-225-872-693-257; 091-992-968-505-904; 094-970-000-847-023; 096-113-871-726-864; 096-307-500-362-737; 097-077-419-267-041; 098-153-811-497-771; 098-588-799-813-569; 098-961-433-011-329; 099-564-669-895-930; 100-423-070-069-59X; 101-045-980-396-662; 103-046-061-501-852; 110-966-096-125-135; 114-307-143-882-574; 116-279-799-605-809; 118-144-380-755-781; 120-478-792-960-839; 121-952-245-026-029; 127-515-001-286-847; 127-748-387-217-250; 128-355-704-484-897; 128-587-874-937-177; 129-210-789-759-739; 129-618-221-605-007; 129-638-321-228-307; 130-360-674-983-385; 132-656-427-096-936; 135-364-345-814-695; 139-315-804-272-974; 139-570-676-491-467; 140-710-991-078-637; 143-436-584-056-799; 144-204-304-189-911; 161-529-078-710-271; 179-241-613-333-342; 183-922-651-403-143; 188-765-889-164-002; 199-799-885-124-366,0
001-461-989-699-560,Biocompatibility and Functionalization of Nanomaterials,,2020,book chapter,Intelligent Nanomaterials for Drug Delivery Applications,,Elsevier,,Fernanda Maria Policarpo Tonelli; Flávia Cristina Policarpo Tonelli; Danilo Roberto Carvalho Ferreira; Karine Emanuelle da Silva; Helon Guimarães Cordeiro; Amanda Tomie Ouchida; Núbia Alexandre de Melo Nunes,"Abstract Nanomaterials can be designed, synthetized, and also functionalized to present key properties to be applied in biological and other kinds of systems. This chapter highlights some of the carbon-based and non-carbon-based nanomaterials, like their use to deliver different substances, imaging/diagnosis, tissue engineering, and energy storage. However, when it comes to their use in live systems it is necessary to check how safe it is to apply these materials, verifying if the desired effect will be achieved and if the action can be site-specific enough to guarantee biosafety. Therefore the chemical modification of nanomaterials is an important tool for its optimized and strategic use. Thus biocompatibility and functionalization of nanomaterials are also discussed in this chapter, which ends by presenting some future perspectives related to these relevant topics.",,,85,103,Surface modification; Nanomaterials; Nanotechnology; Biocompatibility; Computer science; Tissue engineering; Biosafety,,,,,https://www.sciencedirect.com/science/article/pii/B9780128178300000059,http://dx.doi.org/10.1016/b978-0-12-817830-0.00005-9,,10.1016/b978-0-12-817830-0.00005-9,3022132411,,0,000-056-141-280-281; 000-471-558-770-76X; 000-507-050-529-985; 000-715-022-309-324; 000-859-004-005-960; 002-016-477-595-072; 002-102-426-380-814; 002-388-388-320-701; 002-450-499-285-966; 003-220-200-846-38X; 003-329-069-543-250; 003-986-597-492-944; 004-535-845-794-807; 005-121-130-383-832; 005-562-410-739-075; 006-463-492-355-704; 006-551-574-956-941; 006-624-117-094-615; 007-009-759-276-834; 007-166-300-344-417; 007-209-844-156-550; 008-545-459-888-973; 008-780-300-185-301; 009-070-067-667-231; 009-876-935-595-542; 009-943-092-013-491; 010-494-252-655-894; 010-657-152-016-538; 010-979-721-167-89X; 011-290-461-816-158; 012-558-721-600-558; 012-571-031-494-096; 012-751-397-646-136; 012-868-864-795-27X; 013-141-678-329-389; 013-201-715-338-658; 013-884-264-527-905; 014-286-034-228-340; 014-458-071-972-900; 014-782-267-120-560; 015-250-094-080-319; 015-367-229-847-556; 015-806-315-887-230; 015-893-215-413-132; 016-561-245-840-843; 016-678-228-574-343; 017-295-794-518-15X; 017-453-305-781-40X; 017-707-675-871-821; 018-245-858-049-69X; 019-394-979-501-334; 022-667-967-976-075; 023-748-214-520-373; 024-627-950-936-305; 025-983-802-252-187; 027-600-375-073-628; 027-748-683-255-715; 027-986-975-477-989; 028-177-949-708-698; 028-226-402-083-469; 028-742-235-175-091; 028-862-641-742-529; 029-083-713-554-142; 029-475-101-765-697; 030-075-204-645-447; 031-039-969-097-671; 031-458-356-588-159; 032-263-238-959-592; 032-693-683-151-460; 033-832-498-138-380; 034-120-589-063-370; 037-512-248-346-884; 037-840-105-063-687; 038-155-325-056-578; 039-246-406-753-770; 039-348-335-393-364; 042-166-139-469-166; 042-174-475-008-959; 042-187-015-173-331; 042-516-237-071-466; 042-678-005-620-229; 043-476-318-208-009; 043-643-881-635-128; 043-944-702-549-638; 044-248-524-774-951; 044-440-236-432-359; 045-279-851-610-741; 046-437-793-162-078; 046-743-933-048-150; 046-943-257-647-663; 047-693-698-216-030; 049-351-039-037-832; 053-873-985-738-603; 055-665-487-575-115; 056-258-154-144-315; 056-490-194-990-846; 056-872-605-811-229; 056-960-070-430-365; 058-510-434-993-623; 059-449-816-922-253; 060-061-505-881-428; 060-895-829-069-47X; 061-946-183-085-086; 063-152-826-008-526; 063-254-467-822-960; 063-548-000-964-678; 064-552-865-386-852; 064-880-711-375-280; 065-174-637-830-377; 066-754-612-332-74X; 066-819-359-612-24X; 066-947-203-669-852; 068-816-638-219-247; 072-211-108-895-54X; 073-756-868-635-229; 075-019-831-186-274; 075-324-248-672-508; 077-407-764-537-595; 078-515-058-942-459; 079-441-680-414-290; 080-122-871-425-598; 080-175-389-481-398; 081-235-155-218-405; 082-245-768-945-512; 082-894-245-305-620; 084-655-642-255-289; 085-108-834-742-827; 090-669-934-591-377; 091-411-906-938-351; 092-561-938-188-399; 096-646-466-395-872; 099-236-850-429-069; 099-939-695-226-667; 104-021-093-315-291; 104-374-089-732-854; 105-052-954-000-688; 105-164-021-304-141; 108-827-249-569-860; 109-198-672-075-494; 111-428-632-934-12X; 114-324-278-720-630; 116-320-549-036-756; 120-503-674-093-430; 121-869-178-852-074; 122-487-862-603-253; 124-661-887-768-170; 131-470-902-554-333; 134-662-518-890-370; 138-878-224-590-75X; 141-866-424-603-711; 145-770-758-207-97X; 146-849-760-353-595; 150-928-460-596-448; 153-365-251-784-613; 158-192-261-223-077; 158-387-899-625-227; 162-569-135-580-761; 169-070-055-025-794,0
001-465-619-654-371,Where Are Nanomaterials (Nms) Found,2019-06-27,2019,book chapter,Advanced Structured Materials,18698433; 18698441,Springer International Publishing,United States,Loutfy H. Madkour,"Some nanomaterials (NMs) occur naturally, but of particular interest are engineered nanomaterials (EN), which are designed for, and already being used in many commercial products and processes.",,,91,100,Nanomaterials; Nanotechnology; Materials science; Engineered nanomaterials,,,,,https://link.springer.com/chapter/10.1007%2F978-3-030-21621-4_3,http://dx.doi.org/10.1007/978-3-030-21621-4_3,,10.1007/978-3-030-21621-4_3,2953826845,,0,024-303-061-972-700; 050-622-367-801-809,2
001-514-369-284-838,Emerging functional nanomaterials for the detection of food contaminants,,2018,journal article,Trends in Food Science & Technology,09242244,Elsevier BV,Netherlands,Jing-Min Liu; Yaxi Hu; Yukun Yang; Huilin Liu; Guozhen Fang; Xiaonan Lu; Shuo Wang,"Abstract Along with the progress in nanoscience, a variety of advanced functional nanomaterials were constructed to develop effective and innovative analytical techniques for food safety surveillance. In this review, we summarized the advanced analytical methods that have been developed based upon advanced functional nanomaterials, including plasmonic nanomaterial-based colorimetric methods, fluorescent nanomaterial-based fluorescent methods, advanced functional material-based molecular imprinting technology, advanced functional material-based chromatographic methods, plasmonic nanomaterial-based surface enhanced Raman scattering technology, and advanced functional material-based electrochemical methods. This review provides a progressive roadmap for further development of portable, rapid, and in situ detection technology to promote food safety surveillance from bench to market and eventually reduce the gap between research in the laboratory and industrial applications.",71,,94,106,Engineering; Nanomaterials; Nanotechnology,,,,State Key Program of National Natural Science Foundation of China; National Key Research and Development Program of China; Natural Sciences and Engineering Research Council of Canada; Natural Sciences and Engineering Research Council of Canada,http://agris.fao.org/agris-search/search.do?recordID=US201800013173 https://www.sciencedirect.com/science/article/pii/S0924224417304193,http://dx.doi.org/10.1016/j.tifs.2017.11.005,,10.1016/j.tifs.2017.11.005,2768695946,,0,000-569-620-748-244; 001-246-829-526-642; 002-550-209-960-352; 002-766-865-099-68X; 003-609-998-795-379; 003-684-980-380-263; 004-583-762-464-200; 004-868-493-553-06X; 005-230-604-374-296; 007-035-536-692-709; 007-148-260-743-579; 007-884-767-314-621; 009-451-590-072-960; 010-020-914-956-051; 010-318-049-399-466; 010-475-023-733-381; 011-197-568-783-978; 012-359-897-782-058; 012-972-190-313-325; 013-147-406-627-670; 014-892-908-979-584; 015-023-120-658-533; 017-206-969-404-131; 017-592-315-821-700; 018-659-935-260-334; 018-812-849-885-74X; 021-397-344-884-357; 022-831-365-871-171; 023-716-426-091-113; 024-026-664-272-09X; 024-540-389-372-126; 025-813-450-023-951; 027-489-531-595-434; 028-546-126-419-693; 028-633-844-170-277; 032-094-783-731-687; 032-345-139-188-170; 032-884-699-266-918; 033-021-633-589-020; 033-199-794-916-617; 033-494-598-166-611; 033-538-451-496-941; 033-684-911-874-866; 034-926-847-760-551; 035-060-179-406-881; 037-631-535-416-402; 039-728-171-814-103; 040-781-042-902-391; 042-594-993-157-613; 046-748-203-063-036; 047-622-912-702-147; 049-142-655-100-339; 049-568-176-550-402; 051-709-197-705-344; 052-405-224-927-545; 055-490-248-279-966; 056-248-152-530-176; 059-452-500-466-228; 059-721-445-933-673; 059-925-309-723-721; 060-134-855-552-047; 060-316-512-439-066; 061-009-368-620-931; 062-435-203-615-403; 062-916-867-194-32X; 062-928-679-440-763; 064-901-054-872-85X; 065-601-572-778-494; 066-189-959-261-582; 066-654-909-833-686; 072-536-836-030-064; 075-133-326-936-627; 075-203-398-687-106; 075-363-134-899-490; 076-982-311-007-836; 079-784-621-808-34X; 080-385-718-577-768; 082-414-684-480-935; 082-804-677-677-661; 083-433-681-367-646; 085-005-605-799-676; 085-203-785-493-021; 085-276-067-105-511; 086-512-779-069-596; 088-710-146-462-363; 092-409-315-643-635; 098-166-829-170-681; 099-389-289-164-233; 101-903-327-676-74X; 102-665-392-208-657; 102-916-740-145-132; 105-777-627-227-39X; 107-157-918-709-052; 109-363-721-814-975; 110-266-818-453-994; 111-233-619-604-177; 115-779-432-004-075; 116-670-025-913-981; 116-839-931-657-685; 120-643-961-230-201; 124-155-691-440-278; 124-246-316-439-738; 127-021-486-268-195; 127-101-049-101-880; 130-885-073-033-44X; 131-976-988-023-039; 143-572-397-587-267; 164-451-083-294-737; 173-971-980-317-973; 176-497-109-074-708; 182-413-425-884-696,33
001-549-365-662-264,Electrochemistry of Nanomaterials,,2015,journal article,Advances in Analytical Chemistry,21632847,,,Mojtaba Bagherzadeh,"This special issue of Advances in Analytical Chemistry is focused on application of new nanomaterials in the sensing, biosensing, and energy-related. New nanomaterials such as magnetic nanoparticles, graphene, carbon dots, carbon nanotubes, nanosemiconductors, quantum dots etc. due to showing specific characteristics, are promising candidates. The coupling of electrochemical transducers with nanomaterials has allowed for the development of the highly commercially successful sensors. I hope this special issue will be useful to the Advances in Analytical Chemistry readers.",5,,0,0,Quantum dot; Nanomaterials; Biosensor; Nanotechnology; Materials science; Graphene; Carbon nanotube; Electrochemistry; Magnetic nanoparticles,,,,,http://article.sapub.org/10.5923.s.aac.201501.html,http://article.sapub.org/10.5923.s.aac.201501.html,,,1186899679,,0,,0
001-653-291-203-777,Nanomaterials for the optical detection of fluoride.,2017-11-23,2017,journal article,Nanoscale,20403372; 20403364,Royal Society of Chemistry,United Kingdom,Yongming Guo; Jing Li; Shuming Chai; Jingjing Yao,"Overexposure to fluoride ions (F−) causes serious diseases in human beings. Extensive efforts have been made to develop sensitive and selective approaches for F− detection and a variety of F− sensors have been constructed recently. The burgeoning nanotechnology has provided novel materials for F− analysis due to the extraordinary properties of nanomaterials. In this review, we present the recent advances in different nanomaterials-based approaches for the optical F− detection via colorimetric, fluorescent and chemiluminescent responses. The materials include gold nanomaterials, CeO2 nanoparticles, semiconductor quantum dots, carbon quantum dots, metal–organic frameworks, upconversion nanoparticles, micellar nanoparticles, polymer dots, SiO2 nanoparticles and graphene oxide. The recent trends and challenges in the optical detection of F− with various nanomaterials are also discussed.",9,45,17667,17680,Nanomaterials; Nanotechnology; Materials science; Carbon quantum dots; Fluoride; Semiconductor quantum dots; Graphene; Sio2 nanoparticles; Ceo2 nanoparticles; Micellar nanoparticles,,,,,https://pubs.rsc.org/en/content/articlelanding/2017/nr/c7nr05981g https://jglobal.jst.go.jp/detail?JGLOBAL_ID=201702231970634787 https://europepmc.org/article/MED/29135001 http://pubs.rsc.org/en/content/articlelanding/2017/nr/c7nr05981g http://xlink.rsc.org/?DOI=C7NR05981G https://www.ncbi.nlm.nih.gov/pubmed/29135001,http://dx.doi.org/10.1039/c7nr05981g,29135001,10.1039/c7nr05981g,2766820362,,0,001-004-490-057-020; 001-406-662-538-325; 002-247-136-128-909; 002-510-405-693-443; 002-944-935-062-954; 005-099-600-551-805; 005-567-629-402-568; 005-764-839-527-433; 005-976-733-919-96X; 006-474-645-550-038; 007-401-048-569-987; 010-155-656-763-369; 011-233-592-565-669; 014-624-648-794-59X; 015-806-950-534-266; 016-042-871-088-228; 017-608-341-046-561; 018-419-032-085-501; 019-772-543-161-127; 020-308-371-524-169; 020-876-233-333-052; 022-101-453-418-647; 023-746-889-563-575; 025-831-261-100-291; 027-381-787-809-921; 027-454-918-758-576; 028-038-093-238-51X; 030-067-248-395-689; 030-454-098-377-45X; 031-743-954-592-601; 032-465-721-685-611; 033-847-851-344-444; 035-883-915-348-42X; 037-064-541-154-033; 038-600-357-950-841; 042-956-935-318-189; 043-924-280-476-513; 050-325-328-266-734; 051-515-989-110-984; 059-860-024-312-721; 060-561-666-316-615; 060-731-505-608-00X; 060-955-390-111-804; 061-899-953-843-13X; 062-177-592-298-085; 063-068-879-938-08X; 063-775-974-047-94X; 065-858-379-296-702; 067-278-118-340-949; 069-596-799-889-510; 069-980-518-376-556; 071-728-500-106-758; 073-944-278-508-789; 074-932-067-104-504; 077-422-513-161-883; 078-705-790-122-387; 080-254-863-396-189; 080-754-427-983-847; 081-737-217-332-976; 087-031-852-174-755; 089-577-946-596-550; 093-206-331-175-241; 096-082-379-220-846; 096-950-926-063-649; 111-050-054-024-738; 113-462-707-202-372; 116-748-740-336-148; 127-937-732-061-65X; 128-445-364-739-96X; 140-182-323-433-991; 146-204-303-267-386; 146-599-303-276-548; 159-949-356-128-003; 165-879-529-562-024; 177-709-312-054-989,25
001-715-769-370-138,Nanomaterial for Biosensors,2020-08-28,2020,book chapter,Advances in Nanotechnology and Its Applications,,Springer Singapore,,Syed Tawab Shah; Mohammad Khalid; Rashmi Walvekar; Nabisab Mujawar Mubarak,"Biosensors are briefly discussed in this chapter. Components, properties and types of biosensors are discussed. Nanomaterials having 1D, 2D and 3D materials and their application as biosensors are described. The surface chemistry of biomolecules with nanostructured materials is well explored. Nanomaterials improve selectivity, sensitivity, response rate and reduce the cost of fabrication. Ultrasensitive biosensors with higher efficiency have been fabricated by using carbonaceous materials (CNTs, GO, rGO, CNF), metals, metal oxides, conducting polymers, functionalized materials and composites. The exceptional properties of the nanostructured materials such as surface area, biocompatibility, optical and electrochemical properties have been explored to improve the selectivity and sensitivity of the biosensors.",,,35,61,Conductive polymer; Fabrication; Nanomaterials; Biosensor; Nanotechnology; Materials science; Biocompatibility; Nanostructured materials; Graphene; Biomolecule,,,,,https://link.springer.com/chapter/10.1007/978-981-15-4742-3_3,http://dx.doi.org/10.1007/978-981-15-4742-3_3,,10.1007/978-981-15-4742-3_3,3082702881,,0,000-440-836-672-886; 000-513-932-139-007; 000-778-447-017-114; 001-031-245-156-379; 001-721-526-428-279; 001-889-422-456-565; 002-384-225-750-16X; 002-428-321-237-886; 002-750-549-019-397; 003-055-884-069-65X; 003-112-038-917-494; 003-223-870-355-006; 003-506-924-112-529; 003-514-354-957-203; 003-680-898-114-662; 004-799-322-767-77X; 004-835-784-444-583; 005-549-502-104-564; 007-500-825-916-378; 007-693-521-550-50X; 008-122-656-481-844; 008-191-424-456-323; 009-479-503-393-470; 009-692-197-735-446; 010-932-474-188-141; 011-089-587-951-502; 012-111-150-466-47X; 012-277-673-572-925; 012-579-121-284-945; 013-537-641-747-545; 013-774-489-290-542; 014-040-740-905-978; 014-207-105-613-791; 014-418-787-639-242; 015-242-825-313-535; 015-745-443-316-401; 016-118-962-104-914; 016-287-524-161-991; 017-143-712-350-54X; 017-996-859-163-778; 018-525-982-506-698; 018-987-739-424-277; 019-044-880-199-518; 019-074-093-722-83X; 020-782-967-990-775; 021-219-165-502-630; 021-807-824-308-69X; 023-688-248-903-338; 023-952-001-866-803; 025-810-429-019-620; 026-008-419-789-726; 027-666-437-845-85X; 027-786-688-525-494; 028-095-658-110-849; 028-824-614-160-921; 029-444-493-982-532; 032-022-848-200-076; 033-119-519-476-431; 033-310-296-597-329; 033-575-604-445-241; 034-061-710-741-333; 034-500-282-024-558; 035-774-430-595-77X; 036-900-620-243-696; 038-155-325-056-578; 039-777-412-561-022; 040-046-113-291-073; 042-960-942-630-252; 043-644-591-766-343; 044-663-184-363-58X; 044-731-553-254-920; 044-966-221-610-809; 045-027-145-780-419; 046-032-996-659-361; 046-571-646-762-724; 047-091-434-737-598; 048-269-926-049-46X; 049-283-153-013-365; 049-613-183-489-697; 050-117-435-604-878; 050-503-834-045-183; 052-311-754-521-553; 052-485-475-553-966; 053-394-248-611-196; 053-774-163-868-878; 055-546-454-654-181; 055-653-704-403-726; 055-845-703-756-729; 056-581-257-037-192; 056-798-528-769-561; 058-188-556-054-226; 058-581-354-853-987; 058-926-095-672-743; 061-752-776-660-853; 063-361-812-093-118; 064-197-996-874-211; 066-236-604-166-681; 067-273-185-248-461; 068-135-171-085-623; 068-816-638-219-247; 069-863-420-222-257; 070-105-833-645-023; 070-307-268-500-088; 070-429-526-045-563; 073-659-187-753-33X; 074-204-453-242-416; 074-821-782-404-774; 079-485-726-912-717; 080-451-561-175-041; 081-249-097-078-543; 081-623-557-132-182; 081-899-656-728-165; 082-775-612-423-193; 083-706-221-233-381; 084-951-996-767-528; 084-992-603-966-931; 085-283-239-275-580; 089-447-039-606-473; 089-655-962-476-074; 091-122-138-258-394; 091-310-306-040-14X; 093-234-953-837-113; 094-267-788-785-547; 094-418-880-120-906; 095-392-002-623-730; 095-667-646-987-732; 097-142-362-334-298; 099-389-289-164-233; 100-625-017-826-833; 105-038-715-354-525; 105-406-511-677-046; 107-372-338-869-000; 111-454-978-204-633; 111-845-816-634-305; 111-965-741-874-270; 113-079-962-926-157; 114-805-285-639-950; 115-590-746-589-388; 115-730-022-211-218; 118-745-896-481-113; 119-022-493-824-481; 122-143-840-750-173; 124-623-187-704-080; 124-773-509-726-172; 125-960-374-977-926; 127-819-587-123-107; 129-290-072-118-873; 130-509-332-339-912; 130-737-400-247-062; 131-585-212-719-129; 133-018-699-436-72X; 133-632-017-063-189; 145-172-460-589-67X; 149-583-720-989-39X; 152-260-487-570-155; 158-870-596-825-133; 166-456-430-067-789; 170-602-212-740-610; 171-011-509-455-169; 188-304-010-095-260,0
001-727-645-038-000,Nanomaterials for Ultrasensitive Protein Detection,2013-06-06,2013,journal article,"Advanced materials (Deerfield Beach, Fla.)",15214095; 09359648,Wiley-Blackwell,United States,Yi Zhang; Yongming Guo; Yunlei Xianyu; Wenwen Chen; Yuyun Zhao; Xingyu Jiang,"The advances of nanomaterials have provided exciting technologies and novel materials for protein detection, based on the unique properties associated with nanoscale phenomena such as plasmon resonance, catalysis and energy transfer. This article reviews a series of nanomaterials including nanoparticles, nanofibers, nanowires, and nanosheets, and evaluates their performances in the application for protein detection, focusing on approaches that realize ultrasensitive detection. Many of these nanomaterials were used to analyze clinically relevant protein biomarkers. Their detection in the picomolar, femtomolar or even zeptomolar regime has been realized, sometimes even with naked-eye readout. We summarize the detection methods and results according to materials and targets, review the current challenges, and discuss the solution in the context of technological integration such as combining nanomaterials with microfluidics, and classical analytical technologies.",25,28,3802,3819,Energy transfer; Surface plasmon resonance; Nanomaterials; Nanotechnology; Materials science; Context (language use); Nanoscale Phenomena; Protein biomarkers; Protein detection; Microfluidics,detection; nanomaterial; nanotechnology; protein; sensitivity,Animals; DNA/chemistry; Humans; Nanostructures; Nanotechnology/methods; Proteins/analysis,Proteins; DNA,,https://www.onlinelibrary.wiley.com/doi/full/10.1002/adma.201301334 https://core.ac.uk/display/155427305 https://pubmed.ncbi.nlm.nih.gov/23740753/ https://onlinelibrary.wiley.com/doi/10.1002/adma.201301334/full?regionCode=CN-BJ&identityKey=10f6119e-b51c-46e5-9db9-76aacf7b9514&isReportingDone=true https://www.ncbi.nlm.nih.gov/pubmed/23740753,http://dx.doi.org/10.1002/adma.201301334,23740753,10.1002/adma.201301334,1985161649,,1,000-021-700-947-063; 000-083-612-719-996; 000-173-631-875-635; 000-548-785-090-484; 000-678-808-504-439; 000-739-709-572-643; 000-819-009-064-330; 001-040-379-740-049; 001-687-701-497-823; 001-742-330-212-225; 001-899-660-617-423; 002-847-922-836-290; 002-922-489-354-027; 003-348-973-034-888; 004-097-028-631-357; 004-148-694-513-982; 004-376-376-968-142; 004-841-210-210-017; 005-653-815-665-055; 005-732-161-594-141; 006-838-065-406-595; 007-301-101-160-104; 007-668-965-050-990; 007-899-054-133-54X; 008-038-334-326-786; 008-065-219-765-402; 008-233-433-642-243; 009-079-520-331-332; 009-250-203-414-270; 009-727-363-938-845; 011-037-303-214-419; 011-056-622-380-864; 011-147-164-454-021; 011-674-920-217-625; 011-928-269-416-373; 012-196-572-092-418; 012-281-341-155-406; 012-649-984-855-134; 012-950-442-770-534; 013-041-381-447-845; 013-664-680-074-840; 013-874-025-923-709; 013-979-508-545-133; 014-393-330-458-021; 014-413-212-116-202; 015-678-713-965-915; 016-042-871-088-228; 016-708-745-556-48X; 017-586-591-790-639; 017-745-086-376-205; 018-449-425-822-573; 018-459-918-256-10X; 019-260-167-619-659; 020-227-563-858-361; 020-510-031-285-789; 021-069-004-039-859; 021-087-878-585-083; 021-613-887-460-917; 023-255-553-999-547; 024-273-352-168-259; 024-540-389-372-126; 025-742-363-667-112; 025-848-024-383-719; 026-264-238-434-531; 026-328-845-566-448; 026-586-296-859-978; 027-153-445-682-938; 027-245-124-011-154; 028-828-527-313-019; 028-913-204-635-132; 028-955-737-886-247; 029-586-004-377-328; 030-974-337-248-671; 031-625-064-156-376; 032-094-783-731-687; 032-884-699-266-918; 033-499-455-251-491; 035-819-467-625-174; 036-070-574-589-601; 037-747-899-416-731; 038-359-518-175-658; 039-227-640-188-868; 039-577-655-380-422; 039-923-528-421-067; 040-139-026-958-549; 040-835-774-581-774; 041-575-933-299-599; 042-194-160-778-973; 042-479-246-497-872; 042-756-700-893-342; 042-885-019-291-405; 042-960-012-796-176; 044-502-709-509-864; 044-578-934-415-793; 046-052-979-276-199; 046-626-083-292-903; 047-222-133-076-99X; 048-171-188-485-407; 048-434-263-394-786; 048-532-668-387-76X; 048-602-710-322-160; 049-230-923-000-861; 049-748-404-732-709; 050-451-904-821-124; 050-824-039-994-31X; 052-920-742-418-659; 053-450-765-811-990; 054-394-892-902-169; 054-405-484-146-625; 054-553-790-505-758; 055-908-479-148-512; 056-867-102-044-551; 057-175-594-952-394; 058-496-790-912-924; 059-095-103-772-747; 059-201-739-465-351; 061-321-281-345-734; 063-178-399-658-940; 063-274-746-537-853; 063-280-252-045-374; 063-800-555-483-992; 064-741-632-377-851; 068-594-625-116-870; 069-015-722-254-471; 070-374-173-276-642; 070-829-538-838-600; 073-254-495-336-479; 073-459-535-115-70X; 074-110-178-050-26X; 074-528-801-557-58X; 075-497-541-068-516; 075-524-756-554-74X; 076-003-632-359-080; 077-170-773-831-443; 078-758-663-297-298; 079-030-892-435-169; 079-341-822-778-543; 079-397-264-694-793; 082-116-492-039-146; 082-515-950-158-512; 083-692-180-532-46X; 084-128-032-306-240; 085-476-192-174-715; 087-860-039-536-993; 088-453-465-443-878; 088-665-686-020-275; 089-345-562-179-878; 091-511-490-314-278; 092-389-350-277-321; 097-260-336-082-741; 097-729-912-796-562; 098-518-607-766-080; 098-589-516-304-057; 099-463-979-976-434; 099-679-563-627-479; 099-972-723-259-605; 101-124-030-486-213; 101-903-327-676-74X; 102-761-007-241-902; 108-287-209-590-070; 108-307-080-443-744; 110-502-552-380-215; 110-546-603-361-861; 114-769-812-396-415; 115-080-340-725-992; 117-415-567-497-933; 119-045-486-223-567; 126-062-168-893-379; 127-131-013-641-591; 128-335-442-637-321; 130-286-003-231-825; 133-741-954-182-660; 136-045-484-479-792; 139-601-897-582-10X; 139-879-470-412-669; 141-170-220-215-359; 148-508-991-269-662; 153-771-257-440-858; 160-205-411-240-596; 162-735-015-214-557,160
001-763-569-289-200,Nanomaterial exposure and sterile inflammatory reactions.,2018-06-26,2018,journal article,Toxicology and applied pharmacology,10960333; 0041008x,Academic Press Inc.,United States,Veruscka Leso; Luca Fontana; Ivo Iavicoli,"""Sterile inflammation"" is a type of pathogen-free inflammation which may be induced by various physical, chemical, or metabolic insults, including environmental particles e.g. silica dioxide crystals and asbestos. The possible role of nanomaterials as danger signals able to trigger sterile inflammatory responses is not yet fully understood. Therefore, the aim of this review was to investigate conditions of sterile inflammation induced by nanomaterial exposure with a specific focus on possible modes of action. Metal-, metal-oxide- and carbon-based nanomaterials may trigger a sterile inflammatory cascade by means of different damage-associated molecular patterns, including chromatin associated protein high-mobility group box-1 secretion, ATP, ADP and adenosine purinergic signaling, interleukin-1α alarmin, and NLPR-3 inflammasome activation. However, such preliminary results do not enable us to draw definite conclusions regarding the sterile inflammatory potential of nanomaterials and possible underlying molecular mechanisms. Therefore, further research is required to understand the complex ""interplay"" between the multitude of nanomaterial intrinsic or acquired physico-chemical properties and the extremely changeable immunological competence of organisms. The identification of possible nanomaterial modes of action in sterile inflammation could provide early indicators of the biological reactivity of nano-sized chemicals and could direct ""safe by design"" efforts for improving occupational safety and that of the general population. Moreover, the possible pathological consequences of nanomaterial-induced sterile inflammatory reactions need to be clarified in order to define suitable preventive measures to protect the health of chronically exposed subjects.",355,,80,92,Purinergic signalling; Inflammation; Inflammasome; Population; Inflammatory cascade; Sterile inflammation; Medicine; Cell biology,Adenosine signaling; Damage molecular patterns; High-mobility group box-1 (HMGB-1); Inflammasome; Nanomaterials; Sterile inflammation,Animals; Humans; Inflammasomes/drug effects; Inflammation/chemically induced; Nanostructures/toxicity; Occupational Exposure,Inflammasomes,,https://www.ncbi.nlm.nih.gov/pubmed/29959027 https://www.sciencedirect.com/science/article/abs/pii/S0041008X18302874 https://europepmc.org/article/MED/29959027 https://pubmed.ncbi.nlm.nih.gov/29959027/,http://dx.doi.org/10.1016/j.taap.2018.06.021,29959027,10.1016/j.taap.2018.06.021,2811418363,,0,000-138-357-515-747; 000-897-844-746-945; 001-868-730-882-969; 003-311-646-726-765; 004-423-280-093-58X; 006-282-753-749-638; 009-004-034-326-427; 009-670-246-009-962; 009-898-334-143-070; 010-794-584-843-925; 011-340-752-102-174; 011-408-117-519-008; 011-532-020-044-016; 012-579-422-569-59X; 013-060-920-212-564; 014-436-802-080-408; 018-917-050-154-250; 021-128-645-319-815; 023-144-557-727-977; 026-024-543-444-514; 030-434-129-392-524; 030-900-889-874-927; 038-855-488-498-255; 039-262-225-188-67X; 040-753-159-039-431; 046-847-302-731-080; 051-658-768-493-65X; 051-890-078-188-814; 055-656-831-810-053; 055-826-930-629-726; 056-597-043-442-623; 059-203-561-757-224; 059-959-887-444-877; 069-856-369-883-942; 069-947-321-527-15X; 074-996-771-659-91X; 076-358-338-054-684; 079-642-989-704-369; 080-338-072-791-535; 081-550-565-698-851; 086-050-351-787-614; 088-433-326-815-741; 088-439-812-264-639; 091-768-885-189-372; 096-337-628-560-967; 098-646-696-994-62X; 112-619-927-750-721; 117-824-530-724-060; 133-439-303-091-282; 136-451-458-410-672; 140-573-294-049-605; 143-869-612-183-650,15
001-901-740-986-114,Screw dislocation driven growth of nanomaterials.,2013-06-05,2013,journal article,Accounts of chemical research,15204898; 00014842,American Chemical Society,United States,Fei Meng; Stephen A. Morin; Audrey Forticaux; Song Jin,"Nanoscience and nanotechnology impact our lives in many ways, from electronic and photonic devices to biosensors. They also hold the promise of tackling the renewable energy challenges facing us. However, one limiting scientific challenge is the effective and efficient bottom-up synthesis of nanomaterials. We can approach this core challenge in nanoscience and nanotechnology from two perspectives: (a) how to controllably grow high-quality nanomaterials with desired dimensions, morphologies, and material compositions and (b) how to produce them in a large quantity at reasonable cost. Because many chemical and physical properties of nanomaterials are size- and shape-dependent, rational syntheses of nanomaterials to achieve desirable dimensionalities and morphologies are essential to exploit their utilities. In this Account, we show that the dislocation-driven growth mechanism, where screw dislocation defects provide self-perpetuating growth steps to enable the anisotropic growth of various nanomaterials at ...",46,7,1616,1626,Nanomaterials; Dislocation; Nanotechnology; Limiting; Materials science; Anisotropic growth,,,,,http://pubs.acs.org/doi/10.1021/ar400003q https://pubs.acs.org/doi/pdf/10.1021/ar400003q https://pubs.acs.org/doi/10.1021/ar400003q https://europepmc.org/article/MED/23738750 https://www.ncbi.nlm.nih.gov/pubmed/23738750,http://dx.doi.org/10.1021/ar400003q,23738750,10.1021/ar400003q,2321047747,,0,001-188-425-675-374; 003-645-446-948-224; 004-429-130-795-874; 006-387-859-774-322; 007-082-686-708-237; 012-033-732-251-021; 012-912-314-436-470; 015-959-137-299-571; 017-977-052-585-36X; 019-089-119-332-613; 020-670-266-989-273; 022-889-879-892-131; 023-922-451-527-06X; 025-498-495-067-168; 026-028-579-840-859; 027-736-972-546-772; 033-127-453-553-982; 034-242-507-490-818; 034-349-217-271-158; 036-372-161-445-865; 039-040-797-230-235; 047-155-328-209-900; 047-571-324-823-420; 049-000-876-578-957; 049-940-969-753-11X; 052-420-497-581-186; 059-273-741-159-225; 060-450-278-576-149; 062-779-479-448-107; 068-515-917-191-129; 073-255-214-157-955; 083-412-014-951-360; 087-459-874-482-430; 096-096-972-550-43X; 101-957-560-373-992; 106-063-361-036-263; 111-703-482-085-073; 115-479-700-179-505; 117-512-612-747-781; 123-557-622-459-464; 125-817-627-583-596; 128-753-228-292-117; 129-623-247-636-852; 147-872-452-995-387; 154-754-776-093-458; 158-622-284-072-31X; 168-529-326-414-602; 170-110-835-352-04X; 173-136-810-733-414; 188-342-797-191-121,215
001-991-011-722-794,Emerging Strategies of Nanomaterial-Mediated Tumor Radiosensitization.,2018-08-29,2018,journal article,"Advanced materials (Deerfield Beach, Fla.)",15214095; 09359648,Wiley-Blackwell,United States,Jiani Xie; Linji Gong; Shuang Zhu; Yuan Yong; Zhanjun Gu; Yuliang Zhao,"Nano-radiosensitization has been a hot concept for the past ten years, and the nanomaterial-mediated tumor radiosensitization method is mainly focused on increasing intracellular radiation deposition by high atomic number (high Z) nanomaterials, particularly gold (Au)-mediated radiation enhancement. Recently, various new nanomaterial-mediated radiosensitive approaches have been successively reported, such as catalyzing reactive oxygen species (ROS) generation, consuming intracellular reduced glutathione (GSH), overcoming tumor hypoxia, and various synergistic radiotherapy ways. These strategies may open a new avenue for enhancing the radiotherapeutic effect and avoiding its side effects. Nevertheless, reviews systematically summarizing these newly emerging methods and their radiosensitive mechanisms are still rare. Therefore, the general strategies of nanomaterial-mediated tumor radiosensitization are comprehensively summarized, particularly aiming at introducing the emerging radiosensitive methods. The strategies are divided into three general parts. First, methods on account of the intrinsic radiosensitive properties of nanoradiosensitizers for radiosensitization are highlighted. Then, newly developed synergistic strategies based on multifunctional nanomaterials for enhancing radiotherapy efficacy are emphasized. Third, nanomaterial-mediated radioprotection approaches for increasing the radiotherapeutic ratio are discussed. Importantly, the clinical translation of nanomaterial-mediated tumor radiosensitization is also covered. Finally, further challenges and outlooks in this field are discussed.",31,3,1802244,,Materials science; Tumor hypoxia; High atomic number; Cancer research; Radiation therapy,clinical translation; nanomaterial-mediated radiosensitization; nanoradiosensitizers; radioprotection; synergistic radiotherapy,Animals; Humans; Nanostructures/administration & dosage; Neoplasms/metabolism; Radiation-Sensitizing Agents/administration & dosage,Radiation-Sensitizing Agents,National Basic Research Program of China (2016YFA0201600); National Basic Research Program of China (2015CB932104); National Natural Science Foundation of China (51772292); National Natural Science Foundation of China (31571015); National Natural Science Foundation of China (11621505); National Natural Science Foundation of China (11435002); National Natural Science Foundation of China (21320102003); Youth Innovation Promotion Association CAS (2013007); Key Research Program of Frontier Sciences CAS (QYZDJ-SSW-SLH022),https://scholars.houstonmethodist.org/en/publications/emerging-strategies-of-nanomaterialmediated-tumor-radiosensitization(1f61db36-9eb1-4a35-ac8c-969fc97a7041).html https://pubmed.ncbi.nlm.nih.gov/30156333/ https://www.ncbi.nlm.nih.gov/pubmed/30156333 https://europepmc.org/article/MED/30156333 https://www.onlinelibrary.wiley.com/doi/abs/10.1002/adma.201802244,http://dx.doi.org/10.1002/adma.201802244,30156333,10.1002/adma.201802244,2888829434,,0,000-181-073-017-037; 000-533-216-717-361; 000-706-486-488-493; 000-777-628-099-281; 000-822-660-539-275; 000-835-590-016-534; 000-839-572-241-71X; 000-979-301-861-575; 001-400-790-048-34X; 001-870-806-564-661; 002-070-299-644-448; 002-079-963-546-880; 003-068-546-438-750; 003-809-743-428-952; 003-982-752-826-273; 003-986-597-492-944; 004-613-753-549-725; 005-078-152-370-88X; 005-206-029-636-260; 005-576-098-658-859; 006-233-127-290-945; 006-586-404-106-67X; 006-993-956-262-839; 007-213-579-656-491; 007-682-302-604-463; 008-141-174-822-320; 008-255-266-960-769; 008-331-222-021-841; 008-443-707-433-736; 008-643-834-623-74X; 008-827-399-985-709; 009-602-739-803-852; 009-642-816-735-539; 009-966-533-916-883; 010-354-177-343-713; 010-585-649-208-113; 010-791-640-640-812; 010-859-699-057-734; 010-884-686-701-628; 011-360-962-463-38X; 011-866-446-132-160; 011-901-230-380-684; 011-909-851-835-940; 012-519-917-835-146; 012-528-861-350-434; 012-601-723-551-949; 013-034-131-370-413; 013-114-209-887-317; 013-164-851-839-49X; 013-202-076-096-22X; 013-639-529-936-028; 013-737-670-607-476; 014-106-053-203-172; 014-173-016-405-349; 014-468-803-024-877; 014-554-243-635-418; 015-400-503-549-263; 015-429-270-062-233; 016-074-110-622-437; 016-104-997-595-226; 016-576-981-849-127; 016-609-329-001-481; 017-342-456-473-939; 017-411-911-077-53X; 017-790-870-305-577; 017-804-563-415-754; 017-864-645-782-499; 018-291-280-712-981; 018-371-468-090-846; 018-782-952-554-100; 019-309-194-884-073; 019-360-505-584-70X; 019-701-652-533-470; 020-141-523-896-315; 020-449-305-602-527; 020-828-647-875-197; 021-131-426-863-498; 021-364-859-048-082; 021-378-344-349-457; 021-407-219-892-469; 021-512-522-776-799; 021-979-703-878-873; 022-359-781-849-41X; 022-582-489-973-095; 022-649-379-457-712; 022-918-760-814-734; 023-128-919-748-32X; 023-432-699-541-664; 023-540-253-892-978; 023-599-250-055-206; 023-776-416-946-362; 023-952-238-083-487; 024-699-258-758-525; 024-763-440-330-297; 025-219-863-288-542; 025-727-979-640-676; 026-051-791-727-015; 026-341-011-576-638; 027-361-441-584-659; 027-696-771-743-960; 028-045-351-231-368; 028-096-616-457-048; 028-193-617-031-297; 028-715-853-574-758; 029-056-030-913-595; 029-251-927-877-510; 029-366-717-193-874; 030-483-986-314-134; 030-538-164-976-775; 030-630-507-533-370; 030-729-416-268-25X; 031-200-026-767-578; 031-390-064-010-402; 031-638-140-858-277; 031-835-362-572-12X; 032-299-975-894-869; 032-423-965-331-320; 033-410-004-433-25X; 033-459-759-335-33X; 033-557-120-195-347; 033-596-479-947-64X; 033-743-181-379-333; 034-779-607-159-292; 035-476-139-346-975; 035-752-245-449-773; 035-910-200-277-85X; 036-037-038-269-466; 036-072-138-721-345; 037-045-044-051-187; 037-093-044-415-901; 037-109-954-534-487; 037-261-336-813-792; 037-388-543-568-249; 037-462-930-422-680; 037-580-320-933-894; 037-764-827-697-858; 038-082-389-931-699; 038-517-553-125-69X; 038-774-411-658-682; 038-933-158-101-893; 039-068-267-010-088; 039-749-953-156-339; 039-880-827-155-363; 040-792-509-490-17X; 041-125-886-064-624; 041-312-085-066-084; 041-322-150-786-221; 041-558-261-371-732; 043-292-063-083-067; 043-314-923-370-053; 043-749-822-048-359; 043-984-437-455-038; 044-010-423-210-284; 044-046-454-696-998; 044-520-901-284-019; 044-755-818-003-905; 045-728-442-741-995; 046-124-557-142-940; 046-468-568-702-551; 046-750-909-814-973; 046-942-773-067-871; 047-479-361-148-119; 047-542-364-957-068; 047-648-501-530-673; 048-210-996-029-556; 048-497-794-764-887; 048-978-397-395-069; 049-002-679-542-962; 049-698-398-829-383; 050-179-798-199-174; 050-478-280-891-262; 051-032-336-437-692; 051-139-489-191-662; 051-488-929-526-960; 051-969-569-784-989; 051-977-672-941-364; 052-337-608-798-648; 053-196-634-687-271; 053-358-372-653-766; 053-771-342-350-122; 053-927-789-397-216; 054-617-535-141-037; 054-801-550-199-448; 055-838-473-786-280; 055-946-340-988-741; 056-622-655-455-822; 056-855-276-110-776; 057-929-917-004-830; 059-059-003-692-696; 059-104-839-731-069; 059-496-858-216-789; 059-851-389-968-067; 060-736-948-737-858; 061-089-495-593-211; 061-363-051-420-810; 061-737-743-100-897; 062-658-382-215-904; 062-928-679-440-763; 063-078-198-741-184; 063-116-300-670-015; 063-560-747-856-95X; 066-097-684-982-824; 066-655-756-700-085; 066-712-024-344-001; 069-351-408-684-425; 069-629-506-714-302; 070-069-620-492-304; 070-873-707-203-699; 071-116-301-581-76X; 071-544-852-342-74X; 073-076-178-540-215; 073-672-961-250-907; 073-673-156-021-444; 074-042-008-968-690; 074-887-480-288-001; 075-728-041-218-35X; 076-112-367-107-394; 076-773-423-550-795; 076-870-733-422-363; 077-409-123-180-716; 078-567-502-593-086; 079-958-403-102-960; 081-095-401-333-58X; 082-406-861-068-483; 083-019-868-892-156; 083-098-468-238-612; 083-213-156-255-81X; 083-639-977-732-159; 084-060-104-118-284; 085-536-118-749-973; 086-007-409-053-266; 086-558-686-202-873; 086-681-146-579-905; 087-232-155-527-632; 087-624-262-481-054; 088-146-129-383-378; 089-755-434-020-573; 089-854-567-813-685; 090-298-211-558-725; 091-293-027-421-941; 091-351-315-806-400; 091-811-455-452-039; 092-174-253-319-712; 092-252-040-994-838; 093-243-697-887-457; 095-165-094-137-472; 096-596-040-154-307; 096-915-379-959-134; 099-962-729-606-525; 100-295-945-702-703; 103-368-361-469-825; 103-867-604-452-179; 104-837-858-518-835; 105-099-575-310-887; 105-848-805-818-180; 107-049-919-314-038; 107-470-893-066-417; 108-552-766-505-048; 109-076-340-779-123; 109-386-329-320-825; 109-812-041-961-235; 110-698-382-254-28X; 113-603-507-068-97X; 115-710-902-931-645; 118-118-186-285-932; 118-290-151-202-02X; 118-360-968-875-094; 119-446-599-817-545; 124-183-083-516-150; 126-059-795-589-969; 127-227-423-240-463; 128-353-297-865-406; 134-928-273-850-527; 140-693-134-508-717; 147-055-170-193-300; 147-833-510-312-619; 148-835-887-892-495; 153-932-679-623-27X; 154-666-314-987-342; 158-392-660-522-257; 158-446-412-064-470; 159-124-022-471-366; 165-171-193-507-211; 168-988-733-716-23X; 169-298-266-350-168; 176-212-561-877-759; 177-699-393-448-579; 179-860-385-247-487,97
002-016-265-526-876,Antibacterial Activity of Nanomaterials,2018-05-24,2018,journal article,"Nanomaterials (Basel, Switzerland)",20794991,,Switzerland,Ana M. Díez-Pascual,"Bacterial proliferation is a severe and increasing concern in everyday life, which accounts for important damage in a number of industries, from textile and marine transport to medicine and food packaging. Despite the huge efforts by academic and industry researchers, a universal solution for controlling bacterial colonization has not been established yet. In this regard, nanomaterials are more and more used to target bacteria as an alternative to antibiotics. Examples include the use of nanomaterials in antibacterial coatings for implantable devices and other materials to prevent infection and promote wound healing and in antibiotic delivery systems to treat diseases. By exploiting the excellent antibacterial properties of some materials at the nanoscale, namely ZnO, TiO2, Ag, Au, nanodiamond and graphene, effective strategies for the prevention of infections can be developed.The main focus of this book is, therefore, to present selected examples of the most recent advances in the synthesis, characterization, and applications of nanomaterials with antibacterial activity. The book is addressed to scientists and industry researchers, as well as to master and degree students in chemistry, pharmacy, bioengineering, biology and materials science. The Editor would like to thank the staff of Nanomaterials Editorial Office for the constant help and support",8,6,359,,Nanomaterials; Nanotechnology; Chemistry; Antibacterial activity; Carbon nanomaterials,,,,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027337 https://www.mdpi.com/2079-4991/8/6/359/htm https://directory.doabooks.org/handle/20.500.12854/40945 https://doi.org/10.3390/nano8060359 https://www.mdpi.com/2079-4991/8/6/359/pdf http://europepmc.org/articles/PMC6027337,http://dx.doi.org/10.3390/nano8060359,29882933,10.3390/nano8060359,2804836047,PMC6027337,0,009-222-020-115-317; 011-534-864-622-938; 013-929-774-657-116; 014-399-869-403-101; 015-954-240-444-72X; 017-927-534-882-943; 017-958-808-012-200; 018-161-040-424-782; 023-134-897-698-368; 024-716-283-446-904; 025-326-589-249-447; 027-063-748-471-215; 031-803-507-168-288; 032-325-854-987-416; 036-739-660-162-796; 042-771-810-856-943; 042-891-623-878-414; 052-846-589-516-398; 055-638-555-356-229; 058-772-776-126-941; 059-195-067-587-621; 060-550-298-006-176; 067-779-558-814-170; 085-462-025-654-765; 111-222-375-786-686; 115-442-362-443-625; 120-702-604-865-644; 146-838-864-860-512,28
002-088-992-156-229,Modern manufacturing and nanomaterial perspective,,2020,book chapter,Handbook of Nanomaterials for Manufacturing Applications,,Elsevier,,Sukanchan Palit; Chaudhery Mustansar Hussain,"Abstract Nanomaterials and the vast domain of nanotechnology are today in the midst of deep scientific introspection and vision. Nanomaterials are the cornerstones of nanoscience and nanotechnology endeavor today. The world of scientific challenges, the futuristic vision, and ardor of science and engineering are all the forerunners toward a new visionary era in the field of nanoscience and nanotechnology. Nanostructure science and technology is a broad and interdisciplinary area of research and development activity that has been ever-growing worldwide in the past few years. Technological and scientific validation and deep scientific verve are the pillars of research pursuit in the field of nanomaterials and engineered nanomaterials today. In this chapter, the authors discuss in depth with immense insight and far-sightedness the recent developments in nanotechnology, nanomaterials, engineered nanomaterials, and the world of nanomanufacturing. Other areas of research pursuit include the application of nanotechnology in chemical process engineering and the vast world of environmental engineering. Water purification, and water and wastewater treatment stand today at the center of deep scientific introspection and scientific forbearance. In this chapter, the authors focus on the vision, success, and ingenuity of the necessities of nanotechnology and nanomaterials in the furtherance of modern science and human society. A new dawn of human civilization will usher in the field of chemical engineering and environmental engineering as nanotechnology paves the path toward scientific ingenuity.",,,3,20,Engineering; Introspection; Ingenuity; Human society; Science and engineering; Engineered nanomaterials; Process (engineering); Engineering ethics,,,,,https://www.sciencedirect.com/science/article/pii/B9780128213810000016,http://dx.doi.org/10.1016/b978-0-12-821381-0.00001-6,,10.1016/b978-0-12-821381-0.00001-6,3016355313,,0,133-530-075-778-636,2
002-164-316-023-414,Graphene-based nanomaterials for nanobiotechnology and biomedical applications.,,2013,journal article,"Nanomedicine (London, England)",17486963; 17435889,Future Medicine Ltd.,United Kingdom,K. Vijaya Krishna; Cécilia Ménard-Moyon; Sandeep Verma; Alberto Bianco,"Graphene family nanomaterials are currently being extensively explored for applications in the field of nanotechnology. The unique intrinsic properties treasured in their simple molecular design and their ability to work in coherence with other existing nanomaterials make graphene family nanomaterials the most promising candidates for different types of applications. This review highlights the scope and utility of these multifaceted nanomaterials in nanobiotechnology and biomedicine. In a tandem approach, this review presents the smooth inclusion of these nanomaterials into existing designs for creating efficient working models at the nanoscale level as well as discussing their broad future possibilities.",8,10,1669,1688,Nanomaterials; Nanomedicine; Nanotechnology; Materials science; Nanobiotechnology; Graphene; Ability to work,,"Drug Delivery Systems; Genetic Therapy; Graphite/chemistry; Humans; Nanostructures/chemistry; Nanotechnology; Nanotubes, Carbon/chemistry","Nanotubes, Carbon; Graphite",,https://www.ncbi.nlm.nih.gov/pubmed/24074389 https://europepmc.org/abstract/MED/24074389,http://dx.doi.org/10.2217/nnm.13.140,24074389,10.2217/nnm.13.140,1978705236,,0,000-987-127-106-813; 001-003-587-553-093; 001-726-682-855-865; 002-847-922-836-290; 003-551-452-628-078; 004-576-149-458-288; 005-554-695-987-717; 007-049-535-550-597; 007-337-193-838-473; 007-413-524-612-658; 008-196-120-006-107; 009-086-236-549-073; 009-768-691-295-413; 010-504-526-987-906; 010-929-309-091-234; 011-302-017-414-254; 014-205-915-364-37X; 014-383-075-880-161; 016-255-976-515-598; 016-524-858-321-197; 016-820-811-842-362; 016-824-685-436-993; 017-452-794-007-305; 018-628-353-229-108; 019-381-752-117-415; 019-895-663-944-652; 020-154-308-899-508; 021-727-314-004-768; 021-940-123-489-400; 022-872-814-453-735; 023-130-004-949-556; 025-202-604-395-22X; 025-361-715-151-47X; 025-362-065-112-78X; 025-608-533-967-138; 025-752-043-578-419; 025-976-310-008-959; 026-418-320-321-99X; 026-664-393-760-276; 027-232-343-193-223; 027-352-954-526-708; 027-469-607-246-276; 029-872-794-623-024; 030-310-007-170-654; 030-410-910-206-287; 030-599-549-280-348; 031-618-662-459-371; 032-376-348-352-135; 034-095-495-401-162; 034-324-759-288-666; 034-616-458-869-71X; 034-630-299-760-32X; 036-938-405-328-797; 037-161-729-655-299; 037-587-201-682-756; 037-743-812-649-64X; 038-019-988-265-171; 039-227-640-188-868; 040-808-549-647-489; 042-069-719-753-679; 042-080-940-377-155; 042-632-576-060-073; 043-063-662-564-728; 044-311-066-437-497; 044-376-761-094-411; 044-468-816-924-83X; 044-931-821-196-509; 045-723-538-270-929; 047-301-163-716-420; 049-396-283-826-138; 050-741-500-919-235; 050-810-053-355-744; 054-211-452-929-89X; 056-079-390-023-319; 057-753-322-039-624; 058-329-499-228-184; 058-936-711-224-725; 063-453-352-783-318; 064-920-759-625-801; 064-988-078-295-625; 066-208-946-417-85X; 066-446-791-271-393; 067-440-628-179-30X; 067-486-124-169-435; 067-518-965-717-815; 068-366-800-825-830; 069-200-497-739-732; 069-642-148-756-575; 070-629-969-502-707; 071-106-602-926-080; 073-869-674-823-679; 074-078-934-307-482; 076-331-268-922-73X; 077-752-557-033-877; 079-258-400-903-351; 079-375-792-388-32X; 080-451-561-175-041; 080-689-042-304-77X; 081-173-976-683-821; 081-662-646-845-418; 082-231-208-545-177; 084-279-784-563-31X; 087-034-479-228-113; 090-900-551-781-05X; 091-021-498-739-543; 095-400-914-411-148; 096-237-929-239-810; 096-753-263-864-302; 097-513-161-756-582; 099-389-289-164-233; 102-169-488-368-791; 104-066-301-906-061; 105-958-104-139-633; 106-141-470-560-882; 106-149-506-154-066; 111-253-327-803-404; 129-418-479-171-246; 132-480-196-680-409; 143-008-533-672-54X; 149-583-720-989-39X; 151-127-720-241-480; 164-409-307-179-799; 166-574-377-711-690; 188-345-320-693-654,82
002-290-281-249-612,Related topic: Safety evaluation of nanomaterials,2017-06-10,2017,book chapter,Skin Permeation and Disposition of Therapeutic and Cosmeceutical Compounds,,Springer Japan,,Xiaowen Liang; Haolu Wang; Xin Liu; Jeffrey E. Grice; Zhi Ping Xu; Michael S. Roberts,"Since nanotechnology has become increasingly popular and widely used in medicine and cosmetic products, it is crucial to evaluate the safety of nanomaterials. Nanomaterials can diffuse, aggregate, and precipitate in solution according to their size, shape, surface area density, and physicochemical properties. Therefore, traditional in vitro assays may misrepresent the response and cellular-uptake of nanomaterials in living systems. In this chapter, we summarised the potential toxicity of different types of nanoparticles (NPs), as well as the methodology for assessing toxicity of nanomaterials in a biological system based on linked and quantitative descriptions of biological processes at the biochemical, cellular, organ, and system levels. In addition, intentional or non-intentional exposure routes for evaluating NPs toxicity were described, especially for the dermal exposure route which has been investigated in animal species and in vivo human volunteers for examining NP penetration, distribution, and toxicity. Finally, the relationship between skin penetration and nanotoxicity is reviewed to further emphasize the importance of the research in this field.",,,313,322,Nanotoxicology; Nanomaterials; Nanotechnology; Chemistry; Animal model; Animal species; Skin penetration; Dermal exposure; Potential toxicity; In vitro toxicology,,,,,https://rd.springer.com/chapter/10.1007/978-4-431-56526-0_28 https://espace.library.uq.edu.au/view/UQ:724117 https://core.ac.uk/display/156883826 https://link.springer.com/chapter/10.1007/978-4-431-56526-0_28,http://dx.doi.org/10.1007/978-4-431-56526-0_28,,10.1007/978-4-431-56526-0_28,2769554618,,0,000-081-687-671-852; 000-222-412-651-218; 000-335-352-542-60X; 001-013-136-413-082; 002-386-297-064-299; 002-410-004-969-535; 002-618-323-812-490; 005-965-217-752-16X; 009-456-342-310-432; 009-592-459-038-504; 010-723-652-099-416; 011-150-108-999-112; 011-945-574-142-801; 011-961-499-018-404; 014-670-058-130-002; 015-826-076-321-229; 017-532-080-549-647; 020-222-203-286-846; 023-936-661-318-108; 024-503-898-212-187; 030-497-011-651-517; 031-633-185-596-546; 035-883-712-822-136; 036-845-816-511-50X; 039-845-994-188-492; 041-252-844-930-944; 041-495-761-142-949; 041-871-944-415-926; 042-860-866-967-698; 044-279-112-922-884; 044-725-042-245-829; 045-086-434-839-253; 049-765-189-382-869; 050-526-374-865-405; 051-999-364-437-593; 052-898-806-543-347; 053-042-823-744-317; 053-080-572-641-336; 055-756-861-029-362; 055-921-408-762-204; 059-199-604-495-625; 059-636-504-127-393; 060-739-331-202-689; 062-524-319-449-499; 064-350-642-904-557; 066-659-262-260-612; 066-736-108-101-492; 067-814-700-972-681; 068-903-657-655-744; 069-272-263-310-258; 070-079-991-267-375; 074-503-933-888-726; 087-346-740-930-110; 088-758-211-043-134; 091-882-511-165-375; 096-646-466-395-872; 102-525-963-493-734; 104-203-953-605-721; 107-051-984-198-70X; 108-886-617-784-602; 111-010-950-042-639; 116-836-804-114-772; 117-478-364-808-760; 120-068-226-417-514; 129-890-731-028-433; 132-055-033-008-514; 139-752-283-372-886; 146-473-901-763-49X,0
002-298-332-500-157,Nanomaterials and bone regeneration.,2015-11-10,2015,journal article,Bone research,20954700; 20956231,Nature Publishing Group,United Kingdom,Tao Gong; Jing Xie; Jinfeng Liao; Tao Zhang; Shiyu Lin; Yunfeng Lin,"The worldwide incidence of bone disorders and conditions has been increasing. Bone is a nanomaterials composed of organic (mainly collagen) and inorganic (mainly nano-hydroxyapatite) components, with a hierarchical structure ranging from nanoscale to macroscale. In consideration of the serious limitation in traditional therapies, nanomaterials provide some new strategy in bone regeneration. Nanostructured scaffolds provide a closer structural support approximation to native bone architecture for the cells and regulate cell proliferation, differentiation, and migration, which results in the formation of functional tissues. In this article, we focused on reviewing the classification and design of nanostructured materials and nanocarrier materials for bone regeneration, their cell interaction properties, and their application in bone tissue engineering and regeneration. Furthermore, some new challenges about the future research on the application of nanomaterials for bone regeneration are described in the conclusion and perspectives part.",3,1,15029,15029,Nanomaterials; Regeneration (biology); Nanotechnology; Nanocarriers; Chemistry; Nanostructured materials; Bone regeneration; Bone tissue engineering,,,,,https://www.nature.com/articles/boneres201529.pdf https://www.nature.com/articles/boneres201529 http://europepmc.org/articles/PMC4639780 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639780/ https://www.ncbi.nlm.nih.gov/pubmed/26558141 https://dx.doi.org/10.1038/boneres.2015.29 https://cyberleninka.org/article/n/699765,http://dx.doi.org/10.1038/boneres.2015.29,26558141,10.1038/boneres.2015.29,2128089445,PMC4639780,0,000-190-175-442-741; 001-299-216-079-164; 001-645-514-062-511; 003-362-224-011-452; 006-042-593-451-142; 007-301-634-465-402; 009-836-206-052-218; 010-118-203-771-822; 013-685-286-472-990; 015-858-880-011-72X; 016-357-592-802-253; 017-611-155-476-581; 019-381-752-117-415; 020-899-512-220-490; 021-654-654-817-285; 023-897-700-756-647; 025-656-200-119-700; 027-893-447-222-779; 028-251-931-908-985; 028-909-772-795-984; 028-920-898-848-92X; 032-379-616-605-965; 035-137-987-772-145; 041-390-099-580-15X; 042-362-111-530-621; 044-106-053-835-186; 051-705-674-375-547; 062-499-597-868-368; 064-974-915-178-307; 068-627-366-927-238; 072-030-033-133-66X; 074-310-739-495-426; 075-149-065-709-157; 075-853-291-905-315; 080-937-403-345-113; 081-015-039-232-336; 081-400-154-649-63X; 081-437-495-558-698; 096-968-576-946-577; 099-367-644-099-433; 108-963-217-535-566; 116-818-002-200-653; 129-418-479-171-246; 162-307-684-859-802; 166-961-010-659-259,295
002-346-513-216-618,Nanomaterials and the environment [Editorial],,2014,journal article,Journal of Nanomaterials,16874110,,,Prashant Kumar; Arun Kumar; Teresa F. Fernandes; Godwin A. Ayoko,"The subject of nanomaterials is very topical, with advances in knowledge made at a very rapid pace, making dissemination of this new knowledge a need of the hour. Although it is widely recognised that nanotechnology is playing a key role in many areas of societal endeavour, it is still unclear what risks certain nanomaterials may pose to humans and the environment. While nanotechnology has brought enormous benefits to humankind, its impact on human health and the environment is yet to be fully understood.",,,,,Materials science; Pace; Subject (philosophy); Human health; Engineering ethics,,,,,http://eprints.qut.edu.au/79696/,http://eprints.qut.edu.au/79696/,,,3015527972,,0,,0
002-712-567-035-270,Radioactive Nanomaterials for Multimodality Imaging.,2016-03-01,2016,journal article,"Tomography (Ann Arbor, Mich.)",23791381; 2379139x,MDPI AG,United States,Daiqin Chen; Casey A. Dougherty; Dongzhi Yang; Hongwei Wu; Hao Hong,"Nuclear imaging techniques, including primarily positron emission tomography (PET) and single-photon emission computed tomography (SPECT), can provide quantitative information for a biological event in vivo with ultra-high sensitivity, however, the comparatively low spatial resolution is their major limitation in clinical application. By convergence of nuclear imaging with other imaging modalities like computed tomography (CT), magnetic resonance imaging (MRI) and optical imaging, the hybrid imaging platforms can overcome the limitations from each individual imaging technique. Possessing versatile chemical linking ability and good cargo-loading capacity, radioactive nanomaterials can serve as ideal imaging contrast agents. In this review, we provide a brief overview about current state-of-the-art applications of radioactive nanomaterials in the circumstances of multimodality imaging. We present strategies for incorporation of radioisotope(s) into nanomaterials along with applications of radioactive nanomaterials in multimodal imaging. Advantages and limitations of radioactive nanomaterials for multimodal imaging applications are discussed. Finally, a future perspective of possible radioactive nanomaterial utilization is presented for improving diagnosis and patient management in a variety of diseases.",2,1,3,16,Nanomaterials; Magnetic resonance imaging; Nanotechnology; Materials science; Positron emission tomography; Emission computed tomography; Patient management; Nuclear imaging; Multimodal imaging; Optical imaging,MRI; PET; Raman imaging; SPECT; fluorescence; multimodality imaging; optical imaging; photoacoustic imaging; radioactive nanomaterials; review,,,NCI NIH HHS (P01 CA085878) United States; Intramural NIH HHS (Z99 DK999999) United States,https://www.mdpi.com/2379-139X/2/1/00121 https://tomography.org/volume-2/issue-1/review-article/radioactive-nanomaterials-for-multimodality-imaging http://europepmc.org/articles/PMC4876975 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876975/,http://dx.doi.org/10.18383/j.tom.2016.00121,27227167,10.18383/j.tom.2016.00121,2466830218,PMC4876975,0,000-131-896-467-105; 000-236-583-812-829; 002-755-838-067-929; 003-014-174-926-839; 003-408-003-785-690; 003-574-310-678-557; 004-585-897-386-827; 005-154-679-154-835; 005-544-517-879-319; 005-808-474-421-514; 006-207-137-085-858; 008-005-975-582-762; 010-925-101-169-516; 011-570-235-855-227; 011-788-077-853-497; 012-109-408-605-236; 012-947-376-685-042; 013-281-994-083-098; 013-314-709-532-164; 013-798-434-020-218; 014-449-353-334-152; 014-775-026-648-107; 015-105-615-413-035; 015-543-313-224-503; 016-263-466-244-177; 016-274-012-122-590; 017-310-117-145-184; 018-206-309-331-631; 018-892-019-699-131; 019-472-715-138-149; 020-839-829-302-203; 021-229-348-910-927; 021-314-023-193-575; 021-419-521-159-979; 022-848-843-944-568; 025-148-194-366-260; 026-605-223-046-643; 028-117-822-312-077; 029-028-879-630-369; 029-679-580-334-927; 029-990-265-953-332; 030-170-727-313-623; 030-653-071-493-460; 030-793-141-151-39X; 030-800-953-186-03X; 031-029-225-063-891; 033-992-910-179-102; 034-190-096-717-851; 034-964-621-059-428; 035-540-364-544-373; 035-677-766-458-328; 035-902-960-991-191; 035-953-558-953-12X; 038-975-773-769-575; 039-131-324-370-67X; 040-459-151-132-263; 042-506-499-874-227; 043-251-313-533-200; 043-620-375-454-226; 043-996-304-264-981; 045-124-309-910-756; 045-249-342-193-153; 045-354-880-624-197; 045-916-166-759-15X; 046-884-546-117-821; 047-918-867-006-603; 047-953-407-083-37X; 048-333-338-633-591; 049-665-586-719-260; 050-787-872-802-656; 052-395-730-774-282; 052-534-936-010-023; 053-618-901-631-975; 053-734-854-216-207; 055-780-527-662-293; 057-542-800-771-183; 057-660-880-510-123; 058-715-802-979-091; 059-894-264-715-955; 060-016-968-461-988; 060-361-969-791-812; 060-869-554-303-538; 061-496-844-357-048; 063-007-228-430-013; 063-523-585-352-624; 063-530-504-937-969; 064-262-223-093-841; 066-764-037-896-475; 066-817-798-168-495; 069-939-069-689-412; 069-955-097-941-881; 072-697-352-368-912; 072-861-247-129-17X; 073-145-489-739-869; 073-192-124-269-19X; 076-079-367-018-322; 079-924-374-647-13X; 083-784-638-139-095; 084-776-238-988-350; 087-063-291-418-014; 087-404-681-664-15X; 087-855-427-310-981; 089-216-484-795-876; 089-708-110-606-859; 091-234-587-034-923; 097-235-715-421-657; 098-034-798-245-18X; 103-716-629-565-120; 104-165-607-209-801; 104-584-078-114-28X; 105-607-849-167-941; 105-980-974-160-269; 106-544-743-661-707; 106-959-039-113-007; 107-402-159-718-252; 108-400-772-053-735; 109-207-024-871-208; 111-961-330-392-607; 115-131-218-876-559; 128-647-186-968-123; 137-464-593-314-631; 137-748-186-940-883; 138-553-067-246-748; 157-299-981-680-43X,18
002-901-920-205-81X,Chances and Risks of Nanomaterials for Health and Environment,2012-05-28,2012,,,,,,Michael Riediker,"Nanomaterials have properties that are often very different from normal materials made of the same substance, which can be used to create novel products with exciting properties. However, the health and environmental impact of these nanomaterials is also changed and their potential risk needs to be studied. There is evidence that some nanomaterials can pass through tissue barriers (including the blood-brain barrier) and cell membranes. This is interesting for medical applications, but it raises concerns about the impact of non-medical nanomaterials. Current research aims at better coordinating research efforts and at better communication between researchers and involved stakeholders. Many research labs and production sites currently follow strategies that were established for dealing with very toxic chemicals and powders, until future research in this field helps identify the appropriate level of protection. All these efforts will ultimately ensure a safe, healthy and environmental friendly production, use and disposal of nanomaterials.",,,,,Risk analysis (engineering); Nanomaterials; Business; Environmental impact assessment; Environmentally friendly; Potential risk; Environmental health,,,,,,,,,2411457012,,0,,0
002-948-782-567-588,A strategy for assessing workplace exposures to nanomaterials,,2011,journal article,Journal of occupational and environmental hygiene,15459632; 15459624,Taylor and Francis Ltd.,United Kingdom,Gurumurthy Ramachandran; Michele L. Ostraat; Douglas E. Evans; Mark M. Methner; Patrick T. O'Shaughnessy; James B. D'Arcy; Charles L. Geraci; Edward Stevenson; Andrew D. Maynard; Keith Rickabaugh,"This article describes a highly tailorable exposure assessment strategy for nanomaterials that enables effective and efficient exposure management (i.e., a strategy that can identify jobs or tasks that have clearly unacceptable exposures), while simultaneously requiring only a modest level of resources to conduct. The strategy is based on strategy general framework from AIHA® that is adapted for nanomaterials and seeks to ensure that the risks to workers handling nanomaterials are being managed properly. The strategy relies on a general framework as the basic foundation while building and elaborating on elements essential to an effective and efficient strategy to arrive at decisions based on collecting and interpreting available information. This article provides useful guidance on conducting workplace characterization; understanding exposure potential to nanomaterials; accounting methods for background aerosols; constructing SEGs; and selecting appropriate instrumentation for monitoring, providing approp...",8,11,673,685,Risk analysis (engineering); Instrumentation (computer programming); Engineering; Nanotechnology; Accounting method; Exposure assessment; Air pollutants,,"Air Pollutants, Occupational/analysis; Environmental Monitoring/instrumentation; Humans; Nanostructures/adverse effects; Occupational Exposure/analysis; Occupational Health; Risk Assessment; Safety Management; Time Factors; Workplace","Air Pollutants, Occupational",,https://asu.pure.elsevier.com/en/publications/a-strategy-for-assessing-workplace-exposures-to-nanomaterials https://www.researchgate.net/profile/Douglas_Evans4/publication/51738821_A_Strategy_for_Assessing_Workplace_Exposures_to_Nanomaterials/links/00b495271804e40bd0000000.pdf https://jhu.pure.elsevier.com/en/publications/a-strategy-for-assessing-workplace-exposures-to-nanomaterials https://oeh.tandfonline.com/doi/full/10.1080/15459624.2011.623223 https://pubmed.ncbi.nlm.nih.gov/22023547/ https://experts.umn.edu/en/publications/a-strategy-for-assessing-workplace-exposures-to-nanomaterials https://www.ncbi.nlm.nih.gov/pubmed/22023547 https://www.tandfonline.com/doi/abs/10.1080/15459624.2011.623223,http://dx.doi.org/10.1080/15459624.2011.623223,22023547,10.1080/15459624.2011.623223,2022813044,,0,000-597-181-808-281; 000-641-153-487-578; 000-672-679-241-486; 002-943-257-615-243; 003-951-711-476-615; 004-181-475-186-146; 006-612-141-868-432; 009-433-271-836-629; 009-699-291-397-318; 013-273-563-395-41X; 013-529-325-187-179; 013-767-193-529-387; 014-489-333-088-333; 015-222-865-559-806; 016-422-660-905-982; 019-448-237-667-731; 019-481-831-979-724; 021-228-017-624-032; 022-272-697-530-631; 025-370-494-555-95X; 027-471-589-417-520; 027-598-280-908-813; 029-604-137-045-614; 031-372-889-299-977; 032-651-913-843-61X; 033-035-091-212-057; 033-287-977-387-914; 039-847-269-524-392; 040-171-834-919-935; 042-050-183-917-013; 043-164-852-163-848; 043-815-674-167-569; 047-322-812-682-076; 049-991-673-576-732; 050-997-086-958-384; 051-481-940-647-956; 051-564-161-225-715; 052-272-634-984-503; 054-548-243-143-982; 056-382-856-494-588; 057-979-575-986-891; 059-477-601-212-631; 062-650-812-684-57X; 063-478-899-467-678; 064-024-799-303-828; 069-039-667-238-749; 070-509-826-082-059; 071-645-505-212-345; 074-016-843-157-18X; 074-808-346-775-513; 077-514-835-415-063; 079-973-580-570-111; 085-071-082-013-237; 086-160-341-304-575; 086-656-879-573-282; 103-943-787-324-250; 108-070-944-054-234; 113-149-483-559-960; 117-703-439-609-896; 122-538-976-944-918; 146-235-638-804-229; 168-373-981-996-196; 170-992-091-167-921; 174-144-775-839-50X; 179-241-613-333-342,86
003-290-138-283-785,Nanomaterials for the theranostics of obesity,2019-09-04,2019,journal article,Biomaterials,18785905; 01429612,Elsevier BV,United Kingdom,Juanjuan Li; Ruitao Cha; Huize Luo; Wenshuai Hao; Yan Zhang; Xingyu Jiang,"As a chronic and lifelong disease, obesity not only significant impairs health but also dramatically shortens life span (at least 10 years). Obesity requires a life-long effort for the successful treatment because a number of abnormalities would appear in the development of obesity. Nanomaterials possess large specific surface area, strong absorptivity, and high bioavailability, especially the good targeting properties and adjustable release rate, which would benefit the diagnosis and treatment of obesity and obesity-related metabolic diseases. Herein, we discussed the therapy and diagnosis of obesity and obesity-related metabolic diseases by using nanomaterials. Therapies of obesity with nanomaterials include improving intestinal health and reducing energy intake, targeting and treating functional cell abnormalities, regulating redox homeostasis, and removing free lipoprotein in blood. Diagnosis of obesity-related metabolic diseases would benefit the therapy of these diseases. The development of nanomaterials will promote the diagnosis and therapy of obesity and obesity-related metabolic diseases.",223,,119474,,Disease; Life span; Redox homeostasis; Obesity; Bioinformatics; Medicine,Adipocyte; Nanocellulose; Nanomaterials; Obesity,Adipocytes/cytology; Animals; Biocompatible Materials; Cell Differentiation; Cell Proliferation; Humans; In Vitro Techniques; Lipase/antagonists & inhibitors; Lipids/chemistry; Magnetic Resonance Imaging; Metal Nanoparticles/chemistry; Mice; Nanostructures/chemistry; Obesity/therapy; Oxidation-Reduction; Theranostic Nanomedicine/methods,Biocompatible Materials; Lipids; Lipase,National Natural Science Foundation of China; National Natural Science Foundation of China; National Natural Science Foundation of China; National Natural Science Foundation of China; National Key R&D Program of China; Chinese Academy of Sciences; Chinese Academy of Sciences; Innovation and Industry Development in the Core Area in. Haidian District of Beijing,https://www.sciencedirect.com/science/article/pii/S0142961219305733 https://pubmed.ncbi.nlm.nih.gov/31536920/ https://www.ncbi.nlm.nih.gov/pubmed/31536920,http://dx.doi.org/10.1016/j.biomaterials.2019.119474,31536920,10.1016/j.biomaterials.2019.119474,2971476329,,0,000-287-921-392-709; 000-835-265-251-506; 001-495-171-748-579; 001-596-148-351-840; 001-704-748-025-614; 002-190-770-735-664; 002-389-387-542-120; 003-029-205-526-910; 003-315-531-736-996; 003-903-575-261-241; 004-686-894-030-270; 004-817-928-140-601; 005-024-933-190-212; 005-093-216-407-043; 005-407-343-506-502; 006-559-609-272-66X; 007-029-010-329-496; 007-488-137-045-194; 007-574-782-447-680; 007-625-314-669-394; 007-708-689-537-834; 008-346-385-714-556; 009-624-235-261-495; 009-783-409-551-352; 010-181-558-188-603; 010-266-777-976-039; 010-353-522-111-581; 010-845-647-676-309; 011-713-391-380-521; 011-880-405-106-346; 011-914-791-385-04X; 013-285-828-586-341; 013-488-493-455-349; 014-073-951-879-774; 014-305-723-651-751; 014-386-550-081-793; 014-443-300-584-679; 015-126-655-722-054; 016-270-954-886-81X; 017-002-548-668-767; 017-164-620-702-555; 017-427-046-187-086; 017-994-247-480-861; 018-239-718-934-67X; 019-331-406-744-496; 019-362-183-761-820; 020-864-249-656-464; 022-876-384-646-059; 023-067-306-367-931; 024-107-761-218-874; 024-661-601-417-581; 024-916-839-691-849; 025-421-827-682-197; 025-744-981-466-210; 026-467-957-036-214; 027-458-537-435-691; 028-180-757-331-379; 028-551-218-541-828; 030-370-790-029-39X; 030-434-144-783-697; 030-501-101-303-486; 030-672-015-605-097; 031-714-530-870-193; 031-968-915-771-516; 032-684-030-650-719; 034-199-621-983-981; 034-787-511-369-746; 035-106-829-467-59X; 035-233-531-475-046; 036-135-707-445-535; 036-186-863-121-380; 037-414-118-799-712; 037-598-906-459-152; 038-386-983-562-251; 038-600-357-950-841; 038-827-920-578-003; 038-919-090-601-830; 039-606-673-694-046; 039-656-398-904-437; 039-682-803-434-627; 039-700-815-831-829; 040-069-092-679-82X; 040-941-678-977-997; 041-491-867-673-862; 041-562-794-709-064; 042-589-211-721-341; 043-598-888-890-287; 043-876-616-813-066; 044-407-484-419-159; 044-598-459-777-303; 044-748-517-239-660; 044-828-652-994-044; 045-481-359-426-693; 046-477-194-939-398; 047-149-946-620-86X; 047-223-700-429-187; 047-261-822-343-987; 047-304-028-205-402; 047-465-660-470-59X; 047-534-993-294-092; 047-575-167-471-561; 049-044-727-816-864; 049-442-505-599-394; 050-811-856-127-280; 051-473-043-291-494; 051-923-416-484-500; 052-739-682-851-816; 053-712-699-051-248; 054-097-117-783-41X; 054-185-468-634-272; 054-263-694-344-979; 054-290-794-965-063; 054-576-585-941-157; 055-756-355-141-124; 056-263-869-012-11X; 057-698-478-334-997; 057-990-765-118-240; 058-285-549-345-679; 058-381-207-826-00X; 059-328-608-446-546; 059-378-223-283-93X; 060-015-591-155-504; 060-130-894-611-283; 061-491-822-920-677; 062-465-198-701-418; 063-671-379-846-118; 064-014-308-841-156; 064-295-985-230-989; 066-534-586-592-091; 068-008-284-783-055; 068-156-367-828-508; 069-285-709-064-622; 070-312-508-019-522; 070-814-607-248-259; 071-019-843-726-244; 071-951-025-798-258; 072-428-586-602-729; 073-575-929-231-007; 073-893-558-890-495; 076-312-051-282-643; 077-259-536-874-408; 077-514-893-961-679; 078-108-258-670-015; 078-318-335-313-19X; 079-163-287-368-286; 079-651-480-632-651; 080-287-626-160-245; 080-866-227-776-823; 080-962-292-961-822; 081-371-052-262-899; 082-186-608-204-590; 082-345-230-999-031; 083-211-886-539-508; 084-433-525-578-456; 085-374-722-362-514; 086-370-808-362-492; 086-693-563-128-10X; 087-406-160-963-639; 088-117-037-929-553; 088-338-072-767-894; 088-710-565-435-28X; 089-931-104-754-419; 095-282-706-081-813; 095-291-167-606-338; 099-001-855-243-363; 099-013-214-819-607; 103-393-086-359-81X; 103-591-753-148-985; 106-014-804-026-566; 107-741-747-196-813; 108-101-214-203-268; 108-233-057-578-57X; 108-758-571-288-964; 113-073-343-675-814; 113-615-127-208-81X; 114-046-968-818-435; 115-196-406-687-728; 115-340-877-132-968; 117-274-178-033-389; 119-816-740-309-212; 119-966-816-673-090; 120-999-726-542-851; 121-544-079-714-228; 129-545-214-350-603; 132-186-305-689-852; 133-207-763-584-149; 135-098-374-200-28X; 136-993-007-105-78X; 139-962-927-173-221; 142-370-773-552-075; 179-893-281-871-198; 184-478-334-924-293; 185-945-916-609-45X; 190-437-536-642-91X,10
003-314-651-965-692,Advances in Nanomaterials for Brain Microscopy.,2018-08-08,2018,journal article,Nano research,19980124; 19980000,Press of Tsinghua University,China,Jackson Travis Del Bonis-O'Donnell; Linda Chio; Gabriel Dorlhiac; Ian R. McFarlane; Markita P. Landry,"Microscopic imaging of the brain continues to reveal details of its structure, connectivity, and function. To further improve our understanding of the emergent properties and functions of neural circuits, new methods are necessary to directly visualize the relationship between brain structure, neuron activity, and neurochemistry. Advances in engineering the chemical and optical properties of nanomaterials concurrent with developments in deep-tissue microscopy hold tremendous promise for overcoming the current challenges associated with in vivo brain imaging, particularly for imaging the brain through optically-dense brain tissue, skull, and scalp. To this end, developments in nanomaterials offer much promise toward implementing tunable chemical functionality for neurochemical targeting and sensing, and fluorescence stability for long-term imaging. In this review, we summarize current brain microscopy methods and describe the diverse classes of nanomaterials recently leveraged as contrast agents and functional probes for microscopic optical imaging of the brain.",11,10,5144,5172,Nanomaterials; Microscopy; Nanotechnology; Neurochemical; Microscopic imaging; Brain tissue; Computer science; Neuroimaging; Optical imaging,,,,NIDA NIH HHS (R21 DA044010) United States,https://pubmed.ncbi.nlm.nih.gov/31105899/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516768 https://link.springer.com/article/10.1007/s12274-018-2145-2 https://europepmc.org/article/MED/31105899 https://escholarship.org/uc/item/9546k727,http://dx.doi.org/10.1007/s12274-018-2145-2,31105899,10.1007/s12274-018-2145-2,2886422707,PMC6516768,0,000-170-783-395-012; 000-230-479-070-274; 000-456-782-169-287; 000-705-680-564-950; 000-822-914-918-524; 001-224-855-431-834; 001-725-593-856-554; 001-803-132-612-312; 002-137-455-360-775; 002-868-895-980-758; 003-212-642-122-573; 003-240-961-004-599; 003-313-598-560-463; 004-235-022-765-824; 004-658-308-851-706; 005-030-704-307-449; 005-266-083-766-001; 005-378-175-805-852; 005-648-487-716-776; 005-696-228-942-935; 005-978-964-104-038; 006-022-764-969-475; 006-092-505-026-775; 006-157-019-473-670; 006-309-037-688-579; 007-845-808-677-786; 008-458-489-956-337; 009-336-371-581-040; 010-531-109-369-457; 011-488-453-554-243; 011-493-195-510-462; 011-529-031-597-014; 011-538-367-065-905; 011-862-511-034-99X; 012-018-353-224-853; 012-048-310-294-824; 012-390-666-535-047; 013-022-784-689-036; 013-189-208-379-966; 013-486-712-559-895; 014-003-897-344-002; 015-588-272-880-588; 015-852-645-477-055; 015-946-542-985-425; 016-651-641-007-035; 017-843-987-834-102; 018-653-013-240-372; 018-833-245-044-598; 020-123-329-306-167; 020-154-308-899-508; 020-272-584-176-127; 020-980-843-758-488; 022-264-014-640-648; 022-532-246-722-616; 022-607-749-035-010; 022-897-721-252-724; 023-123-491-768-481; 023-980-201-370-368; 024-259-610-388-617; 025-911-273-565-870; 026-076-590-940-494; 026-511-310-524-925; 026-569-886-215-270; 026-599-070-332-543; 027-135-641-720-445; 027-257-161-916-057; 028-413-430-168-543; 028-467-394-897-784; 029-375-382-067-300; 029-473-592-311-841; 029-679-932-337-268; 030-878-258-415-451; 031-328-088-132-618; 031-498-067-983-749; 031-997-582-975-467; 032-283-515-339-876; 032-506-269-277-344; 032-632-984-745-220; 034-007-520-895-49X; 034-380-390-986-697; 034-421-237-002-709; 034-838-036-211-639; 035-557-118-055-76X; 035-726-757-050-88X; 036-349-085-268-928; 036-773-408-500-588; 037-316-584-022-987; 038-759-575-529-646; 038-857-532-163-647; 039-001-250-440-448; 039-196-378-524-037; 039-537-996-295-49X; 040-203-778-250-707; 040-994-991-986-178; 041-122-684-359-869; 041-538-956-241-119; 042-054-473-953-344; 042-072-403-401-447; 042-846-079-260-123; 043-120-285-094-019; 043-192-781-285-933; 043-632-832-459-443; 044-068-350-294-756; 044-376-761-094-411; 044-890-111-754-504; 046-776-321-195-652; 048-132-078-973-061; 048-193-663-354-826; 048-776-585-873-405; 049-757-495-873-092; 049-849-223-052-109; 049-887-353-086-582; 050-118-423-233-314; 050-251-500-719-151; 050-359-510-075-390; 051-976-842-912-853; 052-112-394-558-288; 052-359-220-044-96X; 052-638-320-723-056; 054-273-320-949-665; 054-954-849-417-769; 055-415-402-616-335; 055-870-963-928-288; 058-193-830-876-596; 058-290-653-686-760; 058-936-711-224-725; 059-222-222-025-807; 059-505-197-964-553; 060-080-068-213-328; 061-735-154-737-33X; 062-064-000-464-30X; 062-209-334-077-822; 063-899-074-141-839; 064-244-869-970-744; 065-333-184-289-404; 066-509-008-279-090; 067-722-152-008-913; 067-992-736-817-861; 068-307-884-493-035; 070-122-110-446-631; 071-798-179-220-709; 074-471-721-580-726; 074-707-933-558-369; 075-376-222-122-684; 075-760-278-525-710; 075-912-227-006-689; 077-107-924-919-580; 078-856-259-966-954; 079-233-522-184-382; 080-249-340-523-031; 080-402-819-177-044; 081-254-660-649-541; 083-733-618-666-541; 085-327-477-834-984; 086-429-438-258-607; 086-953-380-365-303; 088-775-131-610-199; 088-901-491-297-890; 089-060-744-172-694; 090-571-145-223-218; 092-356-072-283-682; 094-436-247-465-529; 094-576-596-355-840; 095-110-991-557-815; 096-646-466-395-872; 097-759-953-928-506; 098-089-770-910-190; 099-284-111-453-280; 100-644-086-817-301; 100-656-501-790-491; 102-056-307-062-574; 102-673-123-531-229; 104-262-464-578-048; 105-292-326-785-536; 106-069-882-804-229; 107-075-630-550-59X; 107-157-918-709-052; 107-883-696-561-799; 111-233-619-604-177; 113-046-070-526-691; 114-238-976-812-849; 117-136-877-889-682; 121-300-016-603-503; 121-956-857-950-704; 123-273-355-950-210; 124-023-036-121-727; 131-942-310-195-317; 134-914-706-701-109; 135-067-063-664-042; 136-045-484-479-792; 142-511-858-983-284; 143-831-526-801-260; 143-851-376-425-332; 144-552-984-406-414; 145-519-835-886-743; 161-878-970-661-947; 173-136-810-733-414; 184-762-781-296-389; 187-530-310-554-843,11
003-406-249-065-117,Bimetal catalytic nanomaterials,2014-01-01,2014,journal article,SCIENTIA SINICA Chimica,16747224,"Science China Press., Co. Ltd.",,Xiangwen Liu; Dingsheng Wang; Qing Peng; YaDong Li,"As one kind of unusual catalytic materials in the industrial catalysis community, the bimetal materials have attracted considerable attentions due to the controlled composition, size and nanostruture of crystals and their promising reasonable controlled catalytic activity in the catalytic reaction. In recent years, the controlled preparation of different kinds of nanomaterials has achieved rapid progress, these nanomaterials with little size and controlled structures are very significant to improve the catalytic activity and study the catalytic mechanism. It is a challenge to design and develop more efficient bimetal catalytic materials with the help of modern nanotechnology. In this review, we discussed the bimetal nanomaterials catalytic activity in kinds of catalytic reaction, and the influence factors of the catalytic activity of these bimetallic nanomaterials in the recent catalytic research progress. Some new promising characterization and research methods were also discussed in the end of the review.",44,1,85,99,Nanomaterials; Catalysis; Nanotechnology; Materials science; Bimetallic strip; Bimetal,,,,,https://engine.scichina.com/doi/10.1360/032013-273 https://engine.scichina.com/publisher/scp/journal/SSC/44/1/10.1360/032013-273?slug=full%20text,http://dx.doi.org/10.1360/032013-273,,10.1360/032013-273,2372415766,,0,,1
003-519-163-825-278,Biotechnological synthesis of functional nanomaterials,,2011,journal article,Current opinion in biotechnology,18790429; 09581669,Elsevier Limited,Netherlands,Jonathan R. Lloyd; James M. Byrne; Victoria S. Coker,"Biological systems, especially those using microorganisms, have the potential to offer cheap, scalable and highly tunable green synthetic routes for the production of the latest generation of nanomaterials. Recent advances in the biotechnological synthesis of functional nano-scale materials are described. These nanomaterials range from catalysts to novel inorganic antimicrobials, nanomagnets, remediation agents and quantum dots for electronic and optical devices. Where possible, the roles of key biological macromolecules in controlling production of the nanomaterials are highlighted, and also technological limitations that must be addressed for widespread implementation are discussed.",22,4,509,515,Engineering; Nanomaterials; Nanotechnology,,Anti-Infective Agents/chemistry; Biotechnology/methods; Nanostructures; Oxides; Quantum Dots; Water Purification,Anti-Infective Agents; Oxides,Biotechnology and Biological Sciences Research Council (BB/E004601/1) United Kingdom,https://www.sciencedirect.com/science/article/pii/S0958166911006203 https://www.research.manchester.ac.uk/portal/en/publications/biotechnological-synthesis-of-functional-nanomaterials(733609c3-f461-419c-8b2c-527d10f35d86).html https://www.ncbi.nlm.nih.gov/pubmed/21742483 https://www.escholar.manchester.ac.uk/uk-ac-man-scw:143230 https://agris.fao.org/agris-search/search.do?recordID=US201600019691,http://dx.doi.org/10.1016/j.copbio.2011.06.008,21742483,10.1016/j.copbio.2011.06.008,2015101986,,0,001-844-410-581-319; 007-156-099-336-036; 007-331-379-248-626; 010-340-402-798-494; 012-245-965-921-596; 012-640-262-744-239; 013-370-987-891-681; 014-256-013-051-77X; 016-395-091-510-321; 019-663-681-172-585; 019-975-171-509-62X; 020-053-380-446-64X; 020-163-022-583-326; 020-171-220-628-337; 020-308-177-694-148; 021-665-336-582-234; 022-041-005-141-283; 024-362-357-409-765; 026-869-474-968-836; 031-811-702-056-572; 033-154-530-732-970; 037-157-569-087-699; 038-361-413-806-727; 038-945-397-739-50X; 040-996-601-523-952; 047-162-409-740-15X; 049-121-307-617-072; 049-223-278-019-301; 049-804-413-179-953; 052-263-710-053-213; 055-252-490-301-523; 059-298-884-909-725; 059-591-534-087-672; 065-178-833-499-712; 066-943-029-678-367; 078-529-159-739-182; 080-493-439-205-513; 083-124-727-956-325; 086-635-261-796-705; 088-961-664-432-697; 096-120-628-189-910; 096-474-993-005-356; 097-705-022-088-779; 103-152-621-153-438; 105-114-173-927-377; 114-780-840-930-125; 117-471-426-348-041; 121-803-357-015-288; 138-340-387-594-03X,78
003-599-541-950-635,Contributions of Novel Nanomaterials to Pharmaceutical Analysis,2019-12-19,2019,conference proceedings article,Proceedings of the 2019 6th International Conference on Bioinformatics Research and Applications,,ACM,,Yixin Zhang,"This paper is an analysis of the application of nanomaterials in pharmaceutical situations. The paper discusses the contribution of nanomaterials in liquid chromatography - mass spectrometry (LC-MS), capillary electrophoresis (CE), and chiral separation. Numerous researches demonstrate the positive impact of different types of nanomaterials in a wide range of areas, thus showing their promising future for medical purposes. Moreover, some researches mentioned in this paper are the first reported cases of their areas, indicating that more research needs to be done in order to prove the stability of nanomaterials in certain situations. Overall, the combination of nanotechnology and medical analysis is very efficient, which means this field is highly valuable for further study.",,,,,Nanomaterials; Nanotechnology; Research needs; Computer science,,,,,https://dl.acm.org/doi/10.1145/3383783.3383796,http://dx.doi.org/10.1145/3383783.3383796,,10.1145/3383783.3383796,3021791379,,0,006-792-251-022-543; 015-969-111-571-185; 025-975-027-726-424; 042-677-933-276-825; 053-584-057-528-530; 058-666-145-346-113; 061-991-648-603-019; 080-902-940-700-782; 084-665-341-824-299; 086-361-923-190-61X; 090-454-635-347-595; 094-537-677-921-179; 109-238-597-251-50X; 109-802-641-620-160; 110-733-898-179-736; 120-250-408-333-689; 122-036-893-064-253,0
003-682-990-922-899,Characterization of Nanomaterials Using Nuclear Magnetic Resonance Spectroscopy,,2018,book chapter,Characterization of Nanomaterials,,Elsevier,,Nipanshu Agarwal; Maya S. Nair; Avik Mazumder; Krishna Mohan Poluri,"Abstract Nanotechnology has been a lucrative field of interest for chemists, physicists, biologists, engineers, and even for the scientists working in interdisciplinary sciences. Explicit and novel applications of nanomaterials in nearly all domains make their fabrication inevitable due to their exceptional properties. Nanomaterials find their applications ubiquitously, ranging from conventional antibacterial and antifungal to more advanced fields such as imaging, detoxification, drug delivery, and tissue engineering. However, their amenability in the fields of biomedical and therapeutic sciences is yet to be explored. There is a huge demand to devise characterization strategies for nanomaterials. Several of the biophysical techniques have considerably contributed in solving the problems related to their characterization; albeit, they lack the atomic level resolution. Due to the existence of nanomaterials in various permutations and combinations thereof, comprising different combinations of nanomaterials and ligands for various applications, nuclear magnetic resonance (NMR) spectroscopy can irrevocably analyze diversified range of structural and chemical properties of nanomaterials in both solid and liquid states with a resolution at par to the atomic level, thus justifying the motive of NMR spectroscopy as an unique and prime tool for characterization of nanomaterials. In the current chapter, we aim to bring the contribution of NMR spectroscopy toward nanomaterial characterization by discussing its theoretical aspects, highlighting the practical facet in nanotechnology to colligate these two adorable partners.",,,61,102,Nanomaterials; Nanotechnology; Materials science; Antifungal; Characterization (materials science); Nuclear magnetic resonance spectroscopy,,,,,https://www.sciencedirect.com/science/article/pii/B9780081019733000031,http://dx.doi.org/10.1016/b978-0-08-101973-3.00003-1,,10.1016/b978-0-08-101973-3.00003-1,2808726970,,0,000-056-177-596-237; 000-456-114-918-510; 000-713-094-303-459; 001-906-789-551-122; 002-243-407-886-333; 002-385-860-813-478; 002-867-067-031-368; 002-949-971-175-326; 003-504-863-381-725; 003-964-452-756-892; 004-193-094-427-303; 004-736-888-054-500; 004-833-245-311-432; 004-842-047-459-625; 005-027-836-264-455; 005-814-862-001-125; 005-920-905-365-658; 005-978-964-104-038; 006-718-226-980-066; 006-946-867-598-646; 007-751-296-592-887; 007-783-835-690-811; 008-367-612-288-765; 008-407-317-797-560; 008-720-663-526-107; 008-840-705-783-82X; 010-215-018-709-650; 011-738-813-621-200; 012-368-477-513-024; 012-584-504-550-629; 012-938-578-729-379; 013-334-185-998-905; 013-778-966-431-925; 015-415-253-221-573; 016-249-864-754-040; 016-936-765-488-511; 017-382-221-991-164; 017-747-177-475-048; 018-363-607-755-319; 018-566-308-611-42X; 018-916-850-408-437; 018-921-792-560-217; 019-124-623-398-911; 019-758-282-006-864; 021-399-271-858-244; 021-440-600-016-42X; 022-843-487-336-028; 023-216-805-847-012; 024-916-807-814-699; 025-689-214-696-972; 026-582-667-914-131; 027-777-670-010-930; 028-483-708-770-306; 028-915-569-901-21X; 028-956-145-272-123; 029-074-982-417-23X; 029-237-320-441-170; 029-378-039-271-885; 029-866-418-674-150; 030-763-475-290-00X; 030-960-926-456-607; 031-923-665-299-191; 032-107-134-701-226; 032-285-893-749-978; 032-493-575-776-176; 032-836-771-013-928; 033-027-959-493-085; 033-615-282-551-685; 033-763-740-408-347; 033-985-470-367-533; 035-885-357-374-816; 035-946-900-896-226; 036-301-688-061-536; 036-384-996-717-986; 036-982-986-610-106; 038-300-604-426-330; 041-288-239-618-017; 041-576-846-309-765; 042-038-383-528-184; 042-987-140-283-762; 043-865-898-085-912; 044-576-317-116-721; 044-656-484-565-102; 044-738-743-406-106; 045-471-103-750-191; 047-796-714-600-086; 047-904-108-118-500; 047-978-644-729-710; 048-510-673-436-338; 050-400-427-368-717; 050-520-596-829-330; 051-376-693-375-53X; 052-037-006-386-676; 052-506-576-186-368; 052-732-425-304-692; 053-567-662-606-336; 054-159-512-289-711; 054-508-285-483-591; 055-008-825-164-440; 056-536-952-393-225; 056-889-990-170-683; 058-197-415-835-736; 058-687-769-804-189; 058-727-230-967-527; 059-561-820-854-898; 059-610-363-660-315; 060-867-389-859-17X; 063-333-177-185-081; 064-267-818-328-913; 064-639-743-803-664; 066-595-325-184-216; 067-975-818-830-643; 068-803-592-320-039; 069-588-219-900-737; 069-859-487-231-375; 070-475-862-912-774; 070-627-941-262-220; 070-907-878-479-22X; 071-124-135-072-248; 072-179-951-215-723; 072-657-734-819-225; 076-185-999-463-247; 077-732-109-952-88X; 077-783-881-708-938; 078-462-474-428-276; 078-825-614-765-275; 079-601-946-692-512; 079-611-601-431-236; 079-646-392-922-353; 079-819-680-182-049; 081-966-589-826-618; 082-426-959-452-81X; 085-353-046-085-44X; 086-954-007-710-88X; 087-369-412-617-194; 088-228-984-013-780; 089-754-159-078-855; 089-993-756-661-764; 090-100-542-770-45X; 090-858-388-187-23X; 094-995-350-519-856; 097-440-247-580-376; 098-661-319-880-411; 099-177-787-650-66X; 100-709-857-706-39X; 102-707-254-484-509; 102-747-368-180-163; 103-138-867-357-085; 104-273-549-374-216; 106-032-966-798-293; 106-442-235-274-877; 110-156-622-116-307; 112-873-300-752-698; 115-338-906-243-331; 116-008-863-324-899; 117-182-471-366-90X; 117-706-810-750-602; 118-079-450-024-725; 118-828-403-899-903; 123-350-548-424-600; 132-783-483-011-361; 133-379-405-641-175; 139-502-352-031-216; 150-435-807-735-422; 150-923-271-749-06X; 151-184-406-914-30X; 154-444-342-419-832; 155-902-100-373-802; 156-310-473-427-567; 157-279-389-123-054; 157-864-904-583-299; 181-097-025-590-842,9
003-716-330-773-077,Synthesis and Morphology Control of Janus Nanomaterials,2015-06-10,2015,journal article,Chemical Journal of Chinese Universities-chinese,02510790,,,Zhou Peng; Liu Bao; Liang Fuxin; Wang Qian; Qu Xiaozhong; Yang Zhenzhong,"We propose a facile method to synthesize Janus nanomaterials by seed interfacial sol-gel process against a polystyrene (PS) hollow sphere using three precursor silanes, (3-aminopropyl) triethoxysilane (APTES), methacryloxy propyl trimethoxyl silane (MPS) and tetraethyl orthosilicate (TEOS). The sol-gel process starts from the exterior surface of the seed sphere. Janus nanomaterials were formed in situ onto the seed sphere surface after a self-organized sol-gel process, which possess 3-methacryloxypropyl- and amine-groups terminated at both sides of the shell. Morphology of the Janus nanomaterials could be tunable from intact shell, nanosheet, porous nanosheet and individual nanoparticles by controlling pH, precursor amount and the fraction of binary emulsifier system. After the removal of PS by dissolution under ultrasonication, Janus nanoparticles were eventually achieved. This method is attractive owing to the easiness to continuously adjust morphology of the Janus nanomaterials. On the other hand, composition of the nanomaterials is also flexibly tunable by using different precursors. What's more, the Janus nanomaterials can derive other Janus ones after selective modification and favorable growth of desired materials onto the corresponding side.",36,7,1431,,Nanomaterials; Janus particles; Nanoparticle; Nanotechnology; Materials science; Tetraethyl orthosilicate; Triethoxysilane; Janus; Sol-gel; Nanosheet,,,,,http://www.cjcu.jlu.edu.cn/EN/10.7503/cjcu20150152,http://www.cjcu.jlu.edu.cn/EN/10.7503/cjcu20150152,,,2369456111,,0,,0
003-718-976-297-654,Cytophilic/Cytophobic Design of Nanomaterials at Biointerfaces,2013-02-18,2013,journal article,"Small (Weinheim an der Bergstrasse, Germany)",16136829; 16136810,Wiley-VCH Verlag,Germany,Kang Sun; Hongliang Liu; Shutao Wang; Lei Jiang,"To control interactions between cells and nanomaterials has been a great challenge because numerous nanomaterials have been intensively explored in the fields of biology and medicine. However, current surface modification of nanomaterials is mainly carried out in an empirical way. Herein, a general strategy to tune the surface chemistry of nanomaterials is proposed based on cell affinity, that is, cytophilic or cytophobic. The cell affinity of nanomaterials directly affects cellular response to materials at the very early stage of cell-material interactions before other events, such as endocytosis, cell spreading, and cell differentiation, occur. In this Concept, it is suggested that there is a developing library of cytophilic and cytophobic moieties, and how the cell affinity of nanomaterials functions at biointerfaces is discussed by exemplifying several applications, namely therapy, tissue engineering, and biosensors. It is believed that control of the cytophilic/cytophobic property will be helpful in guiding the design of functional nanomaterials for their biomedical applications.",9,9-10,1444,1448,Surface modification; Nanomaterials; Nanotechnology; Materials science; Cell spreading; Tissue engineering,,Biocompatible Materials; Biosensing Techniques; Cell Adhesion; Cell Differentiation; Cell Movement; Endocytosis; Nanostructures; Surface Properties; Tissue Engineering,Biocompatible Materials,,https://www.onlinelibrary.wiley.com/doi/full/10.1002/smll.201201667 http://www.ncbi.nlm.nih.gov/pubmed/23418017 https://research.monash.edu/en/publications/cytophiliccytophobic-design-of-nanomaterials-at-biointerfaces,http://dx.doi.org/10.1002/smll.201201667,23418017,10.1002/smll.201201667,2100076223,,0,001-808-852-734-273; 002-343-760-603-208; 006-794-867-091-511; 007-223-730-630-593; 010-584-669-155-835; 011-592-211-795-132; 014-851-446-894-429; 016-017-651-165-733; 016-092-243-802-078; 018-661-268-492-846; 020-326-276-726-247; 021-262-660-782-303; 022-463-607-969-520; 023-785-005-312-407; 024-362-184-359-092; 026-776-013-921-231; 027-864-482-917-91X; 028-546-126-419-693; 029-307-883-027-521; 032-054-442-940-652; 032-261-692-660-41X; 033-140-749-934-369; 033-344-162-279-62X; 035-887-199-851-611; 042-166-139-469-166; 042-463-454-635-727; 047-395-255-640-70X; 049-429-419-417-105; 049-544-361-067-678; 051-215-056-781-95X; 053-040-770-174-98X; 053-159-902-721-286; 053-638-041-417-909; 054-151-029-950-921; 056-278-474-509-609; 057-402-243-667-337; 060-031-569-980-778; 060-684-049-132-941; 061-628-106-231-082; 063-305-220-150-952; 064-520-071-952-414; 066-003-063-804-099; 072-030-033-133-66X; 073-640-121-082-65X; 073-991-055-304-035; 074-676-049-689-297; 076-535-389-218-719; 077-730-809-706-699; 079-503-563-073-758; 085-575-954-870-172; 088-183-911-419-775; 089-580-994-329-403; 099-318-813-543-080; 100-204-073-527-146; 103-646-040-158-361; 105-888-442-897-137; 109-082-182-035-030; 122-521-055-052-260; 138-840-290-183-833; 169-374-008-587-885,11
003-752-575-056-453,Mapping the surface adsorption forces of nanomaterials in biological systems.,2011-10-27,2011,journal article,ACS nano,1936086x; 19360851,American Chemical Society,United States,Xin R. Xia; Nancy A. Monteiro-Riviere; Sanjay Mathur; Xuefeng Song; Lisong Xiao; Steven J. Oldenberg; Bengt Fadeel; Jim E. Riviere,"The biological surface adsorption index (BSAI) is a novel approach to characterize surface adsorption energy of nanomaterials that is the primary force behind nanoparticle aggregation, protein corona formation, and other complex interactions of nanomaterials within biological systems. Five quantitative nanodescriptors were obtained to represent the surface adsorption forces (hydrophobicity, hydrogen bond, polarity/polarizability, and lone-pair electrons) of the nanomaterial interaction with biological components. We have mapped the surface adsorption forces over 16 different nanomaterials. When the five-dimensional information of the nanodescriptors was reduced to two dimensions, the 16 nanomaterials were classified into distinct clusters according their surface adsorption properties. BSAI nanodescriptors are intrinsic properties of nanomaterials useful for quantitative structure-activity relationship (QSAR) model development. This is the first success in quantitative characterization of the surface adsorption forces of nanomaterials in biological conditions, which could open a quantitative avenue in predictive nanomedicine development, risk assessment, and safety evaluation of nanomaterials.",5,11,9074,9081,Nanotoxicology; Nanomaterials; Adsorption; Nanomedicine; Nanoparticle; Quantitative structure–activity relationship; Nanotechnology; Nanostructure; Materials science; Characterization (materials science),,Adsorption; Biology; Nanostructures/chemistry; Surface Properties,,NIEHS NIH HHS (R01 ES016138) United States; NIEHS NIH HHS (R01 ES016138-01) United States,https://www.ncbi.nlm.nih.gov/pubmed/21999618 https://pubs.acs.org/doi/full/10.1021/nn203303c https://pubmed.ncbi.nlm.nih.gov/21999618/ https://pubs.acs.org/doi/10.1021/nn203303c https://europepmc.org/articles/PMC3222732/ https://www.researchgate.net/profile/Nancy_Monteiro-Riviere2/publication/51722402_Mapping_the_surface_adsorption_forces_of_nanomaterials_in_biological_systems/links/5453a6920cf2cf51647c1edb.pdf,http://dx.doi.org/10.1021/nn203303c,21999618,10.1021/nn203303c,1971007541,PMC3222732,0,005-685-612-469-827; 010-594-529-718-631; 012-019-878-635-182; 013-652-371-271-113; 014-061-675-606-05X; 015-827-492-981-765; 019-850-711-004-624; 021-767-665-828-087; 022-163-030-913-092; 024-819-813-060-876; 025-284-533-287-820; 027-887-833-618-850; 028-612-918-803-346; 030-020-007-295-945; 031-301-610-601-713; 032-450-257-879-022; 032-775-347-173-678; 032-816-661-064-654; 033-427-841-712-900; 037-930-959-156-253; 038-573-313-649-300; 038-655-574-884-041; 038-769-354-117-727; 039-079-455-504-396; 040-161-699-545-774; 040-295-912-119-218; 040-365-233-559-060; 043-485-193-521-820; 049-809-613-171-879; 050-011-101-462-472; 051-425-605-501-021; 051-501-166-696-286; 052-539-462-020-686; 056-727-058-127-282; 058-646-060-582-290; 069-039-667-238-749; 069-888-527-803-167; 073-453-556-758-678; 075-475-676-609-968; 076-979-851-550-322; 078-536-486-326-997; 088-843-448-365-314; 089-902-960-616-331; 102-188-480-848-911; 105-483-419-431-018; 112-820-016-691-016; 120-789-273-269-77X; 122-573-683-361-835; 132-055-033-008-514; 132-761-346-761-10X; 139-800-181-799-92X; 142-325-179-186-284; 143-396-598-191-576; 164-095-877-958-226; 164-331-223-018-931; 166-184-640-167-968; 169-477-856-446-956; 177-545-381-787-58X; 185-455-414-276-825,118
004-114-018-045-719,The Medical Applications of Nanomaterials in the Central Nervous System,,2017,book chapter,Neurotoxicity of Nanomaterials and Nanomedicine,,Elsevier,,Huile Gao; X. Jiang,"Abstract The restriction of the blood–brain barrier poses a great challenge to manage central nervous system disorders. Nanomaterials showed promising application in the delivery of various kinds of drugs to the brain, including small chemical drugs, peptides and proteins, and genes. In this chapter, we review the most widely used nanomaterials in brain targeting delivery, such as natural materials, anionic and neutral polymers, cationic polymers, dendrimers, metal-based nanoparticles, and carbon-based nanomaterials. We also describe the strategies to modify these nanomaterials to facilitate brain targeting delivery and the treatment outcomes using these strategies.",,,1,31,Gene delivery; Nanomaterials; Nanotechnology; Materials science; Natural materials; Brain targeting; Treatment outcome; Central nervous system,,,,,https://www.sciencedirect.com/science/article/pii/B9780128045985000015 http://www.sciencedirect.com/science/article/pii/B9780128045985000015,http://dx.doi.org/10.1016/b978-0-12-804598-5.00001-5,,10.1016/b978-0-12-804598-5.00001-5,2531907734,,0,000-030-059-438-320; 000-168-016-769-578; 000-286-986-959-011; 000-619-729-760-215; 001-896-466-986-897; 002-435-578-534-961; 002-472-467-994-597; 003-022-603-827-91X; 003-177-325-605-503; 003-283-829-902-092; 003-692-638-106-808; 004-587-986-416-345; 005-377-209-561-821; 005-787-716-337-850; 006-039-250-235-504; 006-650-093-842-920; 008-201-167-014-052; 009-396-397-601-032; 009-646-074-845-63X; 010-313-409-845-00X; 011-834-437-329-651; 012-230-652-008-550; 012-401-169-736-463; 012-536-393-639-295; 013-075-056-590-563; 013-848-027-765-100; 014-131-205-689-71X; 014-687-922-019-990; 015-890-766-904-882; 016-243-940-406-527; 017-074-052-593-282; 017-260-332-689-886; 017-542-256-004-253; 017-654-040-976-033; 018-489-126-577-850; 018-595-465-544-585; 019-278-244-336-122; 019-725-839-917-980; 020-987-114-818-593; 021-237-609-144-58X; 021-854-033-914-855; 022-627-672-527-954; 023-733-914-555-006; 025-023-919-156-692; 025-139-760-391-58X; 025-579-070-119-588; 027-212-834-315-098; 027-453-598-560-442; 028-145-419-049-334; 028-578-427-636-524; 028-801-768-861-331; 028-839-613-713-768; 030-691-719-359-959; 031-145-881-419-655; 031-461-914-276-406; 031-476-001-487-104; 031-853-284-353-325; 032-152-179-887-282; 032-377-925-235-364; 033-972-450-559-180; 034-092-479-318-445; 034-221-076-286-977; 034-280-299-650-617; 034-933-132-843-99X; 037-352-030-473-397; 037-478-719-421-857; 038-363-504-065-222; 038-857-532-163-647; 039-996-242-875-36X; 040-619-977-315-277; 040-668-483-694-976; 041-106-258-409-835; 042-254-203-126-994; 042-457-465-208-076; 042-600-011-504-881; 045-809-639-915-914; 046-671-703-630-41X; 048-509-530-865-364; 048-752-476-426-060; 048-981-500-696-941; 049-066-276-354-29X; 049-270-819-648-824; 050-854-419-785-023; 052-232-539-217-617; 052-529-559-664-120; 052-920-508-506-466; 053-134-558-862-336; 053-204-340-372-351; 053-438-382-362-452; 053-905-617-368-817; 054-540-877-052-293; 054-689-087-584-493; 055-291-694-349-184; 057-330-943-295-837; 057-390-630-157-34X; 058-525-456-816-355; 059-410-913-015-34X; 059-904-692-892-559; 060-454-402-888-755; 060-754-651-953-698; 063-675-490-311-662; 064-931-822-354-359; 065-198-174-726-851; 065-706-756-902-032; 067-267-006-469-277; 068-208-623-552-806; 068-420-012-229-67X; 070-496-398-460-075; 071-160-677-299-592; 071-253-169-209-223; 072-283-855-401-219; 076-050-993-006-813; 076-769-012-246-965; 077-038-673-660-319; 078-885-417-140-457; 078-996-940-939-513; 081-077-507-850-439; 083-275-974-992-348; 084-319-497-755-777; 086-679-356-344-087; 087-151-471-663-535; 088-281-155-771-157; 090-690-437-710-44X; 098-990-063-100-764; 100-445-283-970-266; 101-137-702-847-767; 102-605-665-762-406; 103-077-308-009-213; 105-321-582-198-007; 106-586-898-589-75X; 106-897-862-512-994; 108-278-210-744-167; 110-095-441-667-103; 112-073-361-442-903; 112-391-963-679-127; 114-209-057-216-752; 114-945-863-337-204; 116-552-841-658-790; 116-991-129-619-813; 119-550-819-335-581; 120-355-147-128-396; 123-927-089-000-895; 125-049-253-856-158; 125-155-341-354-19X; 125-564-638-850-845; 132-519-345-648-951; 144-774-291-357-326; 145-362-519-467-798; 147-821-754-881-449; 157-292-018-139-360; 157-898-990-556-769; 169-145-599-946-026,2
004-140-915-659-349,Functionalization of nanomaterials for industrial applications: recent and future perspectives,,2020,book chapter,Handbook of Functionalized Nanomaterials for Industrial Applications,,Elsevier,,Sukanchan Palit; Chaudhery Mustansar Hussain,"Abstract The science and engineering of nanotechnology and nanomaterials are in a period of intense growth. Environmental protection and environmental engineering science are also experiencing similar growth due to the prevalence of environmental disasters, global climate change, and loss of ecological biodiversity. Functionalized nanomaterials are the smart materials of today. Nanomaterials and engineered nanomaterials are changing the face of scientific regeneration globally today. This chapter presents recent and future aims material science and nanotechnology. Today the world of nanomaterials and material science is focused on applications of functionalized nanomaterials in diverse areas such as food, energy, and environment. As discussed in this chapter, this area of science is also aimed at addressing sustainability to ensure the future of mankind.",,,3,14,Engineering; Nanomaterials; Environmental engineering science; Regeneration (ecology); Environmental disaster; Science and engineering; Engineered nanomaterials; Engineering ethics; Sustainability,,,,,https://www.sciencedirect.com/science/article/pii/B9780128167878000016,http://dx.doi.org/10.1016/b978-0-12-816787-8.00001-6,,10.1016/b978-0-12-816787-8.00001-6,3017939893,,0,054-698-615-872-902; 067-120-945-953-255; 122-487-862-603-253,10
004-229-961-544-199,Engineering bacteria for biogenic synthesis of chalcogenide nanomaterials.,2018-10-17,2018,journal article,Microbial biotechnology,17517915; 17517907,John Wiley and Sons Ltd,United Kingdom,Prithiviraj Chellamuthu; Frances Tran; Kalinga Pavan T. Silva; Marko S. Chavez; Mohamed Y. El-Naggar; James Q. Boedicker,"Microbes naturally build nanoscale structures, including structures assembled from inorganic materials. Here, we combine the natural capabilities of microbes with engineered genetic control circuits to demonstrate the ability to control biological synthesis of chalcogenide nanomaterials in a heterologous host. We transferred reductase genes from both Shewanella sp. ANA-3 and Salmonella enterica serovar Typhimurium into a heterologous host (Escherichia coli) and examined the mechanisms that regulate the properties of biogenic nanomaterials. Expression of arsenate reductase genes and thiosulfate reductase genes in E. coli resulted in the synthesis of arsenic sulfide nanomaterials. In addition to processing the starting materials via redox enzymes, cellular components also nucleated the formation of arsenic sulfide nanomaterials. The shape of the nanomaterial was influenced by the bacterial culture, with the synthetic E. coli strain producing nanospheres and conditioned media or cultures of wild-type Shewanella sp. producing nanofibres. The diameter of these nanofibres also depended on the biological context of synthesis. These results demonstrate the potential for biogenic synthesis of nanomaterials with controlled properties by combining the natural capabilities of wild microbes with the tools from synthetic biology.",12,1,161,172,Reductase; Nanomaterials; Chemistry; Synthetic biology; Arsenic sulfide; Context (language use); Arsenate reductase; Bacteria; Escherichia coli; Biochemistry,,"Arsenicals/metabolism; Cloning, Molecular; Escherichia coli/genetics; Gene Expression; Metabolic Engineering/methods; Nanostructures; Oxidoreductases/genetics; Recombinant Proteins/genetics; Salmonella typhimurium/enzymology; Shewanella/enzymology; Sulfides/metabolism",Arsenicals; Recombinant Proteins; Sulfides; arsenic trisulfide; Oxidoreductases,Office of Naval Research,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302716 https://pubmed.ncbi.nlm.nih.gov/30369058/ https://onlinelibrary.wiley.com/doi/pdf/10.1111/1751-7915.13320 https://sfamjournals.onlinelibrary.wiley.com/doi/pdf/10.1111/1751-7915.13320 https://sfamjournals.onlinelibrary.wiley.com/doi/full/10.1111/1751-7915.13320,http://dx.doi.org/10.1111/1751-7915.13320,30369058,10.1111/1751-7915.13320,2949279034,PMC6302716,0,000-052-485-332-075; 002-556-815-977-477; 002-571-215-289-940; 004-162-126-110-633; 004-229-961-544-199; 006-620-262-042-573; 006-805-715-012-854; 007-939-223-172-202; 008-306-537-505-467; 009-446-880-001-523; 014-907-313-935-16X; 015-710-782-146-718; 017-357-035-226-480; 017-860-140-968-900; 018-017-704-700-596; 018-929-742-665-463; 020-915-606-785-692; 021-092-943-844-907; 025-239-976-180-317; 026-120-140-253-57X; 030-511-257-718-636; 030-589-576-573-374; 030-659-057-644-071; 032-419-413-963-387; 032-583-381-160-647; 037-421-277-177-019; 038-294-439-383-85X; 039-001-276-746-840; 042-904-348-105-352; 043-182-379-944-380; 045-817-468-033-14X; 047-854-213-214-630; 048-853-533-106-980; 049-605-239-238-337; 049-705-097-415-630; 050-389-565-118-906; 050-751-363-763-789; 052-937-296-698-881; 054-532-972-418-572; 059-298-884-909-725; 062-259-718-515-006; 064-522-138-556-643; 064-790-425-722-748; 065-672-800-941-635; 066-357-042-303-947; 067-358-436-860-798; 069-997-081-136-525; 071-480-720-706-994; 073-533-799-507-46X; 074-096-416-537-340; 078-519-916-315-987; 080-226-442-877-373; 087-391-099-554-908; 090-112-666-879-172; 090-315-153-830-090; 091-966-403-582-727; 098-289-048-955-750; 098-301-467-013-02X; 103-097-615-912-865; 109-645-998-094-830; 124-628-280-445-987; 127-312-129-058-94X; 127-689-826-966-206; 132-342-245-978-581; 134-352-292-455-910; 136-601-603-000-866; 172-319-458-455-43X; 179-285-406-532-87X; 187-076-005-159-41X,15
004-239-514-716-605,Characterization of particle emissions and fate of nanomaterials during incineration,,2014,journal article,Environ. Sci.: Nano,20518153; 20518161,Royal Society of Chemistry (RSC),United Kingdom,Eric P. Vejerano; Elena C. Leon; Amara L. Holder; Linsey C. Marr,"As the use of nanotechnology in consumer products continues to grow, it is inevitable that some nanomaterials will end up in the waste stream and will be incinerated. Through laboratory-scale incineration of paper and plastic wastes containing nanomaterials, we assessed their effect on emissions of particulate matter (PM) and the effect of incineration on the nanomaterials themselves. The presence of nanomaterials did not significantly influence the particle number emission factor. The PM size distribution was not affected except at very high mass loadings (10 wt%) of the nanomaterial, in which case the PM shifted toward smaller sizes; such loadings are not expected to be present in many consumer products. Metal oxide nanomaterials reduced emissions of particle-bound polycyclic aromatic hydrocarbons. Most of the nanomaterials that remained in the bottom ash retained their original size and morphology but formed large aggregates. Only small amounts of the nanomaterials (0.023–180 mg g−1 of nanomaterial) partitioned into PM, and the emission factors of nanomaterials from an incinerator equipped with an electrostatic precipitator are expected to be low. However, a sustainable disposal method for nanomaterials in the bottom ash is needed, as a majority of them partitioned into this fraction and may thus end up in landfills upon disposal of the ash.",1,2,133,143,Incineration; Nanomaterials; Fraction (chemistry); Nanotechnology; Bottom ash; Materials science; Particulates; Electrostatic precipitator; Oxide; Waste management; Particle number,,,,,https://vtechworks.lib.vt.edu/bitstream/10919/51736/1/2014_Vejerano_et_al.pdf https://pubs.rsc.org/en/Content/ArticlePDF/2014/EN/C3EN00080J https://pubs.rsc.org/en/content/articlelanding/2014/en/c3en00080j#! https://vtechworks.lib.vt.edu/handle/10919/51736 http://xlink.rsc.org/?doi=10.1039/c3en00080j http://pubs.rsc.org/en/content/articlelanding/2014/en/c3en00080j#!divAbstract http://www.rsc.org/suppdata/en/c3/c3en00080j/c3en00080j.pdf,http://dx.doi.org/10.1039/c3en00080j,,10.1039/c3en00080j,2133433097,,0,003-346-572-619-085; 003-515-488-925-105; 010-456-158-675-445; 019-365-529-043-580; 022-331-682-457-539; 023-542-712-726-397; 024-786-164-470-219; 025-800-679-856-617; 027-504-298-892-776; 034-091-381-695-184; 034-416-907-589-240; 035-139-084-880-523; 037-011-955-831-103; 038-671-632-166-970; 046-069-281-292-243; 048-863-079-955-411; 055-579-781-209-078; 057-664-405-623-928; 058-484-352-550-793; 058-865-588-318-287; 061-212-199-694-705; 068-230-670-335-485; 071-645-505-212-345; 077-797-398-455-800; 079-000-794-115-674; 084-190-661-441-231; 086-416-103-518-865; 092-200-233-814-624; 095-062-403-852-102; 096-177-064-548-734; 102-044-833-540-750; 123-919-801-009-616; 125-579-933-845-899; 126-636-487-366-728; 127-743-577-858-793; 129-921-884-541-536; 132-573-733-070-300; 145-251-340-919-174; 149-032-909-826-438; 162-412-530-781-453; 177-270-546-344-825; 181-088-360-448-777; 198-288-097-643-72X,44
004-314-119-539-896,Synthesis and Processing of Nanomaterials,2020-01-08,2020,book chapter,Solar Cells,,Springer International Publishing,,Muhammad Yasin Naz; Shazia Shukrullah; Abdul Ghaffar; Khuram Ali; Surender Kumar Sharma,"Nanomaterials have emerged as a distinct class of modern materials. These materials are of significant importance due to their unique optical, electrical, thermal, and magnetic properties. Due to their tunable physical and chemical characteristics, including melting point, electrical conductivity, wettability, heat conductivity, light absorption, catalytic activity, and scattering, these materials have also gained recognition in high-tech engineering applications. These characteristics reflect better performance and working efficiency of nanomaterials relative to their bulk counterparts. Although there are many naturally occurring nanomaterials, most nanomaterials are engineered in laboratories. Such materials are purposefully synthesized in accordance with the industrial requirements. This chapter deals with the fundamentals of nanomaterials, their history, properties, and industrial applications. Different methods of synthesis of nanomaterials, their merits, demerits, and scale-up potential are also discussed in this chapter.",,,1,23,Wetting; Melting point; Nanomaterials; Nanotechnology; Scattering; Materials science; Thermal; Chemical vapor deposition; Electrical resistivity and conductivity; Thermal conductivity,,,,,https://link.springer.com/chapter/10.1007%2F978-3-030-36354-3_1,http://dx.doi.org/10.1007/978-3-030-36354-3_1,,10.1007/978-3-030-36354-3_1,2998788259,,0,002-108-956-215-020; 009-786-180-137-180; 010-173-592-439-648; 010-756-650-051-508; 013-984-714-752-498; 014-065-237-279-229; 014-670-058-130-002; 016-561-245-840-843; 017-862-081-633-623; 019-518-047-439-958; 024-871-528-163-268; 025-250-929-543-186; 025-861-575-052-189; 026-120-140-253-57X; 027-855-542-085-533; 032-733-373-495-27X; 037-588-803-488-031; 039-287-597-288-154; 041-021-095-489-38X; 042-388-295-589-737; 045-966-554-081-956; 050-282-859-374-390; 051-052-556-808-385; 052-334-665-352-77X; 057-444-997-372-987; 064-753-076-248-845; 064-809-826-416-132; 076-101-524-420-699; 087-605-418-830-06X; 094-845-242-002-901; 104-657-421-587-469; 145-522-530-847-994; 162-414-995-751-747; 165-663-772-698-594; 182-069-577-894-658,2
004-395-078-800-564,Nanomaterials in Diagnostic Pathology,2019-01-25,2019,,,,,,Amir Abbas Samani; Javad Yazdani,"Nanotechnology offers novel materials with new possessions and function for a variety of biomedical fields such as therapy, diagnostics, drug delivery, tissue engineering and biosensors. In nanotechnology field, big things are probable from really small things. The small size of nanomaterials helps them to interact with biomolecules to entree in different areas of the body by passing through intracellular spaces. Identifying DNA changes associated with cancer using nanotechnology and nanomaterials has been recently attained more attention from scientists",2,1,95,96,Engineering; Nanomaterials; Nanotechnology,,,,,,,,,2944436577,,0,,0
004-481-418-551-009,Intracellular signal modulation by nanomaterials.,2014-03-10,2014,journal article,Advances in experimental medicine and biology,00652598; 22148019,Springer New York,United States,Salik Hussain; Stavros Garantziotis; Fernando Rodrigues-Lima; Jean-Marie Dupret; Armelle Baeza-Squiban; Sonja Boland,"A thorough understanding of the interactions of nanomaterials with biological systems and the resulting activation of signal transduction pathways is essential for the development of safe and consumer friendly nanotechnology. Here we present an overview of signaling pathways induced by nanomaterial exposures and describe the possible correlation of their physicochemical characteristics with biological outcomes. In addition to the hierarchical oxidative stress model and a review of the intrinsic and cell-mediated mechanisms of reactive oxygen species (ROS) generating capacities of nanomaterials, we also discuss other oxidative stress dependent and independent cellular signaling pathways. Induction of the inflammasome, calcium signaling, and endoplasmic reticulum stress are reviewed. Furthermore, the uptake mechanisms can be of crucial importance for the cytotoxicity of nanomaterials and membrane-dependent signaling pathways have also been shown to be responsible for cellular effects of nanomaterials. Epigenetic regulation by nanomaterials, effects of nanoparticle-protein interactions on cell signaling pathways, and the induction of various cell death modalities by nanomaterials are described. We describe the common trigger mechanisms shared by various nanomaterials to induce cell death pathways and describe the interplay of different modalities in orchestrating the final outcome after nanomaterial exposures. A better understanding of signal modulations induced by nanomaterials is not only essential for the synthesis and design of safer nanomaterials but will also help to discover potential nanomedical applications of these materials. Several biomedical applications based on the different signaling pathways induced by nanomaterials are already proposed and will certainly gain a great deal of attraction in the near future.",811,,111,134,Nanotoxicology; Nanomaterials; Cell signaling; Nanomedicine; Chemistry; Calcium signaling; Inflammasome; Epigenetics; Signal transduction; Cell biology,,Animals; Cell Death/drug effects; Humans; Intracellular Space/metabolism; Nanostructures/chemistry; Oxidative Stress/drug effects; Protein Binding; Proteins/metabolism; Signal Transduction/drug effects,Proteins,Intramural NIH HHS (Z99 ES999999) United States; Intramural NIH HHS (ZIA ES102605-07) United States,https://pubmed.ncbi.nlm.nih.gov/24683030/ https://rd.springer.com/chapter/10.1007/978-94-017-8739-0_7 https://www.ncbi.nlm.nih.gov/pubmed/24683030 https://link.springer.com/chapter/10.1007/978-94-017-8739-0_7 https://www.researchgate.net/profile/Sonja_Boland/publication/261221804_Intracellular_Signal_Modulation_by_Nanomaterials/links/0046353bd6690ee5e1000000.pdf http://europepmc.org/articles/PMC4800813,http://dx.doi.org/10.1007/978-94-017-8739-0_7,24683030,10.1007/978-94-017-8739-0_7,153854370,PMC4800813,0,000-221-946-441-966; 000-573-899-458-536; 000-886-865-383-617; 001-601-482-882-923; 002-831-468-506-171; 003-436-064-526-703; 003-481-904-872-493; 003-573-450-888-543; 003-609-432-212-381; 003-767-664-311-294; 006-083-738-949-760; 006-283-391-792-800; 006-999-205-316-098; 007-307-019-922-963; 007-525-528-585-999; 007-736-037-782-437; 007-810-568-250-432; 008-665-690-111-602; 008-812-835-061-798; 008-817-677-488-333; 008-882-147-797-578; 009-307-233-872-330; 009-858-333-233-094; 010-080-498-340-825; 010-979-721-167-89X; 011-485-146-059-361; 012-471-091-553-483; 012-749-102-372-172; 013-202-076-096-22X; 013-305-662-702-140; 014-014-946-621-402; 014-670-058-130-002; 014-792-563-856-504; 015-250-813-798-459; 015-282-701-628-021; 015-386-296-605-550; 015-446-389-296-496; 015-595-642-348-704; 015-844-842-428-113; 016-170-777-741-397; 016-593-987-913-577; 016-822-190-593-074; 017-200-238-459-65X; 019-385-187-333-390; 019-577-655-026-313; 019-632-077-367-405; 020-205-607-855-174; 020-378-991-041-17X; 021-409-688-947-222; 021-950-851-099-477; 024-052-704-426-831; 024-119-668-050-26X; 028-184-976-926-864; 028-627-555-880-941; 029-397-597-797-084; 029-923-740-175-462; 030-585-645-242-096; 030-967-138-939-650; 031-336-534-191-504; 031-410-368-468-346; 031-633-185-596-546; 032-210-289-428-362; 032-239-472-273-249; 032-757-197-441-286; 032-785-495-578-406; 032-894-763-095-033; 033-063-087-329-402; 033-082-819-435-90X; 033-359-616-920-410; 033-874-923-796-903; 034-153-973-412-118; 034-190-872-873-612; 034-289-299-047-026; 034-654-230-713-791; 034-794-207-237-971; 034-828-144-196-932; 035-482-313-848-526; 035-821-051-449-982; 035-883-712-822-136; 035-901-781-251-214; 036-758-433-624-923; 037-554-489-734-226; 037-681-376-507-491; 038-552-421-329-993; 039-079-455-504-396; 039-820-394-196-754; 040-095-080-227-518; 040-425-944-732-44X; 040-492-217-005-385; 040-972-258-639-221; 040-975-994-540-24X; 041-084-944-568-540; 041-271-566-047-96X; 042-066-902-954-344; 042-186-788-498-870; 042-708-581-462-921; 043-441-000-059-429; 043-492-803-065-451; 043-977-506-192-45X; 044-815-611-277-652; 045-275-978-520-649; 045-634-262-109-645; 045-867-549-060-751; 046-472-858-673-340; 047-409-525-229-457; 047-473-194-400-630; 047-857-180-956-040; 048-399-088-620-158; 049-253-790-408-880; 050-130-023-756-329; 050-251-083-657-905; 051-032-271-658-987; 051-425-605-501-021; 051-798-691-140-761; 051-886-963-343-467; 051-954-145-574-871; 052-898-806-543-347; 052-949-325-448-186; 053-174-008-269-104; 053-813-821-406-499; 054-599-875-614-287; 055-915-594-317-68X; 057-027-873-517-139; 057-616-856-953-604; 058-510-434-993-623; 059-998-107-702-284; 060-127-441-815-315; 061-939-560-567-115; 063-447-699-872-79X; 064-366-143-789-300; 064-841-916-102-962; 065-280-766-931-042; 066-736-108-101-492; 067-054-473-966-10X; 067-169-654-795-91X; 067-332-453-353-020; 067-352-908-967-079; 070-008-573-854-894; 072-764-978-353-840; 072-807-187-280-830; 074-733-616-505-908; 075-164-138-186-787; 076-769-326-517-537; 077-295-718-367-819; 079-244-228-306-16X; 079-880-120-853-871; 081-186-271-412-661; 083-026-250-159-820; 083-143-633-445-253; 083-866-226-833-725; 083-876-864-898-434; 085-450-645-203-350; 088-356-237-553-544; 088-439-812-264-639; 088-821-411-776-470; 089-078-304-251-490; 089-650-730-415-798; 090-751-112-775-671; 094-935-658-814-101; 095-834-481-661-27X; 096-485-615-336-127; 096-539-544-596-95X; 099-623-416-351-377; 100-785-344-073-085; 104-536-401-994-357; 104-942-088-039-751; 105-561-738-840-135; 106-748-773-604-45X; 108-827-249-569-860; 111-214-716-558-471; 111-479-782-365-591; 114-398-204-387-54X; 114-703-896-822-386; 119-291-696-402-903; 121-225-190-044-527; 122-502-263-940-541; 123-376-834-440-623; 123-705-981-950-951; 124-062-427-843-518; 130-014-653-118-18X; 133-439-303-091-282; 134-358-966-538-235; 135-688-463-744-895; 137-263-696-986-181; 137-969-965-308-43X; 139-315-804-272-974; 141-970-214-443-123; 152-641-065-710-540; 156-611-146-468-264; 165-036-412-354-605; 176-251-692-898-56X,40
004-518-389-369-844,Nanomaterials and Their Applications in Bioimaging,2019-10-01,2019,book chapter,Plant Nanobionics,25238027; 25238035,Springer International Publishing,,Ruma Rani; Khushboo Sethi; Geeta Singh,"Nanomaterials have shown great potential in bioimaging, drug delivery, and targeted cancer therapies owing to their physicochemical properties and good biocompatibility. Among various clinical areas, bioimaging techniques based on nanomaterials have advanced very quickly with the development of nanoparticles with different functionalizations.",,,429,450,Nanomaterials; Nanoparticle; Nanotechnology; Materials science; Biocompatibility; Drug delivery; Graphene; Carbon nanotube,,,,,https://link.springer.com/chapter/10.1007%2F978-3-030-16379-2_15 https://rd.springer.com/chapter/10.1007/978-3-030-16379-2_15,http://dx.doi.org/10.1007/978-3-030-16379-2_15,,10.1007/978-3-030-16379-2_15,2977561153,,0,001-015-022-043-166; 002-468-279-253-183; 003-740-082-770-183; 005-265-803-556-332; 005-386-028-999-431; 006-364-630-174-554; 006-930-909-536-173; 007-845-808-677-786; 008-748-692-777-76X; 008-857-649-049-559; 009-778-684-932-778; 010-544-237-455-539; 010-824-063-478-71X; 011-327-026-962-480; 011-505-245-313-789; 011-672-668-976-937; 011-768-625-689-731; 011-895-973-571-424; 012-791-322-426-960; 013-046-200-535-620; 013-152-892-267-434; 013-766-438-077-880; 013-886-245-440-475; 014-286-034-228-340; 021-596-969-317-215; 021-855-192-205-428; 023-956-916-522-361; 025-272-848-026-723; 025-284-533-287-820; 025-345-381-010-123; 025-598-151-146-792; 026-034-336-339-42X; 026-110-971-522-399; 027-091-297-600-02X; 027-201-814-362-694; 027-286-034-301-853; 029-311-844-408-518; 029-906-989-530-111; 030-053-509-958-244; 030-435-934-592-806; 030-497-011-651-517; 031-934-145-017-764; 032-518-405-712-223; 033-896-984-246-865; 034-095-623-762-481; 035-288-141-465-174; 036-199-442-142-960; 036-409-043-190-618; 036-567-406-202-969; 036-578-053-453-570; 036-696-366-521-658; 036-989-471-271-661; 037-003-564-721-126; 037-267-227-076-639; 038-153-814-636-507; 038-217-064-324-415; 038-321-460-088-506; 041-058-726-253-816; 041-296-719-337-919; 041-607-975-768-801; 042-139-352-241-474; 043-479-153-210-349; 043-707-917-122-720; 044-181-705-954-958; 045-260-843-823-720; 047-178-654-389-240; 047-918-867-006-603; 047-948-221-303-737; 048-803-596-067-856; 048-873-857-391-878; 048-963-624-449-513; 050-495-080-789-428; 050-524-702-064-086; 051-106-582-710-374; 051-195-424-770-651; 051-511-417-779-318; 052-534-936-010-023; 052-708-327-843-211; 052-964-239-218-347; 053-488-926-596-747; 054-031-334-390-91X; 055-305-759-680-13X; 055-915-181-530-458; 057-961-633-765-769; 058-111-434-007-91X; 059-617-100-275-29X; 059-810-350-196-708; 060-016-617-268-641; 065-024-433-137-34X; 065-938-811-965-099; 066-351-724-560-863; 069-409-174-105-062; 070-238-190-282-183; 071-514-846-008-772; 071-635-933-586-977; 074-937-631-120-664; 075-264-563-001-868; 076-662-925-947-539; 076-678-185-102-026; 079-695-200-513-119; 080-661-600-925-294; 081-616-334-298-008; 081-944-135-453-282; 088-665-686-020-275; 091-381-624-398-372; 091-651-783-188-716; 094-516-168-005-209; 100-348-095-135-445; 102-374-646-727-247; 103-360-348-461-531; 103-604-786-684-426; 103-708-421-533-947; 107-076-431-620-449; 108-307-080-443-744; 112-379-978-292-417; 115-546-632-917-576; 117-955-553-920-822; 118-391-418-145-339; 118-948-053-653-618; 119-284-127-803-306; 121-824-726-371-740; 124-701-027-279-266; 124-845-835-125-452; 127-244-189-500-11X; 135-687-024-792-110; 138-103-361-917-735; 143-489-950-971-428; 152-424-315-447-95X; 167-184-646-533-865; 172-539-183-088-830; 173-311-451-322-52X; 176-879-632-604-017; 189-894-406-168-891; 193-325-017-259-209,2
004-550-463-057-540,Antibacterial properties and toxicity from metallic nanomaterials.,2017-05-24,2017,journal article,International journal of nanomedicine,11782013; 11769114,Dove Medical Press Ltd.,New Zealand,Gina V Vimbela; Sang M Ngo; Carolyn Fraze; Lei Yang; David A Stout,"The era of antibiotic resistance is a cause of increasing concern as bacteria continue to develop adaptive countermeasures against current antibiotics at an alarming rate. In recent years, studies have reported nanoparticles as a promising alternative to antibacterial reagents because of their exhibited antibacterial activity in several biomedical applications, including drug and gene delivery, tissue engineering, and imaging. Moreover, nanomaterial research has led to reports of a possible relationship between the morphological characteristics of a nanomaterial and the magnitude of its delivered toxicity. However, conventional synthesis of nanoparticles requires harsh chemicals and costly energy consumption. Additionally, the exact relationship between toxicity and morphology of nanomaterials has not been well established. Here, we review the recent advancements in synthesis techniques for silver, gold, copper, titanium, zinc oxide, and magnesium oxide nanomaterials and composites, with a focus on the toxicity exhibited by nanomaterials of multidimensions. This article highlights the benefits of selecting each material or metal-based composite for certain applications while also addressing possible setbacks and the toxic effects of the nanomaterials on the environment.",12,,3941,3965,Nanomaterials; Nanoparticle; Nanotechnology; Chemistry; Drug delivery; Antibacterial activity; Toxicity; Metal nanoparticles; Genetic therapy,antibacterial reagents; antibiotic resistance; drug delivery; metals; nanomaterials; nanoscale; nanostructure; synthesis; toxicity,Animals; Anti-Bacterial Agents/chemistry; Contrast Media; Copper/chemistry; Drug Liberation; Genetic Therapy; Gold/chemistry; Humans; Magnesium/chemistry; Metal Nanoparticles/chemistry; Silver/chemistry; Tissue Engineering; Titanium/chemistry; Zinc/chemistry,Anti-Bacterial Agents; Contrast Media; Silver; Gold; Copper; Titanium; Magnesium; Zinc,NIGMS NIH HHS (RL5 GM118978) United States; NIGMS NIH HHS (TL4 GM118980) United States; NIGMS NIH HHS (U54 GM119023) United States; NIGMS NIH HHS (UL1 GM118979) United States,https://doaj.org/article/0a6dcd2a4b654aad98b6c771d84bceec https://www.ncbi.nlm.nih.gov/pubmed/28579779 https://www.dovepress.com/getfile.php?fileID=36669 https://www.dovepress.com/antibacterial-properties-and-toxicity-from-metallic-nanomaterials-peer-reviewed-fulltext-article-IJN https://www.europepmc.org/articles/PMC5449158/ https://pubmed.ncbi.nlm.nih.gov/28579779/,https://www.ncbi.nlm.nih.gov/pubmed/28579779,28579779,,2620160911,PMC5449158,0,000-183-913-887-895; 001-020-515-822-439; 001-304-645-444-442; 001-879-494-178-171; 002-426-000-849-487; 003-562-213-261-647; 004-629-751-693-64X; 005-379-965-367-898; 007-632-696-884-254; 007-705-170-784-050; 008-029-987-570-933; 008-493-324-743-759; 009-226-182-114-702; 009-809-663-113-772; 010-188-554-918-340; 011-990-877-225-164; 012-321-631-495-47X; 013-157-050-640-696; 013-590-541-869-863; 013-603-493-516-229; 013-979-947-369-055; 014-588-741-086-269; 014-827-603-740-571; 016-743-984-882-825; 019-175-079-556-110; 019-673-302-084-358; 020-612-623-041-777; 020-748-347-239-156; 021-998-832-360-273; 022-892-313-659-194; 024-522-974-095-861; 024-555-507-801-430; 024-813-655-718-574; 025-408-040-533-490; 026-552-457-361-914; 026-702-694-386-016; 027-269-489-522-519; 028-350-486-262-349; 029-023-316-581-409; 030-708-072-860-029; 030-878-258-415-451; 031-023-512-075-214; 031-948-346-066-80X; 032-382-262-966-161; 033-140-749-934-369; 033-689-836-831-630; 034-129-318-445-669; 034-509-791-755-026; 034-511-758-584-205; 034-976-879-986-278; 035-540-364-544-373; 035-686-900-902-536; 036-765-949-833-019; 038-659-950-107-843; 039-548-614-259-199; 040-485-470-286-525; 042-743-133-921-841; 042-938-641-939-191; 043-988-353-063-983; 044-171-502-872-996; 045-882-475-973-448; 046-625-488-498-147; 046-962-667-473-479; 048-551-543-576-894; 049-727-499-154-434; 050-631-874-851-098; 051-021-590-630-451; 052-906-550-581-629; 055-586-277-339-522; 057-029-966-096-918; 058-926-178-549-441; 059-757-962-901-80X; 060-659-051-081-94X; 062-280-769-183-562; 065-918-483-173-747; 066-043-143-759-757; 068-169-475-482-21X; 070-874-781-289-261; 073-245-562-977-205; 073-958-382-638-96X; 074-664-776-582-439; 076-514-208-050-054; 077-090-575-372-055; 078-357-097-875-606; 080-948-163-342-362; 080-949-517-898-881; 082-537-461-791-613; 091-030-027-554-408; 093-090-075-423-645; 094-862-294-303-065; 095-314-129-148-208; 096-479-747-942-048; 096-555-980-330-541; 097-883-685-517-935; 098-192-141-295-020; 102-041-151-004-316; 107-363-708-120-095; 110-431-510-060-023; 113-013-231-506-245; 113-145-828-034-724; 114-350-330-046-620; 117-478-364-808-760; 119-789-448-915-679; 122-893-762-308-381; 132-082-632-353-858; 133-299-450-790-524; 139-993-426-403-748; 141-763-493-695-427; 142-783-559-636-177; 143-099-137-174-852; 144-140-374-278-346; 144-258-075-214-872; 157-206-082-943-931,199
004-582-984-134-317,Engineering Sensors to Investigate the Intracellular Trafficking of Nanomaterials,2018-05-10,2018,dissertation,,,,,Laura Ina Selby,"Nanomaterials are a promising avenue to address issues associated with traditional drug delivery. Drug encapsulation and targeting has the potential to direct cargo to specific cell types, avoiding off-target effects while offering protection to delicate therapeutics. However, our understanding of how cells interact with nanomaterials is lacking. This thesis details the design and synthesis of fluorescent sensors to study the uptake and trafficking of nanomaterials within cells. In addition, a mathematical process is detailed for improving flow cytometry data analysis. Together, this set of tools can be used to improve the understanding of how nanomaterials interact with cells.",,,,,Nanomaterials; Nanotechnology; Chemistry; Drug delivery; Endocytosis; Drug encapsulation; Mathematical process; Cell specific; Flow cytometry; Intracellular,,,,,https://bridges.monash.edu/articles/thesis/Engineering_Sensors_to_Investigate_the_Intracellular_Trafficking_of_Nanomaterials/6244109,https://bridges.monash.edu/articles/thesis/Engineering_Sensors_to_Investigate_the_Intracellular_Trafficking_of_Nanomaterials/6244109,,,3151868272,,0,,0
004-591-540-817-808,Smart Nanomaterials for Tumor Targeted Hyperthermia,,2020,book chapter,Intelligent Nanomaterials for Drug Delivery Applications,,Elsevier,,Jaidip Jagtap; Abdul K. Parchur; Gayatri Sharma,"Abstract Recent development in nanomaterial has shown great potential for tumor diagnostic and therapeutic applications in hyperthermia. Nanomaterials design, and characteristics plays pivotal role as drug carrier, tumor-focused and controlled release to enhance permeability and retention effect. Hyperthermia technique is based on heat generation and the possible nanomaterial characteristics allows photothermal ablation, magnetic hyperthermia, radiofrequency ablation and ultrasound hyperthermia. Progress in hyperthermia has been reviewed, discussed and summarized for each method. Hyperthermia can be combined with anticancer drugs or chemotherapy to enhance the cancer treatment. Multifunctional nanomaterials are taking attention and now being widely probed to achieve personalized and targeted cancer treatments. In the last, we have listed the challenges associated with hyperthermia treatment with scope of future prospective which could attract researchers and engineers from biomaterial, biomedical and physiological fields.",,,43,59,Nanomaterials; Nanotechnology; Hyperthermia; Magnetic hyperthermia; Hyperthermia Treatment; Photothermal ablation; Cancer treatment; Heat generation; Tumor targeted; Medicine,,,,,https://www.sciencedirect.com/science/article/pii/B9780128178300000035,http://dx.doi.org/10.1016/b978-0-12-817830-0.00003-5,,10.1016/b978-0-12-817830-0.00003-5,3023827774,,0,000-833-383-585-639; 001-046-414-056-814; 002-100-464-184-815; 003-005-058-047-381; 003-145-278-259-874; 003-175-852-645-428; 004-434-438-519-653; 005-181-816-432-752; 005-208-449-859-996; 006-337-745-071-279; 006-928-481-767-831; 007-335-832-558-795; 007-602-654-882-819; 008-883-207-405-922; 009-918-093-522-787; 010-234-141-613-279; 010-952-253-390-731; 011-749-512-567-232; 012-298-980-739-572; 012-737-052-169-601; 012-834-437-227-82X; 013-332-233-158-97X; 015-690-266-835-052; 016-069-545-028-668; 017-011-748-188-797; 017-946-940-877-852; 018-280-386-218-400; 018-759-808-232-726; 018-789-910-831-693; 018-908-244-646-54X; 019-136-795-982-40X; 019-275-108-337-178; 019-551-796-375-984; 020-030-421-014-80X; 020-678-483-002-582; 021-331-823-495-541; 022-075-209-342-445; 022-656-148-736-568; 022-777-155-222-013; 025-481-038-588-741; 025-542-391-277-22X; 028-080-546-828-926; 029-461-723-547-144; 031-595-392-372-604; 032-184-408-351-454; 032-350-452-824-387; 032-465-142-332-90X; 034-037-929-399-931; 034-292-312-384-893; 034-348-527-824-059; 036-485-171-916-705; 036-607-169-502-59X; 036-659-424-717-18X; 037-029-451-226-634; 039-998-984-749-441; 041-521-976-791-408; 041-795-394-265-510; 043-145-903-676-456; 044-098-123-853-017; 045-239-488-315-361; 047-114-251-704-573; 047-697-264-192-586; 047-817-424-187-609; 048-388-939-071-123; 049-025-705-707-161; 049-175-388-137-727; 050-739-968-186-353; 051-688-833-903-975; 052-203-132-427-265; 052-602-693-324-168; 053-008-668-152-602; 053-268-672-465-24X; 054-095-645-678-665; 056-442-566-254-692; 057-406-256-291-39X; 057-656-168-037-625; 057-760-405-123-78X; 058-953-355-918-521; 060-883-514-824-751; 061-757-907-136-641; 062-460-421-873-384; 063-187-674-328-175; 063-244-058-645-909; 064-591-456-939-358; 064-685-185-416-973; 065-176-314-763-260; 066-763-887-477-66X; 067-764-499-905-061; 071-608-544-656-27X; 073-349-585-860-831; 075-226-254-987-160; 076-913-139-588-894; 079-072-159-115-010; 079-262-023-887-289; 080-229-541-322-713; 081-078-909-813-969; 091-581-697-237-242; 096-254-562-784-402; 097-122-877-161-017; 114-702-307-525-451; 115-069-239-599-015; 117-910-504-340-953; 119-972-783-803-629; 121-118-002-095-375; 122-284-724-807-039; 122-309-308-527-394; 125-435-185-318-053; 133-754-565-566-524; 134-366-827-921-744; 137-779-888-844-468; 142-105-191-029-80X; 143-760-354-283-130; 149-505-749-184-313; 156-243-197-364-493,3
004-651-028-094-972,Functional Nanomaterials and Their Potential Applications in Antibacterial Therapy.,2019-06-10,2019,journal article,Pharmaceutical nanotechnology,22117393; 22117385,Bentham Science Publishers Ltd.,United Arab Emirates,Le Hong; Shu-Han Luo; Chen-Hao Yu; Yu Xie; Meng-Ying Xia; Ge-Yun Chen; Qiang Peng,"In the past decades, nanomaterials have shown great potential in biomedical fields, especially in drug delivery, imaging and targeted therapy. Recently, the development of novel functional nanomaterials for antibacterial application has attracted much attention. Compared to the traditional direct use of antibiotics, antibacterial nanomaterials either as drug delivery systems or active agents have a higher efficacy and lower side effects. Herein, we will focus on the antibacterial applications of four commonly used nanomaterials, including metal-based nanomaterials, polymeric nanoparticles, graphene oxides or carbon-based nanomaterials and nanogels.",7,2,129,146,Nanomaterials; Nanotechnology; Materials science; Drug delivery; Antibacterial therapy; Polymeric nanoparticles,Antimicrobial; drug delivery; infection; microbiology; nanomaterials; nanoparticles.,"Anti-Bacterial Agents/chemistry; Drug Carriers/chemistry; Drug Compounding; Drug Resistance, Microbial/drug effects; Gels/chemistry; Graphite/chemistry; Humans; Lipids/chemistry; Nanoparticles/chemistry",Anti-Bacterial Agents; Drug Carriers; Gels; Lipids; graphene oxide; Graphite,Sichuan University; Excellent Young Scientist Foundation of Sichuan University; National Natural Science Foundation of China; National Natural Science Foundation of China,https://www.ncbi.nlm.nih.gov/pubmed/30894114 https://pubmed.ncbi.nlm.nih.gov/30894114/ https://www.eurekaselect.com/170882/article,http://dx.doi.org/10.2174/2211738507666190320160802,30894114,10.2174/2211738507666190320160802,2924597235,,0,000-575-862-564-262; 000-653-283-458-941; 001-051-999-149-480; 001-390-057-920-901; 001-644-186-433-269; 002-609-017-186-642; 003-490-568-316-547; 004-160-779-770-998; 005-915-263-010-698; 006-856-320-585-244; 008-989-902-261-84X; 009-859-712-814-598; 010-317-580-594-931; 010-355-657-859-078; 010-377-875-574-705; 012-397-796-553-093; 013-796-974-643-898; 017-288-668-971-732; 017-696-845-025-062; 019-312-429-920-321; 020-135-504-234-550; 020-844-719-406-796; 020-981-565-582-404; 022-038-364-433-598; 022-916-573-113-28X; 023-257-097-665-20X; 023-335-603-769-169; 023-478-487-962-030; 023-562-015-757-145; 025-512-277-624-294; 026-125-527-512-671; 027-411-103-504-284; 027-493-288-859-744; 028-101-520-752-37X; 029-307-416-884-84X; 030-649-798-531-905; 031-122-032-716-864; 031-125-711-661-125; 031-265-533-694-286; 031-647-293-130-214; 033-875-555-682-017; 035-092-066-298-198; 035-290-065-979-191; 035-345-568-919-479; 035-622-926-795-422; 035-774-455-733-374; 037-133-126-185-074; 038-600-357-950-841; 040-471-534-521-68X; 043-056-075-258-579; 043-351-313-393-090; 043-477-496-960-396; 045-155-362-556-84X; 047-043-085-320-914; 047-659-185-838-476; 048-133-669-783-176; 048-525-703-059-281; 049-955-899-663-523; 050-411-787-604-975; 052-073-165-330-627; 053-006-956-722-463; 057-378-792-353-931; 058-887-486-636-433; 062-763-850-370-863; 064-028-452-283-416; 065-889-948-970-691; 066-020-473-284-983; 066-513-017-190-778; 067-788-515-537-665; 069-654-537-596-489; 071-468-198-380-351; 073-990-967-743-319; 076-212-504-882-740; 077-697-022-262-068; 078-890-382-451-971; 082-275-232-350-470; 084-080-912-670-69X; 084-421-259-725-936; 084-861-541-913-286; 091-145-699-004-396; 094-488-424-798-266; 095-078-697-273-275; 096-968-576-946-577; 101-799-680-854-44X; 104-123-837-316-279; 105-565-880-716-731; 109-006-225-548-545; 109-426-924-756-854; 111-210-354-428-611; 118-040-014-248-994; 120-484-724-353-990; 122-002-535-366-547; 127-560-667-997-760; 128-404-774-035-77X; 133-413-424-186-442; 133-652-377-790-329; 138-878-224-590-75X; 145-674-979-762-475; 149-016-653-346-130; 149-451-012-917-876; 162-307-684-859-802; 171-035-138-242-821; 174-007-570-033-069; 179-408-681-473-429; 181-132-037-506-952; 190-346-532-037-970; 194-618-795-085-01X,8
004-789-040-531-380,Microwave-Assisted Synthesis for Carbon Nanomaterials,,2019,book chapter,Nanomaterials Synthesis,,Elsevier,,Sabzoi Nizamuddin; Sadaf Aftab Abbasi; Abdul Sattar Jatoi; M.T.H. Siddiqui; Humair Ahmed Baloch; Nabisab Mujawar Mubarak; Gregory Griffin; Ezzat Chan Abdullah; Khadija Qureshi; Rama Rao Karri,"Abstract Microwave-assisted synthesis is an enabling technology that has been extensively used in carbon nanomaterials and organic material synthesis. Microwave-enhanced modification of carbon nanomaterials is a noninvasive, simple, fast, environmentally friendly, and clean method as compared to traditional methods. The microwave facilitates and accelerates the reaction, often improving relative yield. In this chapter, a very brief summary of synthesis of carbon nanomaterials is discussed. Hence, microwave-assisted carbon nanomaterials seem to be the most promising method for possible industrial scale up due to the relatively low growth temperature, high surface area, high adsorption capacity, low pollution, and energy saving.",,,121,147,Adsorption; Nanotechnology; Environmentally friendly; Materials science; Material synthesis; Carbon nanomaterials; Industrial scale; Relative yield; Microwave assisted; High surface area,,,,,https://www.sciencedirect.com/science/article/pii/B9780128157510000055,http://dx.doi.org/10.1016/b978-0-12-815751-0.00005-5,,10.1016/b978-0-12-815751-0.00005-5,2955628852,,0,001-302-562-575-130; 003-286-024-157-121; 003-516-169-116-217; 003-516-970-248-389; 003-702-884-093-789; 003-872-870-031-335; 004-161-572-536-824; 004-377-330-992-168; 005-375-704-309-173; 009-522-510-000-285; 009-661-863-203-66X; 009-986-902-724-202; 013-180-044-196-176; 013-576-119-526-75X; 015-429-475-669-143; 016-561-801-903-850; 018-197-305-685-481; 018-679-380-542-407; 018-683-258-658-600; 018-736-344-629-765; 019-827-107-362-42X; 020-300-141-574-543; 021-875-392-327-997; 024-003-531-487-917; 024-173-769-411-666; 025-492-240-540-980; 026-928-804-388-277; 028-592-640-843-38X; 029-135-404-439-273; 029-336-316-308-071; 029-979-728-340-86X; 034-979-008-840-509; 035-654-470-426-907; 036-597-667-124-708; 038-793-415-243-277; 039-154-963-222-755; 039-962-240-517-985; 040-667-612-593-027; 040-946-145-264-356; 041-849-313-218-167; 041-929-077-183-467; 045-053-016-236-838; 045-777-063-030-537; 046-467-860-290-799; 047-248-474-640-486; 047-396-917-640-106; 048-370-403-322-988; 048-480-443-566-896; 049-231-723-907-439; 050-359-510-075-390; 050-481-151-146-079; 054-194-737-616-473; 054-299-647-461-667; 055-657-506-570-062; 059-157-078-449-77X; 059-444-627-150-765; 064-388-240-159-770; 066-391-583-533-453; 070-120-862-432-006; 072-781-653-046-273; 076-186-764-762-466; 077-573-762-051-632; 078-545-063-184-995; 083-123-073-008-89X; 084-000-404-241-132; 086-005-547-923-881; 086-786-633-171-844; 087-540-713-700-386; 087-863-786-428-869; 090-767-416-952-821; 090-805-112-655-101; 090-893-886-957-448; 091-340-334-151-848; 094-004-013-093-33X; 094-753-132-219-247; 094-914-265-986-778; 095-643-159-956-385; 096-221-158-018-596; 096-498-367-918-816; 098-117-555-344-187; 098-672-393-094-498; 098-687-393-925-652; 098-914-649-654-911; 100-529-174-129-118; 103-172-950-054-260; 105-490-093-975-220; 106-512-974-924-82X; 108-959-292-926-928; 109-750-086-087-683; 111-132-485-070-92X; 111-428-676-790-009; 112-269-774-297-518; 113-613-475-258-670; 126-202-488-178-800; 127-235-247-936-380; 129-484-622-313-08X; 129-722-692-834-324; 129-990-584-513-962; 131-054-273-141-815; 131-712-353-939-028; 131-839-546-609-904; 144-765-077-749-885; 148-087-954-925-920; 153-117-281-896-058; 156-029-822-946-409; 165-246-036-130-469; 173-136-810-733-414; 177-477-026-765-288; 179-010-835-918-938; 180-624-510-857-905; 180-824-588-848-343; 181-867-047-035-995; 184-590-565-201-690; 196-545-467-933-591,1
004-954-188-302-927,Introduction to Nanomaterials,2016-03-15,2016,book chapter,Advances in Nanomaterials,18698433; 18698441,Springer India,United States,Zishan H. Khan; Avshish Kumar; Samina Husain; M.F Husain,"The applications of nanomaterials have been enormous, which not only encompasses a single discipline but it stretches across the whole spectrum of science right from agricultural science to space technology. New approaches to synthesize nanomaterials in order to design new devices and processes are being developed and the techniques of fabrication of nanomaterials involve analyzing and controlling the matter at atomic scales. This fascinating research field has started a new era of integration of basic research and advanced technology at the atomic scale which has a potential to bring the technological innovations at highest level. The rudimentary capabilities of nanomaterials today are envisioned to evolve in our overlapping generations of nanotechnology products: passive nanostructures, active nanostructures, systems of nanosystems, and molecular nanosystems. This chapter presents the basic introduction to nanomaterials and their popular applications.",,,1,23,Engineering; Nanomaterials; Nanotechnology; Basic research,,,,,https://link.springer.com/chapter/10.1007/978-81-322-2668-0_1 https://link.springer.com/chapter/10.1007/978-81-322-2668-0_1/fulltext.html https://rd.springer.com/chapter/10.1007/978-81-322-2668-0_1,http://dx.doi.org/10.1007/978-81-322-2668-0_1,,10.1007/978-81-322-2668-0_1,2415077372,,0,,27
004-972-547-540-951,Nanomaterials in cosmetics--present situation and future,2014-01-01,2014,journal article,Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,13475231; 00316903,Pharmaceutical Society of Japan,Japan,Takuji Masunaga,"Cosmetics are consumer products intended to contribute to increasing quality of life and designed for long-term daily use. Due to such features of cosmetics, they are required to ensure quality and safety at a high level, as well as to perform well, in response to consumers' demands. Recently, the technology associated with nanomaterials has progressed rapidly and has been applied to various products, including cosmetics. For example, nano-sized titanium dioxide has been formulated in sunscreen products in pursuit of improving its performance. As some researchers and media have expressed concerns about the safety of nanomaterials, a vague feeling of anxiety has been raised in society. In response to this concern, the Japan Cosmetic Industry Association (JCIA) has begun original research related to the safety assurance of nanomaterials formulated in cosmetics, to allow consumers to use cosmetics without such concerns. This paper describes the activities of the JCIA regarding safety research on nanomaterials, including a survey of the actual usage of nanomaterials in cosmetics, analysis of the existence of nanomaterials on the skin, and assessment of skin carcinogenicity of nano-sized titanium dioxide. It also describes the international status of safety assurance and regulation regarding nanomaterials in cosmetics.",134,1,39,43,Safety assurance; Risk analysis (engineering); Business; Cosmetic industry; Quality (business); Cosmetics; Original research,,"Cosmetics; Health Care Sector; Humans; Nanostructures/administration & dosage; Skin/drug effects; Societies, Pharmaceutical; Titanium/chemistry",Cosmetics; titanium dioxide; Titanium,,https://pubmed.ncbi.nlm.nih.gov/24389615/ https://www.jstage.jst.go.jp/article/yakushi/134/1/134_13-00209-3/_pdf http://www.ncbi.nlm.nih.gov/pubmed/24389615 https://jglobal.jst.go.jp/en/detail?JGLOBAL_ID=201902216524485852,http://dx.doi.org/10.1248/yakushi.13-00209-3,24389615,10.1248/yakushi.13-00209-3,2335136508,,0,034-388-682-384-491; 094-326-360-659-213,4
005-086-358-318-913,The Role of Nanomaterials in the Treatment of Diseases and Their Effects on the Immune System.,2019-06-14,2019,journal article,Open access Macedonian journal of medical sciences,18579655,ID Design 2012/DOOEL Skopje,North Macedonia,Razieh Rezaei; Mohsen Safaei; Hamid Reza Mozaffari; Hedaiat Moradpoor; Sara Karami; Amin Golshah; Behroz Salimi; Hossein Karami,"Nanotechnology has been widely exploited in recent years in various applications. Different sectors of medicine and treatment have also focused on the use of nanoproducts. One of the areas of interest in the treatment measures is the interaction between nanomaterials and immune system components. Engineered nanomaterials can stimulate the inhibition or enhancement of immune responses and prevent the detection ability of the immune system. Changes in immune function, in addition to the benefits, may also lead to some damage. Therefore, adequate assessment of the novel nanomaterials seems to be necessary before practical use in treatment. However, there is little information on the toxicological and biological effects of nanomaterials, especially on the potential ways of contacting and handling nanomaterials in the body and the body response to these materials. Extensive variation and different properties of nanomaterials have made it much more difficult to access their toxicological effects to the present. The present study aims to raise knowledge about the potential benefits and risks of using the nanomaterials on the immune system to design and safely employ these compounds in therapeutic purposes.",7,11,1884,1890,Nanotoxicology; Nanomaterials; Nanomedicine; Biochemical engineering; Engineered nanomaterials; Medicine; Immune system,Autoimmune diseases; Immune system; Nanomaterials; Nanomedicine; Nanotoxicology,,,,https://oamjms.eu/index.php/mjms/article/download/oamjms.2019.486/3483 https://europepmc.org/article/MED/31316678 https://pubmed.ncbi.nlm.nih.gov/31316678/ https://www.id-press.eu/mjms/article/download/oamjms.2019.486/3483 https://oamjms.eu/index.php/mjms/article/view/oamjms.2019.486 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6614262 https://core.ac.uk/download/211049749.pdf,http://dx.doi.org/10.3889/oamjms.2019.486,31316678,10.3889/oamjms.2019.486,2950568772,PMC6614262,0,002-701-337-630-791; 002-843-736-993-42X; 003-153-151-595-395; 007-052-678-930-762; 007-082-007-491-874; 008-664-268-835-790; 008-922-844-523-058; 011-961-499-018-404; 012-704-952-634-184; 013-325-978-144-657; 013-339-094-749-818; 014-378-307-729-502; 017-699-414-449-027; 017-712-268-997-984; 018-332-918-113-637; 018-800-308-129-433; 020-431-083-782-028; 020-770-663-952-122; 024-962-486-024-860; 025-124-809-339-01X; 026-840-288-731-270; 028-750-039-435-028; 029-701-588-093-441; 031-918-819-474-508; 033-671-663-924-111; 034-178-572-136-723; 035-817-719-333-305; 036-176-151-592-644; 037-378-584-425-480; 039-663-518-169-699; 039-663-694-097-516; 040-243-257-373-441; 041-203-994-856-267; 042-680-229-950-537; 043-245-414-103-225; 045-309-917-906-76X; 050-193-932-308-898; 051-204-128-728-557; 053-389-138-566-041; 060-549-173-427-85X; 063-203-691-968-390; 063-801-032-910-830; 064-161-867-482-719; 069-652-175-679-850; 076-685-427-562-961; 080-671-865-057-831; 080-918-755-935-586; 086-375-900-643-214; 086-631-246-695-932; 088-750-687-323-40X; 091-485-631-422-015; 097-774-276-594-689; 099-390-134-287-368; 100-498-571-312-726; 106-682-592-840-542; 112-770-489-590-458; 113-101-937-538-660; 113-481-201-375-034; 117-524-109-570-606; 125-028-551-632-256; 125-907-641-517-359; 145-890-166-698-492; 148-448-314-529-023; 160-180-000-996-155; 180-012-279-545-396; 181-283-844-802-326,9
005-121-729-342-148,Antimicrobial and biocompatible properties of nanomaterials.,2014-01-01,2014,journal article,Journal of nanoscience and nanotechnology,15334880; 15334899,American Scientific Publishers,United States,Mazhar Ul-Islam; Adeeb Shehzad; Shaukat Khan; Waleed Ahmad Khattak; Muhammad Wajid Ullah; J K Park,"The rapid development of drug-resistant characteristics in pathogenic viral, bacterial, and fungal species and the consequent spread of infectious diseases are currently receiving serious attention. Indeed, there is a pressing demand to explore novel materials and develop new strategies that can address these issues of serious concern. Nanomaterials are currently proving to be the most capable therapeutic agents to cope with such hazards. The exceptional physiochemical properties and impressive antimicrobial capabilities of nanoparticles have provoked their utilization in biomedical fields. Nanomaterials of both organic and inorganic nature have shown the capabilities of disrupting microbial cells through different mechanisms. Along with the direct influence on the microbial cell membrane, DNA and proteins, these nanomaterials produce reactive oxygen species (ROS) that damage cell components and viruses. Currently, a serious hazard associated with these antimicrobial nanomaterials is their toxicity to human and animal cells. Extensive studies have reported the dose, time, and cell-dependent toxicology of various nanomaterials, and some have shown excellent biocompatible properties. Nevertheless, there is still debate regarding the use of nanomaterials for medical applications. Therefore, in this review, the antimicrobial activities of various nanomaterials with details of their acting mechanisms were compiled. The relative toxic and biocompatible behavior of nanomaterials emphasized in this study provides information pertaining to their practical applicability in medical fields.",14,1,780,791,Biocompatible material; Nanomaterials; Nanotechnology; Materials science; Antimicrobial,,Animals; Anti-Infective Agents/administration & dosage; Bacterial Physiological Phenomena/drug effects; Biocompatible Materials/administration & dosage; Cell Survival/drug effects; Fungi/drug effects; Humans; Nanostructures/administration & dosage,Anti-Infective Agents; Biocompatible Materials,,https://pubmed.ncbi.nlm.nih.gov/24730297/ https://www.ncbi.nlm.nih.gov/pubmed/24730297,http://dx.doi.org/10.1166/jnn.2014.8761,24730297,10.1166/jnn.2014.8761,2317710118,,0,,19
005-174-657-929-001,Inorganic Nanomaterials for Enhanced Therapeutic Safety,2020-08-20,2020,book chapter,Nanopharmaceuticals: Principles and Applications Vol. 3,22137114; 22137122,Springer International Publishing,,Sunaina Indermun; Mershen Govender; Pradeep Kumar; Yahya E. Choonara; Viness Pillay,"Background/issues: Nanomaterials have been effectively and widely utilized in a variety of scientific disciplines to enhance biomedical applications. These nanomaterials are often organic or inorganic and often comprised of polymers or metal derivatives. The therapeutic safety of these often-toxic materials, however, is of paramount importance to ensure therapeutic safety. The safety of nanomaterials is therefore a widely undertaken research discipline evaluated both in vitro and in vivo. Major advances: This review provides for the currently undertaken research for the determination of therapeutic safety in inorganic nanomaterials. The importance of therapeutic safety, toxicity, and regulation of nanomaterials has been provided prior to the review of the respective nanomaterials. Specific focus has been given to metal-derived nanomaterials including gold, silver, silica, copper, iron, zinc, and titanium nanomaterials. Toxicology profiling and cytotoxicity studies of these nanomaterials have also been provided in addition to the in vivo studies that have been undertaken and the potential for alternative nanomaterial safety assessments.",,,1,24,Engineering; Nanomaterials; Nanotechnology; Scientific disciplines,,,,,https://link.springer.com/chapter/10.1007/978-3-030-47120-0_1,http://dx.doi.org/10.1007/978-3-030-47120-0_1,,10.1007/978-3-030-47120-0_1,3053208991,,0,000-724-668-845-729; 000-777-916-997-713; 001-013-136-413-082; 002-240-030-141-767; 002-407-073-295-936; 002-607-885-249-165; 006-706-859-332-589; 007-227-709-900-147; 008-374-424-488-298; 009-962-303-846-244; 010-291-183-418-341; 010-471-908-185-791; 011-005-809-270-921; 012-181-728-217-888; 012-306-484-748-725; 012-704-952-634-184; 012-847-724-161-90X; 013-409-469-359-690; 016-593-987-913-577; 018-912-584-493-414; 019-642-700-619-520; 019-995-574-026-41X; 020-439-078-701-453; 022-776-684-708-479; 024-080-075-203-86X; 024-289-116-269-396; 025-316-402-802-021; 029-206-953-173-266; 029-990-265-953-332; 031-977-991-106-133; 032-954-563-707-965; 033-011-307-248-758; 033-049-594-382-186; 033-671-663-924-111; 035-016-442-998-493; 035-180-921-348-775; 035-919-228-575-462; 036-171-190-090-310; 037-223-701-080-105; 037-603-700-071-893; 039-563-070-650-899; 042-066-902-954-344; 043-669-425-858-26X; 047-381-255-454-838; 047-759-321-403-417; 047-878-861-403-524; 048-630-799-878-058; 048-777-649-153-613; 050-540-624-520-436; 052-777-189-339-234; 053-257-527-814-518; 053-871-566-238-592; 056-872-605-811-229; 058-416-352-496-93X; 059-032-529-275-66X; 060-403-772-871-31X; 061-922-255-985-336; 062-299-725-315-607; 064-542-843-441-022; 066-163-244-535-003; 068-172-897-599-562; 070-019-416-061-835; 074-143-903-542-613; 074-861-984-373-503; 074-937-631-120-664; 075-618-504-633-553; 076-877-267-350-121; 077-174-111-309-857; 079-438-750-077-895; 079-609-744-811-233; 082-245-768-945-512; 082-548-829-407-485; 086-528-928-858-713; 087-574-721-169-607; 095-020-045-809-183; 103-812-414-163-28X; 108-296-714-722-964; 108-986-548-721-437; 109-995-214-632-195; 112-990-824-814-530; 114-307-143-882-574; 116-998-108-867-908; 122-487-862-603-253; 123-011-906-498-962; 123-384-739-369-97X; 125-519-778-401-328; 129-328-203-204-79X; 130-797-714-746-782; 132-419-216-819-47X; 134-163-624-571-318; 136-510-871-760-761; 137-994-795-755-185; 139-779-488-024-439; 145-616-820-991-916; 146-362-803-998-285; 150-512-405-542-982; 152-277-361-338-917; 157-626-165-083-085; 162-942-502-939-661; 163-154-953-231-194; 173-050-719-708-616; 183-309-451-192-593; 195-534-000-475-70X; 198-808-626-678-343,0
005-184-987-757-221,Magnetic Nanomaterials and Their Applications.,2014-06-23,2014,journal article,"Nanomaterials (Basel, Switzerland)",20794991,,Switzerland,Yurii K. Gun'ko,"This Special Issue of Nanomaterials is dedicated to the development of new magnetic nanomaterials and their applications in biomedicine, catalysis, spintronics and other areas. The publications in this Issue demonstrate that the interest in magnetic nanomaterials is continuously growing and their realm is expanding rapidly. Some highlights of the publications in this issue are discussed below. [...]",4,2,505,507,Nanomaterials; Nanotechnology; Materials science,,,,,https://www.mdpi.com/2079-4991/4/2/505/pdf https://www.mdpi.com/2079-4991/4/2/505 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5304660 http://europepmc.org/abstract/MED/28344234 https://core.ac.uk/display/27239058 http://core.ac.uk/display/27239058,http://dx.doi.org/10.3390/nano4020505,28344234,10.3390/nano4020505,2039311777,PMC5304660,0,003-800-425-512-998; 008-142-135-385-513; 014-848-964-557-142; 019-907-188-483-767; 040-721-239-292-641; 048-573-670-940-879; 073-973-177-223-816,1
005-252-340-649-571,Nanomaterials and Oxidative Stress,2018-04-03,2018,journal article,Challenges,20781547,MDPI AG,,Vytas Reipa; Donald H. Atha,"With the rapid development of new nanomaterials, it was recognized early that together with their beneficial properties, nanomaterials may pose a risk to human health and the environment. Evidence has accumulated over the last twenty years in support of oxidative stress as a broad mechanistic concept to explain the interaction of engineered nanoparticles with biological substances. As oxidative stress as a physiological response was recognized in redox biology, its wide-ranging use in nanotoxicology has exposed new challenges and limitations. In this commentary, we review certain oxidative stress concepts and their relevance to nanotoxicology.",9,1,17,,Nanotoxicology; Nanomaterials; Nanotechnology; Chemistry; Oxidative stress; Biological substances; Human health; Engineered nanoparticles,,,,National Institute of Standards and Technology,https://www.mdpi.com/2078-1547/9/1/17 https://ideas.repec.org/a/gam/jchals/v9y2018i1p17-d139293.html https://www.mdpi.com/2078-1547/9/1/17/pdf https://core.ac.uk/display/153597941,http://dx.doi.org/10.3390/challe9010017,,10.3390/challe9010017,2795501824,,0,000-240-335-592-822; 002-828-175-026-441; 004-030-819-748-387; 008-425-492-886-754; 009-988-904-383-308; 011-656-302-727-186; 014-505-496-682-238; 016-790-672-427-892; 020-119-519-849-46X; 022-017-017-099-561; 022-842-985-770-914; 026-721-772-679-513; 027-020-845-678-920; 027-034-763-765-542; 027-785-736-913-965; 028-330-806-835-831; 028-517-793-741-800; 029-132-838-049-607; 030-974-160-097-336; 049-695-653-444-576; 050-977-446-073-961; 053-080-572-641-336; 054-287-314-652-299; 056-583-923-702-692; 057-518-151-974-182; 064-179-013-863-53X; 084-451-598-374-082; 088-491-475-287-79X; 090-088-037-022-128; 090-457-852-068-14X; 112-990-824-814-530; 114-107-501-629-207; 120-752-472-905-506; 131-586-247-454-110,1
005-379-550-698-644,Application of nanomaterials in sample preparation,2013-04-11,2013,journal article,Journal of chromatography. A,18733778; 00219673,Elsevier,Netherlands,Jingyu Tian; Jianqiao Xu; Fang Zhu; Tong-Bu Lu; Cheng-Yong Su; Gangfeng Ouyang,"Nanotechnology is one of the most important trends in material science. Due to the ultra-small size, nanomaterials possess unique physical and chemical properties. In this review, we summarized and discussed the recent applications of different nanomaterials, including metallic nanoparticles, metal organic frameworks (MOFs) materials, carbonaceous nanomaterials and siliceous nanoparticles, in sample preparation techniques.",1300,,2,16,Nanomaterials; Nanoparticle; Nanotechnology; Metal-organic framework; Chemistry; Sample preparation; Metal nanoparticles,Carbonaceous nanomaterials; Metal organic frameworks materials; Metallic nanoparticles; Nanomaterials; Sample preparation; Siliceous nanoparticles,Analytic Sample Preparation Methods/methods; Nanostructures/chemistry; Nanotechnology/methods; Solid Phase Extraction/methods,,,https://www.sciencedirect.com/science/article/pii/S0021967313005888 http://www.ncbi.nlm.nih.gov/pubmed/23611621 https://europepmc.org/article/MED/23611621,http://dx.doi.org/10.1016/j.chroma.2013.04.010,23611621,10.1016/j.chroma.2013.04.010,2025366404,,0,000-026-844-911-265; 000-049-942-753-303; 000-124-534-585-141; 000-551-568-533-960; 000-974-861-747-508; 001-220-641-603-831; 001-431-210-953-995; 001-699-508-343-978; 002-268-192-208-56X; 002-458-966-858-564; 002-511-734-565-666; 002-526-813-552-03X; 002-793-996-640-601; 002-944-935-062-954; 003-199-254-101-734; 003-427-721-717-661; 003-506-924-112-529; 003-994-838-868-931; 004-051-994-824-634; 004-376-376-968-142; 004-467-622-194-749; 004-495-095-353-936; 004-812-771-967-105; 006-445-815-384-675; 006-746-797-699-647; 007-020-435-916-302; 007-280-548-336-778; 007-756-328-671-33X; 008-186-304-853-803; 008-233-182-685-686; 008-981-595-752-166; 009-025-050-660-161; 009-402-006-899-74X; 009-851-760-699-09X; 010-724-544-602-63X; 010-982-870-179-621; 011-075-283-022-723; 011-237-917-876-86X; 011-252-696-841-633; 011-381-750-251-214; 011-505-245-313-789; 011-848-198-909-049; 012-515-069-307-261; 012-626-675-634-061; 012-872-162-038-161; 012-968-024-284-037; 013-122-646-348-186; 013-230-857-322-275; 013-711-003-702-431; 014-237-064-447-463; 014-412-103-097-116; 014-563-057-353-585; 014-823-355-484-215; 015-473-413-887-311; 015-764-786-006-29X; 016-292-217-248-68X; 016-330-247-757-658; 016-349-405-050-51X; 017-905-522-168-833; 018-158-901-266-003; 018-367-376-514-419; 019-012-890-361-033; 019-103-694-692-218; 019-380-729-460-253; 019-385-824-044-98X; 019-725-449-136-986; 019-860-840-211-872; 020-171-332-271-563; 020-579-770-772-383; 021-713-093-908-44X; 021-918-959-547-112; 023-048-418-824-486; 023-443-091-454-056; 023-669-960-528-531; 023-841-161-539-404; 023-968-750-164-450; 024-372-798-388-196; 024-780-528-984-513; 024-917-496-599-42X; 024-989-768-209-388; 025-025-851-375-678; 025-074-124-695-895; 025-206-195-738-022; 025-695-327-221-149; 026-731-235-975-674; 027-322-512-729-877; 029-288-895-399-102; 029-468-635-769-654; 029-592-524-965-52X; 029-711-824-160-933; 029-742-632-966-344; 030-644-576-465-751; 030-677-754-330-966; 030-830-779-484-388; 031-003-419-038-20X; 031-604-560-795-115; 032-345-843-816-310; 033-161-796-850-822; 033-741-440-550-088; 034-011-990-415-35X; 034-426-538-893-288; 035-737-308-991-450; 035-750-888-654-157; 036-298-714-371-534; 036-455-626-187-784; 036-657-090-038-961; 036-669-143-446-546; 037-058-076-960-409; 037-231-548-090-437; 038-069-387-696-65X; 038-191-851-282-194; 038-286-555-333-470; 039-777-955-714-566; 040-291-519-316-620; 040-954-010-380-042; 041-057-614-293-368; 042-007-407-228-994; 043-108-706-959-657; 043-533-515-952-96X; 043-729-032-870-577; 043-969-407-882-551; 044-361-986-074-321; 044-376-761-094-411; 044-495-341-353-044; 045-819-995-381-778; 047-246-659-671-992; 047-670-455-572-135; 047-923-173-768-714; 048-361-066-079-918; 048-650-897-126-413; 048-669-159-313-989; 049-031-844-351-610; 049-255-975-692-047; 049-707-508-928-246; 049-825-415-813-658; 049-870-347-848-877; 050-281-183-468-156; 051-090-326-881-023; 052-200-243-100-691; 052-688-358-223-730; 053-627-865-189-124; 054-513-703-087-097; 055-337-351-916-643; 055-682-174-712-144; 057-349-599-625-795; 057-941-064-742-736; 058-941-296-537-13X; 063-521-757-800-51X; 064-591-798-325-217; 064-954-446-603-404; 065-208-227-960-139; 065-224-359-187-416; 065-238-468-082-194; 065-723-067-845-727; 066-411-971-683-328; 066-662-583-848-801; 066-850-452-147-536; 066-907-710-090-320; 068-065-780-846-415; 068-301-457-341-830; 068-700-246-072-632; 069-168-860-934-966; 069-313-791-094-593; 069-499-016-957-595; 073-842-336-308-949; 074-014-115-554-145; 075-005-794-388-047; 075-006-600-732-108; 075-089-723-169-251; 076-091-617-909-251; 076-336-726-627-109; 077-695-772-143-886; 080-000-343-665-63X; 080-324-437-289-963; 080-773-525-019-676; 082-013-476-359-041; 082-230-617-285-260; 083-418-869-925-616; 083-547-559-045-729; 083-576-940-621-230; 084-087-879-130-609; 084-238-938-203-165; 084-438-066-147-309; 084-530-836-320-211; 085-334-800-296-019; 085-476-192-174-715; 087-040-359-826-101; 087-856-308-269-829; 087-873-834-706-544; 088-996-513-405-528; 089-340-076-542-034; 090-166-940-249-557; 091-435-052-508-185; 091-637-348-054-640; 092-542-844-338-954; 092-596-667-996-537; 093-589-087-126-173; 093-896-193-529-689; 094-806-627-731-53X; 095-814-252-410-84X; 096-578-985-951-808; 096-770-766-721-869; 097-041-620-414-467; 097-248-893-883-785; 098-156-222-154-74X; 099-314-531-318-08X; 100-024-845-345-775; 100-547-423-216-407; 101-759-445-568-631; 102-830-998-762-325; 103-217-989-987-574; 103-667-608-520-670; 103-915-118-551-634; 106-660-777-173-398; 107-213-100-107-403; 108-419-725-001-684; 109-363-721-814-975; 109-969-051-521-255; 110-383-619-642-170; 111-010-863-558-645; 113-481-946-776-668; 114-047-840-003-047; 114-698-651-184-802; 115-764-490-333-836; 115-968-205-185-542; 116-760-083-154-150; 117-413-828-222-69X; 117-606-316-696-542; 118-200-390-741-301; 118-560-401-151-788; 121-146-271-903-252; 121-707-905-091-119; 121-708-305-798-289; 123-492-986-787-448; 123-990-880-469-873; 124-852-777-908-357; 125-231-435-514-993; 125-242-541-871-840; 125-886-747-830-60X; 128-541-961-527-412; 128-983-255-232-404; 129-852-465-995-465; 129-897-079-871-252; 130-214-946-440-46X; 131-438-339-895-04X; 134-289-043-372-306; 134-411-214-694-577; 134-896-123-408-190; 137-652-855-190-375; 138-065-588-109-180; 138-287-638-636-282; 139-210-550-294-485; 143-355-339-997-099; 143-799-051-518-674; 146-386-814-343-360; 149-815-378-419-550; 149-843-635-237-247; 151-514-187-374-794; 151-671-765-133-861; 151-858-521-842-055; 157-941-053-233-878; 162-789-911-688-64X; 164-140-626-483-625; 164-650-562-044-825; 168-242-401-783-128; 168-736-285-053-952; 171-191-387-985-049; 173-086-100-871-895; 179-470-658-570-391; 179-731-785-111-852; 179-748-707-423-122; 184-019-202-764-205; 188-328-465-241-54X; 190-455-275-868-185; 190-466-230-371-611; 193-105-791-474-157; 194-334-940-171-420; 196-179-447-487-056,155
005-415-222-399-931,Biomedical Applications of Graphene Nanomaterials and Beyond,2018-07-17,2018,journal article,ACS biomaterials science & engineering,23739878,American Chemical Society,United States,Krishanu Ghosal; Kishor Sarkar,"Graphene nanomaterials have been considered as a novel class of nanomaterials that show exceptional structural, optical, thermal, electrical, and mechanical properties. As a consequence, it has been extensively studied in various fields including electronics, energy, catalysis, sensing, and biomedical fields. In the previous couple of years, a significant number of studies have been done on graphene-based nanomaterials, where it is utilized in a wide range of bioapplications that includes delivery of small molecule drugs/genes, biosensing, tissue engineering, bioimaging, and photothermal and photodynamic therapies because of its excellent aqueous processability, surface functionalizability, outstanding electrical and mechanical properties, tunable fluorescence properties, and surface-enhanced Raman scattering (SERS).Therefore, it is necessary to get detailed knowledge about it. In this review, we will highlight the various synthesis procedures of graphene family nanomaterials including graphene oxide (GO)...",4,8,2653,2703,Nanomaterials; Biosensor; Raman scattering; Nanotechnology; Photothermal therapy; Materials science; Drug delivery; Graphene,biomedical application; biosensor; drug delivery; grpahene; nanomaterials,,,University Grants Commission; University Grants Commission; Science and Engineering Research Board; Science and Engineering Research Board,https://research.caluniv.ac.in/publication/biomedical-applications-of-graphene-nanomaterials-and-beyond https://www.ncbi.nlm.nih.gov/pubmed/33434995 https://pubs.acs.org/doi/10.1021/acsbiomaterials.8b00376,http://dx.doi.org/10.1021/acsbiomaterials.8b00376,33434995,10.1021/acsbiomaterials.8b00376,2810274950,,0,000-034-319-219-932; 000-133-630-538-454; 000-159-149-403-145; 000-369-722-326-046; 000-440-836-672-886; 000-598-789-239-704; 001-474-074-281-097; 001-617-369-137-127; 001-683-640-368-105; 001-819-678-635-256; 002-213-804-801-076; 002-367-333-770-569; 002-847-922-836-290; 002-921-643-144-745; 003-553-806-485-30X; 003-868-349-458-23X; 004-036-639-694-657; 004-057-454-128-90X; 004-383-121-147-591; 004-556-883-826-120; 004-635-315-358-678; 004-681-906-395-400; 004-729-171-867-197; 004-775-949-869-992; 004-825-950-361-929; 005-029-085-622-061; 005-321-524-549-870; 005-409-041-285-133; 005-479-524-299-584; 005-762-952-232-275; 006-031-334-894-068; 006-177-659-676-730; 006-365-252-899-439; 006-601-315-153-063; 007-049-535-550-597; 007-178-159-320-704; 007-439-417-741-054; 007-923-327-769-656; 008-487-771-169-524; 008-684-171-356-003; 008-880-169-339-122; 009-155-565-930-891; 009-360-538-886-461; 009-502-934-265-086; 009-559-271-587-056; 009-697-217-311-409; 009-857-947-755-204; 009-876-405-527-024; 010-095-605-315-759; 010-143-638-786-382; 010-885-185-290-108; 011-036-804-641-238; 011-037-303-214-419; 011-078-800-872-333; 011-214-091-489-748; 011-431-675-285-803; 011-505-245-313-789; 011-627-858-370-511; 011-666-588-372-040; 012-070-089-157-230; 012-635-039-540-683; 012-935-816-159-903; 013-516-165-054-242; 013-537-641-747-545; 013-786-627-123-469; 013-897-215-205-793; 014-056-595-553-932; 014-205-915-364-37X; 014-396-035-042-852; 014-630-260-696-361; 015-312-966-817-623; 015-324-315-714-274; 015-419-139-152-760; 015-445-831-656-972; 015-557-255-792-285; 015-877-472-997-52X; 015-914-991-553-568; 016-084-771-640-375; 016-212-060-457-586; 016-240-063-655-535; 016-352-313-868-274; 016-579-162-932-844; 016-587-455-124-04X; 016-824-685-436-993; 017-204-775-274-050; 017-615-918-234-117; 017-938-807-240-22X; 017-996-115-928-109; 018-757-292-307-651; 018-877-794-331-527; 018-878-593-563-537; 019-016-118-151-83X; 019-116-168-314-762; 019-191-200-109-516; 019-217-870-172-058; 019-274-500-418-509; 019-375-688-699-703; 019-732-982-461-184; 020-093-464-288-286; 020-146-954-874-209; 020-154-308-899-508; 020-388-647-827-367; 020-411-810-660-433; 020-465-663-689-239; 020-622-151-791-439; 021-100-730-557-91X; 021-146-487-759-266; 021-279-163-131-439; 021-290-302-792-657; 021-430-029-526-48X; 021-491-293-756-232; 021-630-880-406-752; 021-688-278-668-970; 021-940-123-489-400; 022-338-978-818-876; 022-655-156-345-626; 022-708-269-314-195; 022-872-814-453-735; 023-130-004-949-556; 023-196-630-118-372; 023-410-830-279-255; 024-003-059-923-024; 024-139-924-696-712; 024-162-922-057-824; 024-184-151-369-068; 024-858-037-491-316; 025-156-929-405-006; 025-241-670-309-299; 025-327-496-012-402; 026-044-000-168-822; 026-065-804-999-317; 026-137-737-789-634; 026-693-645-773-51X; 026-734-177-941-372; 027-191-444-561-998; 027-295-400-287-030; 027-469-607-246-276; 027-578-339-543-487; 028-750-438-123-136; 028-910-433-243-091; 029-087-168-066-925; 029-920-422-257-872; 030-075-379-778-719; 030-709-961-420-319; 030-789-306-240-162; 031-211-893-523-604; 031-850-382-845-784; 032-153-647-254-30X; 032-248-811-381-549; 032-792-139-503-307; 032-862-527-313-549; 033-641-914-715-545; 033-920-244-169-144; 034-257-135-397-285; 034-280-299-650-617; 034-346-882-306-505; 034-465-664-808-226; 034-629-603-012-804; 034-744-337-466-849; 034-779-632-450-41X; 034-961-461-412-830; 035-503-410-576-921; 036-125-424-310-703; 036-394-789-496-403; 036-460-938-063-664; 036-650-561-546-902; 036-941-377-880-484; 036-989-471-271-661; 037-343-220-872-159; 037-375-199-428-446; 037-587-201-682-756; 037-711-915-885-948; 037-743-812-649-64X; 037-981-924-583-693; 038-721-935-500-369; 038-781-984-385-170; 038-912-786-066-117; 039-131-324-370-67X; 039-971-359-718-236; 040-143-859-474-946; 040-376-777-773-616; 040-912-336-018-38X; 041-003-849-378-696; 041-127-589-157-700; 041-276-567-608-40X; 041-326-272-321-156; 041-607-975-768-801; 042-080-940-377-155; 042-372-688-773-053; 042-687-408-370-089; 042-730-979-071-657; 043-032-412-606-516; 043-256-719-838-840; 043-801-021-362-255; 044-376-761-094-411; 044-573-786-477-876; 045-133-793-777-356; 046-161-370-694-828; 046-418-180-868-162; 046-419-521-000-981; 047-389-672-553-892; 047-473-909-216-870; 047-774-704-724-141; 048-701-348-047-963; 049-025-936-442-869; 049-054-676-472-887; 049-147-585-908-852; 049-607-212-966-341; 050-377-024-057-399; 050-401-115-394-38X; 051-253-395-075-571; 051-503-730-276-493; 052-164-749-611-805; 052-333-214-814-547; 052-400-453-992-380; 052-702-718-010-826; 052-897-599-990-587; 053-244-438-273-593; 053-303-386-899-216; 053-697-936-661-048; 054-406-094-920-499; 054-516-141-390-564; 054-689-897-548-283; 054-968-712-085-078; 055-224-370-912-989; 055-922-099-096-352; 056-510-939-021-077; 056-736-554-654-860; 057-448-338-997-72X; 057-916-257-181-491; 057-976-109-013-212; 058-028-500-545-402; 058-327-938-779-772; 058-385-316-036-603; 058-653-747-897-77X; 058-670-208-150-604; 058-848-349-571-459; 058-936-711-224-725; 059-532-616-180-934; 059-610-246-322-739; 059-868-491-076-63X; 060-855-894-225-065; 061-502-140-682-297; 061-631-993-379-071; 061-767-827-310-768; 061-976-146-998-334; 062-088-535-413-601; 062-137-103-532-496; 062-338-991-971-710; 062-927-422-347-083; 063-140-575-271-240; 063-226-909-169-80X; 063-801-906-255-030; 063-844-650-765-941; 063-970-688-165-260; 064-500-361-547-515; 065-158-067-051-813; 065-948-528-772-047; 066-020-473-284-983; 066-055-928-340-380; 066-200-568-299-107; 066-246-374-493-802; 066-625-021-232-121; 066-727-988-548-078; 067-099-389-446-952; 067-440-628-179-30X; 067-518-965-717-815; 067-941-638-549-250; 068-104-415-786-150; 068-135-171-085-623; 068-269-930-008-877; 068-272-169-043-986; 068-332-734-039-528; 068-448-469-103-115; 068-724-641-785-356; 068-863-559-091-03X; 069-429-146-085-939; 070-399-501-518-382; 070-863-937-811-527; 071-613-872-743-491; 072-946-008-524-335; 073-292-290-821-494; 073-449-232-959-893; 073-689-312-885-655; 073-869-674-823-679; 073-951-226-141-52X; 074-182-319-702-368; 074-309-803-973-78X; 075-258-903-496-385; 075-481-211-793-807; 075-683-513-040-179; 076-135-192-218-392; 076-676-883-902-590; 076-929-181-554-467; 077-400-920-153-509; 077-481-831-277-697; 078-821-004-430-904; 078-887-121-595-144; 079-164-097-546-47X; 079-308-795-532-614; 079-922-094-173-559; 079-991-647-000-615; 080-451-561-175-041; 080-810-211-114-718; 080-863-908-151-307; 082-277-684-811-169; 082-551-990-724-679; 082-727-311-083-133; 082-757-493-924-278; 082-944-250-461-997; 082-976-479-019-503; 085-661-383-106-744; 085-852-180-295-217; 086-368-515-165-556; 086-474-946-996-457; 086-614-313-065-937; 086-850-411-010-002; 087-082-393-386-942; 087-296-587-629-811; 089-034-598-048-249; 090-234-688-574-738; 090-433-921-938-940; 090-519-015-618-66X; 091-098-352-076-201; 091-570-477-274-11X; 092-663-692-175-543; 092-869-427-740-584; 093-414-905-316-602; 093-629-961-857-575; 093-968-147-417-870; 094-361-352-875-817; 095-237-818-491-46X; 095-400-914-411-148; 095-412-780-278-692; 096-703-778-634-586; 097-657-619-380-357; 098-408-406-611-456; 099-083-179-902-061; 099-243-969-032-099; 099-940-657-328-679; 100-079-699-050-319; 100-143-426-986-385; 100-466-426-171-078; 100-554-295-559-928; 101-516-427-992-707; 102-021-573-140-571; 102-169-488-368-791; 102-651-396-679-408; 103-298-302-256-845; 103-658-512-553-676; 104-636-267-702-269; 104-846-582-637-087; 105-150-998-306-987; 105-233-094-023-961; 105-880-474-920-390; 106-746-010-237-98X; 107-546-120-302-308; 107-580-876-302-235; 107-796-978-160-349; 108-502-016-592-706; 108-603-935-727-838; 109-580-126-593-929; 111-765-235-329-046; 113-908-703-526-349; 114-687-999-554-516; 115-590-746-589-388; 116-719-301-642-087; 117-134-094-196-864; 117-607-592-077-240; 118-040-014-248-994; 118-138-112-525-460; 119-126-121-028-624; 120-431-318-697-166; 124-256-550-105-946; 124-396-863-685-691; 124-769-928-452-864; 125-166-179-011-79X; 126-022-161-567-152; 127-581-870-949-37X; 128-079-229-456-812; 128-788-408-338-995; 130-096-821-514-846; 130-569-802-632-924; 132-868-491-931-013; 133-941-955-908-001; 135-602-642-016-690; 136-349-161-356-707; 137-181-547-509-630; 139-107-551-526-596; 141-170-220-215-359; 145-060-751-536-475; 145-911-246-710-973; 149-583-720-989-39X; 150-864-953-841-130; 153-768-834-270-901; 154-634-514-464-099; 156-013-707-862-780; 159-244-384-112-965; 164-409-307-179-799; 165-259-246-039-711; 169-625-505-487-58X; 176-715-647-418-443; 182-950-408-174-434; 183-285-746-885-043,92
005-443-321-282-649,Engineering Nanomaterials for Biosensors and Therapeutics,2013-12-20,2013,book chapter,Engineering in Translational Medicine,,Springer London,,Tse Ying Liu; Chun Liang Lo; Chih Chia Huang; Syue Liang Lin; C. Allen Chang,"Nanomaterials have attracted lots of recent research attention as they possess unique photophysical, magnetic, and thermal properties with the potential of being engineered for various biomedical theranostic applications. The objective of this book chapter is to provide a timely overview on the synthetic methodology, surface engineering, physiological itinerary, and theranostic applications for the nanophases and nanostructures consisting of inorganic and/or organic materials. This chapter starts with an introduction, followed by a brief review of the applications and preparative methods of the inorganic nanomaterials with surface plasmon resonance, photoluminescence, magnetic, and bioactive properties. The effects of surface modification with polymers and morphology on the physiological itinerary and toxicity of the nanomaterials are then discussed to help the design of vehicles for targeted tissue imaging and drug delivery. Finally, examples of several promising nanotechnologies and theranostic applications are given including biosensors, magnetic hyperthermia, and photodynamic therapy (PDT) for tumor treatment. This chapter ends with a conclusion and future perspective section. To make use of all the innovative ideas and demonstrative prove-of-principles of nanomaterials for practical biomedical applications, it is absolutely necessary to emphasize and expand efforts on their translational research and development, including clinical studies and large-scale manufacturing of these novel engineered nanomaterials.",,,513,534,Engineering; Nanomaterials; Biosensor; Surface engineering; Nanotechnology; Photothermal therapy; Drug delivery; Magnetic hyperthermia; Tissue imaging; Tumor therapy,,,,,https://rd.springer.com/chapter/10.1007/978-1-4471-4372-7_19 https://researchoutput.ncku.edu.tw/zh/publications/engineering-nanomaterials-for-biosensors-and-therapeutics https://link.springer.com/chapter/10.1007/978-1-4471-4372-7_19/fulltext.html https://link.springer.com/chapter/10.1007%2F978-1-4471-4372-7_19,http://dx.doi.org/10.1007/978-1-4471-4372-7_19,,10.1007/978-1-4471-4372-7_19,30017674,,0,000-325-479-764-905; 000-514-920-082-001; 002-149-277-794-754; 002-586-631-249-931; 002-625-643-042-427; 002-901-082-448-846; 004-971-097-571-800; 005-733-117-182-312; 006-851-622-921-909; 007-069-160-418-079; 007-105-825-144-70X; 008-093-100-511-921; 008-906-186-906-128; 009-487-097-955-545; 009-794-214-624-586; 009-863-974-154-974; 010-238-149-881-006; 010-962-708-462-164; 011-146-141-902-915; 011-474-922-050-674; 012-670-391-788-614; 012-868-864-795-27X; 013-546-159-552-904; 013-960-244-456-670; 014-610-260-339-067; 016-571-992-342-636; 017-325-391-468-025; 017-380-528-915-351; 018-637-006-265-010; 019-909-618-942-61X; 021-319-456-108-72X; 023-115-151-519-112; 023-506-525-285-073; 023-519-231-977-376; 024-876-489-911-376; 026-188-593-710-068; 026-240-683-750-317; 027-754-592-221-094; 028-000-551-442-70X; 029-282-950-924-997; 029-404-352-516-478; 032-235-919-554-111; 034-643-297-775-707; 035-919-228-575-462; 036-070-574-589-601; 036-129-423-219-041; 036-493-982-633-426; 036-876-583-684-873; 037-559-465-893-09X; 037-897-291-971-159; 038-430-424-220-074; 038-774-179-578-142; 039-185-157-751-275; 041-200-294-911-356; 041-770-941-663-550; 042-139-352-241-474; 042-166-139-469-166; 043-774-988-490-870; 044-440-236-432-359; 045-403-424-189-142; 046-047-789-005-201; 046-721-465-770-013; 047-693-698-216-030; 048-262-687-246-316; 048-300-894-265-100; 049-377-081-340-515; 050-356-168-824-128; 051-206-480-322-280; 054-140-174-591-757; 054-348-935-518-312; 055-199-372-307-553; 055-713-378-138-833; 056-160-838-642-459; 056-506-175-774-260; 058-222-824-686-323; 059-180-858-379-691; 060-126-888-028-137; 063-164-304-260-060; 063-211-186-343-031; 063-280-252-045-374; 064-161-867-482-719; 064-966-400-579-232; 065-811-981-991-144; 068-937-564-840-321; 070-034-083-877-62X; 071-198-115-315-515; 071-332-881-420-407; 072-706-143-057-44X; 073-020-673-040-063; 073-334-885-160-923; 073-570-356-817-015; 076-419-198-547-722; 078-629-861-814-080; 078-758-663-297-298; 078-842-909-226-863; 078-856-259-966-954; 079-000-726-808-057; 083-790-892-560-732; 086-921-237-392-345; 088-840-273-371-187; 090-082-943-215-08X; 093-121-829-672-680; 093-913-703-063-017; 095-826-200-124-815; 097-121-770-471-387; 098-178-125-953-571; 098-779-800-286-404; 102-169-488-368-791; 105-029-747-194-111; 106-917-381-735-738; 107-130-396-316-007; 108-274-912-203-682; 108-419-725-001-684; 108-464-752-922-430; 110-026-949-707-955; 111-233-619-604-177; 112-399-363-832-788; 112-762-844-466-698; 115-321-334-455-652; 115-332-009-388-373; 117-990-278-694-499; 122-960-605-387-837; 123-727-767-469-988; 125-211-264-275-634; 126-320-790-638-721; 131-886-151-916-004; 142-324-477-082-18X; 148-682-148-797-713; 158-154-285-265-848,4
005-533-368-977-359,Advanced carbon nanomaterials for electrochemiluminescent biosensor applications,,2019,journal article,Current Opinion in Electrochemistry,24519103,Elsevier BV,,Andrea Fiorani; Juan Pedro Merino; Alessandra Zanut; Alejandro Criado; Giovanni Valenti; Maurizio Prato; Francesco Paolucci,"Abstract Electrochemiluminescent biosensors are nowadays an established technology in the field of immunosensors and diagnostics. Along with the advent of nanotechnology, the marriage between electrochemiluminescence and nanomaterials results in promising enhancing strategies in many biosensor applications. Among nanomaterials, carbon-based ones are the most used, as (i) scaffolds, (ii) luminophores and (iii) electrode materials of the sensor. In this review, we describe the importance of a rational modification and functionalization of carbon nanomaterials to optimize electrochemiluminescence signal, and we also resume the latest and most relevant applications of electrochemiluminescent biosensors based on carbon nanomaterials.",16,,66,74,Nanomaterials; Biosensor; Nanotechnology; Materials science; Electrode material; Carbon nanomaterials; Electrochemiluminescence; Carbon nanotube,,,,,https://cris.unibo.it/handle/11585/714439 https://www.sciencedirect.com/science/article/pii/S2451910318302813,http://dx.doi.org/10.1016/j.coelec.2019.04.018,,10.1016/j.coelec.2019.04.018,2940812275,,0,000-167-090-101-440; 002-701-928-684-003; 002-799-642-658-502; 003-270-498-989-927; 004-924-659-215-129; 006-968-468-535-012; 007-692-670-129-415; 009-718-977-776-110; 011-294-622-717-272; 012-406-892-964-185; 014-863-495-716-424; 015-268-152-420-584; 019-648-492-620-312; 022-804-392-558-363; 026-068-517-190-367; 028-845-477-307-407; 029-065-589-772-628; 029-156-759-670-194; 030-294-359-240-188; 031-483-682-753-097; 031-644-024-813-494; 032-625-146-364-298; 033-280-809-212-371; 033-687-256-988-763; 035-726-776-106-164; 038-890-897-327-063; 039-047-908-920-928; 040-857-392-187-875; 045-127-263-008-591; 046-276-211-085-996; 050-459-148-210-737; 051-485-516-215-263; 055-091-264-628-849; 058-487-946-326-514; 059-380-965-277-769; 059-459-679-016-105; 059-828-299-438-518; 059-846-520-847-994; 062-199-428-957-285; 065-090-490-401-819; 066-563-338-181-042; 069-294-738-174-622; 069-671-220-388-619; 072-188-922-679-70X; 078-973-673-507-537; 081-792-177-421-65X; 082-228-493-614-815; 083-867-648-496-903; 085-019-935-171-416; 086-746-929-570-83X; 090-088-241-076-203; 090-407-008-059-584; 098-321-097-239-23X; 098-932-131-578-351; 104-716-680-404-062; 110-369-028-573-475; 117-607-592-077-240; 127-626-969-140-200; 141-448-479-609-748; 171-171-562-758-647,26
005-554-547-335-805,Nanomaterials for enhanced immunity as an innovative paradigm in nanomedicine.,,2015,journal article,"Nanomedicine (London, England)",17486963; 17435889,Future Medicine Ltd.,United Kingdom,Anushree Seth; Doo-Byoung Oh; Yong Taik Lim,"Since the advent of nanoparticle technology, novel and versatile properties of nanomaterials have been introduced, which has constantly expanded their applications in therapeutics. Introduction of nanomaterials for immunomodulation has opened up new avenues with tremendous potential. Interesting properties of nanoparticles, such as adjuvanticity, capability to enhance cross-presentation, polyvalent presentation, siRNA delivery for silencing of immunesuppressive gene, targeting and imaging of immune cells have been known to have immense utility in vaccination and immunotherapy. A thorough understanding of the merits associated with nanomaterials is crucial for designing of modular and versatile nanovaccines, for improved immune response. With the emerging prerequisites of vaccination, nanomaterial-based immune stimulation, seems to be capable of taking the field of immunization to a next higher level.",10,6,959,975,Nanomaterials; Nanomedicine; Nanotechnology; Immunotherapy; Immunity; Immunization; Adjuvanticity; Immune Stimulation; Computer science; Immune system,adjuvant; antigen; antigen presenting cells; cross-presentation; immune response; nanoparticle; vaccine,"Administration, Oral; Animals; Antigen Presentation; Gene Silencing; Humans; Immunosuppressive Agents/chemistry; Immunotherapy/methods; Nanomedicine/methods; Nanoparticles/chemistry; Nanostructures/chemistry; RNA, Small Interfering/metabolism","Immunosuppressive Agents; RNA, Small Interfering",,https://europepmc.org/article/MED/25867860 http://www.ncbi.nlm.nih.gov/pubmed/25867860 https://oak.kribb.re.kr/handle/201005/12579,http://dx.doi.org/10.2217/nnm.14.200,25867860,10.2217/nnm.14.200,2082452673,,0,000-064-276-743-757; 000-250-349-148-756; 000-398-265-658-207; 000-654-617-745-831; 001-484-429-639-887; 001-558-552-275-694; 002-436-926-620-503; 002-986-997-404-660; 003-100-582-115-980; 004-416-033-496-36X; 004-743-133-800-136; 006-348-601-861-603; 008-996-932-462-920; 009-661-309-808-848; 009-828-429-135-117; 010-258-147-250-575; 010-574-162-724-964; 011-255-525-284-899; 011-660-881-060-567; 011-665-826-242-563; 012-359-821-616-053; 012-375-552-417-119; 013-318-403-853-350; 013-802-675-451-288; 014-182-042-258-068; 014-857-286-262-672; 015-313-592-208-341; 015-756-281-444-606; 016-511-714-010-864; 017-151-523-129-109; 017-338-488-252-039; 018-244-808-088-346; 018-402-683-313-167; 018-928-195-472-878; 019-726-914-230-770; 020-251-714-424-633; 020-630-271-579-096; 020-648-485-258-840; 023-708-378-794-323; 025-199-210-461-349; 025-519-472-390-659; 025-550-643-465-324; 026-542-278-270-84X; 027-198-445-222-228; 027-544-780-074-858; 027-685-063-714-09X; 027-988-578-900-340; 029-236-496-041-555; 029-283-678-950-479; 029-344-367-147-706; 029-438-121-699-006; 030-324-567-436-956; 030-350-841-024-073; 030-361-799-541-598; 031-335-390-728-872; 031-671-134-494-651; 031-795-745-531-217; 032-617-451-875-879; 033-459-456-497-235; 034-575-062-338-789; 034-670-723-436-489; 034-695-391-912-602; 035-343-926-516-276; 035-821-181-267-722; 036-036-289-090-423; 036-519-115-001-124; 036-840-807-654-725; 037-780-185-187-88X; 037-859-560-474-795; 039-900-287-022-521; 040-456-712-500-115; 040-542-424-197-685; 041-014-026-853-090; 041-123-366-974-991; 041-315-958-992-524; 041-825-474-470-973; 043-985-666-238-656; 044-475-197-842-012; 044-511-204-683-175; 044-587-797-677-248; 047-224-032-375-033; 048-584-054-063-415; 048-598-812-040-27X; 049-208-025-398-942; 049-507-365-775-185; 049-723-536-368-872; 050-915-984-301-809; 053-372-349-963-687; 053-685-712-344-58X; 053-887-722-459-845; 054-948-356-601-858; 056-014-239-892-055; 056-034-305-451-804; 056-715-998-111-506; 057-351-359-731-081; 058-313-617-778-309; 058-864-277-149-880; 059-184-128-077-630; 059-201-208-224-401; 059-593-942-222-422; 060-219-031-014-310; 060-474-215-897-849; 062-109-774-594-518; 062-299-725-315-607; 062-920-484-971-314; 063-247-272-996-770; 063-596-249-150-422; 063-700-202-062-000; 064-167-857-845-261; 066-008-485-376-760; 066-092-271-177-701; 067-569-862-388-692; 068-905-305-012-787; 069-967-887-517-936; 070-465-017-238-71X; 070-558-586-478-206; 070-888-528-403-347; 071-075-621-040-921; 072-661-820-741-585; 073-287-223-084-23X; 075-236-454-057-733; 075-820-929-547-57X; 076-535-449-703-100; 076-906-545-768-350; 077-428-179-566-857; 078-901-947-368-229; 081-416-642-902-848; 082-181-021-695-738; 082-193-440-806-947; 082-200-106-354-909; 083-875-371-005-103; 084-536-785-700-237; 085-425-738-243-082; 086-667-309-350-988; 089-575-498-607-930; 089-655-613-097-164; 091-532-697-609-906; 091-538-641-026-733; 092-909-175-996-367; 093-871-413-273-646; 104-889-592-677-138; 105-390-041-673-96X; 105-918-213-458-629; 106-396-437-416-672; 106-509-198-883-799; 107-434-805-675-442; 108-827-249-569-860; 109-003-949-952-267; 110-968-879-730-090; 111-101-794-445-682; 114-229-963-256-682; 114-813-543-432-574; 115-324-100-558-02X; 115-657-478-380-708; 118-388-830-806-218; 119-853-820-681-332; 122-832-703-439-497; 124-927-797-015-592; 128-828-683-443-275; 129-797-940-845-230; 129-978-845-543-894; 131-946-699-719-526; 133-004-777-099-443; 133-227-004-749-115; 133-439-303-091-282; 139-970-167-623-989; 154-242-990-193-063; 155-118-216-013-586; 155-997-543-517-902; 163-793-759-498-574; 163-933-523-140-420; 164-000-189-844-634; 166-684-259-891-472; 170-178-518-918-530; 185-399-198-185-406,18
005-638-331-992-230,Nanomaterials Release from Nano-Enabled Products,2015-07-10,2015,book chapter,The Handbook of Environmental Chemistry,1867979x; 1616864x,Springer International Publishing,United States,Alejandro Vílchez; Elisabet Fernández-Rosas; David González-Gálvez; Socorro Vázquez-Campos,"Nanomaterials release quantification and characterization is crucial for risk assessment studies, and experimental simulation studies provide the most concrete basis for estimating the release of nanomaterials in any stage of its life cycle. Nanomaterials are used in a broad range of applications, in different forms (embedded, as coatings, suspended, etc.) and with different size ranges. With all these variables, the number of scenarios where release of nanomaterials could occur is huge. In this chapter, we aim to review use-phase release scenarios that are usually considered in the literature, as well as the results of such studies and the protocols used for product ageing and for nanomaterial quantification and characterization. Finally, we point out the gaps in nanomaterials release studies and identify future research needs.",,,127,158,Nanomaterials; Nanotechnology; Materials science; Nano-; Characterization (materials science); Research needs,,,,,https://link.springer.com/content/pdf/10.1007%2F698_2015_409.pdf https://link.springer.com/chapter/10.1007/698_2015_409 https://link.springer.com/chapter/10.1007/698_2015_409/fulltext.html https://rd.springer.com/chapter/10.1007/698_2015_409,http://dx.doi.org/10.1007/698_2015_409,,10.1007/698_2015_409,1124615694,,0,000-171-383-698-49X; 002-031-329-707-779; 002-086-081-478-412; 002-351-763-877-108; 002-639-172-363-159; 002-684-605-099-377; 003-129-479-981-839; 003-153-016-007-714; 003-722-349-743-039; 004-252-195-354-315; 005-111-091-621-279; 005-822-634-327-967; 005-919-510-744-321; 006-751-806-169-338; 007-716-188-729-010; 007-819-998-574-323; 007-828-621-531-133; 007-975-541-979-843; 008-923-766-689-670; 009-744-890-453-836; 009-888-043-498-905; 009-944-703-118-044; 010-341-760-133-892; 010-390-973-761-295; 010-494-654-678-087; 013-168-678-128-704; 013-724-913-282-600; 014-162-244-110-573; 014-494-452-537-097; 014-939-608-239-782; 015-858-880-011-72X; 016-708-259-506-225; 018-171-721-982-519; 019-393-936-645-149; 021-214-098-010-405; 022-091-457-938-766; 022-960-740-243-662; 023-057-594-132-299; 023-599-172-482-156; 025-252-166-072-919; 026-049-069-050-614; 026-185-740-242-409; 027-403-152-388-275; 027-685-102-826-132; 028-054-895-960-301; 029-141-744-446-841; 029-370-759-849-650; 030-602-587-058-654; 030-773-459-837-633; 032-405-552-081-387; 032-444-971-301-50X; 032-672-997-250-91X; 034-016-458-533-133; 037-279-445-861-334; 038-659-950-107-843; 038-858-954-390-211; 039-273-284-212-469; 040-576-498-066-472; 040-595-354-760-469; 042-185-857-196-688; 043-595-440-725-95X; 044-919-739-806-273; 047-326-868-378-004; 049-888-119-736-65X; 052-262-246-065-098; 052-366-745-815-443; 052-452-993-623-281; 052-878-313-002-800; 052-999-883-840-719; 055-738-210-459-538; 057-109-478-162-55X; 058-842-730-782-207; 060-148-729-194-565; 060-428-767-255-185; 064-505-954-276-581; 065-556-695-469-886; 067-146-090-929-035; 069-193-470-365-328; 070-079-991-267-375; 071-263-099-399-832; 073-544-349-710-51X; 074-700-105-064-302; 074-777-863-210-466; 075-555-480-014-938; 076-270-158-036-298; 077-152-605-459-938; 077-197-722-043-236; 079-299-429-260-936; 079-496-040-621-935; 079-949-821-976-578; 082-485-243-802-255; 084-421-491-309-005; 085-200-304-922-056; 090-664-780-296-945; 091-452-955-186-409; 091-670-952-010-534; 092-606-561-764-857; 094-910-057-907-416; 097-890-374-901-572; 098-098-582-685-840; 101-503-799-154-568; 102-625-099-915-073; 104-398-897-650-626; 106-100-795-833-075; 107-775-446-483-806; 108-173-934-966-872; 110-429-057-371-946; 110-926-232-763-750; 113-467-538-034-699; 119-441-493-537-286; 121-340-144-424-864; 122-714-833-211-362; 123-529-310-999-834; 123-906-665-998-962; 125-993-312-386-347; 126-522-337-500-172; 129-206-510-942-72X; 132-573-733-070-300; 133-002-809-180-635; 133-731-575-831-596; 149-139-424-094-97X; 150-510-497-356-01X; 155-008-971-519-145; 157-360-950-926-281; 157-672-782-073-648; 160-093-175-271-468; 164-296-092-380-760; 165-689-603-693-683; 168-382-989-544-148; 172-196-156-895-950; 174-537-829-227-347; 182-100-924-202-410; 188-872-869-407-314; 194-003-126-462-438; 195-758-667-793-67X,7
005-749-731-096-488,Recent applications of nanomaterials in prosthodontics,,2015,journal article,Journal of Nanomaterials,16874110; 16874129,Hindawi Limited,Egypt,Wei Wang; Susan Liao; Yuhe Zhu; Ming Liu; Qian Zhao; Yating Fu,"In recent years, lots of researches have been launched on nanomaterials for biomedical applications. It has been shown that the performances of many biomaterials used in prosthodontics have been significantly enhanced after their scales were reduced by nanotechnology, from micron-size into nanosize. On the other hand, many nanocomposites composed of nanomaterials and traditional metals, ceramics, resin, or other matrix materials have been widely used in prosthodontics because their properties, such as modulus elasticity, surface hardness, polymerization shrinkage, and filler loading, were significantly increased after the addition of the nanomaterials. In this paper, the latest research progress on the applications of nanometals, nanoceramic materials, nanoresin materials, and other nanomaterials in prosthodontics was reviewed, which not only gives a detailed description of the new related investigations, but also hopefully provides important elicitation for future researches in this field.",2015,,3,11,Nanomaterials; Nanotechnology; Materials science; Nanoceramic; Prosthodontics; Nanocomposite,,,,Shenyang City Science and Technology Project,https://downloads.hindawi.com/journals/jnm/2015/408643.pdf https://dr.ntu.edu.sg/bitstream/10356/106051/1/Recent%20Applications%20of%20Nanomaterials%20in%20Prosthodontics.pdf https://core.ac.uk/display/29447540 http://downloads.hindawi.com/journals/jnm/2015/408643.pdf https://dl.acm.org/citation.cfm?id=2810948 https://dr.ntu.edu.sg/handle/10220/26069 https://doaj.org/article/a5e7388dd42e44f5bfa1d10b8648d8af https://dl.acm.org/doi/10.1155/2015/408643 https://www.hindawi.com/journals/jnm/2015/408643/,http://dx.doi.org/10.1155/2015/408643,,10.1155/2015/408643,1519717689,,0,003-814-900-266-501; 004-239-241-264-120; 005-249-401-284-469; 008-013-199-562-899; 008-301-117-260-624; 008-960-251-720-15X; 010-874-734-319-716; 011-083-654-968-033; 011-188-322-900-21X; 012-217-909-566-990; 012-372-276-666-528; 013-057-375-813-171; 013-158-984-423-753; 013-574-826-180-381; 013-789-196-117-289; 014-337-605-296-804; 014-655-352-325-059; 015-852-117-261-496; 016-963-733-638-70X; 017-421-794-546-526; 019-245-993-426-562; 019-374-581-020-065; 021-658-982-066-538; 021-670-809-819-577; 022-281-207-296-956; 023-467-304-098-638; 023-562-015-757-145; 024-071-691-649-617; 024-541-516-070-257; 025-269-260-301-950; 025-761-380-072-472; 028-289-347-888-691; 029-285-768-646-613; 030-585-252-622-581; 030-994-277-606-219; 031-944-448-172-293; 032-473-067-432-985; 033-379-470-043-491; 033-447-575-719-234; 034-456-075-013-56X; 034-654-901-878-416; 037-454-592-523-920; 041-130-633-826-455; 041-695-614-718-801; 042-081-511-705-135; 043-472-109-048-397; 045-676-140-058-881; 046-196-862-789-065; 048-206-603-680-451; 048-264-637-598-187; 048-866-429-440-228; 050-949-171-504-217; 053-149-123-216-556; 053-437-590-155-656; 053-948-060-290-302; 054-042-471-381-730; 058-224-913-184-105; 060-170-731-372-237; 061-510-889-630-421; 062-302-733-223-82X; 064-718-134-269-385; 074-807-088-367-095; 076-817-343-002-491; 081-236-913-899-284; 083-035-965-840-040; 089-477-310-515-921; 091-740-131-528-484; 095-167-858-524-069; 096-131-349-354-18X; 097-902-956-826-125; 098-665-455-389-633; 102-900-466-523-615; 104-180-315-930-109; 104-385-516-157-713; 106-740-181-884-754; 112-928-403-096-836; 115-962-001-082-579; 126-416-096-245-713; 133-079-097-855-731; 139-253-744-388-615; 140-564-411-117-554; 141-442-088-969-423; 142-884-086-065-10X; 155-008-971-519-145; 159-311-162-213-434; 165-566-816-812-359; 167-862-558-326-639; 194-155-130-416-728,31
005-779-764-009-237,Investigation of nanomaterials with synchrotron radiation-based techniques,,2012,journal article,Physics,19432879,,,Sun Xu,"The synthesis and applications of nanomaterials have seen great progress in recent years.However,with the limitation of effective characterization techniques,our understanding of many key issues in nanotechnology is still restricted.Synchrotron radiation based techniques provide many advantages in nanomaterial charaterization due to their energy tunability,high brightness,polarization,time structure,coherence,and so forth.With the development of the third generation of synchrotron radiation facilities in China,these techniques will offer unique opportunities to investigate nanomaterials and obtain real time,in_situ and dynamic information.Here we will describe recent developments of some new synchrotron radiation-based techniques for nanomaterial studies,illustrated by various examples.",,,,,Nanomaterials; Synchrotron radiation; Nanotechnology; Time structure; Third generation; Key issues; Computer science,,,,,http://en.cnki.com.cn/Article_en/CJFDTotal-WLZZ201204007.htm,http://en.cnki.com.cn/Article_en/CJFDTotal-WLZZ201204007.htm,,,2361543808,,0,,0
005-804-032-108-362,Nanomaterials and Nanotechnology,,2017,book chapter,Purification of Laboratory Chemicals,,Elsevier,,Wilfred L.F. Armarego,"This has only one section viz : Nanomaterials and Nanotechnology . It describes what nanomaterials are and how they can be identified and measured. It includes the preparation and purification of fullerenes and related substances and a variety of functionalised derivatives. The preparation, purification and derivatisation of carbon nanotubes are described, as well as of Graphene materials. Similarly discussed are Self Assembled Nonolayers, Diamond Nanomaterials , and Nano Metals and Metal Derivatives which include the preparation and purification of nanomaterials of Cadmium salts (quantum dots etc), Cobalt, Copper, Gold, Lead, Platinum, Rhodium, Ruthenium, Silver, Tin, Zinc etc . Finally, Organic and Metal-organic Compounds used in Nanotechnology are included. Safety issues associated with working on nanomaterials are pointed out. A bibliography of recent references is provided.",,,1065,1106,Nanomaterials; Fullerene; Nanotechnology; Materials science; Nano-; Graphene; Carbon nanotube; Rhodium; Tin; Ruthenium,,,,,http://www.sciencedirect.com/science/article/pii/B9780128054574500070 https://www.sciencedirect.com/science/article/pii/B9780128054574500070,http://dx.doi.org/10.1016/b978-0-12-805457-4.50007-0,,10.1016/b978-0-12-805457-4.50007-0,2484492512,,0,020-608-893-756-033; 042-220-401-980-192,1
005-926-116-397-689,Multifaceted applications of nanomaterials in cell engineering and therapy,2012-08-19,2012,journal article,Biotechnology advances,18731899; 07349750,Elsevier Inc.,Netherlands,Hui Chen; Yang Zeng; Wei Liu; Shan Zhao; Jinhui Wu; Yanan Du,"Nanomaterials with superior physiochemical properties have been rapidly developed and integrated in every aspect of cell engineering and therapy for translating their great promise to clinical success. Here we demonstrate the multifaceted roles played by innovatively-designed nanomaterials in addressing key challenges in cell engineering and therapy such as cell isolation from heterogeneous cell population, cell instruction in vitro to enable desired functionalities, and targeted cell delivery to therapeutic sites for prompting tissue repair. The emerging trends in this interdisciplinary and dynamic field are also highlighted, where the nanomaterial-engineered cells constitute the basis for establishing in vitro disease model; and nanomaterial-based in situ cell engineering are accomplished directly within the native tissue in vivo. We will witness the increasing importance of nanomaterials in revolutionizing the concept and toolset of cell engineering and therapy which will enrich our scientific understanding of diseases and ultimately fulfill the therapeutic demand in clinical medicine.",31,5,638,653,Regenerative medicine; Cell therapy; Risk analysis (engineering); Nanotechnology; Population; Cell engineering; Cell delivery; Native tissue; Clinical success; Cell isolation,,Animals; Cell Engineering/methods; Embryonic Stem Cells/cytology; Humans; Nanostructures/administration & dosage; Regenerative Medicine/methods; Stem Cell Transplantation/methods,,,https://pubmed.ncbi.nlm.nih.gov/22922117/ http://www.sciencedirect.com/science/article/pii/S0734975012001413 https://europepmc.org/abstract/MED/22922117 https://www.ncbi.nlm.nih.gov/pubmed/22922117 https://www.sciencedirect.com/science/article/pii/S0734975012001413,http://dx.doi.org/10.1016/j.biotechadv.2012.08.002,22922117,10.1016/j.biotechadv.2012.08.002,2000252462,,0,000-168-039-921-448; 000-398-994-829-707; 001-241-894-949-825; 001-451-471-999-594; 001-857-368-433-015; 001-949-734-017-504; 002-233-383-623-790; 002-635-299-497-930; 003-924-703-199-685; 003-987-399-977-582; 005-153-580-373-486; 005-369-936-296-753; 005-604-386-636-369; 006-306-938-788-67X; 008-413-612-710-123; 010-057-892-245-126; 010-637-417-445-787; 011-519-110-265-828; 011-621-088-576-208; 012-554-760-650-437; 014-005-555-911-15X; 014-233-147-370-379; 014-734-407-129-465; 015-145-309-566-312; 015-159-858-231-168; 015-190-463-108-267; 015-255-387-474-090; 015-453-955-064-354; 016-820-199-564-617; 016-907-600-439-76X; 016-991-995-988-53X; 017-222-716-183-625; 017-422-043-898-007; 018-724-071-411-26X; 018-736-038-341-712; 019-303-447-137-352; 020-724-247-127-10X; 023-038-457-436-700; 023-299-710-754-282; 024-120-873-232-722; 024-287-093-244-356; 025-621-634-605-933; 025-978-411-593-092; 027-546-194-568-037; 028-024-267-684-96X; 028-253-404-516-970; 031-767-956-201-746; 032-330-914-541-050; 032-402-330-102-118; 033-560-485-673-222; 034-277-607-624-449; 036-343-899-760-084; 038-153-814-636-507; 039-056-297-084-717; 040-332-392-387-357; 043-019-674-249-399; 043-292-891-178-627; 045-509-907-553-397; 046-919-131-470-188; 047-302-918-606-049; 049-595-148-605-318; 049-603-553-170-992; 051-385-274-443-539; 051-996-654-272-260; 052-002-405-127-33X; 052-543-335-700-488; 054-068-725-429-104; 055-792-171-539-646; 057-086-575-405-577; 059-170-516-978-302; 060-569-064-163-558; 061-798-035-450-043; 062-161-842-779-652; 063-234-660-776-734; 067-228-327-003-900; 067-935-423-082-998; 068-948-077-541-15X; 069-291-266-308-042; 072-030-033-133-66X; 075-215-209-587-797; 075-868-738-180-00X; 080-695-269-938-284; 080-816-158-282-647; 082-185-762-278-577; 090-538-835-141-741; 091-711-953-848-150; 094-949-727-440-850; 097-363-834-906-661; 098-297-396-213-93X; 101-165-882-304-37X; 102-737-534-873-83X; 107-197-234-739-142; 109-230-101-076-570; 110-373-889-331-031; 111-957-011-879-870; 113-869-373-651-569; 116-232-696-362-914; 118-475-156-235-526; 119-805-788-642-168; 122-166-865-294-33X; 123-470-806-656-567; 126-244-382-354-04X; 129-418-479-171-246; 146-894-938-719-017; 149-711-799-179-27X; 156-554-978-875-841; 158-051-896-559-309; 182-582-344-042-11X,18
006-105-239-564-748,Nanotechnology in dentistry: Present and future perspectives on dental nanomaterials.,2020-09-25,2020,journal article,Dental materials : official publication of the Academy of Dental Materials,18790097; 01095641,Elsevier Science,Netherlands,Klaus D. Jandt; David C. Watts,"Abstract Objectives The number of dental nanomaterials has increased significantly over the past years. A variety of commercial dental nanomaterials are available and researched. Nevertheless, how these nanomaterials work, what makes them special and whether they are superior to traditional dental materials is not always clear to dentists and researchers. The objective of this review paper is, therefore, to give an overview of the principles of nanomaterials and basic research and applications of dental nanomaterials. Methods The fundamentals of materials science of nanomaterials as well as their advantages and disadvantages are elaborated. The most important dental nanomaterials are discussed. This is mainly based on a survey of the literature and a review of the most frequently cited scientific papers in the international peer reviewed journal Dental Materials over the past five years. The developments of commercial dental nanomaterials as well as aspects of their clinical use are considered in this review. Results Nanomaterials have unique structures and properties that distinguish them from other materials. The journal Dental Materials is the journal with the highest numbers of articles and citations on the subject of dental nanomaterials. The most frequently reported dental nanomaterials are nanocomposites, nanoparticles, antimicrobial nanomaterials and bio-mineralization systems. Hallmarks of dental nanomaterials include a set of unique properties and challenges in the preparation of these materials. Significance By understanding the physical principles of dental nanomaterials, their strengths, limitations and their specific benefits will be better appreciated. Dental nanomaterials have potential for the future but currently do not always exhibit superior properties, for example in clinical situations.",36,11,1365,1378,Nanomaterials; Materials science; Basic research; Engineering ethics,Antimicrobial biomaterials; Dental nanomaterials nanoparticles; Nanocoatings; Nanocomposites,,,Deutsche Forschungsgemeinschaft; Deutsche Forschungsgemeinschaft; Deutsche Forschungsgemeinschaft; Deutsche Forschungsgemeinschaft; Deutsche Forschungsgemeinschaft; Deutsche Forschungsgemeinschaft,https://www.research.manchester.ac.uk/portal/en/publications/nanotechnology-in-dentistry-present-and-future-perspectives-on-dental-nanomaterials(52745c2a-932e-430c-ac89-a967a05425ec).html https://www.sciencedirect.com/science/article/pii/S0109564120302177 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516471 https://pubmed.ncbi.nlm.nih.gov/32981749/,http://dx.doi.org/10.1016/j.dental.2020.08.006,32981749,10.1016/j.dental.2020.08.006,3088861637,PMC7516471,0,002-386-798-688-892; 005-340-968-723-765; 006-217-976-543-820; 006-360-952-620-248; 006-627-578-161-626; 007-674-361-164-875; 011-500-283-129-015; 012-494-543-418-592; 014-273-197-975-137; 019-795-647-033-316; 027-080-645-479-155; 027-566-586-270-721; 028-461-814-807-179; 029-057-810-839-925; 029-217-578-855-209; 033-009-757-694-955; 034-536-851-256-864; 037-257-860-316-993; 037-606-002-636-440; 038-443-715-036-35X; 038-528-125-048-556; 040-160-422-835-774; 042-845-623-931-740; 045-155-362-556-84X; 046-793-182-550-03X; 047-334-788-017-292; 049-673-586-364-754; 050-411-787-604-975; 050-542-215-019-949; 055-139-167-136-949; 058-171-037-143-103; 058-637-348-405-467; 060-114-130-267-355; 060-751-807-826-633; 064-880-711-375-280; 067-183-828-805-497; 067-319-282-136-366; 067-828-758-776-605; 069-470-381-687-432; 074-347-495-757-950; 074-865-388-982-458; 075-211-109-585-569; 075-343-441-241-287; 080-319-736-265-113; 080-839-324-201-50X; 080-915-873-989-522; 081-890-602-551-332; 083-231-391-478-000; 083-490-087-366-879; 087-414-748-557-906; 089-237-049-027-680; 089-526-866-892-157; 095-746-862-008-522; 097-985-344-284-907; 101-755-620-667-429; 106-001-046-786-79X; 108-973-070-645-46X; 110-661-318-967-083; 116-547-249-384-982; 117-330-243-634-898; 119-402-081-613-623; 120-484-724-353-990; 121-722-416-664-84X; 127-804-500-261-864; 128-134-056-020-453; 129-821-848-602-620; 132-963-185-676-574; 146-454-116-306-396; 153-957-115-513-551; 159-826-181-808-903; 160-601-665-227-791; 161-370-651-483-971; 167-826-696-519-051; 169-760-910-787-529; 172-329-822-200-820; 184-764-716-120-327,16
006-175-583-791-695,"Nanomaterials: Classification, Biological Synthesis and Characterization",2016-12-24,2016,book chapter,Sustainable Agriculture Reviews,22104410; 22104429,Springer International Publishing,,Anbazhagan Mageswari; Ramachandran Srinivasan; Parthiban Subramanian; Nachimuthu Ramesh; Kodiveri Muthukaliannan Gothandam,"Nanomaterial research has recently gained importance due to prospective applications in human life and environment. However, scientific research on nano- and micro-sized materials has reached a saturation state. As a result, researchers planning to further develop nanomaterials, need an outlook on recent advances in synthesis, classification and characterization of nanomaterials. There is a need in particular for an overview of synthesis using biological materials namely bacteria, fungi, yeast, and plants, in order to design eco-friendly nanomaterials. Methods used to characterize these synthesized nanoparticles must also be reviewed to suggest the appropriate techniques in terms of spectroscopic and microscopic methods to study the physio-chemical properties of nanomaterials. Here we review the nature, types and synthesis of nanomaterials, with a detailed evaluation on biological synthesis. We also discuss in detail nanoparticle production by microorganisms including bacteria, fungi and yeasts. This chapter also provides updates on currently available techniques used to characterize nanoparticles.",,,31,71,Nanomaterials; Nanotechnology; Nanoparticle Production; Nanoparticle Characterization; Biological materials; Human life; Synthesis methods; Computer science,,,,,https://link.springer.com/chapter/10.1007/978-3-319-48009-1_2 https://rd.springer.com/chapter/10.1007/978-3-319-48009-1_2,http://dx.doi.org/10.1007/978-3-319-48009-1_2,,10.1007/978-3-319-48009-1_2,2564313907,,0,000-054-789-670-152; 000-858-135-826-414; 001-011-697-136-178; 001-345-972-123-575; 002-670-543-301-391; 002-779-473-386-201; 002-862-817-307-51X; 003-878-339-725-030; 003-990-823-067-869; 005-644-854-228-005; 006-157-561-186-209; 006-620-262-042-573; 006-938-773-370-157; 007-068-740-997-201; 007-826-574-872-648; 008-245-861-719-84X; 008-605-551-726-91X; 008-892-654-835-056; 009-064-835-932-747; 011-274-258-591-459; 011-760-554-474-461; 012-509-654-268-688; 012-904-100-348-192; 013-082-464-394-081; 013-583-346-357-576; 014-269-877-156-926; 014-991-553-385-405; 015-385-169-319-135; 016-457-251-065-054; 016-553-589-975-100; 017-516-481-062-506; 017-700-914-302-502; 020-022-919-850-573; 021-530-293-479-473; 022-130-020-754-808; 024-402-954-701-32X; 025-583-792-505-474; 026-534-983-833-716; 026-884-487-126-414; 027-638-532-904-602; 027-648-704-801-853; 028-596-690-562-189; 029-522-221-444-424; 031-205-720-870-498; 031-676-463-260-509; 031-994-802-269-676; 032-419-413-963-387; 032-752-249-910-791; 033-138-638-707-320; 033-555-458-833-079; 033-943-199-319-642; 035-186-566-129-937; 035-239-401-814-529; 035-867-675-633-829; 035-920-853-680-696; 038-127-102-578-91X; 038-814-694-205-213; 038-859-507-166-458; 039-788-193-635-100; 039-794-370-630-249; 041-439-486-807-048; 041-958-172-617-297; 042-243-218-540-836; 042-276-982-990-964; 043-446-021-638-545; 044-069-724-037-901; 044-078-633-008-202; 044-752-858-181-702; 046-777-436-218-556; 047-419-876-738-543; 047-464-310-371-554; 047-498-092-208-235; 048-530-640-871-462; 048-640-931-702-64X; 049-257-485-713-852; 049-555-017-406-929; 049-823-948-024-484; 050-886-141-331-217; 051-098-793-559-70X; 051-817-193-420-155; 052-122-373-110-037; 053-608-170-911-869; 053-721-590-764-580; 053-900-172-694-608; 054-104-429-598-179; 054-590-437-328-968; 055-180-423-784-617; 055-983-000-814-633; 060-405-878-944-299; 062-379-364-455-136; 062-973-764-270-626; 063-720-765-659-765; 067-832-561-213-018; 067-942-823-368-915; 068-873-515-981-54X; 070-474-444-549-322; 072-014-724-662-296; 072-357-206-386-011; 073-193-238-473-484; 075-323-172-506-188; 079-412-531-942-484; 080-135-754-953-589; 081-337-774-709-470; 081-556-068-915-840; 081-770-363-464-066; 083-121-310-483-928; 084-500-383-732-880; 087-634-544-671-269; 089-253-235-239-855; 091-295-920-041-131; 092-146-930-095-157; 096-033-627-021-758; 098-366-900-017-695; 100-572-747-714-618; 101-879-455-939-586; 103-170-091-388-617; 105-549-115-278-455; 106-305-276-098-119; 106-599-963-364-980; 108-805-471-785-102; 110-928-821-786-466; 114-937-160-749-122; 123-802-666-030-092; 125-118-345-494-920; 128-702-198-070-82X; 130-506-702-360-003; 131-477-360-451-285; 135-580-818-014-425; 135-650-527-448-021; 136-389-535-500-934; 136-601-603-000-866; 139-146-932-067-524; 142-974-393-326-217; 143-169-827-490-888; 143-588-949-538-364; 144-679-228-321-915; 149-087-442-664-145; 151-017-851-834-000; 161-933-135-960-926; 165-225-964-337-283; 171-421-203-111-779; 171-757-342-674-386; 172-319-458-455-43X; 176-794-509-614-217; 178-235-741-409-981; 181-029-034-981-234; 188-566-577-169-857; 198-086-753-586-538,12
006-252-264-657-524,Nano-QSPR Modelling of Carbon-Based Nanomaterials Properties.,2015-06-16,2015,journal article,Current topics in medicinal chemistry,18734294; 15680266,Bentham Science Publishers B.V.,United Arab Emirates,Maryam Salahinejad,"Evaluation of chemical and physical properties of nanomaterials is of critical importance in a broad variety of nanotechnology researches. There is an increasing interest in computational methods capable of predicting properties of new and modified nanomaterials in the absence of time-consuming and costly experimental studies. Quantitative Structure- Property Relationship (QSPR) approaches are progressive tools in modelling and prediction of many physicochemical properties of nanomaterials, which are also known as nano-QSPR. This review provides insight into the concepts, challenges and applications of QSPR modelling of carbon-based nanomaterials. First, we try to provide a general overview of QSPR implications, by focusing on the difficulties and limitations on each step of the QSPR modelling of nanomaterials. Then follows with the most significant achievements of QSPR methods in modelling of carbon-based nanomaterials properties and their recent applications to generate predictive models. This review specifically addresses the QSPR modelling of physicochemical properties of carbon-based nanomaterials including fullerenes, single-walled carbon nanotube (SWNT), multi-walled carbon nanotube (MWNT) and graphene.",15,18,1868,1886,Nanomaterials; Quantitative structure–activity relationship; Nanotechnology; Materials science; Nano-; Quantitative structure; Graphene; Carbon based nanomaterials; Carbon; Carbon nanotube,,"Carbon/chemistry; Models, Molecular; Nanostructures/chemistry; Nanotechnology; Quantitative Structure-Activity Relationship",Carbon,,https://www.eurekaselect.com/131065/article http://europepmc.org/abstract/MED/25961518 https://www.ncbi.nlm.nih.gov/pubmed/25961518,http://dx.doi.org/10.2174/1568026615666150506145017,25961518,10.2174/1568026615666150506145017,325711285,,0,,5
006-571-407-713-836,Hybrids of Fullerenes and 2D Nanomaterials.,2018-09-02,2018,journal article,"Advanced science (Weinheim, Baden-Wurttemberg, Germany)",21983844,Wiley-VCH Verlag,Germany,Muqing Chen; Runnan Guan; Shangfeng Yang,"Fullerene has a definite 0D closed-cage molecular structure composed of merely sp2-hybridized carbon atoms, enabling it to serve as an important building block that is useful for constructing supramolecular assemblies and micro/nanofunctional materials. Conversely, graphene has a 2D layered structure, possessing an exceptionally large specific surface area and high carrier mobility. Likewise, other emerging graphene-analogous 2D nanomaterials, such as graphitic carbon nitride (g-C3N4), transition-metal dichalcogenides (TMDs), hexagonal boron nitride (h-BN), and black phosphorus (BP), show unique electronic, physical, and chemical properties, which, however, exist only in the form of a monolayer and are typically anisotropic, limiting their applications. Upon hybridization with fullerenes, noncovalently or covalently, the physical/chemical properties of 2D nanomaterials can be tailored and, in most cases, improved, significantly extending their functionalities and applications. Here, an exhaustive review of all types of hybrids of fullerenes and 2D nanomaterials, such as graphene, g-C3N4, TMDs, h-BN, and BP, including their preparations, structures, properties, and applications, is presented. Finally, the prospects of fullerene-2D nanomaterial hybrids, especially the opportunity of creating unknown functional materials by means of hybridization, are envisioned.",6,1,1800941,1800941,Nanomaterials; Fullerene; Nanotechnology; Materials science; Graphitic carbon nitride; Boron nitride; Graphene; Carbon; Monolayer; Supramolecular chemistry,2D nanomaterials; black phosphorus; boron nitride; fullerene; graphene; graphitic carbon nitride; transition‐metal dichalcogenide,,,National Key Research and Development Program of China; National Natural Science Foundation of China; National Natural Science Foundation of China; Major/Innovative Program of Development Foundation,https://onlinelibrary.wiley.com/doi/full/10.1002/advs.201800941 https://europepmc.org/article/MED/30643712 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325629 https://pubmed.ncbi.nlm.nih.gov/30643712/ https://onlinelibrary.wiley.com/doi/pdf/10.1002/advs.201800941,http://dx.doi.org/10.1002/advs.201800941,30643712,10.1002/advs.201800941,2891941609,PMC6325629,0,000-093-730-527-417; 001-310-658-957-168; 001-351-347-889-816; 002-743-106-635-179; 003-161-713-132-019; 003-499-955-812-613; 005-081-649-933-104; 005-464-031-292-34X; 006-571-407-713-836; 008-777-861-628-953; 009-585-463-400-70X; 009-720-090-817-308; 010-496-251-685-564; 011-439-155-231-55X; 012-209-681-691-639; 012-223-608-947-483; 012-401-689-516-405; 012-445-185-522-451; 013-342-728-151-453; 013-449-805-016-803; 013-593-325-338-148; 013-867-338-592-810; 014-020-512-579-025; 014-073-525-546-379; 014-189-515-413-120; 014-747-078-212-606; 015-226-859-575-867; 015-552-019-534-679; 018-475-116-902-923; 019-169-252-076-890; 019-250-647-666-543; 020-572-130-619-266; 021-742-945-689-287; 022-698-429-756-851; 022-932-822-672-649; 023-020-565-420-794; 024-681-506-123-92X; 024-761-700-447-469; 025-286-557-193-086; 025-984-706-307-779; 026-170-687-903-076; 027-092-262-014-965; 027-656-481-494-576; 029-698-234-003-635; 031-261-839-149-725; 031-483-682-753-097; 032-263-559-230-217; 033-092-500-069-089; 035-819-448-912-08X; 036-125-424-310-703; 037-291-562-060-052; 037-812-240-399-222; 039-636-272-652-176; 040-314-459-198-480; 041-083-808-097-030; 041-353-014-565-776; 041-453-475-686-579; 042-207-008-799-673; 043-501-694-637-01X; 043-574-849-767-511; 044-376-761-094-411; 046-644-574-167-655; 046-962-968-182-683; 047-278-572-057-128; 047-451-566-853-650; 048-053-859-359-122; 048-349-523-032-604; 049-151-336-143-838; 050-359-510-075-390; 051-580-147-747-621; 051-613-877-041-426; 051-638-342-818-033; 051-679-533-169-858; 054-415-409-837-740; 055-182-652-910-348; 056-310-983-167-763; 058-366-728-687-329; 058-775-363-371-272; 059-026-210-967-970; 059-842-118-629-333; 059-877-379-385-795; 061-284-583-085-755; 061-372-985-633-048; 061-814-153-369-913; 062-966-361-026-391; 067-863-230-856-125; 069-643-623-464-622; 070-604-399-988-870; 071-606-440-148-714; 076-810-439-290-318; 077-145-319-831-270; 077-545-987-998-36X; 078-649-335-675-875; 078-859-326-859-221; 079-124-462-013-377; 079-643-631-931-609; 080-321-141-823-166; 081-173-976-683-821; 082-838-379-671-785; 083-213-156-255-81X; 084-452-494-583-028; 084-492-476-578-205; 085-220-145-123-588; 088-111-712-622-938; 090-000-662-279-552; 094-312-453-086-39X; 095-023-034-220-975; 099-307-504-148-585; 099-735-641-295-419; 100-513-981-999-260; 101-316-485-002-293; 101-499-163-482-401; 102-515-797-993-530; 103-479-504-225-791; 103-723-294-272-961; 104-423-970-075-229; 104-788-103-441-165; 107-796-978-160-349; 108-402-452-282-132; 109-662-104-838-875; 111-496-728-011-21X; 111-814-694-701-802; 112-040-615-350-304; 113-047-437-655-129; 113-953-238-659-009; 117-980-243-344-641; 121-857-432-332-149; 121-946-483-243-001; 124-728-176-978-95X; 128-884-237-956-448; 134-595-250-254-842; 138-172-747-799-830; 144-964-625-434-975; 148-058-739-059-545; 149-640-115-606-491; 152-913-424-490-495; 158-109-470-316-499; 160-881-801-022-416; 174-404-515-084-081; 185-228-552-997-583; 195-009-701-191-333,44
006-642-008-089-461,Biomass-Derived Nanomaterials,2019-02-12,2019,book chapter,Nanostructured Materials for Energy Related Applications,22137114; 22137122,Springer International Publishing,,Sebastian Raja; Luiz H. C. Mattoso; Francys K.V. Moreira,"The arising of global energy crisis and tremendous risk of climate change has drastically endangered the survival and development of human society, which certainly demand for modern technologies that require high-performance materials with superior properties. In this context, nanotechnology has emerged as a powerful tool for the scientific community to the design and development of engineered materials. In particular, nanomaterials derived from biomass (plants or plant-based) resources are gaining much attention by governments, industries, and academia owing to their low-cost, environmental compatibility, and replacement capability for petroleum-derived products for energy and environmental applications. Meanwhile, it is desirable that the development of novel materials from the natural resources that meet our daily needs and at the same time environmental-friendly in nature. This chapter provides a comprehensive understanding for obtaining renewable nanomaterials from natural biomass precursors for energy and environmental applications. Three different nanomaterials (i) cellulose nanostructures, (ii) starch nanocrystals (SNC), and (iii) carbon nanostructures along with their recent advancement in energy and environmental applications are figured out.",,,243,270,Engineering; Nanomaterials; Biochemical engineering; Renewable energy; Biomass; Context (language use); Global energy; Carbon nanostructures; Natural resource; Energy storage,,,,,https://link.springer.com/chapter/10.1007%2F978-3-030-04500-5_10,http://dx.doi.org/10.1007/978-3-030-04500-5_10,,10.1007/978-3-030-04500-5_10,2911511100,,0,003-394-807-213-28X; 004-712-131-135-265; 007-250-934-210-922; 007-263-225-522-440; 008-151-816-360-068; 008-804-834-264-85X; 009-693-036-885-86X; 010-659-012-560-290; 013-120-244-561-524; 013-222-615-152-285; 013-529-898-533-243; 014-294-067-960-597; 014-294-490-342-93X; 014-436-337-639-105; 017-186-964-898-579; 017-747-600-420-782; 020-253-130-171-635; 020-444-796-207-368; 020-502-581-057-430; 021-098-698-822-33X; 022-822-976-480-829; 023-196-127-035-983; 023-390-448-075-184; 024-172-383-354-14X; 024-882-255-971-852; 025-742-091-826-676; 026-335-388-559-837; 026-474-933-070-843; 026-545-793-464-95X; 027-037-823-707-525; 029-417-271-147-394; 029-656-717-758-56X; 031-028-722-449-053; 032-273-302-750-582; 032-782-118-946-054; 033-162-435-606-167; 034-710-794-269-749; 035-112-027-770-23X; 035-808-781-248-908; 036-135-707-445-535; 036-397-530-235-726; 037-093-498-638-501; 038-218-144-268-032; 038-370-308-815-589; 039-706-387-901-76X; 040-085-978-174-548; 041-014-179-870-393; 041-078-288-371-326; 041-987-634-321-574; 043-790-041-456-936; 044-087-238-458-603; 044-291-215-631-272; 045-070-086-007-955; 045-342-331-194-632; 045-850-323-768-73X; 045-929-272-331-336; 047-297-372-218-509; 048-040-081-861-29X; 048-218-798-668-425; 048-752-426-646-735; 050-773-029-231-08X; 051-858-333-626-659; 052-223-243-553-422; 056-310-776-993-827; 057-741-110-030-726; 057-946-552-007-880; 060-834-296-548-590; 062-967-016-500-384; 063-398-594-434-402; 065-952-685-660-876; 066-194-495-887-718; 066-967-093-091-540; 067-650-204-627-426; 069-931-058-946-923; 070-561-056-617-982; 071-416-326-629-912; 073-110-306-690-071; 073-515-617-610-337; 073-839-142-691-436; 074-192-407-112-893; 074-260-998-408-689; 075-497-846-017-832; 076-058-657-724-134; 076-946-611-709-25X; 076-996-906-730-22X; 077-355-767-245-81X; 078-927-290-070-350; 080-081-955-409-116; 080-351-189-067-088; 083-158-022-122-991; 088-782-021-453-714; 089-413-826-095-670; 091-578-581-463-582; 091-772-690-142-613; 092-161-198-945-573; 094-605-158-987-987; 094-843-500-665-013; 096-435-782-481-406; 099-042-626-011-586; 103-327-148-451-481; 105-547-766-971-158; 106-754-546-417-137; 107-058-388-442-421; 109-489-706-960-193; 109-696-574-026-455; 111-643-131-069-758; 113-458-419-869-816; 113-657-274-626-232; 113-985-404-875-687; 116-224-580-726-448; 121-895-657-814-920; 122-830-081-571-207; 127-346-931-903-261; 127-394-365-961-710; 129-635-779-016-572; 130-664-828-773-122; 131-354-007-707-251; 131-392-944-548-803; 136-730-683-276-942; 137-927-602-470-950; 139-893-489-531-730; 140-368-427-193-852; 140-837-254-090-984; 145-838-518-843-721; 163-603-206-502-801; 164-263-404-274-502; 185-291-240-898-414,2
006-686-905-581-549,Applications of Nanomaterials in Construction Industry,,2014,book chapter,"Handbook of Research on Nanoscience, Nanotechnology, and Advanced Materials",23275448; 23275456,IGI Global,,Salim Barbhuiya,"<jats:p>The application of nanomaterials in various applied fields has gained worldwide recognition. Nanomaterials have the ability to manipulate the structure at nano-scale. This leads to the generation of tailored and multifunctional composites with improved mechanical and durability performance. Recognizing this, the construction industry recently has started to use a variety of nanomaterials. The use of these materials is found to improve various fundamental characteristics of construction materials including the strength, durability, and lightness. In this chapter an attempt is made to review the use of various nanomaterials in cementitous system. This is followed by a discussion of the challenges related to their use. Finally, the strategies for using nanomaterials in construction industry for the next ten years are identified. </jats:p>",,,164,175,,,,,,,http://dx.doi.org/10.4018/978-1-4666-5824-0.ch008,,10.4018/978-1-4666-5824-0.ch008,,,0,003-009-275-201-101; 004-799-802-093-786; 006-589-028-556-434; 014-827-638-570-138; 015-047-701-831-863; 015-867-540-134-701; 016-059-238-190-64X; 017-742-757-211-150; 023-008-037-860-874; 024-079-005-598-490; 024-980-290-402-136; 029-065-402-057-772; 031-648-198-059-709; 040-723-657-106-724; 043-687-079-033-191; 044-279-112-922-884; 045-311-323-666-415; 045-942-361-287-978; 047-065-252-124-732; 048-276-316-758-053; 055-165-874-363-170; 056-123-878-458-151; 060-008-587-854-42X; 063-947-939-395-293; 064-494-438-779-026; 066-402-572-616-609; 068-868-355-041-615; 088-575-643-641-611; 094-700-759-728-628; 097-593-987-766-253; 102-021-899-910-345; 105-490-093-975-220; 140-022-489-953-425; 144-848-087-977-922; 151-546-314-781-197; 151-654-839-093-766; 160-726-286-631-910; 162-568-022-043-578; 179-241-613-333-342; 179-782-698-694-762,0
006-739-756-033-210,Modification of Electrode Surfaces with Metallo Phthalocyanine Nanomaterial Hybrids,2016-05-04,2016,book chapter,Electrochemistry of N4 Macrocyclic Metal Complexes,,Springer International Publishing,,Tebello Nyokong; Samson Khene,"The chapter reviews an electrocatalytic behavior of mononuclear metallophthalocyanines (MPcs) when combined with various nanomaterials. In addition, the chapter presents electrode modification using the least studied, binuclear phthalocyanines alone or in the presence of nanomaterials. The nanomaterials included are carbon nanotubes, metal nanoparticles, and semiconductor quantum dots. Different methods of electrode modification using MPc complexes in the presence of nanomaterials are presented. Methods of characterization of the modified electrodes, such as different types of microscopy, voltammetry, and X-ray photoelectron spectroscopy are presented. The chapter contains tables listing the reported electrode modification methods using MPcs in the presence on nanomaterials, and analytes detected on these electrodes. The chapter contains 149 references.",,,225,275,Nanomaterials; Nanotechnology; Electrode; Inorganic chemistry; Materials science; Cyclic voltammetry; Scanning electrochemical microscopy; Voltammetry; Phthalocyanine; Electrocatalyst; Carbon nanotube,,,,,https://link.springer.com/chapter/10.1007/978-3-319-31332-0_6 https://rd.springer.com/chapter/10.1007/978-3-319-31332-0_6,http://dx.doi.org/10.1007/978-3-319-31332-0_6,,10.1007/978-3-319-31332-0_6,2464331010,,0,000-154-298-192-123; 001-734-687-796-964; 001-840-036-576-879; 003-160-482-666-624; 003-761-311-309-175; 006-067-874-782-707; 006-119-689-433-486; 006-684-242-062-289; 007-024-155-126-590; 007-050-767-632-602; 008-191-424-456-323; 009-606-038-959-078; 009-856-911-074-250; 009-968-525-797-035; 010-574-707-554-548; 010-595-954-217-20X; 010-845-908-539-354; 010-932-474-188-141; 012-270-590-952-39X; 012-342-751-831-661; 012-477-107-482-665; 012-681-485-160-75X; 013-278-795-608-974; 014-370-427-045-352; 018-015-242-098-502; 018-265-753-859-221; 018-466-125-201-251; 019-056-863-136-492; 019-115-755-727-540; 020-346-395-124-714; 022-406-765-166-941; 023-504-987-666-71X; 023-909-331-194-532; 025-809-820-437-552; 026-777-818-148-455; 027-059-224-886-004; 029-881-208-447-799; 032-301-788-027-786; 032-467-275-181-454; 032-487-505-074-901; 032-519-886-267-152; 032-569-439-733-698; 033-300-718-506-417; 033-559-879-570-412; 033-561-963-860-239; 033-599-034-262-852; 034-242-495-202-638; 036-153-435-159-920; 038-539-129-176-794; 038-708-305-835-694; 042-390-183-541-977; 042-797-420-549-249; 043-006-790-505-924; 043-243-400-059-025; 045-465-530-654-160; 047-579-917-438-436; 047-732-125-172-762; 047-763-032-852-138; 048-016-428-217-023; 048-119-535-002-927; 048-499-274-437-064; 048-531-246-645-306; 048-780-543-410-105; 049-550-579-285-003; 053-254-775-660-673; 053-685-571-102-199; 053-958-085-907-822; 056-935-603-682-684; 057-235-482-192-273; 057-307-922-314-853; 060-457-368-053-909; 062-614-994-454-936; 062-732-551-272-794; 063-504-164-543-023; 064-100-636-672-102; 065-989-755-265-820; 066-402-572-616-609; 066-508-159-287-173; 067-729-472-099-107; 068-104-848-332-306; 069-706-872-934-58X; 070-057-179-334-752; 070-750-818-489-124; 070-758-490-136-718; 072-932-427-426-943; 073-605-733-514-309; 073-841-765-649-798; 075-002-082-838-587; 075-497-541-068-516; 077-627-003-943-083; 078-383-407-868-743; 078-404-246-401-519; 079-750-332-126-822; 081-092-403-760-75X; 082-113-602-131-645; 084-174-469-404-836; 085-355-153-919-525; 087-908-667-847-303; 090-857-000-006-048; 093-471-100-461-993; 095-365-925-954-18X; 096-753-591-906-09X; 097-142-362-334-298; 098-492-553-791-287; 099-169-816-691-859; 100-343-860-863-077; 100-537-543-664-993; 100-922-623-490-63X; 104-080-505-507-055; 105-011-627-959-479; 107-458-584-758-493; 108-188-931-718-146; 108-300-103-043-179; 109-460-843-165-496; 110-149-088-908-201; 110-339-932-537-942; 111-022-998-104-753; 111-757-207-912-576; 112-824-554-307-753; 115-190-217-446-856; 117-180-307-648-615; 117-845-453-304-443; 118-736-529-953-639; 121-104-736-953-933; 123-284-944-757-308; 126-023-494-721-191; 128-290-578-594-459; 130-809-645-193-592; 131-609-630-835-871; 131-881-677-463-713; 132-870-777-713-786; 134-428-513-156-817; 137-073-749-942-514; 138-409-388-549-743; 141-416-331-714-609; 143-797-709-492-927; 144-010-878-785-880; 144-147-826-875-62X; 149-512-009-879-246; 150-889-633-286-482; 160-229-215-509-101; 160-690-174-571-595; 163-924-828-420-840; 169-864-136-452-813; 172-992-855-452-646; 173-797-477-537-572; 175-531-237-587-284; 181-599-480-450-067; 188-403-583-047-737; 189-470-033-479-769; 197-133-309-929-71X,4
006-785-732-239-182,Therapeutic nanomaterials: from a drug delivery perspective,,2017,book chapter,Nanostructures for Drug Delivery,,Elsevier,,Chityal Ganesh Kumar; Yedla Poornachandra; Sujitha Pombala,"Limitations in conventional chemotherapy have resulted in efforts to develop a good drug delivery system for the treatment of several diseases. Many promising drugs that were identified failed to reach the market due to associated drug delivery problems. The ultimate aim of drug delivery systems is to tailor-make the drug formulation to meet the individual requirements under the control of pathophysiological or in vivo conditions, rather than the in vitro characteristics. However, a challenge remains to develop cost-effective, better, and safer nanomaterials for efficient drug loading and controlled drug release. In the recent past, several nanomaterials have been identified with appreciable biocompatibility and therapeutic properties. This chapter focuses on the subject of nanomaterials with regard to their synthetic routes and application as potential drug delivery agents. Different nanomaterial types, including polymeric nanomaterials, dendrimers, nanoparticles, carbon nanotubes, and quantum dots, have been discussed and a number of case studies have been presented.",,,1,61,Nanomaterials; Nanotechnology; Materials science; Biocompatibility; Drug delivery; Drug; Conventional chemotherapy; Drug release,,,,,https://www.sciencedirect.com/science/article/pii/B9780323461436000014 http://www.sciencedirect.com/science/article/pii/B9780323461436000014,http://dx.doi.org/10.1016/b978-0-323-46143-6.00001-4,,10.1016/b978-0-323-46143-6.00001-4,2600539313,,0,000-507-050-529-985; 000-539-317-376-559; 000-794-618-523-629; 000-940-938-345-828; 001-012-396-461-908; 001-079-089-805-738; 001-232-850-888-157; 001-309-263-259-068; 001-378-764-989-949; 001-393-069-586-14X; 001-473-079-386-651; 001-484-582-534-790; 001-487-277-897-222; 001-596-113-917-939; 001-733-800-316-519; 001-795-563-857-023; 001-797-173-165-215; 001-804-149-026-189; 001-944-418-773-727; 002-011-989-587-807; 002-055-503-685-226; 002-120-683-776-077; 002-294-300-016-469; 002-302-355-031-831; 002-631-105-738-399; 002-773-357-702-425; 002-837-850-258-882; 003-399-311-227-04X; 003-676-458-767-393; 003-874-655-403-262; 003-972-259-804-522; 004-266-289-737-808; 004-448-835-912-915; 004-448-980-130-602; 004-634-772-543-065; 004-637-994-362-714; 004-864-961-104-452; 005-084-495-896-200; 005-341-284-696-350; 005-408-309-796-475; 005-774-207-023-412; 005-774-252-656-809; 005-873-114-974-394; 005-908-884-095-748; 006-080-854-027-778; 006-309-964-190-632; 006-363-181-231-829; 006-384-047-778-615; 006-465-756-139-036; 006-649-612-030-839; 006-782-761-623-892; 006-974-855-561-73X; 007-058-280-106-834; 007-263-675-939-921; 007-282-667-277-757; 007-302-493-601-785; 007-434-964-307-510; 007-484-977-419-971; 007-521-325-809-042; 007-615-931-945-869; 007-634-014-226-051; 007-661-442-504-728; 007-859-124-505-569; 008-009-347-354-839; 008-068-317-934-349; 008-108-997-106-670; 008-132-924-686-926; 008-144-665-220-352; 008-308-267-977-577; 008-308-924-626-911; 008-535-441-211-770; 008-775-403-469-300; 009-201-926-460-018; 009-310-334-199-680; 009-491-846-081-980; 009-514-425-852-889; 009-553-022-411-87X; 009-819-353-449-202; 009-947-728-882-528; 010-256-227-370-623; 010-496-102-410-76X; 010-497-738-264-387; 010-543-065-778-993; 010-788-091-785-308; 010-821-328-901-090; 011-284-354-303-639; 011-539-113-334-858; 011-606-671-489-384; 011-770-070-780-904; 011-783-294-372-689; 011-885-301-371-105; 011-895-973-571-424; 012-007-560-370-737; 012-921-316-518-685; 013-523-641-809-753; 013-538-384-639-213; 013-553-533-109-394; 013-895-025-392-920; 013-979-508-545-133; 014-286-034-228-340; 014-623-478-907-218; 014-706-729-778-494; 014-776-907-973-609; 015-045-891-102-231; 015-408-954-660-397; 015-639-637-767-690; 015-731-352-959-885; 016-158-994-345-938; 016-208-496-951-09X; 016-547-336-477-663; 016-622-134-608-239; 016-694-808-650-429; 016-695-807-161-695; 016-872-508-164-604; 017-033-345-270-910; 017-084-715-302-191; 017-447-782-265-167; 017-620-255-348-813; 017-982-066-339-983; 017-991-915-932-912; 018-060-165-507-976; 018-438-452-881-161; 018-717-878-789-110; 018-728-425-649-178; 019-095-322-243-852; 019-448-368-257-53X; 019-490-550-485-423; 019-543-227-350-154; 019-716-663-314-195; 020-091-299-142-064; 020-096-430-144-843; 020-176-810-826-774; 020-358-134-168-821; 020-850-610-907-07X; 020-921-928-633-131; 021-086-659-140-194; 021-434-101-939-990; 021-440-652-542-691; 021-767-665-828-087; 021-880-324-885-424; 022-615-120-181-651; 022-799-552-333-478; 023-012-119-962-622; 023-604-839-306-147; 023-632-185-207-227; 023-747-669-672-969; 023-936-661-318-108; 024-382-864-030-328; 024-639-034-182-622; 025-063-828-537-728; 025-080-898-701-41X; 025-420-097-724-986; 025-446-816-962-768; 025-460-598-615-194; 025-507-263-820-933; 025-687-202-514-028; 025-826-573-344-520; 025-842-166-888-125; 025-923-265-463-186; 026-674-401-088-926; 026-692-698-331-083; 026-793-385-996-757; 026-861-724-136-148; 026-866-267-798-463; 027-007-656-652-637; 027-147-124-193-040; 027-340-466-508-879; 027-390-084-521-221; 027-489-531-595-434; 027-773-787-435-248; 027-794-690-759-02X; 028-101-520-752-37X; 028-188-691-667-940; 028-275-380-464-068; 028-596-526-433-537; 028-632-972-534-691; 028-732-992-361-845; 028-803-762-226-678; 028-956-876-934-506; 028-972-924-821-996; 029-321-695-690-001; 029-362-202-681-379; 029-764-854-759-882; 030-158-348-790-794; 030-390-517-713-105; 030-643-043-756-869; 030-828-648-979-791; 031-256-475-944-173; 031-535-810-131-893; 031-726-584-028-872; 031-820-752-548-238; 031-846-521-635-380; 032-147-959-755-84X; 033-483-669-132-328; 033-760-218-874-974; 033-899-017-125-287; 034-369-836-125-57X; 034-603-507-491-977; 034-745-086-069-244; 035-294-596-407-748; 035-727-951-917-824; 036-196-370-882-471; 036-355-823-880-467; 036-426-116-530-543; 036-653-085-127-38X; 036-751-902-945-059; 037-003-564-721-126; 037-391-320-917-381; 037-724-636-608-676; 037-780-592-410-372; 037-866-710-701-70X; 037-869-788-765-555; 037-971-561-986-880; 038-153-814-636-507; 038-248-321-585-643; 038-545-532-583-331; 038-792-006-190-691; 038-949-727-079-136; 039-074-524-113-928; 039-459-083-497-66X; 039-697-754-297-727; 039-842-478-683-864; 040-137-696-760-102; 040-196-379-784-493; 040-592-519-371-610; 041-393-492-756-16X; 041-650-238-255-073; 041-715-459-777-814; 043-233-560-237-805; 043-405-784-271-963; 043-621-758-877-95X; 043-645-381-311-177; 044-226-134-690-085; 044-355-763-392-583; 044-556-338-741-683; 044-562-149-797-347; 044-923-258-528-008; 045-017-566-264-915; 045-030-304-019-262; 045-093-423-221-875; 045-331-286-252-536; 045-425-765-916-800; 045-553-445-856-905; 045-817-468-033-14X; 045-916-166-759-15X; 045-919-401-922-177; 046-038-609-884-348; 046-319-333-489-144; 046-791-736-111-807; 046-864-328-876-290; 046-971-000-311-572; 047-171-978-439-951; 047-213-198-532-912; 047-264-436-888-421; 047-588-543-903-237; 047-923-434-408-232; 048-064-544-714-461; 048-161-579-243-676; 048-338-487-559-084; 048-644-611-034-732; 049-080-409-219-392; 049-533-179-532-648; 049-602-563-385-511; 050-236-306-076-986; 050-366-203-670-742; 050-814-597-029-54X; 050-841-888-715-703; 051-035-694-710-605; 051-369-745-054-055; 051-759-600-958-559; 052-111-628-270-785; 052-112-394-558-288; 052-384-271-150-767; 052-440-705-872-112; 052-650-222-565-420; 053-403-260-241-29X; 053-437-590-155-656; 053-613-997-367-79X; 053-886-976-461-836; 053-941-332-211-275; 054-100-292-368-947; 054-316-465-991-263; 054-575-942-838-250; 054-973-992-938-464; 055-142-910-693-141; 055-375-651-805-002; 055-781-233-560-034; 056-071-410-390-487; 056-104-755-960-631; 056-268-790-123-127; 056-445-151-543-496; 056-692-403-401-91X; 056-833-922-314-064; 057-451-031-047-794; 057-549-174-786-258; 057-654-765-213-122; 057-687-398-995-513; 058-422-953-893-966; 058-714-110-751-18X; 058-755-127-243-561; 059-031-369-704-466; 059-101-587-528-342; 059-205-065-032-928; 059-325-521-616-879; 059-335-464-952-516; 059-369-154-738-405; 059-398-859-024-819; 059-516-423-592-916; 059-561-820-854-898; 059-648-769-174-011; 059-933-578-208-373; 059-971-187-897-404; 060-125-445-252-063; 060-301-220-665-473; 060-625-271-187-935; 060-724-023-243-663; 060-796-095-942-925; 061-662-789-880-426; 061-674-814-815-684; 061-694-310-902-168; 061-939-560-567-115; 062-084-952-545-324; 062-560-702-477-044; 062-623-654-660-746; 062-942-795-755-544; 063-008-839-601-736; 063-133-739-396-221; 063-238-362-231-726; 063-384-088-949-756; 063-653-401-342-276; 063-675-786-545-767; 063-746-781-708-26X; 063-773-503-120-38X; 064-035-320-297-694; 064-264-463-404-142; 064-287-235-203-551; 064-499-234-974-21X; 064-752-790-794-11X; 064-757-267-021-975; 064-822-503-387-265; 065-251-902-503-753; 066-287-018-890-730; 066-703-072-235-809; 066-817-806-359-890; 066-818-031-039-596; 067-075-052-753-90X; 067-759-234-091-967; 067-791-868-906-312; 068-525-863-650-762; 068-575-269-960-835; 068-767-967-585-856; 068-820-820-967-331; 069-110-836-291-268; 069-134-142-675-941; 069-451-001-765-520; 069-603-872-253-918; 069-666-678-938-938; 069-977-969-093-064; 070-192-427-045-506; 070-370-781-709-423; 070-475-862-912-774; 070-609-003-769-755; 071-216-935-223-604; 071-398-198-733-320; 071-431-743-739-173; 071-567-869-582-952; 071-731-855-264-904; 072-329-658-757-321; 073-063-637-433-206; 073-119-469-391-261; 073-193-248-903-417; 073-989-137-304-722; 074-010-198-850-565; 074-276-378-417-046; 074-403-257-219-915; 074-485-157-695-836; 074-595-882-022-359; 074-874-816-023-304; 075-576-681-446-895; 075-654-125-668-041; 075-776-883-946-94X; 075-779-913-007-665; 076-044-360-165-661; 076-174-000-950-178; 076-209-396-257-931; 076-665-741-817-530; 076-903-900-541-035; 076-921-485-968-566; 077-121-923-599-440; 077-712-972-071-321; 078-335-557-339-541; 078-417-266-041-891; 079-514-749-506-084; 079-684-416-716-069; 080-425-321-598-441; 080-451-247-391-651; 080-608-399-462-263; 080-689-976-295-643; 081-033-107-147-264; 081-083-592-220-669; 081-523-885-284-005; 081-546-351-273-223; 081-677-721-295-711; 082-089-800-179-888; 082-185-569-856-697; 082-343-957-119-737; 082-398-577-874-544; 082-540-663-847-854; 083-084-477-680-245; 083-249-017-617-061; 083-408-278-685-789; 083-599-855-138-369; 083-972-526-245-131; 084-395-025-540-414; 084-575-922-852-889; 084-841-227-859-113; 085-704-598-079-576; 085-869-799-950-239; 087-017-624-139-682; 087-177-799-378-768; 087-562-353-901-279; 087-686-113-202-57X; 088-160-696-865-403; 088-219-187-328-267; 088-300-775-930-316; 088-527-575-520-773; 088-666-730-980-172; 089-997-853-786-794; 090-017-371-360-992; 090-045-625-379-502; 090-281-829-495-438; 090-303-752-373-41X; 090-872-694-767-874; 090-873-773-152-282; 091-272-752-084-551; 091-311-718-925-790; 091-456-824-651-153; 091-531-489-169-876; 091-651-783-188-716; 091-808-671-892-592; 092-001-846-828-031; 092-191-121-534-933; 092-295-430-538-459; 093-318-431-172-386; 093-349-699-950-937; 093-469-617-324-69X; 093-605-874-287-838; 093-713-898-791-156; 093-947-669-559-339; 094-051-343-116-268; 094-280-082-105-673; 094-325-947-620-495; 094-645-755-937-212; 094-900-349-919-786; 095-170-753-503-242; 095-255-760-159-550; 095-385-465-312-802; 095-700-257-254-342; 096-407-950-845-937; 096-545-393-074-433; 097-078-579-462-262; 097-449-274-319-908; 098-293-945-890-127; 100-017-833-916-475; 100-037-368-052-824; 100-248-230-079-602; 100-261-586-155-713; 100-481-706-633-244; 101-001-739-171-956; 101-813-082-375-682; 101-991-796-939-111; 102-029-290-955-507; 102-116-287-969-102; 102-183-334-943-74X; 102-203-765-105-591; 102-280-756-560-671; 102-318-648-721-774; 102-629-236-491-421; 103-176-478-453-791; 103-385-703-685-662; 104-045-054-300-448; 104-964-545-963-905; 105-035-866-669-213; 105-435-899-626-060; 106-703-660-008-580; 107-213-864-233-899; 107-558-536-330-626; 107-854-969-991-338; 108-240-505-037-562; 108-307-080-443-744; 108-319-396-227-608; 108-382-466-796-016; 108-607-947-100-379; 108-984-229-082-536; 109-278-608-735-806; 110-023-400-001-660; 112-271-670-238-372; 112-485-305-047-600; 112-555-385-837-290; 112-820-617-121-078; 112-962-288-689-933; 113-623-423-626-792; 113-923-515-801-855; 113-931-462-640-487; 114-370-956-310-639; 114-469-529-312-672; 114-780-010-955-753; 114-912-546-138-665; 115-566-242-744-831; 115-707-799-022-162; 116-121-134-914-279; 116-214-452-642-54X; 116-261-594-339-927; 116-263-942-837-519; 116-412-266-534-251; 118-595-017-398-84X; 118-992-869-542-281; 119-173-394-603-69X; 119-245-516-517-459; 119-398-582-771-09X; 119-648-350-332-29X; 119-779-369-718-969; 119-826-988-461-380; 120-043-096-064-106; 120-149-319-646-433; 120-378-237-714-876; 120-856-434-053-441; 121-164-598-995-08X; 121-529-529-577-182; 122-221-686-512-679; 122-523-122-468-637; 123-195-439-459-727; 123-432-289-756-123; 123-821-323-129-959; 125-355-409-950-665; 125-527-704-768-581; 130-506-702-360-003; 130-911-447-256-688; 130-939-700-074-912; 131-383-759-214-655; 131-643-596-628-420; 131-671-193-426-240; 131-907-656-006-911; 131-927-901-763-800; 132-878-137-476-619; 133-689-003-394-865; 134-677-637-830-647; 135-010-076-288-915; 135-971-951-226-257; 136-236-299-387-054; 136-543-222-928-481; 137-010-917-007-923; 137-801-987-410-487; 137-972-157-373-206; 138-200-447-166-244; 138-718-808-902-662; 138-920-748-669-051; 139-240-575-408-829; 140-082-874-897-698; 140-176-247-818-556; 141-065-251-087-519; 142-242-318-584-116; 143-912-572-806-809; 144-528-638-977-185; 145-210-977-776-691; 145-308-404-656-719; 145-674-979-762-475; 146-326-668-673-075; 146-995-720-750-110; 147-861-552-205-713; 148-536-162-755-821; 148-981-416-564-888; 149-451-012-917-876; 149-709-289-987-100; 150-005-347-079-689; 153-771-257-440-858; 154-961-206-502-59X; 155-401-714-588-52X; 155-438-300-377-035; 159-165-876-017-010; 162-734-604-363-564; 163-834-309-569-994; 165-356-309-811-17X; 168-508-331-405-388; 171-498-259-517-570; 171-624-226-359-734; 172-979-359-216-429; 173-136-810-733-414; 180-699-204-713-571; 181-061-872-752-027; 183-418-670-819-889; 188-201-145-284-235; 192-349-412-877-218; 196-690-325-241-574,3
006-834-280-407-859,Emerging functional nanomaterials for therapeutics,,2011,journal article,Journal of Materials Chemistry,09599428; 13645501,Royal Society of Chemistry (RSC),United Kingdom,Xuejia Xue; Feng Wang; Xiaogang Liu,"The recent development of functional crystalline nanomaterials for therapeutics is described. In contrast to conventional therapeutic approaches, nanomaterial-based systems present novel therapeutic opportunities; for example, by allowing active agents to be site-specifically delivered and efficiently absorbed while offering fewer or reduced side effects. In addition, nanomaterials are generally amenable to surface functionalization and interior doping. These attributes provide the nanomaterials with tunable surface, optical, magnetic, thermal and mechanical properties that are important for applications ranging from controlled release of drugs to photothermal therapy. In this article, we seek to provide a conceptual framework for understanding nanomaterial-based therapeutics. We also attempt to highlight recent therapeutic applications involving some representative nanostructured materials. With improved control over the synthesis and functional characteristics of nanomaterials, the emergence of nanomaterial-based therapeutics will likely accelerate future medical research and improve patient care.",21,35,13107,13127,Nanomaterials; Nanotechnology; Photothermal therapy; Materials science; Nanostructured materials; Patient care,,,,,http://pubs.rsc.org/en/content/articlelanding/2011/jm/c1jm11401h#! https://pubs.rsc.org/en/content/articlelanding/2011/jm/c1jm11401h#! http://xlink.rsc.org/?DOI=c1jm11401h http://pubs.rsc.org/en/Content/ArticleLanding/2011/JM/C1JM11401H#!divAbstract,http://dx.doi.org/10.1039/c1jm11401h,,10.1039/c1jm11401h,2172071133,,0,000-064-276-743-757; 000-122-735-953-773; 000-516-101-614-608; 000-595-925-732-111; 000-607-798-909-839; 000-710-575-211-201; 000-783-528-118-044; 001-035-001-441-251; 001-052-226-152-324; 001-077-835-613-326; 001-385-024-097-705; 001-680-299-438-734; 001-907-643-390-578; 002-208-546-117-389; 002-264-242-258-728; 002-328-083-497-261; 002-607-799-238-072; 002-944-935-062-954; 003-072-766-474-480; 003-265-567-369-101; 003-704-995-246-695; 003-949-654-920-384; 004-107-580-818-971; 004-208-947-021-882; 004-768-553-930-149; 005-001-616-391-246; 005-351-442-339-375; 005-814-862-001-125; 006-117-012-421-96X; 006-296-648-083-616; 006-309-964-190-632; 006-661-975-836-403; 006-683-021-031-281; 006-743-480-927-089; 007-238-940-590-595; 007-414-469-434-872; 007-544-169-678-889; 007-736-339-264-168; 008-026-084-779-329; 008-107-829-840-679; 008-227-707-647-842; 008-308-267-977-577; 008-322-270-651-077; 008-627-359-484-946; 009-812-643-987-744; 009-915-429-922-44X; 010-078-564-820-139; 010-097-399-538-837; 010-164-563-597-634; 010-301-718-473-328; 010-995-244-583-38X; 011-833-772-568-428; 011-894-371-920-16X; 011-895-973-571-424; 012-525-657-135-039; 012-575-432-839-33X; 012-633-844-002-790; 013-022-784-689-036; 013-217-900-618-21X; 013-590-908-994-127; 013-611-892-800-331; 014-030-233-512-564; 014-198-761-686-129; 014-608-555-914-02X; 014-888-012-223-782; 014-942-880-411-593; 015-213-731-536-495; 015-935-404-245-556; 016-085-044-155-554; 016-199-175-454-728; 016-559-177-999-39X; 016-730-166-274-18X; 016-880-073-455-778; 017-257-193-479-426; 017-306-898-675-978; 017-791-505-680-816; 017-888-769-942-411; 018-461-660-442-580; 018-987-602-783-383; 019-054-746-834-989; 019-253-590-861-308; 019-826-087-338-953; 019-887-493-985-995; 020-302-376-900-189; 020-987-359-159-418; 021-025-529-879-055; 021-069-004-039-859; 021-151-704-534-343; 021-754-611-799-10X; 022-870-778-198-765; 023-436-084-764-843; 023-764-284-996-270; 024-282-473-635-575; 024-419-743-850-713; 025-001-205-472-581; 025-594-719-706-919; 025-848-024-383-719; 026-188-593-710-068; 026-519-357-685-79X; 027-051-004-798-743; 027-389-596-070-825; 027-438-299-051-888; 027-521-811-732-170; 027-834-598-077-919; 027-986-288-275-015; 028-132-830-261-99X; 028-519-190-558-694; 028-596-526-433-537; 029-309-202-545-702; 029-683-973-208-974; 029-906-989-530-111; 030-126-729-800-443; 031-209-086-691-975; 031-235-272-805-322; 032-076-225-686-800; 032-350-452-824-387; 032-521-802-523-650; 033-207-931-313-079; 033-623-197-668-096; 035-294-596-407-748; 036-242-435-354-878; 037-061-873-444-922; 037-634-833-906-948; 038-648-961-772-124; 039-593-613-726-00X; 041-429-979-909-844; 041-847-566-846-592; 043-315-540-076-783; 043-699-250-285-742; 044-045-412-538-532; 045-470-935-835-505; 045-683-107-327-23X; 046-740-838-073-880; 046-966-551-573-02X; 047-524-151-613-086; 048-351-365-479-904; 049-196-761-954-331; 049-270-239-447-604; 049-621-274-049-03X; 051-040-521-919-677; 051-334-680-904-652; 051-691-551-661-493; 051-705-460-999-231; 051-799-901-446-430; 052-302-018-659-533; 052-600-916-480-717; 052-612-061-167-415; 053-575-261-262-659; 054-305-209-088-573; 055-357-361-080-905; 055-375-651-805-002; 055-625-750-349-136; 056-136-901-342-003; 056-854-330-575-183; 058-061-553-108-163; 058-115-569-666-961; 058-586-269-508-057; 059-463-713-606-224; 060-016-617-268-641; 060-276-436-655-07X; 061-290-771-762-072; 061-420-667-278-646; 062-179-071-679-13X; 062-186-943-262-469; 062-538-608-313-894; 063-164-304-260-060; 063-600-982-638-956; 063-607-610-493-524; 064-612-452-031-297; 064-683-755-889-600; 064-757-267-021-975; 065-099-928-891-068; 065-264-957-715-553; 066-047-310-493-852; 066-351-119-530-770; 066-516-834-894-496; 067-723-462-803-044; 068-631-867-983-723; 068-683-775-313-217; 069-342-161-268-870; 070-141-784-620-011; 070-982-529-972-366; 071-960-695-692-596; 072-520-067-035-330; 073-166-439-693-228; 075-416-438-010-108; 075-434-672-293-555; 075-497-541-068-516; 075-686-067-935-434; 077-467-553-261-984; 077-928-002-218-92X; 078-433-632-111-248; 078-819-176-927-156; 080-254-863-396-189; 080-274-353-475-192; 080-385-718-577-768; 080-981-682-806-821; 082-233-881-911-578; 083-164-553-664-133; 084-026-418-227-601; 086-016-633-199-272; 086-119-155-104-698; 087-732-877-948-982; 088-371-926-638-805; 089-839-633-872-339; 091-717-029-484-491; 092-240-962-023-351; 094-825-965-510-522; 095-248-400-821-613; 095-916-832-224-223; 096-345-848-541-725; 097-759-953-928-506; 098-489-182-800-879; 099-251-422-178-801; 100-090-972-387-164; 101-669-933-335-870; 101-751-394-201-824; 102-853-767-578-901; 103-040-577-009-423; 103-461-115-659-865; 103-845-866-911-753; 103-991-631-720-034; 104-554-540-979-383; 106-273-408-181-237; 106-619-346-378-426; 107-161-915-374-818; 109-711-187-294-196; 110-379-518-580-458; 110-690-378-554-697; 111-563-031-912-525; 112-114-521-800-027; 112-893-773-052-534; 113-540-613-953-299; 114-330-487-601-946; 114-752-379-940-668; 115-215-121-231-920; 115-355-650-015-697; 116-076-784-060-180; 117-349-448-175-47X; 118-264-279-975-604; 120-532-752-221-921; 121-414-015-921-679; 123-183-058-040-297; 123-191-213-547-873; 123-273-355-950-210; 125-404-635-874-611; 128-002-063-970-807; 130-198-410-919-651; 130-823-700-994-722; 131-282-256-175-671; 132-172-129-866-188; 132-336-306-564-833; 134-096-468-871-046; 135-311-755-247-524; 137-748-186-940-883; 141-425-820-871-853; 141-919-449-702-827; 145-711-795-772-580; 153-809-305-665-252; 154-941-661-101-861; 155-261-166-988-474; 157-926-813-916-204; 161-344-852-450-456; 162-041-647-489-018; 164-125-404-583-617; 164-210-556-446-976; 168-847-014-077-436; 169-961-621-533-267; 189-894-406-168-891; 192-080-940-885-319,143
006-854-135-992-156,Exposure Assessment Approaches for Engineered Nanomaterials,2010-07-08,2010,journal article,Risk analysis : an official publication of the Society for Risk Analysis,15396924; 02724332,Wiley-Blackwell,United Kingdom,Linda Carolyn Abbott; Andrew D. Maynard,"Products based on nanotechnology are rapidly emerging in the marketplace, sometimes with little notice to consumers of their nanotechnology pedigree. This wide variety of nanotechnology products will result (in some cases) in unintentional human exposure to purposely engineered nanoscale materials via the dermal, inhalation, ingestion, and ocular pathways. Occupational, consumer, and environmental exposure to the nanomaterials should be characterized during the entire product lifecycle—manufacture, use, and disposal. Monitoring the fate and transport of engineered nanomaterials is complicated by the lack of detection techniques and the lack of a defined set of standardized metrics to be consistently measured. New exposure metrics may be required for engineered nanomaterials, but progress is possible by building on existing tools. An exposure metric matrix could organize existing data by relating likely exposure pathways (dermal, inhalation, ocular, ingestion) with existing measurements of important characteristics of nanoscale materials (particle number, mass, size distribution, charge). Nanomaterial characteristics not commonly measured, but shown to initiate a biological response during toxicity testing, signal a need for further research, such as the pressing need to develop monitoring devices capable of measuring those aspects of engineered nanomaterials that result in biological responses in humans. Modeling the behavior of nanoparticles may require new types of exposure models that individually track particles through the environment while keeping track of the particle shape, surface area, and other surface characteristics as the nanoparticles are transformed or become reactive. Lifecycle analysis could also be used to develop conceptual models of exposure from engineered nanomaterials.",30,11,1634,1644,Nanomaterials; Nanotechnology; Exposure assessment; Environmental exposure; Engineered nanomaterials; Human exposure; Computer science,,Environmental Exposure; Nanostructures; Occupational Exposure,,,https://deepblue.lib.umich.edu/bitstream/2027.42/79200/1/j.1539-6924.2010.01446.x.pdf https://deepblue.lib.umich.edu/handle/2027.42/79200 https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1539-6924.2010.01446.x https://www.ncbi.nlm.nih.gov/pubmed/20626687 https://europepmc.org/abstract/MED/20626687 https://deepblue.lib.umich.edu/bitstream/handle/2027.42/79200/j.1539-6924.2010.01446.x.pdf?sequence=1 https://core.ac.uk/display/3141034 https://asu.pure.elsevier.com/en/publications/exposure-assessment-approaches-for-engineered-nanomaterials http://hdl.handle.net/2027.42/79200,http://dx.doi.org/10.1111/j.1539-6924.2010.01446.x,20626687,10.1111/j.1539-6924.2010.01446.x,1884888520,,0,003-269-421-534-90X; 006-811-738-413-424; 009-985-760-294-926; 010-738-720-496-627; 011-483-307-687-969; 012-521-873-432-806; 013-339-094-749-818; 014-670-058-130-002; 015-561-756-357-187; 016-781-861-064-918; 017-274-328-333-681; 019-448-237-667-731; 021-228-017-624-032; 024-128-055-632-763; 025-370-494-555-95X; 028-035-885-061-843; 028-770-684-547-24X; 029-306-575-245-864; 029-552-765-665-943; 031-633-185-596-546; 033-182-645-818-617; 033-257-685-322-599; 033-943-199-319-642; 035-919-228-575-462; 037-949-122-271-110; 043-746-665-699-92X; 044-166-439-062-731; 046-235-064-974-409; 051-456-882-811-652; 051-481-940-647-956; 052-272-634-984-503; 052-967-099-002-272; 053-131-841-667-292; 055-165-874-363-170; 055-921-408-762-204; 056-914-657-268-179; 059-455-513-985-055; 060-434-483-005-548; 061-643-081-640-941; 063-478-899-467-678; 064-350-642-904-557; 066-736-108-101-492; 067-814-700-972-681; 069-063-551-201-207; 070-079-991-267-375; 070-509-826-082-059; 071-342-464-457-056; 073-393-777-696-819; 074-265-356-347-848; 076-360-985-962-446; 081-229-063-059-485; 084-778-286-968-118; 086-596-251-070-67X; 089-556-369-217-297; 090-800-727-009-808; 091-809-352-811-649; 091-999-371-445-947; 093-976-938-833-299; 096-746-254-336-596; 100-402-378-886-542; 102-084-885-622-412; 104-203-953-605-721; 107-997-508-950-654; 108-182-101-278-527; 108-360-886-172-86X; 110-283-174-208-962; 114-788-726-496-86X; 115-556-345-915-630; 122-245-339-262-130; 126-185-224-718-621; 132-122-728-021-00X; 138-804-070-817-031; 140-307-443-548-01X; 140-589-370-019-800; 143-128-230-186-006; 150-049-649-042-587; 153-927-975-823-632; 157-150-370-870-984; 158-719-376-639-273; 162-348-473-812-378; 168-373-981-996-196; 170-439-429-516-137; 193-616-090-773-482,114
007-196-574-956-530,Safety Assessment of Nanomaterials Using Toxicokinetics and Toxicoproteome Analysis,2010-07-23,2010,journal article,ChemInform,09317597; 15222667,Wiley,,Hiromi Nabeshi; Tomoaki Yoshikawa; Takayoshi Imazawa; Shin-ichi Tsunoda; Yasuo Tsutsumi,"With recent development of the nanotechnology, nanomaterials have been successfully employed in various industrial applications such as medicine and cosmetics. Nanomaterials show the useful properties such as electronic reactivity and the tissue permeability that were not provided by micromaterials. Thus, nanomaterials are expected as innovative materials for the development of medicine and cosmetics. However, these innovative properties may show unknown biological responses that could not been detected by the conventional toxicity assay. For industrial development and affluent society establishment that enjoyed only a benefit of nanomaterials, it is urgent to gather information of the properties and the biological effects, and to establish the standard safety evaluation method of nanomaterials. So, we are analyzing association among property, biodistribution and biological effects of nanomaterials to search for the safety biomarker (functional-, molecular- and biochemical-biomarker) using nanosilicas (nSP) as a standard nanomaterial. Because nSP shows high uniform dispersibility and is already used in medicine, cosmetics and food additive, the results of this study are useful to extrapolate it to other nanomaterials and to make practicable as safety biomarker. In this report, we show the latest knowledge about the linkage information among property, biodistribution and biological effects of nSP by toxicokinetics and toxicoproteomics, and the search study of safety biomarker based on these basic information.",41,32,no,no,Nanomaterials; Biochemical engineering; Chemistry; Toxicokinetics; Cosmetics; Biomarker; Evaluation methods; Pharmacology,,,,,http://onlinelibrary.wiley.com/doi/10.1002/chin.201032270/full?scrollTo=references https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fchin.201032270,http://dx.doi.org/10.1002/chin.201032270,,10.1002/chin.201032270,1968633135,,0,107-590-035-746-367,0
007-354-832-979-999,Nanomaterials in Tissue Engineering,,2019,book chapter,Polymeric Nanomaterials in Nanotherapeutics,,Elsevier,,Lenuta Profire; Sandra Constantin,"Abstract Tissue engineering is an interdisciplinary area of nanomedicine in which the biomaterials are used to replace or restore the structure and function of injured, damaged, or missing tissues following any injury or pathological process. This chapter shows a summary of different nanomaterial-based scaffolds, which are able to mimic the structure and the function of the natural extracellular matrix of different tissues. The most important applications of the nanomaterials in tissue engineering of soft (cardiac, neural, and vascularized), hard–soft (interfaces), and hard (bone, dental, and craniofacial) tissues are presented.",,,421,436,Biomedical engineering; Nanomaterials; Nanomedicine; Chemistry; Extracellular matrix; Process (anatomy); Structure and function; Tissue engineering,,,,,https://www.sciencedirect.com/science/article/pii/B9780128139325000121,http://dx.doi.org/10.1016/b978-0-12-813932-5.00012-1,,10.1016/b978-0-12-813932-5.00012-1,2910892900,,0,000-181-711-207-426; 000-894-071-639-668; 001-649-019-983-143; 001-796-422-182-995; 002-019-797-446-635; 002-303-333-225-55X; 002-552-374-629-03X; 003-091-389-323-567; 004-804-232-272-929; 007-215-124-885-609; 009-079-748-622-873; 010-846-470-399-32X; 011-163-500-869-614; 012-025-876-669-427; 012-884-636-258-835; 013-480-429-822-216; 013-833-704-896-449; 014-511-852-709-216; 016-503-863-897-69X; 016-781-505-871-334; 017-314-622-356-845; 018-333-362-350-294; 018-753-330-524-692; 019-192-936-111-242; 021-103-535-691-391; 023-750-245-954-230; 024-331-998-378-872; 028-398-393-064-071; 030-497-022-332-431; 032-794-369-714-838; 034-704-186-866-768; 035-732-147-002-953; 035-888-039-076-577; 036-110-622-700-380; 037-305-766-669-876; 038-055-144-596-85X; 040-013-387-697-459; 042-713-963-317-937; 044-075-129-496-071; 047-002-962-573-219; 047-436-985-635-61X; 048-607-769-288-430; 053-597-752-088-197; 054-431-641-699-979; 059-977-686-579-029; 060-307-185-608-12X; 061-581-571-363-27X; 062-973-274-656-227; 063-234-660-776-734; 065-158-067-051-813; 068-340-978-942-174; 069-176-238-321-932; 074-090-129-137-427; 074-350-257-276-614; 077-952-925-582-287; 085-577-289-613-879; 086-681-442-606-218; 091-263-650-951-584; 092-936-863-366-194; 099-731-731-090-080; 105-366-797-062-747; 114-462-057-117-921; 121-176-701-543-515; 128-214-566-974-396; 129-435-547-152-560; 176-274-740-243-739,2
007-461-588-735-856,Sewage sludge-based functional nanomaterials: development and applications,,2017,journal article,Environmental Science: Nano,20518153; 20518161,Royal Society of Chemistry (RSC),United Kingdom,Shi-Jie Yuan; Xiaohu Dai,"Sewage sludge, the major by-product of wastewater treatment plants, is defined as a pollutant by the US Environmental Protection Agency. The increasing production of sewage sludge worldwide and the imposition of more stringent regulations, together with the restriction of traditional options for sewage sludge disposal, have prompted new approaches for the cost-effective and environmentally benign treatment and reuse of sewage sludge. This paper seeks to review the published research on the development and applications of sewage sludge-based functional nanomaterials. The production methods of nanomaterials are illuminated, and the textural properties of the as-prepared nanomaterials are summarized. The potential applications of the as-prepared nanomaterials in the fields of pollutant degradation and electrochemical energy storage and conversion are reviewed. The synergistically enhanced performances between the as-synthesized nanomaterials and the specific small inorganic molecular or metal oxides in sewage sludge are discussed. Furthermore, the future opportunities and challenges in this emerging research area of designing functional nanomaterials from sewage sludge are addressed.",4,1,17,26,Nanomaterials; Biotechnology; Materials science; Reuse; Electrochemical energy storage; Waste management; Sewage treatment; Sludge; Pollutant,,,,,http://xlink.rsc.org/?DOI=C6EN00177G https://pubs.rsc.org/en/content/articlehtml/2017/en/c6en00177g https://doi.org/10.1039/c6en00177g http://pubs.rsc.org/en/content/articlelanding/2017/en/c6en00177g,http://dx.doi.org/10.1039/c6en00177g,,10.1039/c6en00177g,2531458981,,0,001-265-863-083-682; 002-048-327-994-963; 002-561-014-516-247; 003-116-632-880-418; 004-856-331-485-465; 005-182-965-887-296; 005-775-755-806-172; 006-896-029-375-539; 006-980-814-245-547; 007-082-754-629-742; 007-786-364-665-348; 008-057-351-297-829; 008-201-167-263-622; 009-558-307-791-442; 010-173-592-439-648; 010-459-069-075-951; 010-836-011-422-018; 011-059-123-945-780; 011-426-427-220-895; 012-931-485-894-146; 013-089-540-969-118; 013-376-067-044-081; 013-562-668-637-551; 015-333-211-457-036; 017-355-619-491-414; 017-512-535-048-390; 017-523-045-322-290; 018-226-360-890-20X; 018-822-588-315-958; 019-809-623-441-109; 020-598-191-305-645; 021-428-966-781-781; 022-096-214-764-426; 023-041-104-852-343; 023-303-046-708-745; 024-711-092-191-942; 024-875-242-765-464; 026-502-161-365-961; 027-236-311-502-608; 027-246-274-700-216; 027-394-391-085-253; 027-504-298-892-776; 028-478-331-235-752; 029-056-627-431-468; 029-167-849-766-396; 031-132-673-791-775; 031-570-341-439-062; 032-986-530-630-726; 034-902-380-343-386; 034-971-782-678-604; 039-003-171-572-847; 040-203-311-076-565; 041-228-092-299-677; 043-071-759-309-678; 044-295-271-838-583; 045-756-849-593-582; 049-088-364-346-06X; 052-922-569-256-981; 053-799-485-410-81X; 054-863-923-281-131; 056-270-616-052-354; 057-986-330-181-660; 058-166-653-785-875; 058-424-293-720-689; 062-064-014-792-742; 066-389-375-980-82X; 068-339-348-736-204; 071-686-791-423-688; 076-499-000-063-013; 077-889-387-303-762; 078-019-691-486-927; 078-055-958-006-098; 080-431-876-864-062; 080-616-504-318-432; 080-906-806-338-207; 083-406-950-235-024; 085-849-979-483-588; 086-357-898-689-352; 090-729-110-282-071; 091-125-940-885-241; 091-143-735-427-013; 095-319-152-485-264; 095-937-141-231-574; 101-571-880-727-612; 103-523-112-373-539; 107-960-667-081-311; 110-376-719-291-085; 110-801-816-010-761; 117-182-905-159-327; 119-960-411-014-508; 123-048-664-562-392; 124-375-519-659-66X; 125-769-498-381-483; 132-455-528-227-412; 138-375-117-684-289; 138-701-540-762-193; 139-869-169-360-282; 142-948-780-346-091; 144-765-006-401-371; 147-268-171-211-59X; 147-483-177-095-552; 147-802-412-273-730; 153-178-566-209-425; 162-217-288-309-826; 166-177-457-353-812; 186-842-991-167-406; 188-612-194-842-738; 198-336-739-059-925,33
007-473-374-962-912,Characterization of Nanomaterials,2010-08-31,2010,book,,,,,Sherrie Elzey,"As nanomaterials become more commonplace, they have the potential to enter ecological and biological environments during their lifecycle. Despite rapid advances in the production and application of nanomaterials, little is known about how they may interact with the environment or affect human health. This work consists of characterization of commonly manufactured or synthesized nanomaterials in specific environmental conditions. Bulk and surface characterization techniques were used to examine carbon nanotubes, titanium dioxide nanoparticles, bare silver nanoparticles and polymer- coated silver nanoparticles, and copper nanoparticles. Lithium titanate nanomaterial collected from a manufacturing facility was also characterized to identify occupational health risks. Size-dependent properties of nanomaterials may influence transport and transformation, and the behavior of larger sized materials cannot be used to predict nanomaterial behavior. These studies are important when considering measures for exposure control and environmental remediation of nanomaterials.",,,,,Nanomaterials; Nanoparticle; Nanotechnology; Materials science; Lithium titanate; Characterization (materials science); Titanium dioxide nanoparticles; Silver nanoparticle; Carbon nanotube; Environmental remediation,,,,,https://www.amazon.com/Characterization-Nanomaterials-Environmental-Health-Studies/dp/3838397061,https://www.amazon.com/Characterization-Nanomaterials-Environmental-Health-Studies/dp/3838397061,,,2973707976,,0,,0
007-581-388-958-680,Mechanisms of Uptake and Translocation of Nanomaterials in the Lung,2018-02-17,2018,journal article,Advances in experimental medicine and biology,00652598; 22148019,Springer New York,United States,Chloé Puisney; Armelle Baeza-Squiban; Sonja Boland,"Nanomaterials are invading our environment due to their increasing use in a very broad range of sectors making human exposure foreseeable during the life cycle of these materials. Inhalation is one of the most frequent routes of exposure in case of unintentional exposure and the small size of nanomaterials allows them to reach the deep lung. Understanding the fate and effects of nanomaterials is a great challenge for scientists as they exhibit a huge physico-chemical diversity that drives their biological reactivity. It is critical to determine the fate of nanomaterials at their route of entry in the organism as this will determine their local and/or systemic effects. In this review we will describe the epithelial barriers and the clearance processes of the respiratory tract. The mechanisms involved in the internalization of nanomaterials by respiratory cells and their ability to cross the epithelial barrier will be presented, highlighting methodologies and the role of the nanomaterial physico-chemical properties.",1048,,21,36,Nanotoxicology; Organism; Nanomaterials; Chemistry; Lung; Lung toxicity; Epithelial barrier; Human exposure; Cell biology,Lung toxicity; Nanomaterials; Nanoparticles uptake; Nanotoxicity,Animals; Humans; Lung/metabolism; Nanoparticles/chemistry; Respiratory Mucosa/metabolism,,,https://rd.springer.com/chapter/10.1007/978-3-319-72041-8_2 https://link.springer.com/chapter/10.1007%2F978-3-319-72041-8_2 https://www.ncbi.nlm.nih.gov/pubmed/29453530 https://pubmed.ncbi.nlm.nih.gov/29453530/,http://dx.doi.org/10.1007/978-3-319-72041-8_2,29453530,10.1007/978-3-319-72041-8_2,2790739331,,0,001-065-513-514-845; 003-134-424-919-84X; 003-447-288-407-221; 004-886-680-708-230; 005-653-666-660-444; 006-295-892-492-580; 007-800-353-373-313; 008-882-147-797-578; 012-380-758-480-793; 013-389-693-325-414; 013-776-575-091-207; 014-943-612-729-137; 015-006-492-368-014; 017-993-029-066-182; 023-042-171-145-90X; 023-901-599-157-680; 029-570-306-203-861; 031-117-733-904-191; 032-239-472-273-249; 033-268-368-621-425; 035-119-471-928-031; 035-558-099-632-713; 035-813-396-883-32X; 036-342-436-638-985; 036-884-747-678-42X; 036-971-566-081-240; 037-616-036-392-228; 037-949-122-271-110; 038-049-008-927-203; 042-990-752-457-484; 047-784-500-744-959; 048-851-672-324-145; 049-469-549-954-36X; 051-477-045-844-02X; 056-559-161-095-602; 060-126-888-028-137; 061-688-484-377-112; 063-462-536-573-934; 067-043-439-302-795; 067-098-324-431-894; 069-781-596-377-587; 069-789-606-731-487; 070-979-811-974-093; 071-755-503-458-648; 073-887-939-961-786; 081-652-066-725-058; 088-476-513-807-800; 090-500-300-266-464; 090-891-660-282-426; 093-048-897-330-481; 094-761-890-154-681; 097-660-939-478-182; 100-159-456-161-92X; 115-556-345-915-630; 117-673-148-128-860; 131-126-712-733-477; 140-109-233-428-629; 146-733-148-571-348; 153-959-006-004-263; 158-719-376-639-273; 193-616-090-773-482,16
007-604-158-976-241,Polymeric nanomaterials in fuel cell applications,,2020,book chapter,"Nanostructured, Functional, and Flexible Materials for Energy Conversion and Storage Systems",,Elsevier,,Kingshuk Dutta,"Abstract Polymeric nanomaterials are getting increasing attention worldwide in many new-generation applications, among which fuel cells are a new entrance. More specifically, fuel cells based on proton exchange membrane (PEM) electrolytes have seen growing trend of utilization of these nanomaterials, especially in the fabrication of their catalyst systems. Materials having nanodimensions in general and polymeric nanomaterials in particular hold certain unique and tailor-made properties suitable for application as catalyst systems in such fuel cells, as compared to their micro- and macro counterparts. For example, higher surface area, better dispersibility, higher reaction kinetics, and easy synthesis and fabrication are some of the properties which we are taking advantage of. This chapter will provide up-to-date information on the research and development that has taken place in this domain of utilization of polymeric nanomaterials in PEM-based fuel cells.",,,105,129,Proton exchange membrane fuel cell; Fabrication; Nanomaterials; Catalysis; Nanotechnology; Materials science; Fuel cells,,,,,https://www.sciencedirect.com/science/article/pii/B978012819552900004X,http://dx.doi.org/10.1016/b978-0-12-819552-9.00004-x,,10.1016/b978-0-12-819552-9.00004-x,3030963146,,0,000-720-627-765-265; 001-846-634-862-055; 002-134-072-598-686; 004-654-019-571-347; 004-954-276-737-891; 005-811-847-649-798; 006-685-883-680-364; 006-963-635-281-53X; 008-694-696-020-632; 009-559-296-109-587; 011-486-018-992-581; 012-956-497-378-174; 013-459-943-732-508; 013-789-845-319-818; 020-273-224-107-667; 021-257-206-782-040; 022-559-995-851-298; 024-293-689-400-47X; 024-513-765-436-063; 025-449-748-923-460; 029-206-349-062-607; 031-642-041-901-42X; 032-177-364-038-398; 032-589-615-673-400; 034-155-109-453-469; 037-466-177-555-552; 038-211-309-272-805; 039-047-211-146-469; 044-128-428-825-492; 045-935-398-963-700; 048-171-110-472-390; 049-033-536-874-689; 049-409-054-890-961; 051-756-227-115-778; 053-697-007-084-856; 054-570-799-681-971; 054-801-628-783-75X; 057-002-811-188-340; 058-637-337-152-708; 059-343-799-326-365; 060-058-991-834-290; 062-366-587-394-577; 065-214-987-118-404; 071-570-862-569-154; 076-336-249-929-912; 078-800-801-431-747; 078-877-613-932-363; 079-800-763-777-283; 081-359-173-108-60X; 084-529-579-524-871; 084-871-949-971-980; 100-974-576-456-31X; 109-133-819-826-209; 131-617-066-176-368; 131-931-853-297-658; 139-934-311-738-345; 139-951-641-299-933; 145-913-543-014-666; 147-279-656-723-562; 150-267-650-505-417; 181-180-847-163-812; 183-201-219-590-859,0
008-083-961-455-379,Advances in Nanomaterials - Advances in Nanomaterials,,2016,book,Advanced Structured Materials,18698433; 18698441,Springer India,United States,Mushahid Husain; Zishan H. Khan,"This book provides a review of the latest research findings and key applications in the field of nanomaterials. The book contains twelve chapters on different aspects of nanomaterials. It begins with key fundamental concepts to aid readers new to the discipline of nanomaterials, and then moves to the different types of nanomaterials studied. The book includes chapters based on the applications of nanomaterials for nano-biotechnology and solar energy. Overall, the book comprises chapters on a variety of topics on nanomaterials from expert authors across the globe. This book will appeal to researchers and professional alike, and may also be used as a reference for courses in nanomaterials",,,,,Engineering; Variety (cybernetics); Nanomaterials; Research findings; Engineering ethics,,,,,https://link.springer.com/10.1007/978-81-322-2668-0,http://dx.doi.org/10.1007/978-81-322-2668-0,,10.1007/978-81-322-2668-0,2488348478,,0,,7
008-183-969-870-700,Advances in nanomaterial application in enzyme-based electrochemical biosensors: a review,2019-12-03,2019,journal article,Nanoscale Advances,25160230,Royal Society of Chemistry (RSC),,I. S. Kucherenko; Oleksandr O. Soldatkin; D. Yu. Kucherenko; O. V. Soldatkina; Sergei V. Dzyadevych,"Electrochemical enzyme-based biosensors are one of the largest and commercially successful groups of biosensors. Integration of nanomaterials in the biosensors results in significant improvement of biosensor sensitivity, limit of detection, stability, response rate and other analytical characteristics. Thus, new functional nanomaterials are key components of numerous biosensors. However, due to the great variety of available nanomaterials, they should be carefully selected according to the desired effects. The present review covers the recent applications of various types of nanomaterials in electrochemical enzyme-based biosensors for the detection of small biomolecules, environmental pollutants, food contaminants, and clinical biomarkers. Benefits and limitations of using nanomaterials for analytical purposes are discussed. Furthermore, we highlight specific properties of different nanomaterials, which are relevant to electrochemical biosensors. The review is structured according to the types of nanomaterials. We describe the application of inorganic nanomaterials, such as gold nanoparticles (AuNPs), platinum nanoparticles (PtNPs), silver nanoparticles (AgNPs), and palladium nanoparticles (PdNPs), zeolites, inorganic quantum dots, and organic nanomaterials, such as single-walled carbon nanotubes (SWCNTs), multi-walled carbon nanotubes (MWCNTs), carbon and graphene quantum dots, graphene, fullerenes, and calixarenes. Usage of composite nanomaterials is also presented.",1,12,4560,4577,Colloidal gold; Nanomaterials; Biosensor; Platinum nanoparticles; Nanotechnology; Materials science; Graphene; Silver nanoparticle; Biomolecule; Carbon nanotube,,,,National Academy of Sciences of Ukraine,https://pubs.rsc.org/en/content/articlelanding/2019/na/c9na00491b http://pubs.rsc.org/en/content/articlelanding/2019/na/c9na00491b http://ui.adsabs.harvard.edu/abs/2019NanoA...1.4560K/abstract https://pubs.rsc.org/en/content/articlepdf/2019/NA/C9NA00491B,http://dx.doi.org/10.1039/c9na00491b,,10.1039/c9na00491b,2984025739,,0,000-266-204-729-601; 000-692-468-972-949; 001-016-830-121-227; 001-348-489-237-402; 001-919-786-249-078; 002-698-088-405-803; 003-061-823-938-365; 003-112-674-610-987; 003-802-481-828-515; 004-099-434-902-596; 004-602-322-044-238; 004-845-046-678-58X; 005-573-488-632-749; 006-167-570-744-240; 006-941-999-559-961; 007-362-856-885-970; 007-376-445-386-226; 007-438-259-380-42X; 008-384-647-725-78X; 008-924-832-807-458; 009-380-705-315-788; 009-867-694-326-784; 010-101-628-593-047; 010-183-980-487-827; 010-527-100-096-825; 010-646-913-158-183; 010-803-120-225-944; 011-260-837-523-584; 011-445-453-500-237; 012-242-280-683-720; 012-943-608-757-845; 013-089-309-668-494; 013-166-823-599-037; 013-296-547-747-640; 014-068-635-691-618; 014-170-542-249-83X; 015-345-842-209-467; 016-167-254-678-571; 016-210-867-052-599; 016-343-004-881-868; 016-939-416-740-284; 017-191-262-372-368; 017-656-341-714-079; 019-195-304-834-577; 019-566-856-169-990; 020-223-331-385-181; 020-913-335-967-427; 021-901-391-250-795; 022-362-468-900-810; 022-545-519-929-210; 023-340-735-641-788; 023-888-945-461-367; 024-804-396-995-491; 024-847-214-200-038; 024-847-657-685-695; 024-899-474-373-562; 025-031-676-447-371; 025-497-787-939-680; 026-567-550-873-158; 026-867-332-739-684; 026-916-811-968-749; 027-153-830-193-495; 027-191-444-561-998; 027-256-936-843-814; 027-439-786-385-767; 028-472-679-355-838; 028-546-883-602-76X; 028-890-818-348-702; 029-052-816-840-799; 030-172-775-178-875; 031-939-309-597-877; 032-272-346-240-934; 032-383-431-813-305; 032-587-010-356-77X; 032-772-270-788-16X; 033-100-899-159-410; 033-141-651-023-780; 034-341-174-634-062; 034-839-186-809-198; 034-921-230-020-868; 035-528-642-925-239; 035-636-776-492-115; 035-711-724-085-70X; 035-712-389-537-530; 036-370-224-062-791; 036-388-100-247-802; 038-088-006-763-091; 038-848-530-159-674; 040-865-014-918-941; 044-117-981-836-564; 046-038-885-635-508; 046-048-503-335-980; 046-937-945-820-14X; 047-426-590-138-601; 048-707-047-742-265; 051-349-967-711-665; 051-819-749-172-310; 051-983-421-611-847; 052-009-132-875-122; 052-315-974-534-450; 054-038-367-004-749; 054-387-302-372-829; 055-097-822-145-700; 055-295-019-957-74X; 056-181-832-459-55X; 056-232-020-574-541; 056-457-754-999-44X; 057-591-821-295-981; 057-916-257-181-491; 058-188-556-054-226; 059-852-801-254-176; 061-887-033-242-210; 063-567-585-429-171; 063-902-356-139-387; 066-256-707-609-981; 066-448-365-975-944; 066-688-857-985-391; 067-247-433-487-746; 068-668-326-633-340; 069-389-236-969-929; 070-403-474-279-783; 071-454-167-063-436; 072-432-201-223-819; 073-037-022-924-376; 073-068-879-383-259; 073-456-972-009-805; 073-566-645-126-323; 075-875-920-959-736; 076-146-489-836-785; 076-395-231-621-32X; 077-724-753-288-334; 078-342-781-680-854; 078-782-575-202-746; 079-107-323-327-144; 080-000-551-457-819; 080-947-702-516-436; 081-372-632-687-273; 082-888-923-708-71X; 083-122-582-996-369; 085-295-621-871-496; 087-972-109-161-266; 088-261-952-857-078; 091-531-482-068-634; 092-149-522-303-571; 093-195-940-406-921; 093-869-286-202-964; 095-002-509-945-361; 095-505-509-777-446; 095-809-725-995-520; 096-008-516-341-092; 097-253-687-296-789; 098-072-300-327-231; 102-803-722-484-113; 103-459-812-228-275; 105-818-397-805-980; 106-165-217-315-433; 107-476-594-996-654; 109-712-911-986-287; 112-046-034-030-895; 115-637-312-387-012; 116-547-503-310-664; 117-479-778-063-652; 117-508-655-363-102; 117-515-600-359-224; 117-686-073-804-942; 118-994-151-158-722; 119-283-670-433-277; 120-930-100-655-242; 122-663-789-682-564; 127-422-800-956-496; 127-627-597-994-567; 138-228-946-978-727; 139-674-402-507-886; 141-381-013-901-997; 145-446-235-225-744; 153-948-587-333-79X; 154-164-612-541-04X; 155-047-950-539-392; 162-841-720-290-757; 165-452-296-106-69X; 165-625-737-430-210; 168-139-309-877-409; 172-524-255-998-138; 181-857-062-900-239; 182-772-345-106-581; 183-023-059-164-869; 193-327-015-388-444,31
008-417-267-085-264,In vivo Assessment of Nanomaterials Toxicity,2015-07-15,2015,book chapter,Nanomaterials - Toxicity and Risk Assessment,,InTech,,Simona Clichici; Adriana Filip,"The concern regarding the safety of nanomaterials for the human body is constantly raising. On one hand, there is an increase in the production of nanomaterials for technological applications, which raises the risk of accidental exposure of the workers during the technological manipulation. On the other hand, nanomaterials can be designed for medical applications and their faith in the human body, along with their interactions with different tissues, becomes of vital importance. The mechanisms involved in nanomaterials toxicity are discussed, including oxidative stress and inflammation. In vivo toxicity evaluation includes different routes of administration or interaction between the nanomaterial and the organism, as well as a short-term or a long-term exposure or evaluation. Also, the characteristics of nanomaterials, including size, shape, impurities, function, surface coating in relation to their toxicity, were discussed. A particular attention has been given to the evalua‐ tion of the toxicity of dendrimers, silver nanoparticles, gold nanoparticles and carbon nanotubes.",,,,,Organism; Nanomaterials; Nanotechnology; Chemistry; In vivo; Accidental exposure; Toxicity; Surface coating; In vivo toxicity; Silver nanoparticle,,,,,https://www.mendeley.com/catalogue/5d9297f2-29e9-3d7b-8c1e-855be8259afd/ https://www.intechopen.com/chapters/48547 https://core.ac.uk/download/322424839.pdf,http://dx.doi.org/10.5772/60707,,10.5772/60707,2136758937,,0,000-042-069-452-570; 000-658-307-861-755; 001-149-007-119-787; 001-783-499-024-36X; 002-618-323-812-490; 002-722-137-265-50X; 003-100-042-324-220; 003-559-522-785-80X; 003-655-028-070-040; 003-914-655-847-924; 004-790-168-854-347; 006-096-500-215-575; 008-131-719-058-950; 009-270-325-506-147; 009-619-838-797-786; 009-906-931-705-243; 009-958-438-397-501; 010-179-905-675-877; 011-507-186-654-24X; 011-692-754-389-497; 012-868-864-795-27X; 013-235-579-793-810; 013-574-334-453-97X; 014-935-842-311-844; 014-939-476-607-263; 017-957-143-201-554; 019-024-860-219-464; 019-227-270-869-694; 019-680-471-436-110; 020-098-546-816-153; 020-378-991-041-17X; 021-437-918-173-92X; 021-557-089-883-508; 022-878-943-408-030; 023-426-250-905-076; 024-604-383-025-289; 024-691-856-045-22X; 025-387-096-294-089; 026-511-310-524-925; 026-528-555-615-981; 027-215-263-452-657; 028-079-723-135-98X; 028-612-918-803-346; 029-431-229-935-208; 029-831-966-538-74X; 029-894-732-105-616; 031-336-534-191-504; 031-900-917-146-65X; 032-093-285-746-347; 032-672-997-250-91X; 033-874-923-796-903; 035-883-712-822-136; 037-254-822-483-746; 038-185-595-332-584; 038-276-059-001-419; 039-761-783-401-398; 039-975-593-603-515; 040-208-913-189-201; 041-871-944-415-926; 042-005-763-245-281; 042-868-156-999-333; 044-100-299-338-887; 044-738-743-406-106; 045-117-367-995-465; 045-373-969-287-653; 045-802-536-424-619; 046-060-026-030-763; 046-247-005-960-187; 047-095-344-834-392; 047-483-010-469-887; 047-960-188-696-744; 049-066-668-746-014; 049-765-189-382-869; 049-767-907-303-803; 050-666-528-694-851; 053-598-443-685-515; 054-246-414-317-091; 054-850-630-256-407; 056-373-212-274-198; 056-717-376-060-141; 058-602-994-933-600; 059-150-974-990-618; 059-299-741-871-197; 064-236-570-982-265; 066-854-903-844-911; 068-575-269-960-835; 069-856-369-883-942; 071-248-052-195-896; 073-172-693-865-778; 074-503-933-888-726; 077-197-722-043-236; 081-114-288-967-601; 082-189-397-540-28X; 082-366-097-794-40X; 084-499-523-507-605; 084-983-996-637-64X; 086-788-061-623-030; 088-758-211-043-134; 089-711-573-194-43X; 090-357-422-488-218; 097-827-006-062-099; 098-218-239-579-737; 101-067-278-582-251; 102-293-002-223-460; 104-191-382-066-043; 106-257-517-128-259; 107-309-082-592-316; 108-464-752-922-430; 108-525-444-662-389; 108-886-617-784-602; 110-219-861-451-052; 110-760-045-272-596; 114-471-025-109-331; 115-332-009-388-373; 118-448-781-935-620; 123-594-719-935-650; 127-489-850-166-712; 129-207-995-251-20X; 134-358-966-538-235; 135-792-955-383-23X; 140-447-872-787-793; 142-325-179-186-284; 146-509-934-955-406; 147-552-158-995-412; 150-928-460-596-448; 159-041-561-510-041; 166-449-649-709-541; 172-319-458-455-43X; 177-906-892-019-161; 190-304-286-852-244,16
008-534-933-373-907,Anti-Stokes Cryoluminescence in Nanomaterials,,2019,conference proceedings article,2019 Conference on Lasers and Electro-Optics Europe & European Quantum Electronics Conference (CLEO/Europe-EQEC),,IEEE,,Anna D. Kudryavtseva; Aleksey Belyanin; Vladimir Borisov; Maxim Karpov; M A Shevchenko; Nikolay V. Tcherniega; Konstantin I. Zemskov,"Study of the electromagnetic fields interaction with structured nanomaterials with photonic band gaps is one of the most rapidly developing areas of nanophotonics. In modern optics, such nanomaterials are actively used to process the characteristics of electromagnetic radiation. Firstly, the properties of amplification of the local field are used, secondly, the properties of the photonic bandgap. A typical example of local field amplification is the work [1], in which the authors used a coating of submicron dielectric spheres on a copper target in order to achieve more than tenfold increasing the efficiency of X-ray generation. Using the properties of the photonic band gap leads to the increasing well-known nonlinear effects efficiency and to the appearance of new nonlinear phenomena. One of these phenomena is anti-Stokes cryoluminescence in nanomaterials — light emission at low temperature under laser action in the spectral range with higher frequency than that of exciting light. We observed bright and long (up to few seconds) emission in blue-green range under 20ns ruby laser pulses excitation in different nanomaterials at low temperatures [2–3]. One of the reasons of this effect is triboluminescence, free radicals appearing and structure defects forming, like in bulk materials [4]. In the present work we show that in nanomaterials of different nature there are two types of temporal dependence: short (few microseconds) and long (up to 10–12 seconds). Long dependence exists at temperatures lower than 110 K. Temporal dependence for anti-Stokes luminescence in synthetic opal matrices for temperatures lower and higher this threshold is shown in Figure 1.",,,,,Nanomaterials; Triboluminescence; Band gap; Materials science; Photonics; Light emission; Optoelectronics; Laser; Photonic crystal; Local field,,,,,https://www.osapublishing.org/abstract.cfm?uri=CLEO_Europe-2019-ck_p_30,http://dx.doi.org/10.1109/cleoe-eqec.2019.8872748,,10.1109/cleoe-eqec.2019.8872748,2981123611,,0,,0
008-570-015-351-280,Self-Assembled Fluorescent Organic Nanomaterials for Biomedical Imaging.,2018-08-23,2018,journal article,Advanced healthcare materials,21922659; 21922640,John Wiley and Sons Ltd,United Kingdom,Kuo Zhang; Yu-Juan Gao; Pei-Pei Yang; Guobin Qi; Jingping Zhang; Lei Wang; Hao Wang,"Fluorescent nanomaterials, self-assembled from building blocks through multiple intermolecular interactions show diversified structures and functionalities, and are potential fluorescence contrast agents/probes for high-performance biomedical imaging. Self-assembled nanomaterials exhibit high stability, long circulation time, and targeted biological distribution. This review summarizes recent advances of self-assembled nanomaterials as fluorescence contrast agents/probes for biomedical imaging. The self-assembled nanomaterials are classified into two groups, i.e., ex situ and in situ construction of self-assembled nanomaterials. The advantages of ex situ as well as in situ constructed nanomaterials for biomedical applications are discussed thoroughly. The directions of future developments for self-assembled nanomaterials are provided.",7,20,1800344,,Nanomaterials; Nanotechnology; Materials science; Circulation time; Self assembled; Fluorescence-lifetime imaging microscopy; Fluorescence,fluorescence imaging; in vivo; nanomaterials; self-assembly; transformation,Animals; Biomedical Technology/methods; Diagnostic Imaging/methods; Fluorescent Dyes/chemistry; Humans; Nanostructures/chemistry,Fluorescent Dyes,National Natural Science Foundation of China; National Natural Science Foundation of China; National Science Fund for Distinguished Young Scholars; Chinese Academy of Sciences; Science Fund for Creative Research Groups of the National Natural Science Foundation of China; Key Project of Chinese Academy of Sciences in Cooperation with Foreign Enterprises; Jilin Province Key Laboratory of Organic Functional Molecular Design and Synthesis,https://www.onlinelibrary.wiley.com/doi/full/10.1002/adhm.201800344 https://www.ncbi.nlm.nih.gov/pubmed/30137689 https://pubmed.ncbi.nlm.nih.gov/30137689/,http://dx.doi.org/10.1002/adhm.201800344,30137689,10.1002/adhm.201800344,2888689036,,0,000-275-486-889-789; 000-347-468-577-175; 002-596-587-047-302; 005-620-958-878-890; 005-978-964-104-038; 006-035-363-224-643; 006-726-586-574-782; 007-215-655-577-744; 007-556-035-195-476; 010-341-150-339-80X; 010-573-029-804-442; 010-658-023-797-483; 010-698-683-258-967; 010-933-020-673-163; 011-592-211-795-132; 012-309-102-393-812; 012-625-165-844-857; 012-769-991-655-313; 014-123-216-144-125; 014-286-073-395-213; 014-667-958-679-845; 016-199-350-101-795; 016-412-317-595-025; 017-307-195-097-045; 017-534-552-587-203; 018-414-919-743-648; 019-089-884-840-80X; 019-559-723-772-512; 020-389-137-379-837; 020-495-357-877-060; 020-745-184-170-540; 020-994-604-048-590; 022-079-358-252-679; 022-455-798-614-385; 025-427-451-249-172; 026-343-914-596-305; 026-627-177-918-590; 028-293-105-912-347; 028-486-887-839-930; 030-039-076-229-917; 031-317-012-934-32X; 032-562-148-996-496; 032-648-392-195-153; 032-930-925-604-036; 033-293-665-155-189; 035-154-070-741-00X; 035-394-754-894-763; 036-784-852-575-870; 037-949-458-388-021; 038-064-826-989-292; 039-068-689-595-071; 040-324-949-930-83X; 041-290-993-663-963; 042-080-940-377-155; 042-584-257-427-006; 042-682-204-112-720; 042-703-168-676-499; 044-667-228-101-425; 044-819-882-808-804; 045-014-655-151-580; 045-391-244-860-861; 045-974-872-905-631; 046-513-069-500-269; 047-498-691-303-461; 047-628-457-328-778; 050-440-805-106-690; 050-878-671-646-62X; 051-509-042-878-893; 051-982-660-782-753; 051-996-666-598-815; 052-109-182-782-854; 053-042-823-744-317; 053-240-936-591-684; 053-614-688-553-155; 053-638-985-768-925; 054-542-384-730-366; 055-146-151-447-078; 056-856-182-501-359; 057-918-034-431-480; 058-408-324-781-987; 058-958-164-330-98X; 059-150-804-453-481; 059-783-933-503-596; 062-263-687-698-242; 063-288-119-093-584; 064-033-912-375-28X; 064-228-483-906-280; 064-346-913-543-182; 064-483-677-767-256; 065-694-725-925-279; 066-097-161-896-708; 066-810-092-220-667; 067-286-607-780-996; 070-212-198-635-494; 071-582-857-685-300; 071-674-421-091-614; 071-890-709-730-530; 072-335-772-389-623; 074-468-198-032-284; 075-380-430-319-774; 078-968-186-014-931; 079-044-703-717-966; 079-068-649-410-264; 080-700-232-919-315; 081-831-608-647-650; 082-876-559-408-615; 083-445-039-132-573; 085-062-640-166-170; 086-532-059-103-889; 088-052-988-244-029; 088-334-590-284-94X; 088-891-055-498-18X; 090-202-684-930-786; 090-440-210-717-119; 090-744-457-566-175; 092-285-955-706-540; 096-768-682-669-562; 099-208-179-428-968; 099-823-622-054-177; 101-825-197-934-120; 101-885-346-905-409; 107-110-677-092-793; 107-891-720-087-784; 119-076-830-931-290; 119-706-900-886-709; 122-371-182-342-497; 134-111-626-765-445; 136-670-496-574-58X; 141-091-644-567-731; 144-345-648-601-892; 152-466-235-712-237; 171-491-443-416-305,18
008-631-916-462-881,Traditional Nanostructures and Nanomaterials in Batteries,2019-05-18,2019,book chapter,Nanostructures and Nanomaterials for Batteries,,Springer Singapore,,Xing-Long Wu; Jin-Zhi Guo; Yu-Guo Guo,"Traditional nanostructures and nanomaterials, such as conductive additives, separators and current collectors also play a key role in batteries although they are minority components. In this section, we summarize the research progress of traditional nanostructures and nanomaterials in rechargeable batteries, discussing the effects of these nano components on the electrochemical properties of batteries.",,,313,357,Nanomaterials; Nanotechnology; Nanostructure; Materials science,,,,,https://link.springer.com/chapter/10.1007/978-981-13-6233-0_7 https://rd.springer.com/chapter/10.1007/978-981-13-6233-0_7,http://dx.doi.org/10.1007/978-981-13-6233-0_7,,10.1007/978-981-13-6233-0_7,2945574851,,0,000-213-772-576-165; 001-581-319-876-421; 002-417-648-739-85X; 002-649-527-403-586; 003-998-708-129-389; 004-490-092-827-371; 005-219-289-623-338; 005-641-950-649-033; 005-694-803-508-483; 005-977-434-968-731; 006-407-826-273-711; 006-714-255-353-557; 007-552-895-417-560; 007-770-619-589-521; 007-952-675-132-769; 008-647-676-563-734; 008-916-969-613-793; 009-489-761-498-872; 010-487-955-948-153; 010-599-164-824-716; 011-561-260-375-415; 011-785-239-193-791; 012-624-268-400-357; 013-304-798-157-327; 013-664-200-818-485; 013-918-736-931-598; 014-632-530-622-928; 015-970-484-487-179; 016-016-162-992-215; 017-108-517-459-204; 018-269-816-882-794; 018-340-933-239-422; 018-604-344-999-032; 018-820-391-715-844; 020-176-423-803-847; 020-631-819-103-494; 021-238-385-186-768; 021-713-053-756-680; 021-734-393-591-272; 022-963-975-925-426; 023-310-732-635-115; 023-602-335-951-602; 023-672-527-848-283; 023-937-087-720-710; 025-706-838-851-063; 025-879-784-871-100; 026-055-669-954-300; 028-208-812-552-011; 029-284-128-575-04X; 029-784-630-095-747; 030-031-013-508-314; 030-158-445-802-179; 030-317-721-220-040; 031-018-350-779-502; 031-912-873-339-967; 033-677-258-873-16X; 036-292-268-851-978; 036-453-420-027-364; 036-692-376-519-852; 036-891-273-162-223; 038-214-505-392-234; 038-635-591-734-100; 038-854-199-710-606; 039-876-209-805-62X; 040-010-403-348-352; 040-266-157-724-63X; 040-395-766-214-679; 042-571-120-191-503; 042-748-088-294-238; 042-854-691-114-747; 043-793-383-746-638; 045-322-031-587-76X; 045-500-895-042-205; 045-753-961-897-072; 045-801-117-607-942; 046-747-793-859-442; 047-259-180-222-012; 047-692-676-842-167; 048-686-668-072-380; 048-857-518-421-34X; 048-863-860-464-610; 052-278-525-906-060; 053-281-354-796-71X; 053-566-223-410-548; 053-692-289-132-12X; 054-482-723-047-026; 054-779-477-768-967; 054-903-409-557-530; 055-704-213-611-181; 055-812-999-773-163; 056-319-229-013-448; 056-886-373-232-566; 057-899-654-061-184; 059-796-555-493-011; 060-162-124-062-78X; 062-885-074-631-703; 063-342-853-074-024; 063-981-206-008-777; 064-561-290-915-745; 064-604-298-875-204; 065-138-104-765-885; 065-287-015-424-818; 065-864-850-857-622; 067-084-824-666-633; 068-486-138-922-260; 068-507-623-716-807; 069-193-636-303-937; 069-410-803-764-342; 069-494-907-559-379; 070-202-812-223-213; 070-274-391-858-925; 070-829-178-020-863; 074-504-181-828-054; 076-137-060-840-808; 076-530-855-566-882; 076-946-195-017-552; 077-096-114-484-975; 078-003-522-831-084; 079-427-217-211-677; 079-652-209-752-677; 082-682-948-153-366; 082-835-812-260-159; 084-588-688-024-630; 085-184-590-548-247; 086-940-201-137-119; 088-165-471-665-219; 089-170-170-631-683; 089-429-489-838-192; 090-465-172-168-745; 091-503-278-603-275; 091-563-264-849-666; 092-543-834-997-15X; 093-560-681-095-411; 094-996-511-461-160; 095-299-851-843-547; 097-480-575-740-339; 098-467-832-347-715; 098-963-834-273-193; 102-224-623-303-624; 102-422-118-733-444; 102-815-596-274-876; 104-836-930-099-803; 105-011-635-499-564; 105-101-608-964-626; 106-746-010-237-98X; 108-107-604-332-775; 108-593-509-211-648; 109-592-872-118-634; 109-730-293-321-235; 109-971-913-625-860; 110-389-285-402-042; 110-402-053-675-82X; 111-510-667-711-295; 111-725-021-664-707; 113-861-859-311-461; 114-596-080-165-933; 115-278-804-854-906; 115-357-155-723-636; 116-075-232-342-433; 116-667-424-462-770; 117-981-064-139-567; 119-404-512-701-916; 120-060-159-425-955; 120-449-303-020-801; 123-404-177-183-836; 125-716-518-722-339; 126-055-980-411-654; 129-232-642-441-168; 133-369-926-707-820; 135-142-816-248-981; 137-045-644-764-506; 137-652-484-337-998; 138-549-242-535-706; 146-007-213-781-290; 146-736-213-369-546; 147-582-682-151-766; 147-800-750-820-371; 151-722-755-961-599; 164-973-200-009-084; 169-064-267-291-241; 170-179-486-565-690; 173-985-464-980-127; 174-368-128-712-230; 179-933-286-042-501; 192-387-598-719-759; 198-618-404-139-400; 199-010-559-537-279,0
008-986-738-887-117,Directed Assembly of Hybrid Nanomaterials and Nanocomposites.,2018-03-09,2018,journal article,"Advanced materials (Deerfield Beach, Fla.)",15214095; 09359648,Wiley-Blackwell,United States,Shanju Zhang; Candice I. Pelligra; Xunda Feng; Chinedum O. Osuji,"Hybrid nanomaterials are molecular or colloidal-level combinations of organic and inorganic materials, or otherwise strongly dissimilar materials. They are often, though not exclusively, anisotropic in shape. A canonical example is an inorganic nanorod or nanosheet sheathed in, or decorated by, a polymeric or other organic material, where both the inorganic and organic components are important for the properties of the system. Hybrid nanomaterials and nanocomposites have generated strong interest for a broad range of applications due to their functional properties. Generating macroscopic assemblies of hybrid nanomaterials and nanomaterials in nanocomposites with controlled orientation and placement by directed assembly is important for realizing such applications. Here, a survey of critical issues and themes in directed assembly of hybrid nanomaterials and nanocomposites is provided, highlighting recent efforts in this field with particular emphasis on scalable methods.",30,18,1705794,,Nanorod; Nanomaterials; Nanotechnology; Materials science; Inorganic materials; Organic component; Nanosheet; Nanocomposite,directed assembly; hybrid nanomaterials; nanocomposites; templated assembly,,,National Science Foundation; National Science Foundation; National Science Foundation,https://jglobal.jst.go.jp/detail?JGLOBAL_ID=201802277006237696 https://www.onlinelibrary.wiley.com/doi/full/10.1002/adma.201705794 http://europepmc.org/abstract/MED/29520839 https://www.ncbi.nlm.nih.gov/pubmed/29520839,http://dx.doi.org/10.1002/adma.201705794,29520839,10.1002/adma.201705794,2791114656,,0,000-083-656-324-961; 000-828-130-081-129; 000-894-184-959-107; 001-534-881-716-669; 001-608-971-984-316; 001-942-424-586-750; 002-002-593-893-66X; 002-106-590-447-409; 002-198-578-163-607; 002-557-413-713-588; 003-131-883-947-141; 003-204-009-402-414; 003-315-342-258-569; 003-318-972-532-060; 003-564-067-752-534; 003-638-958-608-236; 003-696-270-619-362; 003-803-805-701-639; 003-859-188-922-454; 004-588-098-297-514; 005-052-976-491-961; 005-384-285-242-270; 005-463-122-963-028; 005-550-985-040-603; 005-663-872-456-742; 005-828-054-846-32X; 006-068-225-749-936; 006-087-396-202-015; 006-127-481-720-013; 006-844-134-803-254; 007-370-374-014-494; 007-749-083-857-949; 008-070-551-962-148; 008-263-347-410-136; 008-743-720-630-624; 008-984-844-512-053; 009-023-812-957-318; 009-518-690-738-612; 009-537-028-190-895; 009-570-813-479-98X; 009-622-970-190-129; 010-006-893-374-456; 010-177-933-967-827; 010-320-775-726-751; 010-388-291-220-958; 010-411-787-074-74X; 010-415-737-848-928; 010-593-020-057-709; 011-107-760-167-970; 011-613-714-143-275; 011-796-674-548-722; 011-879-188-670-240; 012-134-676-845-599; 012-204-483-955-573; 012-420-712-488-320; 012-586-812-593-574; 012-763-939-599-45X; 012-766-237-781-859; 012-826-149-935-469; 013-567-743-966-906; 013-689-891-820-170; 013-707-166-512-438; 014-120-885-236-98X; 014-813-607-768-996; 015-098-983-269-492; 015-136-853-949-144; 015-765-022-186-475; 015-879-725-403-427; 016-284-246-587-429; 016-410-083-259-790; 016-425-000-943-477; 016-845-922-023-58X; 018-587-187-959-130; 018-714-408-471-278; 019-093-133-960-634; 019-322-429-204-922; 019-412-654-366-636; 019-558-560-407-080; 019-960-668-712-269; 020-343-883-515-235; 020-786-119-938-593; 020-954-627-498-176; 021-247-204-039-799; 021-297-968-264-393; 021-360-695-353-84X; 021-540-987-542-341; 022-164-436-060-514; 022-180-765-775-633; 022-847-378-777-391; 023-133-927-031-990; 023-422-919-058-414; 023-929-889-135-513; 023-956-590-499-13X; 024-024-067-072-103; 024-213-508-620-164; 024-385-381-664-901; 024-471-078-747-035; 024-825-700-532-794; 025-050-715-202-136; 025-188-965-598-817; 025-799-029-586-867; 025-895-188-962-217; 026-068-528-823-502; 026-629-505-365-884; 026-712-222-989-352; 027-031-250-201-190; 027-205-035-377-932; 027-307-677-879-704; 027-447-240-019-191; 027-819-867-719-081; 027-936-176-282-100; 028-064-563-166-266; 028-341-473-788-670; 028-823-770-754-292; 028-911-399-949-334; 029-027-717-926-269; 029-040-364-844-650; 029-317-731-560-772; 029-627-279-630-60X; 029-888-311-791-979; 030-294-734-281-636; 030-490-011-014-188; 030-656-312-555-145; 030-974-143-321-121; 031-473-303-655-333; 031-767-936-773-819; 032-697-708-350-270; 032-755-364-195-053; 032-770-163-307-042; 032-773-555-490-046; 033-018-507-462-662; 033-120-529-627-123; 033-189-352-534-057; 033-281-790-403-753; 033-696-693-737-596; 034-172-466-147-27X; 034-264-778-510-427; 034-959-187-330-863; 035-016-974-964-219; 035-716-576-424-134; 035-718-015-027-007; 035-819-448-912-08X; 036-011-150-745-674; 036-184-047-251-866; 036-258-678-418-73X; 037-235-313-120-10X; 037-486-363-445-240; 037-554-538-353-199; 037-891-719-278-13X; 038-215-789-542-402; 038-283-049-990-220; 039-415-105-537-948; 039-491-280-244-426; 040-368-319-951-198; 040-466-628-548-043; 040-680-977-604-522; 040-970-507-668-615; 041-426-965-163-347; 041-811-586-010-528; 041-849-175-852-986; 042-542-479-724-887; 043-092-633-681-696; 043-462-007-096-225; 043-904-101-445-52X; 044-016-781-274-197; 044-282-443-073-925; 044-642-250-960-057; 044-936-984-075-800; 045-037-080-669-910; 045-640-635-054-431; 045-960-556-845-289; 046-336-852-243-239; 046-756-223-147-94X; 046-892-768-477-646; 047-011-339-369-835; 047-456-904-111-83X; 047-559-646-875-926; 047-612-913-984-490; 048-014-438-320-666; 048-531-556-472-893; 048-631-573-642-434; 048-963-156-033-41X; 049-422-019-312-37X; 049-525-738-848-877; 049-982-197-751-493; 050-063-866-692-83X; 050-791-036-963-51X; 051-449-535-222-081; 051-677-174-392-265; 051-918-016-799-566; 052-005-156-126-566; 052-254-660-526-144; 052-311-183-459-484; 052-678-417-794-615; 053-264-346-199-46X; 054-643-642-916-749; 055-077-115-338-361; 055-183-626-393-505; 056-280-186-592-244; 056-617-437-476-442; 056-855-818-961-541; 057-868-309-973-148; 057-959-226-556-908; 058-081-625-926-930; 058-619-237-693-049; 059-693-194-294-76X; 060-399-507-798-191; 060-923-799-796-654; 061-684-903-785-025; 061-914-309-839-546; 062-764-622-409-396; 062-796-476-432-278; 062-988-667-043-087; 063-256-139-085-219; 063-381-030-371-53X; 063-720-510-408-497; 063-722-691-389-801; 066-714-124-953-444; 067-722-152-008-913; 068-025-749-042-260; 068-028-309-883-983; 068-696-139-629-74X; 068-704-021-895-775; 069-052-343-452-112; 069-135-706-656-223; 069-358-241-431-89X; 069-504-602-145-999; 069-798-006-709-862; 070-601-341-351-021; 071-581-703-118-659; 071-617-501-580-353; 072-605-581-679-019; 073-688-441-453-782; 074-688-417-149-015; 075-120-386-773-96X; 075-259-824-075-990; 075-364-788-290-830; 075-559-642-726-101; 075-803-524-356-471; 076-007-217-870-912; 076-013-130-078-00X; 077-403-309-859-674; 078-033-601-591-83X; 078-584-517-487-889; 078-614-518-374-960; 080-032-876-185-408; 080-078-972-809-122; 080-409-048-312-27X; 081-848-715-245-404; 084-360-629-618-550; 084-775-306-093-846; 086-042-758-715-815; 086-273-521-442-597; 086-563-144-380-081; 086-764-494-126-180; 086-881-802-032-438; 087-118-334-194-547; 087-190-762-567-596; 087-190-989-594-177; 087-632-863-212-423; 088-525-073-974-215; 089-689-196-794-975; 089-756-929-754-469; 089-945-451-318-491; 090-512-567-730-930; 091-297-717-825-845; 091-687-672-119-464; 092-659-176-786-012; 093-048-763-729-892; 093-904-387-803-292; 094-925-011-077-56X; 095-398-759-385-591; 095-453-390-999-057; 097-827-139-981-62X; 098-226-473-901-149; 101-349-564-795-552; 101-896-899-694-57X; 101-933-987-084-261; 103-240-908-715-362; 104-123-026-678-970; 104-421-119-235-55X; 104-674-231-753-897; 105-831-322-153-910; 105-896-839-489-22X; 107-237-715-093-841; 107-855-275-510-231; 108-064-673-109-908; 108-607-947-100-379; 109-717-367-985-215; 112-150-971-301-696; 113-042-461-256-950; 114-059-012-969-303; 114-078-814-255-322; 114-380-810-740-037; 114-567-475-613-136; 116-467-125-631-160; 117-629-491-282-779; 118-270-473-632-550; 120-290-691-310-20X; 120-301-461-508-617; 121-462-134-810-433; 121-709-272-545-385; 121-786-503-758-628; 122-464-394-704-640; 122-570-962-694-022; 123-092-758-822-966; 123-720-794-878-03X; 124-181-757-580-273; 125-900-899-428-474; 128-025-565-621-457; 129-107-679-264-203; 130-626-264-879-29X; 131-300-547-664-201; 132-289-856-436-634; 133-366-165-567-478; 133-821-200-509-188; 133-886-537-977-056; 133-943-693-264-54X; 134-210-638-988-359; 137-896-022-076-659; 139-910-388-217-98X; 143-518-161-117-253; 144-481-244-416-574; 144-755-420-322-75X; 145-105-144-752-754; 151-282-396-141-997; 154-754-776-093-458; 154-870-873-561-899; 157-427-433-894-334; 158-191-252-341-456; 159-094-284-890-574; 159-472-711-922-354; 167-286-877-627-305; 167-656-898-714-649; 169-060-597-379-950; 172-765-000-998-459; 174-678-848-895-219; 177-878-446-437-042; 180-628-544-018-93X; 182-547-422-361-359; 183-534-898-622-01X,46
008-995-094-249-682,Nanomaterials for Biosensing Lipopolysaccharide.,2019-12-21,2019,journal article,Biosensors,20796374; 0265928x,Multidisciplinary Digital Publishing Institute (MDPI),Switzerland,Palak Sondhi; Helal Uddin Maruf; Keith J. Stine,"Lipopolysaccharides (LPS) are endotoxins, hazardous and toxic inflammatory stimulators released from the outer membrane of Gram-negative bacteria, and are the major cause of septic shock giving rise to millions of fatal illnesses worldwide. There is an urgent need to identify and detect these molecules selectively and rapidly. Pathogen detection has been done by traditional as well as biosensor-based methods. Nanomaterial based biosensors can assist in achieving these goals and have tremendous potential. The biosensing techniques developed are low-cost, easy to operate, and give a fast response. Due to extremely small size, large surface area, and scope for surface modification, nanomaterials have been used to target various biomolecules, including LPS. The sensing mechanism can be quite complex and involves the transformation of chemical interactions into amplified physical signals. Many different sorts of nanomaterials such as metal nanomaterials, magnetic nanomaterials, quantum dots, and others have been used for biosensing of LPS and have shown attractive results. This review considers the recent developments in the application of nanomaterials in sensing of LPS with emphasis given mainly to electrochemical and optical sensing.",10,1,2,,Nanomaterials; Biosensor; Nanotechnology; Chemistry; Lipopolysaccharide; Optical sensing; Chemical interaction; Pathogen detection; Biomolecule,biosensing; endotoxin; lipopolysaccharides (LPS); nanomaterials,Biosensing Techniques; Lipopolysaccharides/analysis; Nanostructures/chemistry,Lipopolysaccharides,,https://www.mdpi.com/2079-6374/10/1/2/htm https://www.mdpi.com/2079-6374/10/1/2/pdf https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168309 https://works.bepress.com/keith-stine/122/ https://works.bepress.com/keith-stine/122/download/ https://pubmed.ncbi.nlm.nih.gov/31877825/ https://europepmc.org/article/MED/31877825,http://dx.doi.org/10.3390/bios10010002,31877825,10.3390/bios10010002,2994780676,PMC7168309,0,000-006-223-761-761; 000-833-741-735-001; 002-043-481-846-886; 002-750-549-019-397; 004-450-066-816-293; 005-014-194-366-499; 005-103-806-295-105; 006-063-221-065-358; 006-209-171-139-29X; 006-857-302-608-945; 007-633-506-395-826; 010-025-040-511-328; 010-319-078-530-173; 011-017-324-759-743; 011-118-588-955-513; 012-140-276-548-422; 012-611-717-474-042; 013-088-244-489-246; 014-464-960-480-51X; 016-561-690-328-549; 016-607-162-545-436; 017-521-785-085-551; 019-682-072-324-153; 021-448-179-593-173; 022-008-797-629-484; 023-462-401-772-046; 023-888-945-461-367; 023-916-425-705-829; 025-927-542-806-086; 026-408-302-714-483; 026-895-072-628-82X; 026-980-862-205-166; 027-752-412-675-592; 027-818-824-116-657; 028-345-924-419-662; 028-365-377-697-759; 029-793-401-627-441; 029-959-178-611-873; 030-567-028-532-849; 031-525-102-093-161; 031-527-304-865-800; 032-722-365-475-873; 033-802-751-443-171; 034-357-371-656-099; 034-654-598-581-985; 038-423-570-494-588; 038-756-785-155-167; 039-163-221-457-955; 039-245-117-377-495; 043-917-460-337-945; 044-550-256-701-832; 046-735-208-868-287; 047-513-876-700-386; 048-259-874-419-756; 048-873-857-391-878; 048-953-866-704-864; 053-085-928-406-701; 053-354-912-051-048; 058-637-715-858-573; 060-205-505-697-794; 060-854-996-307-550; 061-628-106-231-082; 063-285-234-765-231; 064-150-300-534-123; 065-304-898-883-429; 065-574-436-183-575; 067-225-892-544-386; 067-235-045-483-85X; 067-485-455-754-562; 069-553-377-393-427; 070-467-597-562-071; 072-506-112-317-003; 073-643-428-867-084; 075-237-483-972-302; 076-654-570-678-80X; 079-180-864-849-720; 079-309-320-270-678; 079-804-636-173-063; 081-573-948-177-801; 084-624-889-697-263; 089-938-602-014-204; 091-649-848-359-975; 092-272-486-518-674; 093-264-274-759-608; 093-651-167-886-45X; 095-727-470-782-363; 097-206-260-024-424; 097-393-077-272-370; 099-178-290-457-893; 100-486-399-306-683; 111-695-400-293-550; 111-699-505-676-02X; 112-409-205-116-862; 113-266-972-417-034; 115-198-862-960-504; 117-453-852-218-849; 121-856-912-591-655; 122-030-212-281-838; 126-380-315-672-394; 131-332-758-604-723; 137-304-098-841-474; 141-933-198-306-061; 154-381-564-635-084; 160-504-685-502-629; 161-847-325-691-412; 177-072-480-850-68X; 182-353-804-716-527; 184-686-998-677-738; 184-708-597-562-598,18
009-169-958-323-088,Health hazards associated with nanomaterials,2012-09-25,2012,journal article,Toxicology and industrial health,14770393; 07482337,SAGE Publications Ltd,United States,Gurulingappa Pattan; Gautam Kaul,"Nanotechnology is a major scientific and economic growth area and presents a variety of hazards for human health and environment. It is widely believed that engineered nanomaterials will be increasingly used in biomedical applications (as therapeutics and as diagnostic tools). However, before these novel materials can be safely applied in a clinical setting, their toxicity needs to be carefully assessed. Nanoscale materials often behave different from the materials with a larger structure, even when the basic material is same. Many mammals get exposed to these nanomaterials, which can reach almost every cell of the mammalian body, causing the cells to respond against nanoparticles (NPs) resulting in cytotoxicity and/or genotoxicity. The important key to understand the toxicity of nanomaterials is that their minute size, smaller than cellular organelles, allows them to penetrate the basic biological structures, disrupting their normal function. There is a wealth of evidence for the noxious and harmful effects of engineered NPs as well as other nanomaterials. The rapid commercialization of nanotechnology field requires thoughtful, attentive environmental, animal and human health safety research and should be an open discussion for broader societal impacts and urgent toxicological oversight action. While 'nanotoxicity' is a relatively new concept to science, this comprehensive review focuses on the nanomaterials exposure through the skin, respiratory tract, and gastrointestinal tract and their mechanism of toxicity and effect on various organs of the body.",30,6,499,519,Nanotoxicology; Nanomaterials; Business; Nanotechnology; Diagnostic tools; Human health; Engineered nanomaterials; Mechanism (biology),Nanoparticle; nanotubes; oxidative stress; toxicity,Animals; Cardiovascular System/drug effects; Gastrointestinal Tract/drug effects; Humans; Magnetite Nanoparticles/toxicity; Nanoparticles/toxicity; Nanostructures/toxicity; Nervous System/drug effects; Respiratory System/drug effects; Skin/drug effects; Urogenital System/drug effects,Magnetite Nanoparticles,,http://journals.sagepub.com/doi/10.1177/0748233712459900 https://europepmc.org/article/MED/23012342 https://www.ncbi.nlm.nih.gov/pubmed/23012342 http://journals.sagepub.com/doi/abs/10.1177/0748233712459900 https://pubmed.ncbi.nlm.nih.gov/23012342/ https://journals.sagepub.com/doi/10.1177/0748233712459900,http://dx.doi.org/10.1177/0748233712459900,23012342,10.1177/0748233712459900,2113976663,,0,000-314-031-439-166; 000-672-679-241-486; 000-886-865-383-617; 001-221-071-682-850; 001-415-774-876-008; 001-607-574-969-839; 002-543-154-505-997; 003-872-870-031-335; 004-134-130-843-567; 004-766-529-796-032; 004-790-168-854-347; 006-083-738-949-760; 006-185-472-961-822; 006-195-313-710-70X; 006-401-461-090-148; 008-123-115-895-977; 008-267-502-679-601; 009-456-342-310-432; 009-619-838-797-786; 010-087-758-042-923; 011-639-997-433-234; 013-235-579-793-810; 013-685-537-528-662; 014-489-333-088-333; 014-670-058-130-002; 015-639-690-963-893; 016-371-586-665-644; 016-991-995-988-53X; 019-065-788-148-50X; 020-609-530-194-128; 020-630-515-014-64X; 020-947-975-707-901; 021-741-215-410-964; 022-031-039-355-475; 022-331-682-457-539; 023-050-342-035-722; 024-223-298-535-509; 025-411-221-860-244; 026-539-850-656-43X; 027-215-263-452-657; 027-393-328-794-116; 027-567-200-977-295; 030-598-783-201-375; 031-336-534-191-504; 032-239-472-273-249; 032-709-633-617-211; 032-956-822-086-614; 033-955-555-654-630; 034-710-371-999-985; 035-658-483-763-775; 035-863-379-372-099; 036-163-695-473-392; 036-437-791-427-113; 037-641-958-764-395; 037-681-376-507-491; 038-521-745-811-995; 038-531-502-834-286; 039-845-994-188-492; 040-182-714-423-736; 041-216-550-853-893; 042-401-983-650-785; 043-382-328-133-445; 044-634-958-565-167; 045-117-367-995-465; 047-270-592-494-628; 048-555-581-905-925; 048-810-078-034-152; 049-747-451-548-23X; 053-517-250-763-110; 054-191-637-985-630; 055-165-874-363-170; 055-921-408-762-204; 056-189-544-723-439; 057-914-714-336-120; 058-149-370-955-286; 058-510-640-776-152; 059-150-974-990-618; 060-126-984-877-198; 060-564-848-038-269; 061-185-597-288-728; 061-939-320-934-377; 062-524-319-449-499; 065-698-597-611-547; 065-832-172-760-357; 066-772-965-283-436; 066-819-359-612-24X; 068-506-775-980-071; 070-115-710-558-439; 070-458-576-001-65X; 070-506-692-951-365; 070-553-415-254-061; 070-609-412-419-06X; 070-775-687-325-269; 072-232-249-974-463; 072-311-335-363-154; 073-890-626-406-877; 074-503-933-888-726; 074-660-736-899-10X; 076-877-267-350-121; 077-434-721-600-447; 079-880-120-853-871; 081-077-111-727-530; 081-235-155-218-405; 081-712-057-311-373; 084-339-866-620-295; 084-662-189-272-616; 090-045-625-379-502; 093-297-226-155-210; 095-055-834-611-380; 095-732-706-324-77X; 096-987-221-456-011; 098-257-859-777-090; 098-327-629-083-887; 099-497-634-955-342; 102-525-963-493-734; 102-808-611-822-098; 105-103-075-942-510; 106-039-919-559-099; 106-337-509-868-855; 107-034-552-871-142; 107-471-756-291-575; 109-194-480-058-405; 110-112-375-411-944; 112-597-701-751-292; 113-203-533-230-27X; 113-206-721-948-530; 114-468-850-861-091; 117-096-487-765-98X; 118-144-380-755-781; 125-870-373-393-823; 129-890-731-028-433; 130-014-653-118-18X; 130-797-714-746-782; 131-947-455-390-650; 132-890-385-061-879; 134-358-966-538-235; 136-062-727-152-992; 140-710-991-078-637; 142-314-501-958-69X; 142-388-370-174-335; 152-900-148-691-81X; 158-008-337-246-935; 158-719-376-639-273; 160-179-339-855-855; 160-922-092-970-242; 162-304-141-522-791; 178-732-294-561-072; 181-563-722-856-621; 188-510-978-822-236; 189-910-478-237-865,30
009-374-462-971-711,Extraction of environmental pollutants using magnetic nanomaterials,,2010,journal article,Analytical Methods,17599660; 17599679,Royal Society of Chemistry (RSC),United Kingdom,Jia-Hui Lin; Zong-Han Wu; Wei-Lung Tseng,"Magnetic nanomaterials are particularly useful for extracting and enriching a large volume of target analytes because they provide high surface-to-volume ratio, easy surface modification, and strong magnetism. This review summarizes the recent advance in synthesis, modification, and application of magnetic nanomaterials for the preconcentration of environmental pollutants. The extraction of environmental pollutants with magnetic nanomaterials is generally based on hydrophobic interaction, electrostatic attraction, and/or covalent bonding formation. Environmental pollutants adsorbed on the surface of nanomaterials are released by exchanging ligands, adjusting pH, or adding organic solvent. The liberated environmental pollutants are commonly detected by gas chromatography, high-performance liquid chromatography, and inductively coupled plasma-optical emission spectrometry. The basic principle of each nanomaterial and its advantages for the extraction of environmental pollutants are discussed in this review.",2,12,1874,1879,Surface modification; Gas chromatography; Nanomaterials; Adsorption; Nanotechnology; Chemistry; Magnetism; Extraction (chemistry); Pollutant; Hydrophobic effect,,,,,http://pubs.rsc.org/en/content/articlelanding/2010/ay/c0ay00575d#! https://www.cabdirect.org/cabdirect/abstract/20113032473 https://www.cabdirect.org/abstracts/20113032473.html https://pubs.rsc.org/en/Content/ArticleLanding/2010/AY/C0AY00575D,http://dx.doi.org/10.1039/c0ay00575d,,10.1039/c0ay00575d,2009864857,,0,000-647-101-899-439; 002-511-734-565-666; 004-281-285-116-09X; 005-808-474-421-514; 007-280-548-336-778; 009-642-405-479-614; 012-757-654-274-140; 012-872-162-038-161; 015-239-892-062-193; 017-651-158-462-480; 021-189-027-924-603; 024-348-346-719-927; 028-982-977-531-326; 029-871-959-013-79X; 030-868-543-959-088; 033-944-381-898-905; 034-426-538-893-288; 039-060-364-043-221; 039-922-066-073-066; 049-404-234-311-848; 050-289-810-171-607; 054-020-419-860-147; 055-683-806-122-797; 055-699-915-377-090; 063-732-165-968-503; 070-670-019-931-641; 074-484-809-644-504; 076-021-213-583-247; 078-689-617-555-667; 080-392-386-015-739; 081-646-818-452-267; 087-301-492-639-738; 087-491-848-858-30X; 091-067-090-442-23X; 093-808-438-219-222; 094-681-719-051-084; 094-806-627-731-53X; 095-814-252-410-84X; 103-477-239-947-304; 104-686-361-504-934; 107-556-927-264-962; 108-526-228-321-437; 116-417-448-553-237; 121-222-243-385-71X; 123-273-355-950-210; 157-186-980-449-390; 187-398-248-746-987; 194-764-705-264-889,49
009-656-197-967-492,Application of Functional Nanomaterials in Food Safety,,2010,journal article,Chinese Journal of Analytical Chemistry,02533820,,,Chu Hua,"The fast development of nanomaterials supplies the theory basis and technique support to solve the problems in the field of food safety detection. By the combination with the functional nanomaterials and traditional detection methods,novel detection methods with higher sensitivity,high throughput and rapid detection time could be developed,which attracted much attention in the detection of microorganism,chemical residues and biological toxins. In this article,we summarize the recent progress of the application of the main functional nanomaterials in food safety.",,,,,Nanomaterials; Nanotechnology; Chemistry; Rapid detection; Food safety,,,,,http://en.cnki.com.cn/Article_en/CJFDTotal-FXHX201003036.htm,http://en.cnki.com.cn/Article_en/CJFDTotal-FXHX201003036.htm,,,2385357954,,0,,1
009-715-313-633-869,Toxicity of Engineered Nanomaterials: A Physicochemical Perspective,2012-11-05,2012,journal article,Journal of biochemical and molecular toxicology,10990461; 10956670,John Wiley and Sons Inc.,United States,Ramakrishna Podila; Jared M. Brown,"The global market for nanomaterial-based products was forecasted to reach 100 billion dollars per annum for 2011–2015. Extensive manufacturing and the use of engineered nanomaterials (ENM) have raised concerns regarding their impact on biological response in living organisms, and the environment at large. The fundamental properties of nanomaterials exhibit a complex dependence upon several factors such as their morphology, size, defects, chemical stability, etc. Therefore, it is exceedingly difficult to correlate their biological response with their intricate physicochemical properties. For example, varying toxic response may ensue due to different methods of nanomaterial preparation, dissimilar impurities and defects. In this review, we surveyed the existing literature on the dependence of cytotoxicity on physicochemical properties. We found that ENM size, shape, defect density, physicochemical stability and surface modification to be the main causes that elicit altered physiological response or cytotoxicity.",27,1,50,55,Nanomaterials; Nanotechnology; Chemistry; Engineered nanomaterials,,Animals; Humans; Nanoparticles/chemistry; Nanostructures/chemistry; Surface Properties,,NIEHS NIH HHS (R01 ES019311) United States,https://www.ncbi.nlm.nih.gov/pubmed/23129019 https://www.onlinelibrary.wiley.com/doi/full/10.1002/jbt.21442 http://europepmc.org/articles/PMC3778677,http://dx.doi.org/10.1002/jbt.21442,23129019,10.1002/jbt.21442,1491666770,PMC3778677,0,000-289-398-938-138; 000-598-789-239-704; 002-351-763-877-108; 003-009-275-201-101; 003-901-670-284-995; 004-659-121-661-755; 005-387-467-793-288; 005-574-381-503-802; 005-704-293-540-518; 005-716-268-121-272; 009-252-410-431-689; 010-340-402-798-494; 011-181-272-451-257; 011-292-340-588-581; 012-868-864-795-27X; 013-138-889-663-080; 013-420-277-034-231; 014-662-820-947-699; 015-844-842-428-113; 018-091-194-570-685; 018-992-693-252-655; 023-399-948-780-577; 023-731-947-341-566; 023-920-911-456-102; 024-742-271-975-875; 026-503-655-286-985; 026-771-905-068-19X; 030-053-820-661-160; 030-517-471-364-311; 030-934-624-291-158; 032-305-493-812-865; 035-883-712-822-136; 039-079-455-504-396; 039-388-964-528-811; 039-587-679-716-970; 042-166-139-469-166; 047-157-933-733-320; 049-765-189-382-869; 050-193-932-308-898; 054-778-203-774-310; 055-165-874-363-170; 058-640-350-311-643; 061-368-916-870-427; 062-850-955-186-283; 064-957-606-328-450; 067-227-408-798-309; 067-945-713-101-711; 071-259-804-036-841; 078-725-939-571-470; 079-609-744-811-233; 084-516-025-301-649; 084-778-286-968-118; 086-312-117-467-812; 086-526-415-163-714; 087-605-418-830-06X; 091-486-302-710-782; 092-445-685-268-80X; 093-222-188-101-361; 098-443-959-952-430; 139-064-290-179-567; 177-906-892-019-161; 192-689-719-434-017,101
009-988-811-763-619,Biosynthesis of Nanomaterials Using Algae,,2020,book chapter,Microalgae Cultivation for Biofuels Production,,Elsevier,,Ashiqur Rahman; Shishir Kumar; Tabish Nawaz,"Abstract Nanomaterials synthesized by microalgae have a wide range of applications in the fields of medical treatment and reaction catalysis. The availability of hydrophilic surface groups, such as sulfate, carboxyl, and hydroxyl on algae-mediated nanomaterials, gives them unique applicability. This chapter discusses algae-mediated biosynthesis processes and identifies their differences, advantages, and disadvantages. Additionally, various significant process parameters such as the pH, temperature, incubation time, precursor concentration, and light intensity that affect the biosynthesis process are identified and discussed in detail. The extensive applications of as-produced nanomaterials are also highlighted. Overall, this chapter aims at advancing this high potential biosynthesis process to reach a scalable platform.",,,265,279,Nanomaterials; Nanotechnology; Chemistry; Scientific method; Medical treatment; Light intensity; High potential; Biosynthesis; Algae,,,,,https://www.sciencedirect.com/science/article/pii/B9780128175361000175,http://dx.doi.org/10.1016/b978-0-12-817536-1.00017-5,,10.1016/b978-0-12-817536-1.00017-5,2989937499,,0,000-062-281-248-575; 000-312-901-688-109; 001-674-259-159-449; 001-724-004-962-46X; 002-093-242-645-249; 002-224-695-528-667; 002-609-017-186-642; 002-887-714-508-475; 003-112-255-485-253; 004-015-154-876-775; 004-134-222-595-521; 004-491-850-239-558; 004-519-161-243-908; 004-911-089-360-97X; 005-591-109-619-763; 006-644-196-673-970; 007-255-428-556-990; 007-532-749-616-037; 011-007-960-122-795; 011-053-837-037-736; 012-172-493-115-769; 013-681-114-452-75X; 014-345-833-397-631; 016-018-355-408-985; 017-700-914-302-502; 018-269-272-122-26X; 019-596-298-821-40X; 019-942-649-737-648; 020-210-182-670-495; 020-597-526-406-495; 021-179-349-252-249; 025-206-195-738-022; 029-699-283-001-542; 029-779-412-488-44X; 032-128-435-606-698; 032-319-521-089-131; 032-624-415-544-947; 033-281-928-303-211; 033-353-060-007-193; 034-061-710-741-333; 035-788-038-361-167; 036-667-666-069-568; 037-134-045-861-83X; 037-157-569-087-699; 038-635-643-553-222; 039-128-217-207-140; 039-604-933-036-017; 039-759-860-060-177; 041-324-903-983-027; 041-489-311-760-52X; 042-270-101-609-514; 042-529-871-910-282; 044-196-031-267-175; 045-423-766-603-989; 045-585-487-542-847; 046-091-757-934-733; 046-383-583-759-545; 048-741-696-124-941; 050-039-251-442-99X; 050-225-940-823-834; 052-107-266-558-420; 052-232-182-966-577; 053-206-576-391-048; 056-007-122-818-841; 059-210-736-188-795; 059-996-675-815-384; 066-602-800-833-266; 070-752-393-856-636; 073-005-850-924-260; 080-241-132-079-005; 083-563-917-436-333; 085-370-925-894-547; 087-725-928-582-998; 090-184-237-508-958; 090-497-017-814-686; 092-624-355-199-737; 096-391-204-781-851; 102-504-571-651-702; 103-097-615-912-865; 105-439-804-690-093; 106-426-659-963-705; 106-883-191-593-019; 108-376-471-148-063; 109-135-008-418-198; 113-205-528-423-180; 128-831-977-356-617; 130-611-875-739-905; 131-907-656-006-911; 139-273-760-302-285; 141-350-602-054-747; 141-621-185-885-989; 155-584-691-681-442; 175-215-440-017-215,11
010-073-445-297-717,Toxicity of nanomaterials to biomedical applications— A review,,2018,book chapter,Fundamental Biomaterials: Ceramics,,Elsevier,,R. Mala; A. S. Ruby Celsia,"Nanomaterials have tremendous potential in medicine, agriculture, bioremediation, food industry, lab on chip, etc. Biomedical applications of nanomaterials are immense. The characteristics of nanomaterials can be engineered to be suitable for specific application. Wide variety of nanomaterials is in preclinical and clinical studies. Associated with the fastest development of nanomaterials, there is an increasing concern over the possible negative effects of nanomaterials on the living organisms. This review discusses the application of nanomaterials in biomedical field and the toxic effect of nanomaterials on in vitro and in vivo system. The effect of nanomaterials is discussed with respect to reproductive and developmental toxicity in Zebra fish and other animal models. Further, the physicochemical characteristics of a nanomaterial that influences the absorption, distribution, metabolism, and excretion of nanomaterials are elaborated. Understanding the principle behind toxicity will assist in the preparation of materials with less toxicity.",,,439,473,Engineering; Nanomaterials; Nanotechnology; Fish <Actinopterygii>,,,,,https://www.sciencedirect.com/science/article/pii/B9780081022030000159,http://dx.doi.org/10.1016/b978-0-08-102203-0.00015-9,,10.1016/b978-0-08-102203-0.00015-9,2789608376,,0,000-107-847-200-535; 000-181-024-347-523; 000-226-902-121-98X; 000-283-550-210-620; 000-724-668-845-729; 000-726-232-921-507; 000-769-538-211-92X; 000-886-865-383-617; 001-374-812-886-437; 002-172-660-475-735; 002-441-424-531-937; 002-661-712-656-616; 002-853-464-091-711; 003-205-424-117-455; 003-574-826-904-252; 003-590-691-106-471; 003-750-949-804-307; 004-790-168-854-347; 005-011-041-378-559; 005-109-805-340-514; 005-443-653-750-912; 006-635-254-834-839; 006-834-675-488-278; 007-620-472-680-879; 007-646-719-837-723; 007-897-999-545-157; 008-026-084-779-329; 009-226-182-114-702; 009-646-707-168-780; 009-775-927-098-332; 009-789-098-634-173; 009-955-080-762-717; 010-016-593-413-571; 010-543-473-605-178; 010-802-514-795-435; 010-979-721-167-89X; 011-483-307-687-969; 012-571-031-494-096; 012-674-733-839-556; 013-061-851-870-954; 013-294-433-904-880; 013-435-742-998-469; 014-374-864-063-303; 014-662-820-947-699; 015-746-584-106-605; 015-762-897-625-318; 015-773-422-088-831; 016-734-834-369-036; 016-951-550-954-971; 017-423-278-488-453; 017-711-193-525-020; 018-071-246-408-586; 018-298-420-711-473; 018-507-784-973-261; 018-734-749-115-405; 019-350-959-781-856; 020-013-224-074-833; 020-378-991-041-17X; 021-032-317-418-949; 021-237-609-144-58X; 021-767-665-828-087; 021-909-073-732-007; 021-988-950-142-657; 022-468-043-720-676; 022-746-388-298-99X; 022-878-943-408-030; 023-194-783-753-378; 023-267-308-492-417; 023-428-156-545-202; 023-979-658-703-849; 024-100-456-290-43X; 024-713-506-023-340; 025-317-047-073-913; 025-911-273-565-870; 026-783-867-191-485; 026-899-362-164-144; 027-361-441-584-659; 027-571-172-174-525; 028-242-373-007-386; 028-475-734-279-246; 028-517-793-741-800; 028-680-965-832-97X; 029-591-800-139-933; 030-497-011-651-517; 030-773-459-837-633; 031-524-015-335-447; 031-633-185-596-546; 031-867-940-859-357; 033-140-749-934-369; 033-414-966-682-730; 033-908-220-206-543; 035-290-065-979-191; 035-384-771-433-142; 035-843-052-708-12X; 035-883-712-822-136; 035-919-228-575-462; 036-218-714-276-569; 036-349-407-037-760; 036-392-108-455-253; 036-971-566-081-240; 037-288-813-451-449; 037-559-465-893-09X; 037-714-285-367-567; 038-004-890-940-771; 039-171-359-712-55X; 040-182-714-423-736; 040-641-088-971-611; 040-782-969-198-760; 041-040-354-537-096; 041-429-979-909-844; 041-871-944-415-926; 042-164-383-242-714; 042-166-139-469-166; 042-341-129-495-040; 042-739-592-705-978; 042-743-133-921-841; 042-785-254-084-264; 043-082-492-648-120; 043-167-710-752-210; 043-492-803-065-451; 043-685-876-034-614; 043-747-732-942-374; 044-080-573-794-653; 044-785-150-446-083; 045-086-434-839-253; 045-271-512-889-497; 046-742-685-839-150; 046-930-831-521-481; 047-065-252-124-732; 047-788-677-476-142; 048-263-431-180-274; 048-399-088-620-158; 050-431-920-282-089; 050-865-725-841-226; 051-549-006-723-620; 051-798-691-140-761; 051-961-951-747-920; 052-526-438-175-159; 052-539-462-020-686; 052-878-565-545-123; 053-477-833-444-740; 054-091-048-924-25X; 054-418-820-112-188; 055-036-820-861-640; 055-268-992-141-79X; 056-773-949-586-949; 057-128-464-752-325; 057-452-026-390-365; 057-857-900-996-802; 058-061-553-108-163; 061-258-808-105-026; 062-596-676-295-451; 063-068-818-346-232; 063-837-283-697-098; 064-161-867-482-719; 064-841-916-102-962; 065-075-192-716-93X; 066-070-353-616-643; 066-105-986-235-936; 067-227-408-798-309; 068-172-897-599-562; 068-424-737-879-918; 068-984-448-091-994; 069-272-263-310-258; 070-211-798-475-872; 070-407-135-511-187; 070-775-687-325-269; 071-574-151-928-884; 071-774-823-910-596; 071-910-982-579-072; 075-392-855-368-537; 075-787-443-355-461; 075-816-346-769-347; 076-769-326-517-537; 076-890-997-236-028; 076-906-545-768-350; 078-417-875-166-075; 078-549-698-488-94X; 079-510-359-105-877; 082-245-768-945-512; 082-894-245-305-620; 083-790-892-560-732; 085-286-364-293-95X; 086-044-915-388-432; 088-368-368-445-242; 089-013-662-093-528; 089-545-201-732-136; 090-045-625-379-502; 090-284-949-583-671; 090-357-422-488-218; 090-418-884-268-021; 090-445-438-903-228; 091-659-917-833-511; 093-455-690-325-499; 094-970-000-847-023; 096-730-153-354-414; 097-638-427-381-845; 098-291-589-215-619; 098-841-785-113-015; 101-053-119-525-025; 101-384-625-673-967; 101-943-883-705-077; 105-243-639-816-611; 105-600-171-778-631; 105-619-141-543-188; 106-039-919-559-099; 106-337-509-868-855; 109-577-975-894-307; 109-721-498-657-125; 110-043-871-130-184; 111-141-759-298-943; 113-222-331-770-968; 113-488-949-926-125; 113-583-901-399-35X; 115-004-023-516-21X; 115-556-345-915-630; 116-517-968-247-514; 116-700-309-186-75X; 117-864-741-366-706; 121-869-178-852-074; 122-893-762-308-381; 123-963-931-197-30X; 128-334-426-865-944; 128-387-536-749-986; 128-697-414-323-091; 129-063-143-840-901; 130-037-626-643-693; 130-797-714-746-782; 131-268-242-599-00X; 131-300-848-557-59X; 134-461-991-773-179; 137-197-250-958-394; 138-933-760-925-436; 142-325-179-186-284; 143-173-231-841-562; 145-649-462-545-537; 146-509-934-955-406; 148-607-190-574-02X; 148-615-439-976-228; 149-556-113-600-940; 151-954-266-381-668; 154-794-705-399-544; 155-237-165-456-046; 156-611-146-468-264; 160-313-725-679-495; 168-702-224-467-339; 173-127-284-398-913; 173-131-654-023-53X; 174-661-342-119-799; 176-738-673-022-356; 177-301-792-048-799; 193-616-090-773-482,4
010-330-869-511-347,Current Progress of Nanomaterials in Molecularly Imprinted Electrochemical Sensing,2017-10-24,2017,journal article,Critical reviews in analytical chemistry,15476510; 10408347,Taylor and Francis Ltd.,United Kingdom,Chunju Zhong; Bin Yang; Xinxin Jiang; Jianping Li,"Nanomaterials have received much attention during the past decade because of their excellent optical, electronic, and catalytic properties. Nanomaterials possess high chemical reactivity, also high surface energy. Thus, provide a stable immobilization platform for biomolecules, while preserving their reactivity. Due to the conductive and catalytic properties, nanomaterials can also enhance the sensitivity of molecularly imprinted electrochemical sensors by amplifying the electrode surface, increasing the electron transfer, and catalyzing the electrochemical reactions. Molecularly imprinted polymers that contain specific molecular recognition sites can be designed for a particular target analyte. Incorporating nanomaterials into molecularly imprinted polymers is important because nanomaterials can improve the response signal, increase the sensitivity, and decrease the detection limit of the sensors. This study describes the classification of nanomaterials in molecularly imprinted polymers, their analytical properties, and their applications in the electrochemical sensors. The progress of the research on nanomaterials in molecularly imprinted polymers and the application of nanomaterials in molecularly imprinted polymers is also reviewed.",48,1,15,32,Analyte; Nanomaterials; Molecularly imprinted polymer; Nanotechnology; Molecular recognition; Electrochemical gas sensor; Materials science; Molecular imprinting; Biomolecule; Polymer,Electrochemical sensor; molecularly imprinted polymers; nanomaterials; review,Electrochemical Techniques; Molecular Imprinting; Nanostructures/chemistry; Polymers/chemistry,Polymers,,https://pubmed.ncbi.nlm.nih.gov/28777018/ https://www.ncbi.nlm.nih.gov/pubmed/28777018 https://www.tandfonline.com/doi/full/10.1080/10408347.2017.1360762 https://europepmc.org/article/MED/28777018,http://dx.doi.org/10.1080/10408347.2017.1360762,28777018,10.1080/10408347.2017.1360762,2743287315,,0,000-037-654-306-80X; 000-627-382-510-208; 001-263-314-996-324; 002-489-802-014-80X; 003-216-619-306-583; 003-831-307-130-069; 003-882-328-509-668; 003-964-777-788-032; 004-531-785-349-171; 004-589-695-985-440; 004-616-950-290-576; 005-949-718-612-341; 006-028-410-450-825; 006-372-349-123-43X; 007-073-932-960-186; 007-135-931-919-238; 007-329-497-616-554; 008-892-320-460-194; 009-131-093-678-731; 009-250-203-414-270; 010-087-341-061-571; 010-414-611-039-813; 010-528-145-238-721; 011-019-302-768-824; 011-875-032-075-762; 012-196-572-092-418; 012-406-892-964-185; 013-204-257-763-043; 013-485-740-149-952; 014-275-417-471-82X; 014-653-519-810-429; 014-746-220-737-67X; 015-257-096-376-430; 015-638-018-768-972; 015-940-643-305-284; 016-948-918-029-040; 017-150-554-038-643; 017-638-060-278-574; 018-088-168-736-007; 019-203-315-496-136; 019-281-826-101-208; 019-281-871-877-099; 021-498-057-460-693; 021-854-163-946-476; 021-854-272-728-515; 021-991-357-399-168; 022-551-174-087-409; 023-184-202-494-787; 023-267-374-784-522; 023-838-437-214-137; 025-081-691-108-402; 025-677-175-025-587; 025-893-095-597-311; 025-904-206-655-512; 026-190-734-308-770; 028-732-078-636-27X; 029-135-404-439-273; 030-304-896-576-273; 031-192-363-554-955; 031-686-568-218-04X; 031-843-016-378-746; 032-538-408-386-118; 032-571-725-698-590; 032-780-483-581-082; 032-972-487-366-378; 033-270-669-654-338; 034-102-448-249-64X; 034-521-185-535-594; 034-997-016-549-278; 035-595-842-246-011; 035-614-003-186-952; 037-526-774-411-372; 038-193-923-930-410; 039-830-482-618-442; 040-016-092-207-292; 040-326-693-623-64X; 040-403-139-747-57X; 040-416-851-407-264; 040-470-278-897-826; 040-623-912-530-98X; 041-139-297-284-431; 042-914-570-823-75X; 043-014-629-236-000; 043-875-627-889-66X; 044-874-189-838-038; 044-949-728-531-021; 045-610-767-893-555; 045-794-955-221-640; 047-385-219-731-47X; 047-933-264-936-698; 049-895-864-709-243; 050-130-712-241-021; 050-131-540-859-611; 050-221-915-375-963; 050-685-830-336-936; 051-303-875-162-01X; 051-403-876-888-611; 052-563-969-846-153; 052-960-785-145-722; 053-813-072-782-71X; 056-993-411-688-104; 057-161-818-130-983; 057-676-816-878-050; 058-188-556-054-226; 058-193-620-011-826; 058-208-751-366-482; 059-170-647-443-682; 059-413-765-402-703; 059-831-377-148-08X; 060-197-386-662-750; 063-277-641-021-31X; 063-977-771-472-300; 064-361-873-901-234; 064-773-177-877-497; 065-089-169-297-885; 067-504-409-357-786; 068-690-772-073-989; 072-363-960-375-139; 072-736-919-666-267; 072-920-291-656-409; 073-112-115-800-994; 075-392-729-866-949; 075-597-475-478-901; 076-108-265-854-901; 077-956-230-238-234; 078-685-971-309-014; 079-295-450-349-654; 079-496-308-666-772; 079-529-145-157-540; 079-552-931-064-734; 079-564-723-062-660; 080-223-030-610-943; 082-729-779-701-039; 084-179-275-613-624; 084-268-403-666-099; 085-170-476-494-735; 085-706-520-654-250; 085-763-349-541-213; 086-084-929-796-644; 086-988-801-533-038; 087-898-271-644-124; 088-665-686-020-275; 089-590-721-136-592; 090-503-606-516-191; 090-750-231-120-761; 090-874-664-568-195; 094-428-932-649-30X; 094-980-509-783-033; 095-685-187-110-163; 098-065-881-967-003; 098-167-212-905-099; 100-511-491-066-098; 101-284-434-763-873; 102-120-015-478-010; 102-382-431-586-993; 103-676-163-310-252; 105-245-267-012-418; 105-392-605-307-471; 108-316-889-296-034; 108-464-752-922-430; 112-880-952-851-865; 112-909-108-646-889; 114-957-509-267-854; 116-068-669-013-987; 116-677-935-884-034; 119-048-663-364-031; 119-605-904-789-401; 121-364-491-083-300; 121-638-973-630-472; 123-311-336-646-939; 124-917-535-339-352; 130-054-734-336-257; 131-684-181-470-423; 131-952-036-323-484; 132-009-434-770-211; 134-116-393-490-737; 136-191-878-984-041; 138-579-617-427-216; 138-826-889-606-862; 147-485-404-707-918; 153-529-018-670-570; 172-302-178-635-11X; 175-564-012-581-915; 194-157-496-838-81X,36
010-382-927-957-166,Bifunctional nanomaterials for the imaging and treatment of cancer,2017-07-06,2017,book,Oxford Handbooks Online,,Oxford University Press,,Andrew R. Burke; David L. Carroll; Frank M. Torti; Suzy V. Torti,"<p>This article examines the potential of bifunctional nanomaterials for the imaging and treatment of cancer. Several nanomaterials possess properties desirable for a cancer therapy and have been the subject of research as anticancer agents. Those that have received the most attention include encapsulated iron oxides, single- and multiwalled carbon nanotubes, gold nanorods and gold nanoshells. This article first considers thermal ablative therapy incancer, focusing on the mechanisms of thermotoxicity and thermoresistance before discussing a number of nanomaterials with applications for cancer treatment. In particular, it evaluates the use of nanomaterials in thermal therapy. It also looks at gold nanoshells and nanorods, taking into account their physical properties, and concludes with an assessment of iron-oxide nanoparticles and future directions for nanomaterials as multifunctional agents for cancer therapy.</p>",,,,,Cancer; Nanorod; Nanomaterials; Nanotechnology; Materials science; Iron oxide nanoparticles; Bifunctional; Cancer therapy; Thermal therapy; Gold nanoshells,,,,,https://www.oxfordhandbooks.com/view/10.1093/oxfordhb/9780199533060.001.0001/oxfordhb-9780199533060-e-13,http://dx.doi.org/10.1093/oxfordhb/9780199533060.013.13,,10.1093/oxfordhb/9780199533060.013.13,2756390857,,0,,0
010-516-945-814-514,"Engineered Nanomaterials: Hazard, Exposure, Risk Assessment - Regulation and Legislation",,2017,book chapter,Adverse Effects of Engineered Nanomaterials,,Elsevier,,Rasmussen Kirsten; Sokull-Kluettgen Birgit; Yu Il Je; Kanno Jun; Hirose Akihiko; R Gwinn Maureen,"Regulation of nanomaterials is debated. The European Union has started to introduce specific requirements for nanomaterials in some of its legislation; however, it is recognized that questions related to the risks of exposure to nanomaterials are still unanswered. The focus of this chapter is on the existing legislations currently used for regulation of nanomaterials. This includes the Toxic Substances Control Act (TSCA) in the USA and the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) in the European Union, as well as Toxic Chemical Control Act and the Chemical Registration and Assessment Act in Korea, and the Act on the Evaluation of Chemical Substances and Regulation of their Manufacture in Japan. The OECD is the global forum for information exchange between regulators and other stakeholders on safety of nanomaterials. Even though the OECD confirmed that the standard chemicals methodology is applicable to nanomaterials, risk assessment of nanomaterials is complicated by limited exposure and hazard data. These data limitations impact the ability to adequately assess the risks associated with nanomaterials, making it difficult to evaluate nanomaterials beyond a case-by-case basis. Recent studies have moved beyond analysis of pristine nanomaterials to better understand the impact of environmental contaminants on the nanomaterials and the potential effects on human health.",,,159,188,Authorization; Risk analysis (engineering); Risk assessment; Engineering; Legislation; European union; Toxic chemical; Data limitations; Engineered nanomaterials; Hazard; Environmental health,,,,,http://publications.jrc.ec.europa.eu/repository/handle/JRC106288,http://dx.doi.org/10.1016/b978-0-12-809199-9.00007-0,,10.1016/b978-0-12-809199-9.00007-0,2606014810,,0,016-966-412-866-596; 042-281-633-258-640; 084-546-849-809-717; 091-313-014-681-467; 124-699-878-421-486; 129-844-690-338-55X; 134-496-020-738-928,1
010-564-580-936-389,Biological responses to engineered nanomaterials: Needs for the next decade,2015-06-09,2015,journal article,ACS central science,23747943; 23747951,American Chemical Society (ACS),United States,Catherine J. Murphy; Ariane M. Vartanian; Franz M. Geiger; Robert J. Hamers; Joel A. Pedersen; Qiang Cui; Christy L. Haynes; Erin E. Carlson; Rigoberto Hernandez; Rebecca Klaper; Galya Orr; Zeev Rosenzweig,"The interaction of nanomaterials with biomolecules, cells, and organisms is an enormously vital area of current research, with applications in nanoenabled diagnostics, imaging agents, therapeutics, and contaminant removal technologies. Yet the potential for adverse biological and environmental impacts of nanomaterial exposure is considerable and needs to be addressed to ensure sustainable development of nanomaterials. In this Outlook four research needs for the next decade are outlined: (i) measurement of the chemical nature of nanomaterials in dynamic, complex aqueous environments; (ii) real-time measurements of nanomaterial–biological interactions with chemical specificity; (iii) delineation of molecular modes of action for nanomaterial effects on living systems as functions of nanomaterial properties; and (iv) an integrated systems approach that includes computation and simulation across orders of magnitude in time and space.",1,3,117,123,Nanomaterials; Nanotechnology; Living systems; Integrated systems; Research needs; Engineered nanomaterials; Computer science,,,,Division of Chemistry,https://experts.umn.edu/en/publications/biological-responses-to-engineered-nanomaterials-needs-for-the-ne https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827556/ https://europepmc.org/articles/PMC4827556 https://www.scholars.northwestern.edu/en/publications/biological-responses-to-engineered-nanomaterials-needs-for-the-ne https://www.osti.gov/pages/biblio/1224506-biological-responses-engineered-nanomaterials-needs-next-decade https://experts.illinois.edu/en/publications/biological-responses-to-engineered-nanomaterials-needs-for-the-ne https://core.ac.uk/display/145614828 https://pubs.acs.org/doi/10.1021/acscentsci.5b00182 http://pubs.acs.org/doi/full/10.1021/acscentsci.5b00182 https://pubs.acs.org/doi/abs/10.1021/acscentsci.5b00182 http://pubs.acs.org/doi/pdf/10.1021/acscentsci.5b00182,http://dx.doi.org/10.1021/acscentsci.5b00182,27162961,10.1021/acscentsci.5b00182,2408087543,PMC4827556,0,000-046-368-576-387; 000-724-668-845-729; 003-238-069-060-44X; 006-108-702-955-825; 006-363-181-231-829; 007-498-275-008-091; 008-663-302-939-135; 009-686-645-772-611; 010-503-779-736-430; 010-585-649-208-113; 014-829-032-243-908; 015-595-686-341-096; 016-542-926-548-078; 020-243-707-620-10X; 020-538-997-662-663; 024-163-903-600-515; 024-876-489-911-376; 029-906-989-530-111; 032-219-139-429-125; 036-971-566-081-240; 038-298-259-159-840; 039-228-542-003-254; 042-239-820-484-521; 043-485-193-521-820; 043-699-250-285-742; 044-020-986-290-862; 044-695-787-311-398; 046-000-204-037-411; 046-741-787-731-04X; 046-745-180-484-677; 046-981-958-849-038; 049-864-410-663-816; 050-302-753-281-503; 053-871-566-238-592; 054-010-489-803-085; 055-357-361-080-905; 059-277-843-399-412; 060-136-404-456-725; 060-267-393-125-436; 062-212-899-169-852; 064-547-715-640-345; 067-603-942-502-295; 068-889-808-702-272; 069-148-368-378-314; 070-959-897-163-188; 074-093-262-305-171; 074-621-734-895-197; 074-810-838-335-680; 079-609-744-811-233; 080-602-227-494-560; 083-093-820-907-609; 084-558-519-598-142; 089-466-093-324-956; 090-937-892-757-495; 093-327-234-347-09X; 093-701-753-853-020; 095-248-400-821-613; 096-005-641-693-464; 097-759-953-928-506; 099-527-265-187-011; 100-638-640-657-253; 101-298-817-274-070; 102-318-239-064-187; 107-556-496-008-982; 108-126-125-506-962; 110-975-283-529-332; 113-541-720-815-670; 115-380-322-266-475; 121-869-178-852-074; 122-371-182-342-497; 122-960-605-387-837; 130-344-635-120-747; 135-870-673-170-472; 147-241-943-972-349; 157-896-953-181-866; 163-047-342-361-607; 178-110-624-155-362; 184-816-600-672-105; 189-894-406-168-891; 190-536-113-106-529,84
010-571-618-855-548,The Preparation and Photo-Thermal Property of Ag2S Nanomaterials,,2014,journal article,Materials Science Forum,16629752,"Trans Tech Publications, Ltd.",,Xiao Zhen Yuan; Hai Qing Xu; Yan Shan; Ke Zheng Chen,"In this paper, Ag2S nanomaterials with good morphology and crystalline have been prepared successfully by a hydrothermal method with AgNO3 and (CH2)2CS as raw materials, SUDEI and PVP as surfactant, respectively. The photo-thermal transformation performance of the nanomaterials was studied. It was found that the Ag2S nanomaterials had a good photo-thermal property and the corresponding photo-thermal transformation efficiency could reach up to 63%.",809-810,,39,42,Nanomaterials; Hydrothermal circulation; Nanotechnology; Materials science; Thermal; Raw material; Pulmonary surfactant,,,,,https://www.scientific.net/MSF.809-810.39,http://dx.doi.org/10.4028/www.scientific.net/msf.809-810.39,,10.4028/www.scientific.net/msf.809-810.39,1968777040,,0,021-203-137-905-049; 043-302-336-867-980; 053-377-328-698-119; 055-126-099-333-824; 058-748-315-825-723; 071-940-660-011-158; 072-221-669-832-927; 087-712-969-951-013; 095-748-257-843-991; 098-580-660-966-812; 112-572-217-661-761; 119-787-390-042-019; 151-127-720-241-480,1
010-821-886-570-177,The biocatalytic activity of inorganic nanomaterials,2014-01-01,2014,journal article,Chinese Science Bulletin,0023074x,"Science China Press., Co. Ltd.",,Yi Zhang; Tian Tian; Yanhong Sun; Ying Zhu; Qing Huang,"The inorganic nanomaterials have received considerable attention in nanotechnology field because of their biocatalytic activity,such as gold nanoparticles and Fe3 O4 nanoparticles.Compared to biologic enzymes,inorganic nanoparticles have the better stability,biocompatibility,and can be easily modified and marked.These properties make it possible that inorganic nanomaterials could play an important role in the physiological and metabolic processes in the living body.A series of recent papers have implicated the enzymatic properties of nanomaterials and preliminary catalytic mechanisms.This review aims to summarize recent research on biocatalytic activity of the inorganic nanoparticles and provide useful information for the design of biologic enzymes based on inorganic nanoparticles.",59,2,158,168,Colloidal gold; Nanomaterials; Nanotechnology; Chemistry; Biocompatibility; Inorganic nanoparticles,,,,,http://csb.scichina.com:8080/kxtb/CN/abstract/abstract511405.shtml http://en.cnki.com.cn/Article_en/CJFDTOTAL-KXTB201402007.htm,http://dx.doi.org/10.1360/972013-311,,10.1360/972013-311,2389100790,,0,,1
010-851-153-407-249,"Engineered nanomaterials: learning from the past, planning for the future.",,2011,journal article,Journal of occupational and environmental medicine,15365948; 10762752,Lippincott Williams and Wilkins,United States,Timothy Kreider; William E. Halperin,"OBJECTIVE The ongoing explosion in creation and use of engineered nanomaterials leaves stakeholders in government, industry, and labor uncertain of how best to proceed in protecting worker health. METHODS A synopsis is presented of the conference Nanomaterials and Worker Health, along with considerations of prior, analogous challenges in occupational health. RESULTS Progress has been made in defining and addressing the occupational threat of engineered nanomaterials, but future success demands coordinated effort. CONCLUSIONS The conference Nanomaterials and Worker Health laid necessary groundwork for collaboration to proactively and preemptively address the occupational health effects of engineered nanomaterials.",53,6 Suppl,S108,12,Business; Government; Occupational safety and health; Engineered nanomaterials; Worker health; Engineering ethics,,Epidemiologic Studies; Humans; Nanostructures/adverse effects; Occupational Exposure/adverse effects; Public-Private Sector Partnerships; Registries; Risk Assessment,,,https://journals.lww.com/00043764-201106001-00024 http://www.ncbi.nlm.nih.gov/pubmed/21654410 https://insights.ovid.com/occupational-environmental-medicine/joem/2011/06/001/engineered-nanomaterials-learning-past-planning/24/00043764,http://dx.doi.org/10.1097/jom.0b013e31821b146a,21654410,10.1097/jom.0b013e31821b146a,2313829186,,0,005-883-201-943-819; 007-409-214-794-845; 018-711-150-887-44X; 065-545-458-560-797; 159-207-406-153-846,7
011-104-399-876-595,Safety and risk assessment of nanomaterials,2011-01-01,2011,journal article,Chinese Science Bulletin,0023074x,"Science China Press., Co. Ltd.",,Liu Ying Chen ChunYing; null 陈春英,"Development of new nanomaterials and nanotechnology and their widespread application have increased the risk of human contact with various nanomaterials. Consequently, ethical, social and legal questions regarding the use of nanomaterials/ nanotechnology in society need to be addressed. The potential adverse effects of nanomaterials in the human body and the environment need to be investigated. To understand safety assessment and a series of related ethical problems, we summarize the latest experimental results and epidemiological data in this area. A health and safety evaluation of nanomaterials and nanotechnology can be performed using the following five aspects: the toxicity of the nanomaterials themselves, synergistic safety issues related to other chemical substances involved in the production and use of the nanomaterials, evaluation of exposure and risk assessment of nanomaterials, and the effective regulation of nanomaterials and nanotechnology.",56,2,119,125,Risk analysis (engineering); Risk assessment; Engineering; Nanomaterials; Health impact of nanotechnology; Nanotechnology; Health impact,,,,,http://engine.scichina.com/downloadPdf/9qxb8pDQFch963e9n http://www.scichina.com:8080/kxtb/CN/abstract/abstract502089.shtml http://en.cnki.com.cn/Article_en/CJFDTOTAL-KXTB201102005.htm,http://dx.doi.org/10.1360/972010-1477,,10.1360/972010-1477,2326624430,,0,,2
011-106-741-631-657,Nanomaterials for Electrochemical Immunosensing.,2017-05-05,2017,journal article,"Sensors (Basel, Switzerland)",14248220; 14243210,Multidisciplinary Digital Publishing Institute (MDPI),Switzerland,Mingfei Pan; Ying Gu; Yaguang Yun; Min Li; Xincui Jin; Shuo Wang,"Electrochemical immunosensors resulting from a combination of the traditional immunoassay approach with modern biosensors and electrochemical analysis constitute a current research hotspot. They exhibit both the high selectivity characteristics of immunoassays and the high sensitivity of electrochemical analysis, along with other merits such as small volume, convenience, low cost, simple preparation, and real-time on-line detection, and have been widely used in the fields of environmental monitoring, medical clinical trials and food analysis. Notably, the rapid development of nanotechnology and the wide application of nanomaterials have provided new opportunities for the development of high-performance electrochemical immunosensors. Various nanomaterials with different properties can effectively solve issues such as the immobilization of biological recognition molecules, enrichment and concentration of trace analytes, and signal detection and amplification to further enhance the stability and sensitivity of the electrochemical immunoassay procedure. This review introduces the working principles and development of electrochemical immunosensors based on different signals, along with new achievements and progress related to electrochemical immunosensors in various fields. The importance of various types of nanomaterials for improving the performance of electrochemical immunosensor is also reviewed to provide a theoretical basis and guidance for the further development and application of nanomaterials in electrochemical immunosensors.",17,5,1041,,Nanomaterials; Biosensor; Nanotechnology; Materials science; Electrochemical immunoassay; Small volume; High selectivity; Carbon based nanomaterials,carbon-based nanomaterials; electrochemical immunosensors; metal nanomaterials; review; semiconductor nanomaterials,Biosensing Techniques; Electrochemical Techniques; Immunoassay; Nanostructures; Nanotechnology,,National Natural Science Foundation of China; Program for Changjiang Scholars and Innovative Research Team in University; The Innovative Team project from Tianjin University of Science and Technology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469646 https://pubmed.ncbi.nlm.nih.gov/28475158/ https://dblp.uni-trier.de/db/journals/sensors/sensors17.html#PanGYLJW17 https://europepmc.org/abstract/MED/28475158,http://dx.doi.org/10.3390/s17051041,28475158,10.3390/s17051041,2610463728,PMC5469646,0,000-105-599-613-023; 000-243-096-159-944; 000-604-020-023-62X; 000-615-515-317-383; 001-139-753-916-981; 002-176-784-213-559; 003-062-900-375-063; 003-175-479-562-99X; 003-194-785-909-449; 003-219-860-313-652; 004-270-106-559-28X; 004-905-208-928-310; 004-906-160-540-193; 005-208-631-821-839; 006-107-334-391-303; 006-312-086-602-652; 007-781-806-323-810; 008-541-621-262-808; 009-024-021-154-257; 009-228-135-705-381; 009-531-993-482-235; 009-748-755-025-992; 010-925-327-478-776; 011-314-417-754-838; 013-537-641-747-545; 013-664-680-074-840; 014-093-722-195-668; 014-124-255-894-871; 014-124-899-990-105; 014-600-145-519-477; 015-250-984-460-276; 015-662-049-542-60X; 016-594-348-501-917; 016-910-378-621-516; 017-286-683-547-893; 019-306-865-054-676; 019-861-885-163-207; 020-301-415-739-515; 020-462-160-786-703; 021-308-961-580-669; 021-367-910-844-126; 021-439-878-371-081; 021-963-260-910-347; 022-792-337-977-551; 022-932-445-185-182; 023-245-215-861-204; 025-630-448-580-730; 027-384-125-776-562; 027-555-861-048-970; 027-684-818-174-307; 032-585-050-650-333; 033-024-170-016-827; 033-252-300-503-75X; 033-416-255-884-933; 033-914-917-718-996; 034-803-614-296-858; 034-982-620-676-511; 035-058-807-737-41X; 036-465-928-236-675; 036-631-762-759-118; 037-190-889-905-413; 037-289-430-575-473; 038-982-416-726-820; 039-370-269-611-490; 039-625-313-316-803; 039-832-778-277-746; 040-331-548-604-211; 040-907-975-054-479; 040-974-909-251-028; 041-077-426-628-309; 043-032-412-606-516; 044-164-893-855-994; 047-028-710-836-217; 047-068-727-939-964; 048-012-850-917-756; 048-664-586-151-328; 048-927-625-245-899; 050-819-392-033-214; 051-176-103-026-596; 052-349-576-776-820; 052-570-266-427-265; 052-800-666-606-829; 052-835-716-062-402; 055-989-191-161-272; 058-530-312-191-743; 058-581-354-853-987; 059-880-116-888-89X; 060-854-996-307-550; 060-989-373-093-486; 062-460-196-322-163; 062-696-185-510-880; 062-704-757-368-793; 063-610-148-593-839; 064-146-430-368-31X; 064-524-148-541-612; 067-887-696-050-023; 068-159-881-773-70X; 069-645-146-873-843; 069-650-704-439-985; 069-671-220-388-619; 070-829-538-838-600; 071-761-977-520-010; 072-725-056-689-100; 073-510-579-113-66X; 075-173-310-061-068; 075-279-878-655-77X; 075-406-066-829-526; 075-847-160-677-366; 076-766-414-707-88X; 076-914-065-657-811; 077-968-202-518-675; 080-545-331-350-630; 081-540-404-366-953; 082-667-239-375-307; 086-283-322-541-903; 087-667-903-269-02X; 088-808-352-356-460; 090-255-562-531-591; 090-710-109-850-158; 091-116-826-502-484; 094-369-566-576-499; 096-297-150-625-966; 096-744-104-936-116; 098-199-393-382-165; 100-275-424-027-185; 101-005-921-174-211; 101-261-945-540-610; 103-970-131-742-031; 107-650-129-424-133; 108-526-871-582-097; 113-382-274-489-178; 116-719-301-642-087; 117-571-501-799-968; 119-181-840-173-061; 119-491-194-897-121; 120-896-179-146-478; 122-281-107-902-205; 126-908-057-750-873; 126-942-265-908-742; 127-235-743-186-988; 128-441-354-227-946; 132-236-309-204-86X; 133-415-611-433-452; 136-497-650-469-889; 144-522-555-748-873; 147-579-063-172-624; 152-000-778-154-230; 152-703-520-587-419; 153-287-675-145-486; 164-681-603-716-520; 165-676-453-831-004; 172-205-967-297-497; 173-342-287-214-093; 180-959-125-630-573; 189-122-339-815-349; 198-289-323-659-100,21
011-394-201-764-423,Detection of DNA damage induced by nanomaterials,,2018,book chapter,"Nanoscale Fabrication, Optimization, Scale-Up and Biological Aspects of Pharmaceutical Nanotechnology",,Elsevier,,Burcu Dogan-Topal; Bengi Uslu; Sibel A. Ozkan,"Abstract Study on DNA damage has received more and more attention, due to its relation to cancer, aging and neurological diseases. The DNA damage may result from hydrolytic deamination, alkylating agents, free radicals and reactive oxygen species formed by various photochemical processes including UV radiation. Like other chemical carcinogens, nanomaterials may cause cancer via oxidative DNA damage. The development of novel engineered nanomaterials has been of importance for the industry, owing to the beneficial physico-chemical features they offer, some of which include improved electrical and/or thermal conductivity. Also, nanomaterials have improved optical properties and catalytic activity. Recently, human exposure to nanomaterials is already occurring and is set to increase dramatically. However, due to their small size as well as the novel physico-chemical properties may also be responsible for adverse biological effects. Moreover, the limited information that is gradually arising does indicate that nanomaterials induce oxidative stress, cytotoxicity and inflammatory responses. The DNA damage is usually detected by separation techniques such as electrophoresis, liquid chromatography and electrochemical technique. In this chapter, the DNA damage induced by various nanomaterials will be assessed in terms of DNA damage products, types and detections techniques.",,,547,577,Cytotoxicity; Biophysics; Nanomaterials; Radical; DNA damage; Deamination; Chemistry; Oxidative stress; Engineered nanomaterials; Reactive oxygen species,,,,,https://www.sciencedirect.com/science/article/pii/B9780128136294000140,http://dx.doi.org/10.1016/b978-0-12-813629-4.00014-0,,10.1016/b978-0-12-813629-4.00014-0,2793284323,,0,000-578-072-769-099; 000-835-062-859-378; 001-607-574-969-839; 001-642-488-687-871; 004-045-443-662-586; 004-134-130-843-567; 004-281-271-966-966; 006-099-842-565-667; 007-863-425-137-247; 008-031-420-291-987; 008-254-957-534-633; 008-308-267-977-577; 008-808-965-616-307; 008-858-574-763-575; 009-391-397-354-016; 010-472-434-649-148; 010-820-629-960-938; 011-091-579-392-205; 011-314-538-227-372; 011-357-513-274-324; 011-371-876-412-141; 011-639-997-433-234; 013-245-048-269-752; 013-710-455-456-02X; 014-670-058-130-002; 017-549-472-015-59X; 017-694-151-203-312; 020-470-702-878-830; 020-943-044-177-369; 025-358-532-053-44X; 025-537-804-630-241; 025-629-002-537-748; 026-511-310-524-925; 027-519-002-834-262; 028-447-169-539-026; 029-659-831-835-518; 029-906-989-530-111; 031-171-815-015-301; 031-410-368-468-346; 032-295-551-661-908; 033-381-501-540-347; 033-670-420-006-514; 035-697-449-015-281; 037-344-232-723-016; 037-699-280-121-629; 037-783-805-573-831; 038-077-608-786-609; 039-139-008-937-634; 043-774-988-490-870; 044-459-341-984-50X; 045-552-776-319-94X; 046-200-121-328-009; 046-470-143-601-483; 046-759-751-114-950; 049-009-346-066-584; 054-322-649-981-618; 057-045-536-735-628; 057-689-706-244-682; 059-718-458-401-505; 062-524-319-449-499; 064-347-913-777-434; 066-620-146-768-648; 066-722-860-693-177; 067-531-801-890-95X; 070-609-412-419-06X; 070-711-689-161-381; 071-152-518-865-219; 071-162-046-345-475; 071-505-960-527-387; 072-562-724-896-049; 072-954-501-514-579; 073-228-687-883-689; 074-091-364-137-35X; 074-819-300-399-747; 080-254-863-396-189; 080-636-263-036-095; 084-220-333-182-861; 084-628-739-960-984; 088-383-271-616-151; 090-505-520-461-264; 091-386-644-762-699; 101-793-757-250-891; 102-968-244-856-992; 108-886-617-784-602; 109-368-459-076-526; 112-893-773-052-534; 113-206-721-948-530; 114-522-211-723-439; 116-565-327-054-639; 117-375-685-581-075; 117-396-002-932-677; 140-591-885-755-375; 143-688-782-133-776; 149-095-109-932-871; 150-840-126-398-60X; 162-208-615-241-394; 164-621-873-985-865; 178-273-333-500-943; 191-509-066-861-507; 199-468-898-187-394,3
011-474-775-723-540,Toxicity of pristine and paint-embedded TiO2 nanomaterials:,2018-05-16,2018,journal article,Human & experimental toxicology,14770903; 09603271,SAGE Publications Inc.,United States,Anne T. Saber; Alicja Mortensen; Józef Szarek; Nicklas Raun Jacobsen; Marcus Levin; Ismo K. Koponen; Klara Jensen; Ulla Vogel; Håkan Wallin,Little is known on the toxicity of nanomaterials in the user phase. Inclusion of nanomaterials in paints is a common nanotechnology application. This study focuses on the toxicity of dusts from san...,38,1,11,24,Nanomaterials; Nanotechnology; Chemistry; Titanium dioxide; Intratracheal instillation; Toxicity,DNA damage; Nanomaterial; inflammation; intratracheal instillation; nano alkyd paint; paint dust; sanding dust; titanium dioxide,"Animals; Bronchoalveolar Lavage Fluid/cytology; Cell Count; Comet Assay; DNA Damage; Dust; Female; Liver/drug effects; Lung/drug effects; Mice, Inbred C57BL; Nanostructures/toxicity; Neutrophils/drug effects; Paint; Titanium/toxicity",Dust; titanium dioxide; Titanium,The Danish Working Environment Research Fund,http://journals.sagepub.com/doi/10.1177/0960327118774910 https://orbit.dtu.dk/en/publications/toxicity-of-pristine-and-paintembedded-tio2-nanomaterials(016bea94-1334-4dda-95d4-be589016ae06).html https://www.ncbi.nlm.nih.gov/pubmed/29766753 https://journals.sagepub.com/doi/10.1177/0960327118774910 https://europepmc.org/article/MED/29766753 https://journals.sagepub.com/doi/pdf/10.1177/0960327118774910,http://dx.doi.org/10.1177/0960327118774910,29766753,10.1177/0960327118774910,2804283994,,0,002-607-885-249-165; 003-040-791-312-890; 003-153-016-007-714; 003-631-244-197-824; 010-078-212-079-893; 012-964-475-035-12X; 017-857-268-330-677; 020-205-607-855-174; 027-430-495-363-890; 029-331-259-929-345; 030-345-724-268-523; 032-089-640-102-625; 033-096-259-659-389; 050-616-703-322-292; 052-272-634-984-503; 056-261-990-768-016; 056-698-427-918-048; 059-946-162-276-535; 078-924-381-085-730; 080-298-357-732-412; 094-601-394-139-981; 096-115-182-638-024; 112-741-405-046-867,13
011-687-813-632-148,Advances in nanotechnology and nanomaterials based strategies for neural tissue engineering,,2020,journal article,Journal of Drug Delivery Science and Technology,17732247,Elsevier BV,France,Raj Kumar; Keshaw Ram Aadil; Shivendu Ranjan; Vijay Bhooshan Kumar,"Abstract Recent development in science and technology and invention of wonderful nanomaterials by nanotechnology helps advances in healthcare and treatment. Nerve degeneration, scar tissue formation and loss of communication between neurons and cells are the major issues of nerve injury. Till date it is remain a major challenge the regeneration of nerve tissue at injury site. There are various kinds of nanomaterials-based engineering approaches have been developed and under investigation to prevent or treat nerve injuries. Different nanomaterials are classified into two categories such as inorganic and organic nanomaterials. Inorganic nanomaterials such as metal, alloys, silica, magnetic, upconversion nanoparticles and quantum dots; and organic nanomaterials such as polymeric nanoparticles, nanofibers, carbon-based nanomaterials namely carbon nanotubes and graphene, liposomes, micelles and dendrimers. These are promising nanomaterials with suitable physicochemical properties and hence employed for neural tissue engineering applications. The nanomaterials showed promising results and able to support cells adhesion, proliferation and promote neuronal cell differentiation and enhance regeneration of neuron. Here, in this review we have discussed brief overview of different nanomaterials, their properties, merits and demerit, promising results and progress towards neural tissue engineering applications.",57,,101617,,Nanomaterials; Regeneration (biology); Nanotechnology; Neural tissue engineering; Materials science; Nerve degeneration; Polymeric nanoparticles; Scar tissue; Carbon nanotube; Nanofiber,,,,"Science and Engineering Research Board, India",https://www.sciencedirect.com/science/article/pii/S177322471931963X,http://dx.doi.org/10.1016/j.jddst.2020.101617,,10.1016/j.jddst.2020.101617,3008681431,,0,000-314-431-666-720; 000-705-278-726-456; 000-763-558-657-817; 001-013-472-092-96X; 001-341-726-948-792; 001-643-262-212-173; 001-658-895-033-10X; 002-531-206-217-367; 002-536-936-445-823; 002-944-935-062-954; 003-658-000-243-898; 003-661-788-342-636; 003-821-011-073-203; 004-532-135-706-362; 004-576-855-207-574; 005-048-162-314-454; 005-258-465-353-798; 005-488-809-445-543; 005-740-409-518-178; 006-546-074-695-136; 007-158-430-536-986; 007-634-014-226-051; 007-845-808-677-786; 008-101-550-752-666; 008-321-132-261-957; 008-545-433-839-663; 011-101-832-627-685; 011-768-625-689-731; 012-192-439-481-619; 012-517-052-635-006; 012-929-760-032-362; 013-022-784-689-036; 013-558-281-995-029; 013-711-030-966-141; 014-233-147-370-379; 014-449-353-334-152; 014-600-695-997-641; 014-825-784-845-516; 014-857-422-140-099; 014-990-091-202-71X; 016-135-861-305-383; 016-645-364-713-28X; 016-705-225-655-683; 017-083-189-819-996; 017-314-622-356-845; 017-432-799-859-39X; 017-547-237-237-679; 017-741-200-857-494; 018-061-460-046-935; 018-107-153-867-240; 018-139-070-998-284; 018-193-378-490-281; 019-027-604-350-651; 019-113-883-172-931; 019-174-260-814-765; 019-175-079-556-110; 019-824-421-497-783; 020-193-084-478-14X; 020-588-455-922-745; 021-097-642-152-264; 021-419-521-159-979; 021-846-189-081-095; 022-049-760-315-765; 022-391-441-274-226; 022-402-733-640-532; 022-694-055-434-461; 022-812-483-225-53X; 023-076-347-260-705; 023-078-477-272-017; 023-093-286-600-650; 023-501-019-961-697; 023-881-736-541-342; 025-085-683-909-259; 025-164-491-717-020; 025-429-956-429-303; 025-722-262-444-691; 026-273-333-273-89X; 026-418-828-486-584; 026-489-992-651-981; 026-509-790-440-276; 028-439-735-371-222; 028-612-057-437-371; 028-634-124-150-66X; 028-913-990-574-09X; 029-323-537-673-096; 029-579-377-318-448; 031-688-547-004-498; 031-851-797-320-271; 031-993-854-590-221; 031-997-297-730-065; 032-523-538-655-943; 032-579-770-112-313; 032-749-301-303-669; 032-879-388-119-789; 033-289-334-177-613; 033-327-178-490-062; 033-352-298-994-446; 033-646-848-078-930; 033-920-035-339-346; 034-041-005-103-733; 034-077-145-053-787; 035-311-163-428-174; 035-676-374-721-268; 036-673-421-524-156; 037-102-034-281-526; 037-823-291-584-149; 038-156-094-431-151; 038-410-420-643-581; 038-636-899-128-718; 038-954-239-034-656; 040-066-620-848-620; 040-601-266-574-293; 040-715-282-104-406; 042-790-840-025-159; 043-939-171-387-257; 044-297-295-258-064; 044-557-108-637-420; 045-470-330-458-583; 045-509-907-553-397; 045-633-402-370-585; 046-385-186-545-470; 046-847-916-400-577; 046-904-580-095-991; 048-448-512-581-88X; 048-525-703-059-281; 048-592-723-088-514; 048-927-787-571-46X; 049-027-078-163-976; 050-131-865-066-636; 050-985-912-120-121; 051-390-840-050-235; 051-798-691-140-761; 052-109-182-782-854; 052-331-440-266-48X; 052-636-464-606-984; 052-638-320-723-056; 055-479-856-041-997; 055-556-697-842-493; 055-900-155-684-814; 057-832-081-137-391; 057-872-065-504-768; 057-945-006-268-819; 059-079-563-154-667; 059-335-464-952-516; 061-656-442-978-431; 061-753-397-952-535; 062-123-480-328-856; 062-669-816-515-642; 064-084-912-100-542; 064-614-774-992-268; 064-774-056-318-116; 064-893-725-549-408; 065-024-433-137-34X; 065-647-012-702-882; 065-756-749-683-703; 066-669-776-449-673; 066-962-953-545-862; 067-184-267-012-001; 067-296-524-820-322; 067-472-642-838-144; 067-687-117-454-175; 071-095-150-813-702; 071-223-920-404-192; 072-514-946-620-375; 072-689-121-484-887; 073-418-779-546-169; 073-869-674-823-679; 074-143-903-542-613; 074-743-922-932-907; 075-376-222-122-684; 075-770-520-230-662; 075-869-563-413-813; 076-781-380-016-17X; 077-135-664-912-830; 077-418-862-613-137; 078-335-557-339-541; 081-379-013-136-546; 082-722-364-618-098; 083-898-633-547-909; 084-106-442-022-091; 084-237-874-777-519; 084-883-773-066-087; 085-789-322-241-574; 085-910-539-962-294; 086-179-242-892-631; 086-886-635-858-330; 087-369-412-617-194; 088-112-712-697-440; 089-704-712-248-405; 091-343-812-351-531; 091-411-906-938-351; 091-493-588-127-941; 093-911-862-396-178; 094-658-730-656-812; 095-110-991-557-815; 095-170-753-503-242; 097-446-296-221-641; 098-622-976-915-213; 100-617-430-662-940; 100-639-588-405-941; 101-150-510-421-493; 102-097-665-003-356; 102-651-396-679-408; 103-658-512-553-676; 103-970-131-742-031; 104-006-063-960-067; 104-800-257-275-293; 104-857-901-129-607; 109-444-005-586-814; 111-233-619-604-177; 113-494-001-461-627; 114-572-641-119-018; 117-631-178-904-407; 118-746-630-469-20X; 119-708-084-216-633; 119-805-788-642-168; 121-739-446-878-380; 122-763-109-312-227; 123-273-355-950-210; 124-167-178-306-148; 125-336-741-357-528; 125-754-676-699-16X; 126-379-117-156-876; 126-449-216-006-241; 126-955-977-758-490; 128-842-390-465-236; 129-091-767-176-058; 130-328-301-535-58X; 132-515-050-584-956; 133-497-772-021-733; 138-543-384-771-176; 140-590-133-484-651; 140-821-092-714-443; 142-770-300-286-726; 151-784-555-680-526; 156-867-433-832-777; 158-456-089-977-630; 162-861-434-437-269; 165-008-940-323-388; 165-763-310-886-388; 170-450-327-122-775; 173-256-629-919-077; 180-489-760-836-657; 183-789-292-858-209,26
011-716-713-196-81X,Engineering long-circulating nanomaterial delivery systems.,2020-08-12,2020,journal article,Current opinion in biotechnology,18790429; 09581669,Elsevier Limited,Netherlands,Zhiyuan Fan; Pu Zhu; Yucheng Zhu; Kevin Wu; Christopher Y. Li; Hao Cheng,"One of the grand challenges at the forefront of bionanomaterials is their quick clearance in blood circulation. Progress has been made in understanding nanomaterial-biological system interactions and in developing new strategies to extend the blood circulation time of nanomaterials. Here, we first review interactions between the complement system and nanomaterials as well as clearance pathways in major organs such as the liver, spleen, and kidneys. We then discuss new approaches to prolong the blood circulation of nanomaterials with a focus on grafting polymers and biomimetic camouflages including cell membrane coating and hybrid vesicles. In the end, we provide insights into the pros and cons of these approaches and our perspectives for advancing this field.",66,,131,139,Engineering; Nanomaterials; Nanotechnology; Grand Challenges; Blood circulation; Long circulating,,Biomimetics; Cell Membrane; Nanostructures,,National Science Foundation,https://www.ncbi.nlm.nih.gov/pubmed/32795661 https://www.sciencedirect.com/science/article/pii/S095816692030094X,http://dx.doi.org/10.1016/j.copbio.2020.07.006,32795661,10.1016/j.copbio.2020.07.006,3048479945,,0,001-391-175-984-185; 001-920-288-590-271; 003-455-464-181-306; 003-580-942-789-344; 004-536-922-388-664; 004-682-939-558-696; 004-909-062-597-237; 005-163-422-142-323; 006-614-033-487-754; 006-991-371-323-182; 007-859-164-755-917; 008-267-476-957-283; 008-289-950-532-811; 011-295-339-426-984; 011-337-150-331-976; 013-097-696-909-816; 013-861-009-963-150; 014-847-111-101-122; 016-267-015-310-380; 016-486-374-954-348; 017-051-588-726-686; 018-501-367-701-874; 019-175-353-429-81X; 020-216-069-305-362; 023-278-455-154-219; 023-480-821-274-413; 023-811-845-708-849; 024-018-911-430-236; 025-011-920-188-167; 025-400-128-373-480; 025-623-385-496-594; 027-050-104-656-705; 028-985-059-478-419; 032-803-809-470-040; 032-809-544-063-219; 034-490-629-909-237; 036-171-190-090-310; 037-406-883-216-764; 039-419-826-077-345; 048-893-723-967-139; 049-424-502-548-672; 051-695-161-292-627; 053-055-536-681-029; 058-102-137-258-400; 058-862-102-656-232; 065-811-981-991-144; 073-009-324-404-634; 077-641-710-174-894; 085-582-026-104-462; 092-118-215-755-71X; 097-140-336-454-916; 100-404-382-763-931; 107-833-210-435-712; 109-056-483-213-620; 113-081-594-570-734; 135-934-237-969-966; 145-818-940-273-113,2
011-922-351-618-954,Nanomaterials for Membrane Fouling Control: Accomplishments and Challenges,,2013,journal article,Advances in chronic kidney disease,15485609; 15485595,W.B. Saunders Ltd,United Kingdom,Qian Yang; Baoxia Mi,"We report a review of recent research efforts on incorporating nanomaterials—including metal/metal oxide nanoparticles, carbon-based nanomaterials, and polymeric nanomaterials—into/onto membranes to improve membrane antifouling properties in biomedical or potentially medical-related applications. In general, nanomaterials can be incorporated into/onto a membrane by blending them into membrane fabricating materials or by attaching them to membrane surfaces via physical or chemical approaches. Overall, the fascinating, multifaceted properties (eg, high hydrophilicity, superparamagnetic properties, antibacterial properties, amenable functionality, strong hydration capability) of nanomaterials provide numerous novel strategies and unprecedented opportunities to fully mitigate membrane fouling. However, there are still challenges in achieving a broader adoption of nanomaterials in the membrane processes used for biomedical applications. Most of these challenges arise from the concerns over their long-term antifouling performance, hemocompatibility, and toxicity toward humans. Therefore, rigorous investigation is still needed before the adoption of some of these nanomaterials in biomedical applications, especially for those nanomaterials proposed to be used in the human body or in contact with living tissue/body fluids for a long period of time. Nevertheless, it is reasonable to predict that the service lifetime of membrane-based biomedical devices and implants will be prolonged significantly with the adoption of appropriate fouling control strategies.",20,6,536,555,Fouling; Nanomaterials; Nanotechnology; Membrane fouling; Service lifetime; Metal oxide nanoparticles; Long period; Membrane; Biofouling; Medicine,Carbon-based nanomaterials; Membrane fouling; Metal/metal oxide nanoparticles; Nanomaterials; Polymeric nanomaterials,"Biofouling/prevention & control; Humans; Kidney Failure, Chronic/therapy; Membranes, Artificial; Nanostructures/chemistry; Renal Dialysis/adverse effects","Membranes, Artificial",,https://www.ackdjournal.org/article/S1548559513001262/pdf https://www.ncbi.nlm.nih.gov/pubmed/24206605 http://www.sciencedirect.com/science/article/pii/S1548559513001262 https://www.ackdjournal.org/article/S1548-5595(13)00126-2/pdf https://pubmed.ncbi.nlm.nih.gov/24206605/ https://www.sciencedirect.com/science/article/pii/S1548559513001262 https://www.ackdjournal.org/article/S1548-5595(13)00126-2/fulltext,http://dx.doi.org/10.1053/j.ackd.2013.08.005,24206605,10.1053/j.ackd.2013.08.005,1966102614,,0,000-191-866-112-893; 000-677-816-637-288; 000-747-413-798-942; 001-104-170-246-058; 001-606-537-741-785; 002-440-979-803-751; 002-542-107-727-066; 003-004-779-419-208; 003-599-073-004-022; 003-942-202-572-786; 003-995-124-994-949; 004-267-975-699-658; 004-526-847-606-756; 004-621-116-790-030; 004-870-260-459-374; 006-010-077-927-646; 006-188-275-072-042; 006-456-024-303-158; 006-839-337-784-616; 007-724-819-804-022; 008-159-474-355-432; 008-691-772-109-724; 009-258-365-006-209; 009-705-791-088-368; 009-891-346-786-549; 009-911-117-849-791; 010-739-686-249-669; 010-927-754-730-445; 011-801-332-945-350; 011-989-585-313-949; 012-020-714-446-359; 012-277-673-572-925; 013-815-415-110-391; 014-783-789-087-176; 015-433-424-412-147; 015-667-340-167-14X; 016-012-153-231-213; 016-128-946-420-342; 016-485-688-702-982; 017-309-550-599-402; 017-489-748-916-769; 017-642-508-043-83X; 017-696-845-025-062; 017-905-522-168-833; 017-920-261-257-883; 019-237-521-935-262; 019-349-223-527-195; 019-382-236-196-625; 019-603-166-032-997; 020-186-396-256-532; 022-595-252-988-89X; 023-098-325-147-995; 023-731-947-341-566; 024-180-962-411-807; 025-778-427-975-523; 025-926-166-661-391; 026-334-077-299-586; 026-432-075-746-046; 027-194-089-162-258; 027-381-570-068-835; 028-102-666-434-678; 028-548-323-192-626; 028-895-401-836-404; 028-917-711-023-139; 030-058-616-020-983; 030-649-798-531-905; 031-956-711-891-198; 032-391-593-776-551; 033-329-547-485-170; 033-486-256-964-795; 033-551-608-364-717; 034-401-054-264-548; 035-495-603-935-129; 035-515-401-855-88X; 035-905-590-811-424; 035-929-046-884-124; 036-138-494-712-372; 036-231-790-486-871; 036-278-819-531-997; 036-337-234-192-472; 036-377-634-075-685; 037-420-062-106-112; 037-750-003-465-635; 038-055-212-967-801; 040-899-702-244-763; 041-233-361-042-754; 042-436-536-808-210; 042-808-418-130-511; 044-862-600-670-864; 045-308-749-441-881; 045-913-041-420-941; 046-105-694-259-439; 046-319-123-927-433; 046-424-669-316-495; 046-663-017-535-084; 047-011-069-572-840; 047-324-514-849-092; 048-747-376-086-808; 049-939-292-432-112; 050-280-038-935-390; 050-552-423-997-519; 050-557-676-967-513; 051-469-244-030-854; 051-545-056-610-327; 054-123-031-552-625; 054-746-344-048-551; 055-232-370-264-627; 055-380-926-366-069; 056-435-990-686-640; 057-106-793-047-881; 057-388-507-260-672; 057-645-226-553-537; 057-901-965-593-540; 060-190-278-812-019; 060-938-891-802-289; 060-959-999-721-07X; 061-126-975-516-020; 062-330-160-222-157; 062-572-435-435-701; 063-819-113-585-115; 064-320-310-808-895; 064-517-033-753-126; 064-918-491-644-549; 064-935-130-816-231; 066-141-965-154-959; 066-727-988-548-078; 066-980-488-397-807; 068-122-995-878-156; 068-448-469-103-115; 068-742-490-281-730; 069-491-833-181-778; 070-289-721-705-342; 070-421-144-062-652; 070-475-862-912-774; 071-093-994-903-557; 071-552-391-542-617; 071-805-654-097-133; 072-237-720-806-967; 072-292-617-923-614; 072-938-164-209-740; 073-245-562-977-205; 073-340-463-530-614; 073-861-878-251-872; 074-490-298-425-676; 075-217-560-298-756; 076-222-771-772-06X; 076-540-217-715-619; 078-759-400-571-800; 079-681-713-301-368; 079-858-099-032-663; 080-707-369-150-270; 081-174-036-283-283; 081-614-191-870-898; 082-664-409-512-404; 082-757-063-152-546; 084-177-309-656-43X; 085-825-102-694-470; 086-476-283-542-17X; 087-490-475-903-731; 087-937-609-506-941; 088-302-447-593-778; 089-171-470-356-841; 090-293-162-956-088; 091-022-827-490-721; 091-479-068-085-767; 092-001-846-828-031; 092-825-729-068-418; 093-033-710-130-542; 094-254-144-663-55X; 094-765-356-671-29X; 096-270-503-021-480; 096-717-846-747-361; 097-764-979-045-804; 097-885-120-994-581; 097-938-794-382-078; 098-187-195-814-969; 099-940-657-328-679; 100-550-876-109-556; 101-334-630-220-780; 101-457-358-185-567; 102-124-726-835-457; 105-327-910-445-327; 105-460-313-281-291; 105-640-268-484-169; 106-642-239-409-376; 106-916-603-991-098; 107-503-367-532-279; 108-310-729-212-770; 108-457-656-498-347; 108-458-557-726-484; 108-668-365-492-64X; 109-498-684-408-932; 109-888-195-434-121; 110-054-803-931-311; 110-808-049-802-582; 112-899-043-592-19X; 113-133-307-940-280; 114-128-066-618-564; 114-350-070-887-318; 114-693-925-367-292; 122-210-129-887-378; 124-430-150-591-392; 126-123-255-786-850; 128-868-640-709-121; 131-779-712-021-996; 134-622-006-258-420; 137-852-449-759-665; 139-453-970-904-397; 141-290-445-080-535; 142-666-725-132-474; 142-791-911-129-386; 144-733-633-818-76X; 144-756-646-322-490; 144-810-466-022-241; 144-956-842-764-081; 146-385-742-841-592; 148-637-732-182-686; 148-817-035-656-207; 150-024-002-209-525; 152-341-235-380-755; 152-876-959-220-336; 158-680-141-219-252; 160-387-549-522-545; 160-982-303-055-007; 162-683-655-155-151; 164-332-696-810-691; 164-940-754-152-703; 165-345-172-655-589; 170-901-950-802-393; 171-911-907-953-992; 173-136-810-733-414; 173-872-748-153-157; 175-143-247-703-854; 176-679-454-532-64X; 176-796-462-039-743; 177-792-271-996-469; 198-018-595-738-713; 198-998-766-357-840,24
012-038-515-176-259,Nanomaterials and Its Application for Clean Environment,,2018,book chapter,Nanomaterials for Green Energy,,Elsevier,,Bhaskar Bethi; Shirish H. Sonawane,"Abstract The increasing demand of safe and clean water pushes scientists to develop advanced treatment techniques to overcome the water scarcity problem. Scientists have developed different nanomaterials for the treatment of contaminated water. Nanomaterials play an important role in environmental remediation. Nanotechnology is an emerging technology in the field of wastewater treatment, and it effectively destroys/removes most of the recalcitrant organic pollutants and toxic compounds from wastewater. In this book chapter, the application of nanomaterials such as nanoadsorbents, namely bentonite nanoclay, polymer nanocomposite hydrogels, nanophotocatalysts such as bentonite nanoclay–TiO2, and titanium dioxide coupled with ultrasound/hydrodynamic cavitation is reported with few case studies for the removal of various organic pollutants such as dyes (crystal violet and basic methylene blue dye [CI 52015]) and phenol from wastewater. This book chapter also provides the basic knowledge to readers about the synthesis of different nanomaterials and their application in the field of wastewater treatment. The application of new ultrasound/sonochemical method for synthesis of nanomaterials was also reported.",,,385,409,Nanomaterials; Nanotechnology; Materials science; Titanium dioxide; Clean environment; Polymer nanocomposite; Environmental remediation; Sewage treatment; Pollutant; Wastewater,,,,,https://www.sciencedirect.com/science/article/pii/B9780128137314000126,http://dx.doi.org/10.1016/b978-0-12-813731-4.00012-6,,10.1016/b978-0-12-813731-4.00012-6,2802159693,,0,000-745-241-562-888; 001-223-343-516-784; 001-739-471-136-10X; 001-766-941-567-419; 001-856-679-648-991; 006-441-453-815-176; 008-177-478-467-713; 008-877-584-801-129; 010-998-103-861-87X; 011-195-719-082-169; 012-049-842-805-909; 012-298-762-325-558; 012-901-919-438-256; 013-981-596-622-647; 014-050-091-648-412; 014-196-917-247-642; 014-987-141-585-580; 015-483-142-872-730; 015-723-215-617-299; 017-308-525-618-451; 019-076-808-314-741; 021-530-293-479-473; 023-629-068-266-749; 024-400-529-615-931; 024-541-516-070-257; 027-129-630-864-477; 029-490-793-021-466; 033-849-860-293-748; 035-936-503-795-254; 038-298-259-159-840; 038-774-742-038-533; 039-192-490-051-665; 041-237-523-161-907; 041-944-730-302-402; 047-234-466-287-507; 047-691-927-290-666; 049-229-158-269-717; 053-851-858-326-73X; 059-826-140-743-220; 062-940-983-635-743; 063-350-586-464-350; 064-270-688-099-119; 065-392-973-784-264; 067-029-420-386-860; 067-323-124-527-590; 071-416-536-407-496; 071-718-674-598-28X; 076-856-428-128-140; 077-889-387-303-762; 080-216-552-431-314; 081-855-070-426-069; 081-999-380-058-102; 082-268-450-890-787; 086-193-742-177-352; 086-894-567-145-530; 091-387-821-756-842; 093-428-622-275-780; 093-544-805-413-486; 093-772-736-212-06X; 097-849-126-536-380; 098-354-597-981-626; 098-356-315-829-917; 099-825-690-963-988; 103-259-002-301-585; 104-663-506-359-845; 106-819-921-720-440; 112-504-108-280-594; 117-579-104-069-60X; 125-022-249-753-009; 126-263-835-741-792; 130-154-819-825-445; 134-509-113-568-868; 142-103-702-729-631; 143-875-563-170-191; 143-881-796-522-240; 154-704-729-892-593; 158-364-810-905-475; 166-227-064-678-029; 166-975-865-483-882; 172-186-988-577-630; 172-366-097-962-277; 175-314-625-008-095; 176-053-608-122-578; 179-263-493-194-129; 183-759-425-071-737,5
012-103-873-347-044,Nanomaterials for optical data storage,2016-10-11,2016,journal article,Nature Reviews Materials,20588437,Springer Science and Business Media LLC,,Min Gu; Qiming Zhang; Simone Lamon,"The growing amount of data that is generated every year creates an urgent need for new and improved data storage methods. Nanomaterials, which have unique mechanical, electronic and optical properties owing to the strong confinement of electrons, photons and phonons at the nanoscale, are enabling the development of disruptive methods for optical data storage with ultra-high capacity, ultra-long lifetime and ultra-low energy consumption. In this Review, we survey recent advancements in nanomaterials technology towards the next generation of optical data storage systems, focusing on metallic nanoparticles, graphene and graphene oxide, semiconductor quantum dots and rare-earth-doped nanocrystals. We conclude by discussing the use of nanomaterials in data storage systems that do not rely on optical mechanisms and by surveying the future prospects for the field. New solutions are needed to meet the growing demand for data storage systems with ultra-high capacity, ultra-long lifetime and ultra-low energy consumption. Nanomaterials, including metal nanoparticles, graphene and graphene oxide, semiconductor quantum dots and rare-earth-doped nanocrystals, hold promise for the next generation of optical data storage methods.",1,12,16070,,3D optical data storage; Nanomaterials; Photon; Nanotechnology; Nanocrystal; Materials science; Computer data storage; Photonics; Energy consumption; Graphene,,,,,https://www.nature.com/articles/natrevmats201670.pdf http://ui.adsabs.harvard.edu/abs/2016NatRM...116070G/abstract https://nature.com/articles/natrevmats201670,http://dx.doi.org/10.1038/natrevmats.2016.70,,10.1038/natrevmats.2016.70,2530194892,,0,000-838-553-617-756; 003-186-864-037-060; 003-265-567-369-101; 003-405-500-949-103; 003-641-664-348-587; 005-269-547-576-921; 005-488-809-445-543; 006-486-667-801-916; 008-416-523-740-682; 008-487-728-057-682; 008-842-543-277-447; 010-531-436-285-357; 011-505-245-313-789; 012-807-591-391-35X; 016-158-791-788-237; 016-775-668-645-955; 017-475-424-540-243; 018-314-370-999-030; 019-796-370-564-302; 021-720-750-975-235; 021-855-192-205-428; 022-509-086-907-471; 024-435-836-718-447; 024-445-383-365-288; 026-079-953-298-896; 027-051-004-798-743; 027-343-076-561-395; 027-778-826-544-993; 029-209-596-635-461; 029-300-029-558-129; 030-288-345-339-047; 031-241-811-918-715; 033-555-539-369-351; 034-438-054-439-562; 035-134-183-500-546; 035-369-066-023-011; 036-394-789-496-403; 037-831-963-984-189; 037-887-946-304-797; 038-799-480-168-928; 039-716-494-406-843; 043-417-281-361-260; 044-097-349-704-191; 044-330-295-670-94X; 044-376-761-094-411; 044-573-786-477-876; 047-006-220-990-863; 047-351-343-147-486; 047-795-246-473-316; 051-036-361-157-033; 052-050-716-550-086; 054-559-196-756-404; 055-357-361-080-905; 056-218-978-515-901; 059-479-568-508-084; 059-517-964-838-637; 059-610-246-322-739; 062-329-963-540-484; 062-581-246-203-658; 062-606-119-955-484; 063-077-578-923-030; 064-059-929-337-197; 065-103-419-259-91X; 066-727-988-548-078; 067-342-089-070-110; 068-047-400-899-242; 069-200-497-739-732; 069-678-828-150-571; 070-158-879-688-271; 076-546-076-727-25X; 077-769-020-718-826; 078-158-580-925-210; 078-427-744-041-669; 079-953-619-802-293; 080-956-069-504-927; 085-734-949-462-057; 085-807-791-650-73X; 086-746-515-175-565; 097-395-008-967-768; 098-133-414-381-961; 098-545-257-009-816; 099-940-657-328-679; 100-348-095-135-445; 100-383-581-417-695; 100-847-711-169-929; 101-969-519-911-240; 102-235-903-027-015; 106-340-922-940-619; 106-493-481-497-443; 108-151-613-248-354; 110-591-814-449-532; 111-233-619-604-177; 113-758-049-230-859; 117-243-299-679-707; 121-217-678-641-165; 125-147-859-566-189; 126-355-167-998-311; 127-859-041-942-916; 128-419-199-392-106; 135-381-470-620-616; 141-464-522-682-917; 141-523-808-623-557; 149-683-292-806-988; 150-604-538-120-132; 168-810-520-428-922; 188-378-073-629-567; 197-333-071-338-587; 197-390-595-018-892; 199-523-080-147-467,129
012-274-995-892-67X,Nanomaterials for Advanced Analytical Applications in Chemo- and Biosensors,2019-03-15,2019,book chapter,Environmental Chemistry for a Sustainable World,22137114; 22137122,Springer International Publishing,,S. Devi; Vairaperumal Tharmaraj,"Nanomaterials with unique optical properties and biocompatibility have been widely employed for designing and fabricating highly selective and sensitive nanosensors for the detection of various chemical and biological species. The development of nanomaterial-based chemo- and biosensors is studied usually under direct spectroscopic and reagent-mediated sensor platforms using both unmodified and surface-functionalized nanomaterials. This chapter mainly focuses on selective sensing of chemical and biological molecules using various types of nanomaterials. The main readouts are absorption (colorimetric, UV-visible), fluorescence, Raman/SERS spectroscopic, and electrochemical sensing techniques. The detailed discussion on the design of nanomaterial-based sensing systems, sensing principle, sensing method, and their signaling mechanisms has been provided. The sensing systems can also be ideally utilized for real-time applications.",,,91,110,Nanomaterials; Biosensor; Nanotechnology; Materials science; Biocompatibility; Sensing system; Biological species; Highly selective; Nanosensor; Biomolecule,,,,,https://link.springer.com/chapter/10.1007%2F978-3-030-04477-0_4,http://dx.doi.org/10.1007/978-3-030-04477-0_4,,10.1007/978-3-030-04477-0_4,2920866321,,0,000-200-221-216-419; 000-820-477-597-072; 002-526-603-394-125; 003-242-084-827-735; 006-127-406-201-379; 006-792-267-974-098; 007-556-035-195-476; 010-048-650-943-429; 010-316-172-400-136; 010-506-065-629-290; 011-543-764-054-667; 012-195-007-699-909; 012-768-185-140-839; 013-580-318-147-439; 014-125-746-361-556; 014-286-034-228-340; 015-744-282-876-349; 016-204-647-264-900; 016-670-742-869-869; 016-869-130-634-047; 017-187-358-692-153; 018-221-655-471-288; 018-902-074-469-271; 019-295-436-398-20X; 020-650-966-017-354; 020-986-972-037-860; 024-338-782-445-02X; 025-174-598-948-557; 025-737-622-338-457; 025-755-777-871-298; 027-936-176-282-100; 032-522-699-804-052; 034-959-718-659-204; 035-842-190-793-866; 038-303-653-586-705; 041-247-704-634-741; 042-375-288-995-929; 043-301-723-236-340; 049-660-771-347-283; 050-276-671-234-336; 053-465-681-124-263; 053-653-769-927-210; 053-844-026-847-457; 054-791-281-945-898; 056-267-254-030-563; 058-673-474-041-148; 059-405-444-651-522; 059-419-760-970-821; 061-136-654-944-947; 062-454-667-944-890; 067-756-504-917-631; 067-951-996-924-216; 072-342-349-249-346; 072-635-395-112-817; 076-596-110-512-398; 079-095-435-687-624; 080-031-647-499-10X; 081-985-972-110-704; 086-275-469-243-388; 088-364-258-665-043; 090-608-326-968-805; 093-325-678-830-18X; 099-655-124-697-209; 100-345-396-505-530; 101-283-029-010-996; 101-528-014-826-688; 105-370-620-669-553; 105-471-563-430-96X; 105-996-218-453-310; 107-279-184-222-928; 109-408-678-098-577; 125-958-410-422-707; 130-276-924-714-435; 130-469-714-558-746; 139-126-857-313-108; 146-390-727-906-171; 153-222-149-917-389; 156-631-705-027-835; 163-092-730-245-221; 163-096-773-978-167; 193-604-822-684-429,0
012-306-484-748-725,Toxicity of nanomaterials,2011-12-14,2011,journal article,Chemical Society reviews,14604744; 03060012,Royal Society of Chemistry,United Kingdom,Shahriar Sharifi; Shahed Behzadi; Sophie Laurent; M. Laird Forrest; Pieter Stroeve; Morteza Mahmoudi,"Nanoscience has matured significantly during the last decade as it has transitioned from bench top science to applied technology. Presently, nanomaterials are used in a wide variety of commercial products such as electronic components, sports equipment, sun creams and biomedical applications. There are few studies of the long-term consequences of nanoparticles on human health, but governmental agencies, including the United States National Institute for Occupational Safety and Health and Japan's Ministry of Health, have recently raised the question of whether seemingly innocuous materials such as carbon-based nanotubes should be treated with the same caution afforded known carcinogens such as asbestos. Since nanomaterials are increasing a part of everyday consumer products, manufacturing processes, and medical products, it is imperative that both workers and end-users be protected from inhalation of potentially toxic NPs. It also suggests that NPs may need to be sequestered into products so that the NPs are not released into the atmosphere during the product's life or during recycling. Further, non-inhalation routes of NP absorption, including dermal and medical injectables, must be studied in order to understand possible toxic effects. Fewer studies to date have addressed whether the body can eventually eliminate nanomaterials to prevent particle build-up in tissues or organs. This critical review discusses the biophysicochemical properties of various nanomaterials with emphasis on currently available toxicology data and methodologies for evaluating nanoparticle toxicity (286 references).",41,6,2323,2343,Risk analysis (engineering); Nanomaterials; Business; Nanotechnology; sports equipment; Human health; Titanium dioxide nanoparticles; In vivo biodistribution; Christian ministry,,Animals; Catalysis; Free Radicals/chemistry; Humans; Nanostructures/chemistry; Reactive Oxygen Species/chemistry,Free Radicals; Reactive Oxygen Species,NIGMS NIH HHS (P20 GM103418) United States; NCI NIH HHS (R01 CA173292) United States,https://pubs.rsc.org/en/content/articlelanding/2012/cs/c1cs15188f#! https://pubag.nal.usda.gov/catalog/6613518 https://kuscholarworks.ku.edu/handle/1808/23227 https://www.rug.nl/research/portal/en/publications/toxicity-of-nanomaterials(691ae3e0-3cd8-443f-9b3e-f0cc953e42c7).html http://dx.doi.org/10.1039%2Fc1cs15188f https://core.ac.uk/display/92661885 http://pubs.rsc.org/en/content/articlelanding/2012/cs/c1cs15188f https://www.europepmc.org/articles/PMC4703119/ https://www.narcis.nl/publication/RecordID/oai%3Apure.rug.nl%3Apublications%2F691ae3e0-3cd8-443f-9b3e-f0cc953e42c7 https://research.rug.nl/en/publications/toxicity-of-nanomaterials https://kuscholarworks.ku.edu/bitstream/1808/23227/1/forrest_toxicity.pdf https://dx.doi.org/10.1039%2Fc1cs15188f http://xlink.rsc.org/?DOI=C1CS15188F https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703119/ http://pubs.rsc.org/en/content/articlepdf/2012/CS/C1CS15188F,http://dx.doi.org/10.1039/c1cs15188f,22170510,10.1039/c1cs15188f,1984753398,PMC4703119,1,000-041-213-742-050; 000-107-847-200-535; 000-573-796-170-484; 000-672-679-241-486; 001-379-722-240-897; 002-901-082-448-846; 003-590-691-106-471; 003-609-432-212-381; 003-924-224-395-654; 004-208-947-021-882; 004-729-739-817-732; 004-790-168-854-347; 006-112-146-521-103; 006-130-201-157-025; 006-581-035-617-796; 006-938-773-370-157; 007-172-725-597-63X; 007-237-421-393-819; 007-367-257-630-602; 007-618-461-614-945; 007-620-472-680-879; 007-648-310-394-823; 008-026-084-779-329; 008-069-825-434-169; 009-182-283-373-787; 009-456-342-310-432; 009-592-459-038-504; 009-740-188-959-644; 009-826-583-611-258; 009-865-750-516-963; 010-081-927-718-051; 010-544-724-684-160; 010-570-405-463-933; 010-594-529-718-631; 010-638-378-520-055; 010-781-987-695-143; 010-979-721-167-89X; 011-256-358-392-263; 011-315-891-733-81X; 011-405-260-740-510; 011-672-668-976-937; 012-090-501-847-347; 012-427-065-033-670; 012-868-864-795-27X; 013-198-881-159-458; 014-406-144-108-271; 014-495-664-939-818; 014-939-476-607-263; 015-427-478-265-217; 015-827-492-981-765; 015-994-732-809-648; 016-658-934-283-57X; 016-734-834-369-036; 016-920-837-111-769; 017-077-548-439-944; 017-711-193-525-020; 017-733-816-345-85X; 017-957-143-201-554; 018-341-951-827-038; 019-024-860-219-464; 019-035-179-182-465; 019-299-754-950-168; 020-357-860-791-170; 020-378-991-041-17X; 020-752-508-998-48X; 020-782-157-972-911; 020-791-427-103-113; 021-240-216-096-000; 021-538-895-708-655; 021-863-160-617-313; 022-163-030-913-092; 022-836-431-302-827; 023-434-709-343-194; 023-597-860-207-992; 023-980-201-370-368; 024-119-668-050-26X; 024-391-762-181-074; 024-583-470-646-438; 024-590-629-109-147; 024-704-667-371-800; 025-010-576-105-160; 025-329-017-123-244; 025-382-747-590-71X; 026-104-978-126-590; 026-501-477-662-765; 026-990-617-458-329; 027-188-985-361-895; 027-344-707-657-09X; 027-458-537-435-691; 028-447-169-539-026; 028-467-394-897-784; 029-350-475-031-322; 029-850-342-521-310; 029-851-211-591-639; 029-869-351-189-911; 029-942-543-329-665; 029-968-478-433-92X; 030-497-011-651-517; 030-673-713-512-036; 030-934-624-291-158; 031-633-185-596-546; 031-643-677-934-66X; 031-887-855-479-032; 032-162-023-323-260; 032-382-262-966-161; 032-672-997-250-91X; 032-816-661-064-654; 033-261-421-776-628; 033-671-953-849-105; 034-289-299-047-026; 034-459-653-644-78X; 035-384-771-433-142; 035-649-970-971-454; 035-883-712-822-136; 035-919-228-575-462; 036-332-331-649-70X; 036-628-436-704-114; 037-559-465-893-09X; 037-949-122-271-110; 038-430-424-220-074; 039-079-455-504-396; 039-962-603-841-371; 040-501-328-435-398; 040-641-088-971-611; 041-871-944-415-926; 041-893-864-767-662; 042-005-763-245-281; 042-166-139-469-166; 042-281-633-258-640; 042-739-592-705-978; 043-881-289-670-016; 044-248-524-774-951; 044-930-790-682-058; 046-358-862-322-210; 047-379-524-130-629; 047-759-321-403-417; 047-830-981-006-184; 047-857-180-956-040; 048-251-062-203-021; 048-263-431-180-274; 048-399-088-620-158; 048-817-046-806-72X; 048-874-176-840-943; 049-100-882-186-19X; 049-704-398-407-63X; 049-930-443-374-765; 050-011-101-462-472; 050-238-175-002-117; 050-867-709-305-473; 050-956-400-958-200; 051-215-056-781-95X; 051-425-605-501-021; 051-481-940-647-956; 052-061-515-757-260; 052-159-229-101-426; 052-366-933-468-039; 052-898-806-543-347; 053-080-572-641-336; 053-371-374-720-682; 054-113-129-198-59X; 054-461-141-830-413; 054-494-462-139-093; 054-884-651-646-426; 055-134-703-769-289; 055-165-874-363-170; 055-921-408-762-204; 057-166-616-681-595; 058-646-060-582-290; 059-150-974-990-618; 059-516-311-187-983; 059-784-196-336-306; 060-421-684-364-704; 061-079-168-629-919; 061-423-515-504-222; 061-813-389-495-495; 061-992-525-130-260; 062-741-216-396-356; 062-993-504-443-349; 063-168-835-144-681; 064-161-867-482-719; 064-910-341-675-597; 064-957-606-328-450; 065-075-192-716-93X; 066-144-507-830-191; 066-819-359-612-24X; 067-310-717-296-895; 067-725-485-039-746; 067-732-975-240-712; 067-974-525-427-186; 068-208-623-552-806; 069-429-492-229-456; 070-775-687-325-269; 070-962-523-284-118; 071-755-503-458-648; 072-828-147-767-081; 073-124-852-575-043; 073-925-756-823-676; 074-503-933-888-726; 074-565-376-197-298; 074-660-736-899-10X; 075-758-250-780-434; 076-151-027-399-783; 077-670-128-744-583; 077-978-826-651-924; 078-091-999-689-76X; 078-252-623-750-74X; 078-650-068-179-268; 079-660-056-922-275; 079-880-120-853-871; 081-303-451-170-436; 082-512-666-548-499; 083-790-892-560-732; 083-910-159-234-858; 084-220-333-182-861; 084-778-286-968-118; 086-491-388-111-128; 088-135-814-991-431; 089-013-662-093-528; 090-045-625-379-502; 090-284-949-583-671; 091-411-906-938-351; 091-659-917-833-511; 091-882-511-165-375; 091-935-872-852-708; 094-377-725-226-390; 094-970-000-847-023; 095-134-643-924-830; 095-136-685-812-764; 095-732-706-324-77X; 096-307-500-362-737; 096-646-466-395-872; 096-987-221-456-011; 097-401-583-946-611; 098-126-229-267-520; 098-693-697-713-73X; 100-159-456-161-92X; 101-669-933-335-870; 103-488-845-623-282; 105-710-397-258-476; 106-041-664-455-089; 107-034-552-871-142; 107-087-739-556-993; 108-886-617-784-602; 108-962-833-460-33X; 110-043-871-130-184; 110-379-518-580-458; 110-690-378-554-697; 110-741-449-798-822; 111-361-666-578-537; 112-183-380-411-309; 112-965-155-948-595; 112-990-824-814-530; 113-599-541-422-398; 114-807-794-083-160; 115-148-448-030-912; 116-205-689-204-076; 116-283-002-321-705; 116-517-968-247-514; 117-103-583-115-154; 117-478-364-808-760; 120-068-226-417-514; 123-384-739-369-97X; 123-526-095-108-395; 125-908-326-174-645; 129-848-931-465-989; 130-014-653-118-18X; 130-822-050-261-863; 132-761-346-761-10X; 133-753-797-968-00X; 136-510-871-760-761; 137-197-250-958-394; 139-752-283-372-886; 139-800-181-799-92X; 142-324-477-082-18X; 142-325-179-186-284; 143-396-598-191-576; 143-453-578-365-477; 145-649-462-545-537; 146-362-803-998-285; 146-417-678-197-301; 146-849-760-353-595; 148-615-439-976-228; 152-047-288-777-089; 152-564-856-801-143; 153-961-499-699-026; 153-982-841-342-528; 159-529-189-273-615; 159-562-848-251-423; 164-000-189-844-634; 164-331-223-018-931; 164-779-098-660-815; 168-702-224-467-339; 170-441-368-501-726; 172-089-412-314-542; 173-299-931-419-831; 177-906-892-019-161; 181-871-250-300-813; 184-352-343-109-617; 196-545-392-493-092,965
012-318-759-639-156,Perovskite ferroelectric nanomaterials,2013-08-05,2013,journal article,Nanoscale,20403372; 20403364,Royal Society of Chemistry,United Kingdom,Nurxat Nuraje; Kai Su,"In this review, the main concept of ferroelectricity of perovskite oxides and related materials at nanometer scale and existing difficulties in the synthesis of those nanocrystals are discussed. Important effects, such as depolarization field and size effect, on the existence of ferroelectricity in perovskite nanocrystals are deliberated. In the discussion of modeling works, different theoretical calculations are pinpointed focusing on their studies of lattice dynamics, phase transitions, new origin of ferroelectricity in nanostructures, etc. As the major part of this review, recent research progress in the facile synthesis, characterization and various applications of perovskite ferroelectric nanomaterials, such as BaTiO₃, PbTiO₃, PbZrO₃, and BiFeO₃, are also scrutinized. Perspectives concerning the future direction of ferroelectric nanomaterials research and its potential applications in renewable energy, etc., are presented. This review provides an overview in this area and guidance for further studies in perovskite ferroelectric nanomaterials and their applications.",5,19,8752,8780,Nanomaterials; Phase transition; Perovskite (structure); Nanotechnology; Materials science; Characterization (materials science); Lattice dynamics; Ferroelectricity,,,,,https://ui.adsabs.harvard.edu/abs/2013Nanos...5.8752N/abstract https://pubs.rsc.org/en/content/articlelanding/2013/NR/C3NR02543H http://www.ncbi.nlm.nih.gov/pubmed/23912964 http://europepmc.org/abstract/MED/23912964 http://pubs.rsc.org/en/content/articlelanding/2013/nr/c3nr02543h#!,http://dx.doi.org/10.1039/c3nr02543h,23912964,10.1039/c3nr02543h,2165429900,,2,001-133-509-085-883; 002-290-625-004-45X; 002-334-640-994-721; 003-028-369-267-72X; 003-129-712-484-848; 003-259-775-245-508; 003-299-162-391-541; 003-510-582-150-892; 004-270-344-595-374; 004-374-692-294-937; 004-857-189-772-395; 005-222-627-628-738; 005-452-442-420-061; 005-587-947-304-910; 005-839-539-412-849; 005-864-910-919-690; 005-980-515-459-864; 006-104-299-720-47X; 006-246-571-144-373; 006-317-421-929-891; 006-543-353-398-333; 006-949-637-740-508; 007-273-000-746-952; 007-298-050-230-808; 007-449-251-024-600; 007-923-721-842-292; 008-329-266-391-083; 008-378-462-085-244; 008-678-948-009-836; 009-022-328-096-849; 009-080-092-390-659; 009-114-589-246-495; 009-668-227-563-869; 009-753-922-153-163; 009-832-759-485-218; 009-915-402-318-04X; 010-166-317-044-822; 010-301-718-473-328; 010-710-537-049-648; 010-777-857-569-307; 010-963-702-406-65X; 010-977-484-162-69X; 011-214-967-867-61X; 011-705-180-719-847; 011-717-247-704-681; 012-809-435-127-468; 013-633-328-262-429; 013-753-341-108-65X; 013-775-755-184-107; 013-993-003-915-726; 014-602-148-245-159; 015-009-368-202-926; 015-313-929-066-896; 015-703-508-830-546; 015-952-287-628-922; 016-000-357-212-390; 016-068-975-410-344; 016-601-365-348-929; 016-604-348-354-693; 016-642-967-695-275; 017-142-920-564-249; 017-277-336-786-879; 017-296-874-197-100; 017-786-002-442-22X; 018-197-221-916-625; 018-514-642-487-677; 018-689-692-633-219; 018-896-351-453-457; 018-981-904-871-197; 021-236-302-222-593; 021-256-354-425-876; 021-643-042-778-920; 021-693-590-059-615; 022-707-706-266-896; 022-773-121-268-285; 024-663-562-450-707; 025-423-754-742-353; 025-524-228-315-75X; 026-868-475-932-515; 026-999-547-650-729; 027-180-013-396-78X; 027-535-120-782-598; 027-711-343-920-070; 027-846-592-171-056; 027-848-445-362-986; 028-095-864-645-684; 028-183-664-611-148; 028-392-920-910-552; 028-478-331-235-752; 028-873-740-938-109; 029-030-054-724-865; 029-196-351-940-070; 029-259-166-253-135; 029-262-677-624-687; 029-478-406-590-027; 029-498-255-150-072; 029-610-955-533-872; 029-985-306-155-737; 030-116-772-243-209; 030-217-549-766-544; 030-475-285-006-710; 030-497-445-583-435; 031-468-846-050-457; 031-727-864-106-067; 031-753-035-474-494; 031-806-273-661-507; 031-841-128-571-066; 032-887-285-916-531; 033-378-153-448-183; 034-290-965-709-473; 034-684-839-502-983; 035-009-613-602-268; 035-246-842-187-546; 035-741-416-570-647; 035-916-549-540-769; 036-265-254-212-864; 036-284-005-004-865; 036-512-719-227-499; 036-722-251-410-452; 037-062-680-071-714; 037-106-506-827-311; 037-135-804-278-157; 037-144-752-374-159; 037-370-335-822-550; 037-843-545-374-415; 038-153-232-838-846; 038-461-543-748-842; 038-693-915-148-083; 038-707-142-426-591; 038-724-457-998-37X; 038-927-741-554-493; 039-342-921-306-676; 039-980-548-794-603; 040-008-590-845-553; 040-297-816-513-636; 040-409-533-286-879; 040-453-285-646-617; 041-373-485-595-427; 041-420-552-630-86X; 041-946-874-927-646; 042-318-865-660-731; 042-731-859-183-843; 042-871-392-319-675; 043-042-529-732-021; 043-149-140-135-341; 043-692-432-921-939; 043-713-987-227-14X; 044-077-136-502-870; 044-426-781-244-15X; 044-495-517-334-745; 044-500-531-075-720; 044-594-551-122-424; 044-739-444-784-531; 044-755-062-283-598; 044-808-732-280-860; 045-023-925-486-802; 045-073-761-389-584; 046-129-634-606-503; 046-993-847-964-787; 047-079-019-976-397; 047-553-947-208-572; 047-820-643-061-691; 047-892-871-766-709; 048-571-984-613-863; 048-885-260-377-406; 049-020-697-021-203; 049-070-602-227-766; 049-666-127-795-074; 049-922-318-785-442; 050-147-545-315-580; 050-364-200-670-027; 050-378-063-223-438; 050-427-954-539-696; 050-715-477-673-046; 050-723-572-798-373; 050-815-677-316-025; 051-417-064-290-371; 051-757-035-439-537; 052-209-254-683-061; 052-697-440-827-079; 053-109-574-535-912; 054-305-995-401-335; 054-934-625-690-207; 055-480-419-755-957; 056-746-519-663-509; 057-468-702-540-645; 057-936-416-411-249; 057-983-239-056-443; 058-546-968-903-13X; 059-634-792-776-275; 059-855-119-219-638; 060-176-392-302-759; 060-355-068-598-926; 060-764-261-360-669; 061-589-425-387-544; 061-889-897-147-658; 062-076-429-376-685; 062-944-337-664-388; 062-977-426-821-593; 063-161-490-137-029; 063-653-187-320-833; 065-243-036-904-971; 065-268-804-534-215; 066-160-566-373-955; 067-161-428-576-173; 067-512-908-897-576; 067-605-297-233-406; 067-630-185-526-591; 068-068-538-754-129; 068-585-726-712-511; 068-740-099-900-624; 068-866-258-385-02X; 071-145-199-396-113; 071-428-878-045-649; 072-270-886-290-993; 072-470-676-149-250; 072-777-361-913-409; 072-875-687-436-947; 072-961-331-043-756; 073-413-152-181-976; 073-591-501-510-152; 073-607-633-381-392; 074-477-716-621-199; 074-907-784-432-426; 075-228-612-236-287; 075-719-831-560-075; 076-511-086-109-113; 077-613-268-323-050; 078-769-451-452-245; 080-516-239-308-701; 081-873-162-550-066; 083-561-563-250-54X; 084-246-736-295-460; 085-353-583-112-263; 085-485-530-919-316; 085-717-654-637-898; 086-100-245-112-210; 086-208-765-164-297; 086-706-896-245-144; 086-777-637-129-999; 088-088-224-655-068; 088-292-323-640-513; 088-772-188-847-88X; 088-929-609-955-006; 088-979-767-330-584; 089-757-882-983-92X; 090-410-678-133-090; 091-879-359-178-384; 092-007-996-274-14X; 095-405-825-608-064; 096-511-725-883-291; 097-110-955-378-046; 097-382-149-885-202; 097-867-092-378-79X; 097-938-360-921-994; 098-236-173-848-998; 099-570-294-478-356; 101-045-186-605-607; 101-558-430-406-129; 101-957-337-012-254; 102-008-782-551-020; 103-037-765-770-925; 104-242-561-310-141; 104-536-984-431-512; 104-916-937-740-181; 105-468-920-383-78X; 105-475-682-816-388; 105-560-174-359-56X; 105-689-591-468-422; 106-300-681-550-356; 106-368-135-458-465; 106-461-562-491-266; 106-916-911-018-468; 107-188-045-880-492; 107-368-994-329-035; 107-393-620-246-395; 107-724-495-381-03X; 107-990-100-351-170; 108-010-564-784-716; 109-472-491-516-798; 109-786-302-099-000; 110-915-790-344-24X; 110-974-077-780-206; 111-088-782-601-330; 111-129-543-868-845; 111-140-343-842-373; 113-013-666-205-492; 113-243-635-433-752; 113-712-046-280-435; 113-731-245-984-922; 115-778-295-734-797; 115-823-936-438-833; 115-911-765-652-885; 116-644-218-127-953; 117-218-234-822-15X; 118-488-656-747-037; 118-720-677-602-009; 120-391-482-644-003; 121-160-690-407-481; 122-245-826-563-66X; 124-574-936-665-966; 124-732-801-269-350; 126-003-848-669-469; 126-879-270-937-645; 127-445-076-923-029; 128-164-107-778-203; 129-362-979-521-660; 130-779-466-258-456; 132-903-976-836-365; 132-962-478-695-731; 133-921-842-421-637; 134-967-380-310-851; 134-972-384-728-16X; 136-126-767-240-604; 138-958-369-357-158; 139-433-462-077-593; 140-202-003-063-587; 141-132-181-434-42X; 143-263-316-995-500; 144-564-934-692-502; 145-486-824-468-820; 149-642-398-397-595; 150-290-945-300-051; 150-637-256-779-714; 150-658-983-768-045; 152-042-977-527-859; 152-045-639-344-658; 153-975-866-748-270; 157-210-830-632-568; 165-371-860-414-542; 166-130-825-801-239; 166-203-841-966-943; 167-517-524-445-691; 167-586-273-015-011; 171-891-754-966-403; 172-278-440-974-428; 173-084-645-174-02X; 174-667-472-912-565; 176-918-312-074-132; 180-404-033-529-671; 189-457-971-193-226; 191-831-519-850-575; 196-291-522-622-888; 199-905-765-105-36X,133
012-434-099-106-36X,Antitumor therapy using nanomaterial-mediated thermolysis.,2014-09-01,2014,journal article,Journal of biomedical nanotechnology,15507033,American Scientific Publishers,United States,Alicia J. Sawdon; Ethan Weydemeyer; Ching-An Peng,"Nanomaterial-based systems present several novel therapeutic opportunities for cancer therapy based solely upon their unique physical and chemical properties. Despite advances in current cancer treatment, collateral damage to neighboring healthy tissues still cannot be avoided. By exploiting the strong optical and/or electromagnetic properties offered by nanomaterials, they are being employed as thermal nanoscalpels for the ablation of cancer cells. Through surface functionalization, these nanomaterials can be specifically targeted to tumorous tissue allowing for an increase in therapeutic potential and reduction in side effects. Moreover, these features provide nanomaterials with a tunable surface which can be used to modify optical, magnetic, thermal and mechanical properties. This review highlights carbon nanomaterials, nanogolds, magnetic nanoparticles and emerging hybrids applied for the thermolysis of cancer cells.",10,9,1894,1917,Surface modification; Nanomaterials; Thermal decomposition; Nanotechnology; Materials science; Cancer therapy; Collateral damage; Antitumor therapy; Magnetic nanoparticles; Cancer cell,,"Animals; Antineoplastic Agents/therapeutic use; Carbon/chemistry; Gold/chemistry; Humans; Hyperthermia, Induced; Magnetite Nanoparticles/chemistry; Nanostructures/chemistry",Antineoplastic Agents; Magnetite Nanoparticles; Carbon; Gold,,https://www.ncbi.nlm.nih.gov/pubmed/25992445 http://openurl.ingenta.com/content/xref?genre=article&issn=1550-7033&volume=10&issue=9&spage=1894,http://dx.doi.org/10.1166/jbn.2014.1917,25992445,10.1166/jbn.2014.1917,2326083866,,0,,10
012-454-078-041-606,Risk assessment strategies as nanomaterials transition into commercial applications,2012-03-14,2012,journal article,Journal of Nanoparticle Research,13880764; 1572896x,Springer Science and Business Media LLC,Netherlands,Mira S. Olson; Patrick L. Gurian,"Commercial applications of nanomaterials are rapidly emerging in the marketplace. The environmental and human health risks of many nanomaterials remain unknown, and prioritizing how to efficiently assess their risks is essential. As nanomaterials are incorporated into a broader range of commercial products, their potential for environmental release and human exposure not only increases, but also becomes more difficult to model accurately. Emphasis may first be placed on estimating potential environmental exposure based on pertinent physical properties of the nanomaterials. Given that the greatest potential for global environmental impacts results from nanomaterials that are both persistent and toxic, this paper advocates screening first for persistence since it is easier to assess than toxicity. For materials that show potential for persistence, a higher burden of proof of their non-toxicity is suggested before they enter the commercial marketplace whereas a lower burden of proof may be acceptable for nanomaterials that are less persistent.",14,4,786,,Risk analysis (engineering); Risk assessment; Nanomaterials; Nanotechnology; Materials science; Burden of proof; Environmental exposure; Human health; Human exposure,,,,,https://rd.springer.com/article/10.1007/s11051-012-0786-8 https://ui.adsabs.harvard.edu/abs/2012JNR....14..786O/abstract https://link.springer.com/article/10.1007%2Fs11051-012-0786-8,http://dx.doi.org/10.1007/s11051-012-0786-8,,10.1007/s11051-012-0786-8,1977345405,,0,005-588-798-016-329; 013-079-906-360-851; 018-042-411-992-69X; 023-697-251-211-011; 032-421-729-075-469; 032-444-971-301-50X; 035-629-739-087-748; 043-002-155-619-043; 047-773-431-676-759; 051-101-646-160-955; 053-131-841-667-292; 066-818-198-602-766; 066-903-772-666-091; 067-603-942-502-295; 068-984-448-091-994; 081-693-198-670-600; 106-827-989-969-63X; 113-838-095-049-989; 132-573-733-070-300,26
012-504-940-134-557,Liquid-liquid Interfacial Synthesis of Nanomaterials,,2014,journal article,Chinese Journal of Applied Chemistry,10000518,,,Zhao Hail,"Recently,the liquid-liquid interfacial synthesis is emerging as an efficient strategy for the preparation of nanomaterials,which exhibits several outstanding characteristics: mild,inexpensive,convenient and template-free. Owing to the unusual physicochemical properties,the liquid-liquid interface possesses unique advantages in the synthesis of nanomaterials and thin films. In this paper,the recent advances in the preparation of nanomaterials at the liquid-liquid interface were reviewed in details. By applying this simple strategy,a variety of nanomaterials were easily obtained,including metal,metal oxides,metal chalcogenides,polymers,heterodimers,and metal-organic frameworks. Particularly,the new protocol of ""tunable ionic liquids-H2 O interfacial synthesis""was commented. Finally,the advantages and problems in the liquid-liquid interfacial synthesis of nanomaterials were also discussed,and the future development in this research area was presented.",,,,,Nanomaterials; Nanotechnology; Chemistry; Thin film; Ionic bonding; Metal chalcogenides; Liquid liquid; Polymer,,,,,http://en.cnki.com.cn/Article_en/CJFDTOTAL-YYHX201409003.htm,http://en.cnki.com.cn/Article_en/CJFDTOTAL-YYHX201409003.htm,,,3149425101,,0,,0
012-586-183-094-958,Applications of nanomaterials as vaccine adjuvants,2014-09-02,2014,journal article,Human vaccines & immunotherapeutics,2164554x; 21645515,Landes Bioscience,United States,Motao Zhu; Rongfu Wang; Guangjun Nie,"Vaccine adjuvants are applied to amplify the recipient's specific immune responses against pathogen infection or malignancy. A new generation of adjuvants is being developed to meet the demands for more potent antigen-specific responses, specific types of immune responses, and a high margin of safety. Nanotechnology provides a multifunctional stage for the integration of desired adjuvant activities performed by the building blocks of tailor-designed nanoparticles. Using nanomaterials for antigen delivery can provide high bioavailability, sustained and controlled release profiles, and targeting and imaging properties resulting from manipulation of the nanomaterials' physicochemical properties. Moreover, the inherent immune-regulating activity of particular nanomaterials can further promote and shape the cellular and humoral immune responses toward desired types. The combination of both the delivery function and immunomodulatory effect of nanomaterials as adjuvants is thought to largely benefit the immune outcomes of vaccination. In this review, we will address the current achievements of nanotechnology in the development of novel adjuvants. The potential mechanisms by which nanomaterials impact the immune responses to a vaccine and how physicochemical properties, including size, surface charge and surface modification, impact their resulting immunological outcomes will be discussed. This review aims to provide concentrated information to promote new insights for the development of novel vaccine adjuvants.",10,9,2761,2774,Nanomaterials; Nanotechnology; Immunology; Vaccination; Adjuvant; Antigen delivery; Margin of safety; Vaccine adjuvant; Medicine; Immune system,antigen delivery; immune response; nanomaterials; nanotechnology; vaccine adjuvant,"Adjuvants, Immunologic/administration & dosage; Animals; Drug Carriers/administration & dosage; Humans; Nanostructures/administration & dosage; Vaccines/administration & dosage","Adjuvants, Immunologic; Drug Carriers; Vaccines",,https://scholars.houstonmethodist.org/en/publications/applications-of-nanomaterials-as-vaccine-adjuvants https://europepmc.org/article/MED/25483497 https://scholars.houstonmethodist.org/en/publications/applications-of-nanomaterials-as-vaccine-adjuvants(381d1d36-d93e-448e-8c2f-e9758520faab).html https://www.tandfonline.com/doi/full/10.4161/hv.29589 http://www.ncbi.nlm.nih.gov/pubmed/25483497 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977448 https://www.tandfonline.com/doi/pdf/10.4161/hv.29589 https://pubmed.ncbi.nlm.nih.gov/25483497/,http://dx.doi.org/10.4161/hv.29589,25483497,10.4161/hv.29589,2024954594,PMC4977448,0,001-557-668-419-659; 001-703-796-054-175; 002-055-577-743-679; 003-372-446-364-041; 003-676-099-062-809; 004-046-732-346-840; 004-865-686-973-577; 005-259-907-367-121; 005-550-834-653-293; 005-716-268-121-272; 006-044-553-036-752; 006-279-058-122-908; 006-756-927-895-187; 006-821-228-957-914; 006-869-225-303-029; 007-958-145-489-370; 009-412-228-602-55X; 010-248-044-979-575; 010-344-226-080-261; 011-255-525-284-899; 011-569-412-545-185; 011-749-864-372-498; 011-900-954-746-341; 011-985-664-323-530; 013-479-326-820-682; 014-599-689-757-275; 014-727-302-169-780; 014-809-102-134-267; 015-022-366-267-212; 016-193-770-451-495; 016-261-069-394-594; 016-408-123-272-63X; 016-561-245-840-843; 016-658-934-283-57X; 016-987-201-126-97X; 017-428-507-694-908; 017-827-157-930-912; 018-499-456-129-048; 018-509-532-010-353; 018-747-721-332-670; 018-845-954-978-156; 019-070-939-478-159; 019-385-187-333-390; 020-714-849-130-657; 023-296-894-622-722; 023-311-203-146-740; 023-824-742-588-197; 025-175-494-277-079; 026-282-350-066-23X; 026-902-364-593-22X; 027-124-036-318-526; 027-699-664-009-406; 028-680-965-832-97X; 030-521-568-104-42X; 032-067-290-927-266; 032-723-848-490-394; 033-323-049-012-963; 033-752-945-019-253; 034-866-437-356-589; 034-984-917-240-857; 035-216-455-594-494; 035-473-941-085-801; 035-821-181-267-722; 035-883-712-822-136; 036-779-478-082-630; 037-580-650-464-074; 037-859-560-474-795; 039-079-455-504-396; 040-575-468-838-692; 040-719-299-594-606; 041-014-026-853-090; 041-825-474-470-973; 042-166-139-469-166; 042-177-781-848-706; 043-714-610-175-743; 044-456-773-230-847; 046-494-623-147-925; 047-678-264-012-027; 047-693-698-216-030; 048-380-092-146-241; 048-470-495-599-025; 049-270-819-648-824; 050-415-935-669-235; 051-684-998-258-558; 051-894-290-928-988; 055-921-408-762-204; 056-715-998-111-506; 057-156-828-544-833; 057-308-102-554-151; 058-057-451-686-008; 058-622-350-396-270; 058-747-331-629-402; 058-862-102-656-232; 059-116-387-405-550; 059-311-261-904-26X; 059-347-978-254-895; 059-500-907-183-338; 059-591-953-426-448; 059-722-935-993-948; 061-069-649-953-016; 061-568-334-770-772; 062-367-976-083-478; 062-965-812-807-505; 064-550-044-666-516; 065-904-620-730-646; 065-992-474-303-365; 066-047-310-493-852; 067-151-508-027-28X; 070-113-748-933-936; 071-918-484-026-72X; 073-172-693-865-778; 074-079-334-152-047; 075-236-454-057-733; 077-637-425-701-526; 081-550-565-698-851; 084-799-188-253-031; 086-179-242-892-631; 086-238-055-694-40X; 087-216-225-850-807; 088-120-218-434-231; 088-439-812-264-639; 088-821-411-776-470; 090-068-130-950-49X; 091-826-671-771-773; 092-909-175-996-367; 093-750-269-867-739; 096-337-628-560-967; 097-026-009-600-796; 097-076-789-372-944; 098-103-504-168-593; 098-300-896-250-23X; 102-999-420-891-327; 103-086-638-159-462; 103-553-538-761-851; 103-687-279-724-944; 104-579-393-463-109; 104-889-592-677-138; 106-021-775-231-442; 107-140-328-051-798; 109-525-793-950-49X; 109-827-433-226-370; 111-039-240-646-330; 114-625-780-091-349; 119-853-820-681-332; 126-526-774-206-957; 126-730-303-998-79X; 128-697-414-323-091; 129-978-845-543-894; 133-439-303-091-282; 133-575-667-843-242; 135-256-765-805-834; 140-736-628-582-236; 143-396-598-191-576; 145-619-394-483-532; 147-717-029-544-511; 164-000-189-844-634; 169-024-675-815-28X,59
012-781-471-224-992,Insights into the epigenetic effects of nanomaterials on cells,2019-12-06,2019,journal article,Biomaterials science,20474849; 20474830,Royal Society of Chemistry,United Kingdom,Jie Yu; Xian Jun Loh; Yifei Luo; Shengfang Ge; Xianqun Fan; Jing Ruan,"With the development of nanotechnology, nanomaterials are increasingly being applied in health fields, such as biomedicine, pharmaceuticals, and cosmetics. Concerns have therefore been raised over their toxicity and numerous studies have been carried out to assess their safety. Most studies on the toxicity and therapeutic mechanisms of nanomaterials have revealed the effects of nanomaterials on cells at the transcriptome and proteome levels. However, epigenetic modifications, for example DNA methylation, histone modification, and noncoding RNA expression induced by nanomaterials, which play an important role in the regulation of gene expression, have not received sufficient attention. In this review, we therefore state the importance of studying epigenetic effects induced by nanomaterials; then we review the progress of nanomaterial epigenetic research in the assessment of toxicity, therapeutic, and other mechanisms. We also clarify the possible study directions for future nanomaterial epigenetic research. Finally, we discuss the future development and challenges of nanomaterial epigenetics that must still be addressed. We hope to understand the potential toxicity of nanomaterials and clearly understand the therapeutic mechanism through a thorough investigation of nanomaterial epigenetics.",8,3,763,775,Nanomaterials; Transcriptome; Regulation of gene expression; DNA methylation; On cells; Epigenetics; Biomedicine; Computational biology; Biology; Mechanism (biology),,"Animals; DNA Methylation/drug effects; Epigenesis, Genetic/drug effects; Humans; Nanostructures/toxicity; Nanotechnology",,National Natural Science Foundation of China; National Natural Science Foundation of China; Shanghai Rising-Star Program; National Basic Research Program of China; Shanghai Jiao Tong University; Science and Technology Commission of Shanghai Municipality,https://pubag.nal.usda.gov/catalog/6832473 https://www.ncbi.nlm.nih.gov/pubmed/31808476 https://pubs.rsc.org/en/content/articlelanding/2020/bm/c9bm01526d#!,http://dx.doi.org/10.1039/c9bm01526d,31808476,10.1039/c9bm01526d,2990888454,,0,000-153-049-963-965; 001-172-390-253-65X; 001-820-354-321-240; 002-691-923-791-524; 003-288-258-305-94X; 004-488-983-105-919; 006-740-040-847-612; 007-097-762-901-189; 007-595-186-603-619; 007-604-017-139-669; 008-568-862-971-322; 009-092-372-714-29X; 009-532-898-373-895; 010-929-927-443-516; 017-950-664-698-234; 017-955-283-229-138; 018-796-842-324-926; 019-069-096-658-03X; 019-217-870-172-058; 019-680-471-436-110; 019-931-938-508-135; 021-546-646-483-416; 021-723-734-905-126; 023-453-439-306-249; 023-697-839-716-061; 025-162-820-526-876; 027-717-530-612-898; 029-296-747-177-305; 029-579-111-776-572; 030-282-098-520-908; 030-967-138-939-650; 031-390-064-010-402; 032-106-556-590-867; 032-330-204-183-340; 032-673-680-771-770; 033-106-194-637-504; 035-628-598-693-917; 036-123-327-664-180; 036-299-971-568-578; 037-695-188-076-847; 038-819-174-557-218; 042-177-138-582-726; 042-850-413-470-794; 045-592-031-690-871; 047-974-933-794-81X; 047-992-306-466-373; 048-090-539-817-254; 050-277-598-225-234; 052-938-056-102-203; 052-947-338-062-304; 053-786-801-256-242; 056-648-214-401-138; 058-129-387-583-038; 065-316-476-914-051; 065-364-899-724-897; 066-012-330-473-170; 066-481-447-242-941; 066-565-955-175-448; 067-209-101-699-34X; 069-140-925-075-388; 070-389-958-745-180; 074-295-525-684-077; 076-449-461-904-932; 078-215-388-844-822; 078-373-817-458-561; 079-219-149-449-889; 088-512-065-087-699; 089-263-396-082-480; 093-463-656-573-00X; 094-342-690-930-889; 103-842-434-198-057; 104-979-666-639-978; 107-320-422-493-187; 109-473-866-388-214; 111-824-675-075-737; 112-522-539-717-398; 117-035-371-300-022; 122-445-855-555-710; 125-670-972-679-923; 128-348-668-881-784; 144-431-864-565-604; 147-036-934-710-002; 157-813-420-213-136; 157-947-970-896-166; 177-840-081-298-719; 184-209-656-216-93X,16
012-894-565-313-380,Nanomaterials in wastewater treatments,,2020,book chapter,Nanotechnology in the Beverage Industry,,Elsevier,,Bapun Barik; Pratap S. Nayak; Priyabrat Dash,"Abstract The generation of large amount of wastewater due to modern globalization has brought huge challenges for wastewater treatment as they pose serious threat to living organisms and environment. This has urged the scientific community to look for newer innovations and novel technologies. Some fundamental and practical methodologies for wastewater remediation processes have found nanomaterials as the most efficient and potential materials to support this sustainable concern. Among various nanomaterials, metal oxides have shown great promise due to their unique physicochemical properties. By supporting these, nanomaterials on suitable support materials have significantly improved their performances in wastewater treatment processes. Keeping an eye on these developments, this chapter overviews various advantages associated with metal oxide nanomaterials and their improvement after modification with support materials like graphene oxide and biopolymers. Various graphene oxide and biopolymer-supported metal oxide nanomaterials are discussed for the removal of wastewater pollutants such as dyes, heavy metals, and pesticides.",,,185,206,Nanomaterials; Heavy metals; Oxide; Support materials; Environmental science; Environmental remediation; Waste management; Sewage treatment; Pollutant; Wastewater,,,,,https://www.sciencedirect.com/science/article/pii/B9780128199411000079,http://dx.doi.org/10.1016/b978-0-12-819941-1.00007-9,,10.1016/b978-0-12-819941-1.00007-9,3023426304,,0,000-583-409-714-760; 002-906-812-996-573; 003-861-865-215-654; 003-959-136-376-664; 004-601-266-052-852; 005-677-519-985-085; 007-367-147-871-309; 007-906-652-872-943; 008-822-562-153-011; 008-872-112-870-481; 009-164-005-824-075; 011-209-013-315-316; 012-449-102-307-894; 013-182-927-369-770; 014-188-091-072-427; 014-749-269-508-804; 014-852-598-433-503; 015-676-468-397-803; 018-767-823-883-375; 018-875-153-757-385; 019-518-047-439-958; 019-549-275-529-295; 020-237-663-630-97X; 020-483-896-892-501; 020-843-566-869-663; 020-981-565-582-404; 024-125-072-079-951; 028-011-980-246-866; 028-054-895-960-301; 028-864-354-323-89X; 029-432-068-087-483; 032-767-728-098-376; 033-473-679-911-078; 033-959-044-590-709; 034-288-311-811-951; 034-742-807-480-778; 034-756-171-992-432; 034-808-744-463-450; 038-186-291-905-990; 042-033-431-406-315; 042-498-025-391-226; 043-449-748-699-22X; 044-940-682-539-229; 046-717-907-226-460; 046-964-802-954-451; 048-256-137-487-907; 049-139-192-687-614; 051-647-827-249-814; 051-747-084-798-967; 051-954-513-099-50X; 053-872-464-180-54X; 054-902-988-062-852; 056-318-274-129-568; 057-970-209-130-478; 061-213-526-079-57X; 063-768-003-032-109; 067-796-096-125-366; 068-710-496-033-782; 069-678-828-150-571; 074-637-617-111-900; 076-474-376-340-356; 077-954-850-591-320; 077-956-230-238-234; 078-744-605-191-041; 080-561-423-209-175; 083-607-726-921-83X; 087-441-499-722-352; 087-520-622-285-473; 087-672-124-107-490; 089-789-999-286-286; 097-053-638-355-352; 098-417-646-295-792; 099-296-419-765-553; 103-708-421-577-958; 106-207-873-777-321; 108-193-219-054-602; 109-992-232-721-091; 113-471-067-433-395; 117-810-028-554-222; 121-270-400-490-676; 122-996-060-647-743; 123-038-238-938-095; 126-355-167-998-311; 131-280-849-057-284; 138-222-961-730-474; 142-092-197-484-598; 145-076-957-238-410; 150-727-451-874-53X; 169-595-834-421-085; 175-743-772-001-331; 180-758-603-319-480; 191-972-179-037-703,0
013-046-705-606-762,Grouping of nanomaterials for risk assessment,2014-11-21,2014,journal article,Archives of toxicology,14320738; 03405761,Springer Verlag,Germany,Hermann M. Bolt,"2013; Schluesener and Schluesener 2013), study the biokinetics (Landsiedel et al. 2012; Klein et al. 2012) or establish in vitro systems for testing of nanomaterials (Hoelting et al. 2013; Haase et al. 2012; Kroll et al. 2012). However, because of the high number of different materials and the difficulty to interpret many of the in vitro studies with respect to their in vivo relevance, the present categorization concept proposed by Gebel et al. (2014) will contribute to a better overview and a more straightforward hazard identification. When novel nanomaterials have to be evaluated, it seems reasonable to check initially whether they fulfill one of the three “Gebel-criteria.” Besides introducing the novel categorization concept, the review addresses the question whether nanomaterials act by novel mechanisms. The authors conclude that despite the intensive research in this field, not a single “nanospecific” mechanism of action has been identified so far. All molecular mechanisms described for nanomaterials have already been identified for chemicals or described in conventional particle toxicology. The present article (Gebel et al. 2014) is of high interest to anyone working in the field of nanotoxicity, because it introduces a straightforward concept and gives the risk evaluator a better overview.",88,12,2077,2078,Data science; Pharmacology toxicology; High interest; Computer science; Relevance (information retrieval); Categorization,,Animals; Hazardous Substances/chemistry; Humans; Nanostructures/chemistry; Toxicology/methods,Hazardous Substances,,https://link.springer.com/content/pdf/10.1007%2Fs00204-014-1416-2.pdf https://link.springer.com/article/10.1007/s00204-014-1416-2 https://www.ncbi.nlm.nih.gov/pubmed/25413730 https://paperity.org/p/52501837/grouping-of-nanomaterials-for-risk-assessment https://link.springer.com/article/10.1007/s00204-014-1416-2/fulltext.html,http://dx.doi.org/10.1007/s00204-014-1416-2,25413730,10.1007/s00204-014-1416-2,2094944034,,0,001-148-107-778-582; 002-905-078-211-991; 003-425-101-723-009; 007-026-394-140-620; 008-886-657-695-254; 010-431-126-914-711; 036-218-811-362-207; 038-875-513-090-779; 039-754-517-081-058; 041-980-068-539-63X; 046-671-879-296-312; 049-276-699-436-989; 054-010-489-803-085; 054-913-179-875-216; 064-477-491-097-548; 064-845-608-892-139; 065-677-700-653-671; 071-441-580-300-957; 073-840-027-443-232; 083-003-134-636-480; 085-926-981-713-318; 103-299-071-371-241; 143-605-000-100-691,6
013-433-406-455-327,Importance of Nanomaterials in Engineering Application,2020-12-18,2020,book chapter,Engineering Materials,16121317; 18681212,Springer International Publishing,,Lau Yien Jun; Fahad Saleem Ahmed Khan; Nabisab Mujawar Mubarak; Lau Sie Yon; Chua Han Bing; Mohammad Khalid; Ezzat Chan Abdullah,"Nanomaterials have gained prominence in technological advancement due to their exceptional tunable properties and enhanced performance over their bulk counterparts. These nanomaterials are revolutionising various industrial applications due to their outstanding, and unique characteristics. In this chapter, a summary of the fundamental engineering concept of nanomaterial, particularly carbon nanomaterials are included. Besides, this chapter also highlights the engineering applications of nanomaterials in diverse industrial fields, such as biomedical, food processing, biotechnology, environmental remediation, construction, renewable energy, electronics, and energy storage. Lastly, the potential effects of nanomaterials on human health are briefed. In short, nanomaterials are expected to bring breakthrough development field of the leading cutting edge of nanotechnology.",,,1,20,Engineering; Electronics; Nanomaterials; Nanotechnology; Human health; Technological advance; Carbon nanomaterials,,,,,https://link.springer.com/chapter/10.1007/978-3-030-62761-4_1,http://dx.doi.org/10.1007/978-3-030-62761-4_1,,10.1007/978-3-030-62761-4_1,3111578761,,0,000-081-687-671-852; 001-603-750-759-980; 003-547-905-209-457; 004-436-626-426-592; 004-907-375-683-137; 005-147-049-299-380; 005-262-178-164-320; 006-718-226-980-066; 006-770-063-384-806; 007-290-533-369-664; 008-835-760-036-636; 009-690-033-335-017; 010-925-800-631-343; 011-019-302-768-824; 012-535-014-751-486; 012-926-927-040-37X; 012-943-338-850-272; 013-016-675-019-008; 013-339-094-749-818; 014-508-427-573-592; 017-409-330-431-753; 018-312-499-556-75X; 018-640-610-865-677; 021-209-241-108-290; 022-885-370-704-62X; 023-214-549-678-897; 023-490-025-558-916; 024-214-884-015-237; 024-741-104-365-426; 025-560-850-034-155; 027-540-257-959-186; 027-921-416-814-320; 028-985-995-985-616; 029-230-576-869-339; 029-932-548-014-372; 030-988-420-119-667; 032-559-418-493-534; 033-119-419-347-034; 033-822-611-780-801; 033-958-630-504-16X; 034-507-607-372-06X; 036-769-847-546-615; 039-950-219-636-869; 040-351-867-447-581; 041-873-092-638-511; 043-143-551-911-467; 043-353-497-145-225; 044-376-761-094-411; 045-788-586-063-278; 046-118-678-429-808; 050-359-510-075-390; 051-855-111-662-677; 052-083-854-500-707; 052-351-823-562-364; 052-666-322-940-044; 052-808-308-938-088; 052-976-279-482-490; 057-259-180-900-584; 057-430-952-376-258; 061-322-465-522-779; 061-740-016-913-303; 061-865-432-133-815; 062-850-955-186-283; 063-090-958-863-988; 064-239-246-218-234; 065-426-834-202-108; 067-184-168-583-407; 067-780-381-946-730; 068-372-803-242-21X; 068-885-680-130-085; 070-519-854-436-706; 073-006-120-851-383; 074-090-129-137-427; 074-499-011-681-199; 075-051-656-620-976; 075-896-583-893-360; 080-693-597-755-998; 083-583-895-816-535; 087-410-138-474-400; 092-814-006-629-484; 098-167-703-457-956; 102-202-608-748-759; 102-429-678-348-909; 102-734-209-446-195; 103-381-691-238-671; 107-033-290-543-151; 110-326-145-085-446; 114-125-092-832-325; 118-913-562-658-214; 122-254-709-004-281; 123-094-428-893-779; 124-706-221-490-80X; 128-467-110-286-97X; 128-988-513-701-756; 135-029-422-474-391; 136-793-972-426-351; 143-602-138-209-995; 153-821-390-453-845; 167-571-718-197-283; 174-368-126-005-292; 186-205-851-239-293; 190-769-041-563-663,0
013-440-966-633-932,Treatment of Soil Pollutants With Nanomaterials,,2019,book chapter,Nanomaterials Applications for Environmental Matrices,,Elsevier,,Ricardo Jardim de Paula; Amauri J. Paula,"Abstract Soil aging and deterioration can be enhanced due to pollutant accumulation, which can impact food security in the near future. Considering the advances in soil decontamination strategies, nanomaterials have been successfully applied in the remediation of metalloids and organic pollutants accumulated in a variety of soils. The use of nanomaterials is justified by their high reactivity and catalytic and optical properties that are made manifest by their small size and high surface area. In this panorama, this chapter discusses achievements in the use of nanomaterials in the remediation of soils contaminated with arsenic, mercury, chromium, lead, polychlorinated biphenyls, polycyclic aromatic hydrocarbons, organic solvents, and pharmaceutical and personal care products.",,,355,368,Human decontamination; Environmental chemistry; Nanomaterials; Soil water; Soil Pollutants; Environmental science; Environmental remediation; Mercury (element); Metalloid; Pollutant,,,,,https://www.sciencedirect.com/science/article/pii/B9780128148297000100,http://dx.doi.org/10.1016/b978-0-12-814829-7.00010-0,,10.1016/b978-0-12-814829-7.00010-0,2949247719,,0,001-021-027-300-863; 002-753-753-176-799; 004-331-505-940-199; 006-933-167-775-135; 007-197-027-817-00X; 007-217-687-608-794; 007-382-668-315-59X; 009-216-321-875-714; 009-764-429-562-338; 010-513-678-647-390; 010-843-039-581-841; 012-924-926-605-755; 013-886-477-189-638; 016-969-595-439-055; 018-091-194-570-685; 018-406-247-803-336; 023-092-072-280-36X; 024-608-192-515-611; 027-776-035-842-100; 027-846-285-952-741; 028-745-245-467-470; 029-283-431-170-710; 033-701-877-533-575; 035-286-759-484-896; 036-142-456-010-179; 038-822-969-949-474; 045-602-183-975-725; 046-452-767-021-20X; 047-208-198-304-120; 047-618-207-503-976; 048-309-767-561-805; 052-788-397-047-694; 054-346-412-175-753; 054-381-415-195-374; 056-001-207-642-470; 056-702-689-204-378; 057-704-604-955-056; 058-158-750-033-923; 059-306-485-225-921; 059-386-408-908-035; 059-512-220-087-575; 061-026-704-990-689; 062-691-323-906-857; 064-746-559-034-467; 067-452-072-728-745; 068-080-234-838-640; 070-957-756-690-153; 072-268-244-153-660; 073-003-433-143-616; 074-294-717-558-759; 079-205-857-403-403; 080-133-308-409-621; 086-853-851-753-989; 090-013-972-214-538; 090-087-559-426-563; 093-748-477-055-775; 094-130-187-777-835; 099-942-327-558-868; 105-382-489-482-627; 105-460-301-165-082; 106-032-478-373-085; 112-455-460-465-354; 132-426-274-590-306; 150-505-744-952-104; 152-084-255-861-826; 157-725-514-778-04X; 159-409-899-276-435; 169-595-834-421-085; 190-185-107-263-673,1
013-452-104-477-639,Plasmonics of 2D Nanomaterials: Properties and Applications.,2017-02-16,2017,journal article,"Advanced science (Weinheim, Baden-Wurttemberg, Germany)",21983844,Wiley-VCH Verlag,Germany,Yu Li; Ziwei Li; Cheng Chi; Hangyong Shan; Liheng Zheng; Zheyu Fang,"Plasmonics has developed for decades in the field of condensed matter physics and optics. Based on the classical Maxwell theory, collective excitations exhibit profound light-matter interaction properties beyond classical physics in lots of material systems. With the development of nanofabrication and characterization technology, ultra-thin two-dimensional (2D) nanomaterials attract tremendous interest and show exceptional plasmonic properties. Here, we elaborate the advanced optical properties of 2D materials especially graphene and monolayer molybdenum disulfide (MoS2), review the plasmonic properties of graphene, and discuss the coupling effect in hybrid 2D nanomaterials. Then, the plasmonic tuning methods of 2D nanomaterials are presented from theoretical models to experimental investigations. Furthermore, we reveal the potential applications in photocatalysis, photovoltaics and photodetections, based on the development of 2D nanomaterials, we make a prospect for the future theoretical physics and practical applications.",4,8,1600430,1600430,Plasmon; Classical physics; Nanomaterials; Nanotechnology; Materials science; Molybdenum disulfide; Characterization (materials science); Graphene; Photovoltaics; Monolayer,2D materials; light‐matter interactions; optoelectronics; surface plasmons,,,National Basic Research Program of China; National Natural Science Foundation of China; National Natural Science Foundation of China; National Natural Science Foundation of China; National Natural Science Foundation of China; Natural Science Foundation of Beijing Municipality; Foundation for the Author of National Excellent Doctoral Dissertation of the People's Republic of China; National Program for Support of Top-notch Young Professionals,http://onlinelibrary.wiley.com/doi/10.1002/advs.201600430/full https://europepmc.org/article/MED/28852608 https://pubmed.ncbi.nlm.nih.gov/28852608/ https://core.ac.uk/display/155745551 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566264 https://onlinelibrary.wiley.com/doi/full/10.1002/advs.201600430 https://www.onlinelibrary.wiley.com/doi/pdf/10.1002/advs.201600430,http://dx.doi.org/10.1002/advs.201600430,28852608,10.1002/advs.201600430,2588612993,PMC5566264,0,000-079-493-128-760; 000-526-744-327-599; 000-794-350-538-183; 001-087-739-810-660; 001-362-404-479-359; 001-616-849-394-099; 001-847-825-294-964; 003-280-584-277-693; 003-405-500-949-103; 003-509-043-746-234; 004-352-912-386-765; 004-627-988-660-927; 004-812-897-697-569; 005-814-857-846-211; 006-396-185-703-310; 006-622-643-916-050; 007-158-934-904-113; 007-439-260-299-324; 008-306-065-798-950; 009-011-526-176-715; 009-271-869-041-389; 009-644-857-234-449; 009-808-406-911-840; 010-189-266-209-579; 010-470-517-994-415; 011-505-245-313-789; 011-997-003-921-996; 013-287-330-976-042; 013-452-104-477-639; 013-875-659-364-309; 013-922-138-084-28X; 014-862-930-598-414; 015-723-192-747-540; 015-843-119-157-057; 015-925-445-562-33X; 017-529-704-619-870; 017-759-849-433-659; 018-298-698-967-107; 018-628-353-229-108; 019-090-981-750-214; 020-086-109-262-641; 020-686-932-917-316; 022-218-597-959-695; 022-406-223-355-748; 025-593-056-292-609; 025-852-490-513-420; 026-213-645-426-918; 026-454-682-394-289; 027-524-992-668-828; 027-683-842-216-63X; 028-689-801-426-976; 029-493-070-120-843; 030-073-374-390-564; 030-094-965-962-870; 030-532-345-931-210; 030-830-779-484-388; 033-310-842-539-274; 033-323-383-357-174; 034-043-399-294-243; 034-918-684-558-155; 035-966-651-427-24X; 036-125-424-310-703; 037-135-404-804-541; 037-300-330-117-920; 037-621-261-070-926; 038-234-208-439-188; 038-657-114-945-009; 038-791-576-100-868; 038-947-330-527-499; 039-442-531-838-501; 039-717-237-453-846; 040-339-285-720-531; 041-504-570-906-426; 041-913-224-127-814; 042-689-330-480-075; 044-376-761-094-411; 044-564-279-399-733; 044-573-786-477-876; 044-885-609-996-096; 045-374-439-162-17X; 046-439-359-225-303; 046-962-968-182-683; 047-325-223-933-854; 047-712-302-255-385; 048-230-874-134-559; 048-575-391-182-250; 049-550-730-304-765; 050-216-511-802-109; 050-415-206-791-257; 052-232-095-782-85X; 052-929-461-919-298; 054-741-640-527-941; 055-808-227-087-604; 056-167-504-647-091; 058-193-732-800-934; 058-967-247-692-69X; 059-465-320-853-792; 059-792-141-735-529; 059-953-022-122-986; 061-122-660-108-438; 061-266-939-461-952; 063-016-511-675-23X; 063-073-392-713-328; 065-674-554-068-971; 067-923-889-730-792; 069-246-489-118-999; 070-974-422-951-434; 072-337-118-804-764; 073-354-823-522-624; 073-435-476-599-161; 073-623-863-528-732; 073-641-079-420-284; 073-881-005-219-337; 074-916-317-040-946; 075-618-008-001-864; 075-674-632-941-194; 076-220-729-212-342; 077-679-738-384-205; 078-203-773-291-285; 079-234-648-866-359; 087-528-957-681-335; 092-005-401-423-777; 092-256-058-870-604; 092-514-415-143-544; 092-581-833-222-835; 092-643-120-367-330; 095-078-697-273-275; 096-627-471-131-632; 097-095-447-473-343; 099-004-921-056-288; 099-601-528-032-840; 099-735-641-295-419; 102-673-449-176-992; 104-253-099-318-314; 104-329-559-940-832; 105-934-194-772-62X; 106-415-865-217-603; 108-378-701-081-570; 111-239-928-945-837; 114-370-403-005-191; 114-925-166-040-378; 116-246-553-105-336; 122-693-674-637-541; 126-811-871-037-019; 129-977-250-315-804; 130-459-759-907-525; 131-330-767-667-604; 142-091-606-303-555; 149-736-194-399-246; 156-735-846-858-188; 160-023-777-674-412; 177-212-981-873-398; 196-346-931-260-545,94
013-480-429-822-216,Carbon‐Based Nanomaterials for Tissue Engineering,2012-11-19,2012,journal article,Advanced healthcare materials,21922640; 21922659,John Wiley and Sons Ltd,United Kingdom,Sook Hee Ku; Minah Lee; Chan Beum Park,"Carbon-based nanomaterials such as graphene sheets and carbon nanotubes possess unique mechanical, electrical, and optical properties that present new opportunities for tissue engineering, a key field for the development of biological alternatives that repair or replace whole or a portion of tissue. Carbon nanomaterials can also provide a similar microenvironment as like a biological extracellular matrix in terms of chemical composition and physical structure, making them a potential candidate for the development of artificial scaffolds. In this review, we summarize recent research advances in the effects of carbon nanomaterial-based substrates on cellular behaviors, including cell adhesion, proliferation, and differentiation into osteo- or neural- lineages. The development of 3D scaffolds based on carbon nanomaterials (or their composites with polymers and inorganic components) is introduced, and the potential of these constructs in tissue engineering, including toxicity issues, is discussed. Future perspectives and emerging challenges are also highlighted.",2,2,244,260,Nanomaterials; Nanotechnology; Materials science; Physical structure; Graphene; Potential candidate; Carbon based nanomaterials; Tissue engineering; Carbon; Carbon nanotube,,Animals; Carbon; Cell Adhesion; Cell Differentiation; Cell Proliferation; Graphite; Humans; Nanostructures/chemistry; Tissue Engineering/methods,Carbon; Graphite,,https://experts.umn.edu/en/publications/carbon-based-nanomaterials-for-tissue-engineering https://www.ncbi.nlm.nih.gov/pubmed/23184559 https://onlinelibrary.wiley.com/doi/10.1002/adhm.201200307 https://pubmed.ncbi.nlm.nih.gov/23184559/ https://koasas.kaist.ac.kr/handle/10203/174545,http://dx.doi.org/10.1002/adhm.201200307,23184559,10.1002/adhm.201200307,2060785405,,0,000-160-422-354-929; 000-250-674-780-085; 002-717-055-960-30X; 002-990-554-747-068; 003-126-666-576-528; 003-180-543-220-377; 003-675-705-563-183; 003-942-202-572-786; 004-206-095-128-794; 004-666-459-693-311; 005-095-929-278-80X; 005-778-847-062-602; 006-012-687-858-827; 006-346-939-977-815; 006-660-743-288-888; 006-773-568-926-205; 008-096-202-867-308; 008-112-346-371-771; 008-586-229-088-488; 009-291-443-393-406; 009-456-342-310-432; 010-552-415-534-708; 010-948-806-601-139; 011-092-574-354-466; 011-866-243-421-552; 012-935-816-159-903; 014-205-915-364-37X; 014-405-615-810-338; 014-825-784-845-516; 015-222-865-559-806; 015-914-991-553-568; 016-240-063-655-535; 016-267-786-993-650; 016-820-811-842-362; 016-824-685-436-993; 017-615-918-234-117; 017-761-634-186-526; 018-033-018-916-08X; 018-094-933-135-067; 018-833-245-044-598; 019-191-200-109-516; 019-217-870-172-058; 020-024-195-391-613; 020-885-210-727-926; 020-899-512-220-490; 021-103-535-691-391; 021-612-438-075-963; 022-874-994-556-588; 023-130-004-949-556; 023-194-884-200-625; 023-731-947-341-566; 023-811-015-254-534; 023-866-491-922-108; 024-184-151-369-068; 024-619-921-219-825; 024-785-018-259-939; 024-876-489-911-376; 025-164-491-717-020; 026-423-375-079-973; 028-612-057-437-371; 028-634-124-150-66X; 030-614-004-586-841; 031-442-263-456-919; 032-045-431-207-08X; 032-267-502-857-789; 032-272-195-413-577; 032-744-779-725-147; 033-553-476-086-83X; 034-077-145-053-787; 034-245-878-120-510; 035-976-852-800-580; 037-587-201-682-756; 039-051-276-994-823; 039-239-854-261-598; 039-272-582-423-040; 041-607-975-768-801; 042-811-195-386-663; 044-376-761-094-411; 045-155-949-580-451; 046-904-580-095-991; 047-118-761-693-745; 049-547-918-000-758; 049-851-396-178-036; 050-359-510-075-390; 050-712-796-877-413; 050-751-464-094-959; 050-957-319-691-822; 051-242-996-816-714; 051-351-577-389-474; 051-567-966-322-524; 051-798-691-140-761; 052-554-981-354-579; 053-241-485-173-583; 055-303-681-450-73X; 056-143-462-635-829; 056-278-424-283-701; 056-394-098-941-833; 056-692-403-401-91X; 056-888-324-543-500; 056-968-963-663-656; 057-043-079-025-284; 058-155-909-814-737; 058-397-890-092-296; 059-193-112-807-832; 060-421-684-364-704; 060-569-064-163-558; 060-730-335-537-450; 061-131-966-932-969; 061-552-924-499-090; 061-976-146-998-334; 062-186-943-262-469; 062-584-435-112-070; 062-961-350-650-495; 064-500-361-547-515; 065-128-560-355-960; 066-020-473-284-983; 066-208-946-417-85X; 066-242-570-932-202; 066-625-021-232-121; 067-472-642-838-144; 069-779-803-673-109; 070-044-462-413-189; 070-761-015-621-017; 071-468-198-380-351; 072-538-575-619-004; 073-383-759-488-486; 073-412-672-998-766; 073-861-878-251-872; 074-506-625-744-441; 077-434-721-600-447; 079-607-585-837-807; 079-874-142-934-196; 081-776-508-310-461; 081-987-480-464-839; 082-468-008-022-334; 082-512-666-548-499; 083-298-478-556-311; 084-840-587-348-46X; 085-789-322-241-574; 085-910-539-962-294; 088-793-228-766-391; 088-915-709-226-372; 090-404-890-208-220; 091-493-588-127-941; 092-385-391-018-272; 096-732-059-689-84X; 098-187-195-814-969; 100-079-699-050-319; 100-634-277-566-016; 101-572-065-272-724; 103-479-504-225-791; 103-928-207-092-444; 105-126-223-511-571; 105-281-363-570-725; 107-668-670-505-674; 107-836-313-211-352; 108-319-396-227-608; 108-563-116-470-502; 108-959-292-926-928; 111-180-259-651-992; 113-608-360-827-013; 117-087-119-957-713; 118-139-772-415-27X; 119-357-230-897-982; 119-727-695-360-144; 121-284-353-743-905; 122-960-605-387-837; 125-059-722-505-094; 126-491-069-775-866; 129-418-479-171-246; 131-196-539-329-772; 133-804-040-570-806; 135-043-797-151-506; 136-349-161-356-707; 138-632-604-261-982; 139-088-437-226-273; 146-417-678-197-301; 148-152-014-104-370; 153-616-179-977-536; 173-136-810-733-414; 175-946-815-036-199; 180-717-200-496-019; 182-582-344-042-11X; 182-794-900-218-273; 183-285-746-885-043; 184-361-976-273-69X; 184-756-130-128-751,145
013-484-849-917-869,Segmented Microfluidic Flow Reactors for Nanomaterial Synthesis.,2020-07-21,2020,journal article,"Nanomaterials (Basel, Switzerland)",20794991,,Switzerland,Yujuan He; Ki-Joong Kim; Chih-Hung Chang,"Microfluidic reactors have remarkably promoted the synthesis and investigation of advanced nanomaterials due to their continuous mode and accelerated heat/mass transfer. Notably, segmented microfluidic flow reactors (SMFRs) are an important class of microfluidic reactors that have been developed to accurately manipulate nanomaterial synthesis by further improvement of the residence time distributions and unique flow behaviors. This review provided a survey of the nanomaterial synthesis in SMFRs for the aspects of fluid dynamics, flow patterns, and mass transfer among and within distinct phases and provided examples of the synthesis of versatile nanomaterials via the use of different flow patterns.",10,7,1421,,Nanomaterials; Nanotechnology; Materials science; Continuous reactor; Residence time (fluid dynamics); Flow pattern; Flow (mathematics); Mass transfer; Microfluidics; Fluid dynamics,microfluidic reactors; micromixer design; nanomaterials synthesis; reaction kinetics; segmented flow,,,National Science Foundation (CBET-1449383),https://pubmed.ncbi.nlm.nih.gov/32708175/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407902 https://www.scilit.net/article/6a145df7322617aab8944484cd3f3e13 https://www.mdpi.com/2079-4991/10/7/1421,http://dx.doi.org/10.3390/nano10071421,32708175,10.3390/nano10071421,3044809714,PMC7407902,0,000-158-661-923-284; 000-458-101-464-491; 002-600-786-021-630; 003-295-278-209-336; 003-367-703-605-98X; 003-581-200-598-471; 004-258-395-203-391; 004-871-557-532-397; 005-577-301-594-171; 005-706-994-830-947; 006-836-404-982-548; 007-223-952-959-597; 008-323-482-139-934; 008-392-378-413-111; 010-663-002-937-447; 010-719-738-653-965; 011-457-927-075-841; 011-875-971-641-910; 012-318-161-227-86X; 015-973-624-334-865; 016-162-094-759-846; 016-420-762-662-505; 017-483-341-681-059; 018-357-950-728-341; 018-359-874-375-570; 018-785-178-208-324; 018-935-131-082-542; 019-040-846-042-543; 019-736-693-261-707; 020-426-043-077-520; 022-317-084-800-770; 022-533-699-427-649; 025-022-017-328-905; 025-154-850-074-794; 027-012-558-762-919; 027-272-673-397-831; 029-901-720-867-579; 031-404-789-287-358; 032-266-721-746-005; 032-390-323-520-885; 033-715-182-183-166; 033-949-636-168-748; 034-483-238-955-548; 036-831-978-053-882; 039-213-350-110-459; 040-000-040-379-483; 040-577-558-984-510; 041-507-403-643-730; 042-050-444-177-042; 042-670-669-576-340; 043-258-357-756-221; 043-311-994-071-145; 047-392-740-779-955; 048-320-683-879-055; 049-520-130-361-785; 052-181-173-721-28X; 056-406-806-179-065; 056-622-052-735-585; 057-898-383-037-099; 057-982-627-940-80X; 058-314-692-887-964; 060-529-987-148-296; 061-074-792-764-45X; 061-262-798-404-146; 062-953-334-282-784; 066-128-096-275-751; 067-871-703-020-695; 068-411-336-410-657; 069-812-893-258-639; 072-975-553-854-463; 074-960-956-386-87X; 075-764-013-491-592; 081-127-568-870-196; 082-311-226-816-786; 082-514-647-838-115; 083-425-153-287-060; 083-731-104-007-910; 083-908-321-661-354; 085-824-157-249-775; 088-339-977-435-40X; 090-122-683-003-497; 090-839-912-463-517; 093-097-807-342-480; 093-310-816-504-162; 094-074-031-822-536; 097-766-511-908-650; 099-068-494-729-54X; 099-915-497-744-15X; 101-558-890-101-617; 101-934-177-129-880; 102-627-536-373-954; 102-977-151-504-351; 104-407-126-253-106; 105-303-157-228-042; 106-390-131-481-562; 108-348-969-392-436; 108-946-799-469-372; 109-492-535-266-910; 112-109-373-196-924; 112-463-973-092-450; 113-886-967-624-423; 114-817-344-004-84X; 117-534-435-960-262; 121-669-549-553-561; 124-630-208-651-404; 127-549-817-057-735; 128-721-276-953-550; 129-189-197-861-728; 132-022-216-924-178; 134-877-563-584-012; 136-903-964-539-334; 138-619-521-642-070; 166-533-493-446-598; 167-369-966-814-43X; 173-509-386-127-667; 184-195-903-379-484; 185-291-053-111-719; 186-303-994-163-299,2
013-676-455-065-225,Uptake and Toxicity of Nanomaterials in Plants,2017-07-14,2017,book chapter,Sustainable Agriculture Reviews,22104410; 22104429,Springer International Publishing,,Atul Dev; Anup K. Srivastava; Surajit Karmakar,"Rapid development of nanomaterials has induced their diffusion in our environment, reaching plants that are the primary link of the food chain. Studies show that plant behaviour is changing by interaction with nanomaterials, notably due to their toxicity. Plant physiological barriers are providing some resistance against nanomaterial-mediated toxicity. Indeed, plant turn on and off machinery to overcome nanomaterial-mediated stresses, which result in unusual growth patterns. This article reviews the mechanisms of interaction of nanomaterials with plants, with focus on uptake, translocation and toxicity behaviour at physiological, proteomic, transcriptomic and metabolomic level. We discuss the toxicity of the following nanomaterials: silver, CeO2, ZnO, cupric oxide, fullerene, nickel oxide, zero valent iron, gold, aluminium oxide, titania and silica.",,,169,204,Nanotoxicology; Nanomaterials; Nanotechnology; Chemistry; Metabolomics; Nickel oxide; Oxide; Biotransformation; Toxicity; Zerovalent iron,,,,,https://link.springer.com/chapter/10.1007%2F978-3-319-58496-6_7,http://dx.doi.org/10.1007/978-3-319-58496-6_7,,10.1007/978-3-319-58496-6_7,2735266459,,0,000-058-137-989-748; 000-629-157-834-301; 000-788-726-748-023; 000-936-474-539-058; 001-323-670-575-309; 001-730-126-486-941; 002-586-819-103-395; 003-706-468-768-44X; 004-030-819-748-387; 004-140-886-600-654; 004-308-307-684-811; 004-635-577-387-428; 005-251-353-082-207; 007-345-535-311-509; 007-827-143-152-942; 008-332-843-903-139; 009-183-833-869-010; 009-463-152-853-490; 009-732-954-780-046; 010-310-691-792-322; 010-566-404-188-376; 010-802-888-606-395; 011-872-862-217-009; 014-079-866-160-914; 014-617-187-324-425; 014-975-451-384-874; 015-270-428-925-94X; 015-506-319-329-864; 015-517-737-335-304; 015-746-584-106-605; 018-044-017-422-110; 018-044-303-419-166; 018-121-855-812-149; 018-845-116-074-019; 019-366-107-190-462; 019-632-077-367-405; 019-970-409-797-818; 020-758-177-208-03X; 021-676-799-067-814; 022-468-223-889-815; 023-045-653-615-111; 023-396-359-564-83X; 023-398-317-119-470; 023-564-514-468-785; 023-945-089-110-289; 024-243-039-782-677; 024-387-814-068-38X; 024-639-076-095-869; 025-451-054-657-535; 025-557-523-657-518; 026-005-742-071-112; 026-026-921-280-115; 026-034-614-014-845; 026-693-972-750-622; 028-431-322-596-232; 028-982-452-183-04X; 029-121-152-912-29X; 030-498-850-507-887; 030-672-592-021-737; 030-696-285-671-146; 031-182-901-425-263; 031-194-224-888-284; 031-358-248-495-432; 033-611-867-133-739; 033-958-630-504-16X; 034-760-333-584-32X; 035-186-398-644-55X; 035-883-712-822-136; 037-248-217-445-599; 037-378-421-300-181; 037-551-960-986-019; 038-384-380-313-601; 038-750-683-766-314; 038-976-049-485-293; 039-088-904-440-91X; 039-163-532-878-36X; 039-861-120-758-714; 040-121-184-160-019; 040-121-452-614-09X; 040-128-352-286-588; 040-353-889-419-003; 041-393-367-695-329; 041-644-150-678-791; 043-163-703-492-838; 043-471-923-886-075; 043-994-382-314-826; 044-947-647-031-608; 045-013-667-285-231; 046-120-233-350-585; 047-394-795-509-089; 047-811-511-015-760; 049-678-788-300-831; 049-893-607-340-730; 051-098-224-120-043; 052-396-080-334-801; 052-797-145-116-934; 053-371-635-408-268; 053-600-795-686-319; 055-402-589-021-709; 055-709-977-143-763; 058-012-337-832-383; 058-033-377-686-774; 060-290-577-031-165; 060-679-132-693-575; 061-011-141-856-248; 061-160-864-596-143; 062-112-388-708-772; 063-437-814-589-430; 063-860-470-934-437; 065-245-245-292-288; 068-768-177-568-079; 069-033-249-146-991; 069-441-735-793-476; 070-051-288-339-643; 070-065-402-663-365; 070-283-492-850-53X; 071-230-540-487-147; 071-350-205-175-468; 071-645-257-689-610; 072-681-849-776-261; 073-548-790-294-826; 074-419-187-813-893; 074-887-619-579-285; 075-150-564-469-993; 075-787-443-355-461; 076-429-213-919-125; 077-124-985-868-523; 077-140-659-122-443; 078-833-032-987-863; 081-016-121-752-861; 081-905-138-169-613; 083-195-957-093-439; 084-965-091-791-803; 085-243-939-347-913; 086-375-812-966-638; 087-341-855-405-591; 088-674-846-974-508; 088-810-286-967-134; 088-867-054-601-229; 088-869-421-969-754; 089-962-570-830-169; 091-676-912-170-59X; 094-715-287-692-621; 095-423-585-873-991; 096-710-984-891-829; 097-329-334-915-837; 098-398-032-567-617; 099-006-453-519-163; 099-738-741-412-583; 104-661-717-011-84X; 106-103-059-893-508; 106-131-195-342-59X; 108-646-714-037-526; 109-353-507-533-364; 112-330-555-439-790; 114-532-973-682-118; 115-282-975-661-270; 116-207-266-569-523; 117-187-486-696-736; 120-563-179-264-348; 120-608-201-690-850; 123-162-521-724-058; 127-036-128-295-646; 134-091-578-198-11X; 134-566-387-882-302; 136-496-274-260-381; 139-977-824-712-503; 144-147-683-674-862; 150-844-495-178-782; 156-474-738-767-083; 159-363-026-394-87X; 168-848-544-550-213; 168-970-501-986-999; 175-333-726-184-243,4
013-909-409-819-895,Processing Methods of Nanomaterials,,2017,book chapter,Defect Structure and Properties of Nanomaterials,,Elsevier,,Jenő Gubicza,"In this chapter, the processing methods of bulk nanomaterials and nanocrystalline particles are overviewed. Mostly, those techniques are presented here that are used for production of the materials studied in this book. These processing methods include “top-down” procedures that produce nanomaterials by severe plastic deformation, such as equal-channel angular pressing, high-pressure torsion, twist extrusion, and accumulative roll bonding. In addition, an overview of “bottom-up” synthesis methods of nanoparticles, such as inert gas condensation, electro-explosion of wire, sonochemical and hydrothermal syntheses, is also presented. In these processes, the particles are built up from individual atoms or from their clusters. Another route for production of nanostructured powders is milling, which is a “top-down” nanopowder processing technique. The powders obtained by either “top-down” or “bottom-up” methods can be sintered into bulk nanomaterials. The most frequently used consolidation techniques, e.g., hot isostatic pressing and spark plasma sintering, are described in this chapter. Finally, the details of electrodeposition of nanostructured thin films and nanocrystallization of bulk amorphous materials are presented.",,,1,25,Nanomaterials; Nanocrystalline material; Nanoparticle; Metallurgy; Materials science; Spark plasma sintering; Severe plastic deformation; Accumulative roll bonding; Hot isostatic pressing; Amorphous solid,,,,,https://www.sciencedirect.com/science/article/pii/B9780081019177000013,http://dx.doi.org/10.1016/b978-0-08-101917-7.00001-3,,10.1016/b978-0-08-101917-7.00001-3,2592667488,,0,003-891-466-202-474; 004-404-485-459-633; 007-129-308-529-472; 009-990-778-759-601; 013-806-152-106-782; 014-604-570-714-909; 015-965-126-987-089; 019-527-020-051-552; 022-162-806-401-787; 023-093-574-384-26X; 024-269-787-434-788; 025-859-703-889-635; 026-112-076-137-709; 026-624-956-773-585; 026-938-989-103-029; 030-377-168-565-098; 030-862-442-655-141; 031-456-184-225-087; 031-624-843-344-590; 032-553-736-749-809; 034-080-444-023-227; 034-173-972-841-963; 034-507-422-156-782; 035-477-484-369-929; 037-637-740-165-654; 043-249-576-783-751; 044-058-850-544-337; 045-506-499-854-137; 045-985-405-937-830; 054-301-319-361-210; 055-544-739-489-563; 058-551-127-401-924; 059-452-340-906-107; 061-685-839-214-619; 062-820-826-884-686; 064-929-492-637-053; 066-954-426-599-199; 069-460-602-313-76X; 073-053-283-985-265; 073-857-401-423-487; 074-379-388-352-671; 076-975-334-467-75X; 077-784-741-251-07X; 078-779-153-140-170; 080-192-972-113-941; 081-520-486-972-325; 082-516-419-204-427; 090-897-426-091-717; 091-627-053-629-647; 094-992-101-662-359; 100-324-371-352-539; 101-760-079-754-538; 111-267-116-994-180; 111-509-879-963-920; 113-149-719-445-194; 115-872-856-041-212; 117-117-404-907-269; 118-104-791-492-297; 119-426-921-253-349; 133-286-916-663-621; 141-491-024-045-142; 141-983-685-087-850; 142-128-153-689-809; 147-198-810-709-976; 152-302-343-458-570; 157-094-655-812-944; 197-709-006-833-517,0
014-284-920-627-718,Categorization of Next Generation Nanomaterials: International Cooperation on the Categorization of Nanomaterials in the Regulatory Chemical Context,2020-12-26,2020,,arXiv: Materials Science,,,,Maria J. Doa,"Categorization approaches have been effectively applied to chemicals, and many have tried to apply variations of these approaches to nanomaterials. Given the added complexities of nanomaterials, this has been challenging. International cooperation on categorization approaches has been made, primarily through the Organization for Economic Cooperation and Development. Progress has been limited given the complexities of nanomaterials, especially given the need to consider not only the intrinsic properties of the materials but also properties dependent on the system into which it is introduced. Consideration must also be given to the different purposes and contexts, in particular regulatory contexts, to which the categorization schemes would be applied. More progress can be anticipated by focusing on areas of overlap among countries such as physicochemical properties.",,,,,Materials science; Context (language use); Economic cooperation; Management science; Categorization,,,,,https://tw.arxiv.org/abs/2101.03870 https://uk.arxiv.org/abs/2101.03870 https://export.arxiv.org/abs/2101.03870 https://aps.arxiv.org/abs/2101.03870 https://arxiv.org/abs/2101.03870v1 https://arxiv.org/pdf/2101.03870,https://tw.arxiv.org/abs/2101.03870,,,3118350389,,0,022-610-727-309-831; 027-644-806-946-22X; 069-393-902-692-59X; 106-827-989-969-63X; 164-874-123-013-042,0
014-446-271-495-91X,The EU Regulation of Nanomaterials: Smoother or Harder? The Precautionary Tool Chest as the Basis for Better Regulating Nanomaterials,,2015,book chapter,Nanoengineering,,Elsevier,,Raphaël Gellert; Eugenio Mantovani; Paul De Hert,"Abstract This chapter discusses the current regulatory approach within the European Union (EU) to nanomaterials, with a focus on its (lack of) precautionary dimensions. A first section discusses the general policy framework: the 2008 and 2012 European Commission Communications containing the EU starting points for regulating nanomaterials. In these communications the Commission spells out its regulatory strategy for nanomaterials. The section also discusses the role of Joint Research Center and Scientific Committee on Emerging and Newly Identified Health Risks in collecting policy relevant data on nanomaterials and the idea of a nanomaterials registry. In a second section we pass in review applicable legislation. We explain how nanomaterials are addressed in Registration, Evaluation, Authorisation, and Restriction of Chemicals (REACH) and six other regulatory areas, and assess whether these regulatory instruments correspond to what was foreseen in the European Commission's general policy framework. When discussing REACH we will also highlight the role of expert groups that gravitate around this regulatory field: CASG, ECHA-NMWG, and Group Assessing Already Registered Nanomaterials. In a third section, we discuss whether the EU strategy can be qualified as precautionary, which we argue is an effective and indeed “harder” manner of regulating the risks stemming from nanomaterials. In doing so, we use the so-called “precautionary tool chest” developed by Myers et al. as a benchmark for sound implementation of the precautionary principle. In a final section we assess the precautionary dimension of the EU approach to nanomaterials. Our findings are far from optimist. Risks of nanomaterials are not taken into account adequately by the European legislator To remedy we discuss two possible regulatory strategies: adopting integrated legislation or pursuing the current scattered approach.",,,339,374,Authorization; Risk analysis (engineering); Engineering; Precautionary principle; Commission; Legislation; Legislator; European union; Joint research; European commission; Environmental engineering,,,,,https://research.tilburguniversity.edu/en/publications/the-eu-regulation-of-nanomaterials-smoother-or-harder-the-precaut https://researchportal.vub.be/en/publications/the-eu-regulation-of-nanomaterials-smoother-or-harder-the-precaut https://www.sciencedirect.com/science/article/pii/B9780444627476000129,http://dx.doi.org/10.1016/b978-0-444-62747-6.00012-9,,10.1016/b978-0-444-62747-6.00012-9,2480088638,,0,005-111-788-004-65X; 006-797-135-458-705; 010-617-581-013-080; 013-438-603-222-090; 018-257-794-835-269; 030-224-227-916-429; 032-408-559-110-084; 034-895-998-217-338; 048-712-829-990-446; 050-839-883-165-551; 054-193-593-436-937; 061-987-395-648-689; 084-148-606-620-852; 084-841-743-465-698; 094-219-171-222-887; 095-020-045-809-183; 101-357-685-684-832; 108-395-386-937-82X; 113-671-942-321-647; 119-246-686-882-322; 131-889-987-652-102; 144-183-371-020-307; 169-652-717-303-74X; 171-592-900-274-916; 199-294-641-920-741,0
014-505-496-682-238,Techniques for Investigating Molecular Toxicology of Nanomaterials.,2016-06-01,2016,journal article,Journal of biomedical nanotechnology,15507033,American Scientific Publishers,United States,Wang Yanli; Chenchen Li; Chenjie Yao; Lin Ding; Zhendong Lei; Minghong Wu,"Nanotechnology has been a rapidly developing field in the past few decades, resulting in the more and more exposure of nanomaterials to human. The increased applications of nanomaterials for industrial, commercial and life purposes, such as fillers, catalysts, semiconductors, paints, cosmetic additives and drug carriers, have caused both obvious and potential impacts on human health and environment. Nanotoxicology is used to study the safety of nanomaterials and has grown at the historic moment. Molecular toxicology is a new subdiscipline to study the interactions and impacts of materials at the molecular level. To better understand the relationship between the molecular toxicology and nanomaterials, this review summarizes the typical techniques and methods in molecular toxicology which are applied when investigating the toxicology of nanomaterials and include six categories: namely; genetic mutation detection, gene expression analysis, DNA damage detection, chromosomal aberration analysis, proteomics, and metabolomics. Each category involves several experimental techniques and methods.",12,6,1115,1135,Engineering; Nanotoxicology; Nanomaterials; Nanotechnology; Molecular Toxicology; Human health; Molecular level,,Genetic Techniques; Nanostructures/toxicity; Proteomics; Toxicology/methods,,,https://www.ncbi.nlm.nih.gov/pubmed/27319209 https://www.ingentaconnect.com/content/10.1166/jbn.2016.2220 https://pubmed.ncbi.nlm.nih.gov/27319209/ https://europepmc.org/abstract/MED/27319209,http://dx.doi.org/10.1166/jbn.2016.2220,27319209,10.1166/jbn.2016.2220,2340384234,,0,,9
014-715-701-617-44X,Hybrid nanomaterials as chemical sensors,,2020,book chapter,Multifunctional Hybrid Nanomaterials for Sustainable Agri-Food and Ecosystems,,Elsevier,,Khemchand Dewangan; Kamlesh Shrivas; Ramsingh Kurrey,"Abstract Pure nanomaterials are made from a single component whereas, as the name implies, hybrid nanomaterials (nanocomposites) are made of more than one component within the same matrix. Hence, hybrid nanomaterials are nanocomposites having at least one component in the nanodimension range. At present, nanocomposites have materialized as appropriate alternatives to surmount the boundaries of microcomposites and the pure single nanocounterpart. These materials are accounted as 21st century materials in their uniqueness and unusual properties with required design possibilities that are not available in the usual composites. Due to this distinctiveness of nanocomposites, researchers and engineers have devoted their efforts to develop materials for various kinds of basic and technological applications. However, hybrid nanomaterials face fabrication challenges related to controlling the stoichiometric composition of elements as well as the shape, size, and stability in the nanoscale. In this chapter, we have reviewed fundamental principles with design and preparation protocols of the hybridization of nanomaterials. Also, we have classified hybrid nanomaterials according to the interactions between components. Moreover, polymer-, carbon-, and noncarbonaceous-based nanocomposites are discussed. There are several studies suggesting that the hybridization of nanomaterials will play a vital role in the advancement of chemical sensors for high accuracy, sensitivity, response time, and life cycle. Therefore, the current chapter mainly focuses on the use of nanocomposites as chemical sensors in various fields such as biology, the environment, security, and many other related areas. In the near future, process scalability with specific morphology from the laboratory to the commercial scale is required. Also, advanced existing fabrication infrastructure and more theoretical simulation studies will be needed for a better understanding of the mechanism of the exceptional properties of nanocomposites. It is anticipated that this chapter will assist and serve as a small platform for future advancements of nanocomposite-based sensors with enhanced performance, desirable design potential, low cost, and an ecofriendly nature.",,,213,239,Fabrication; Nanomaterials; Nanotechnology; Stoichiometric composition; Single component; Computer science; Process (engineering); Scalability; Component (UML); Nanocomposite,,,,,https://www.sciencedirect.com/science/article/pii/B9780128213544000091,http://dx.doi.org/10.1016/b978-0-12-821354-4.00009-1,,10.1016/b978-0-12-821354-4.00009-1,3023453422,,0,000-197-515-622-354; 000-883-064-295-963; 002-152-476-359-402; 002-548-045-801-431; 003-142-358-136-010; 004-385-471-513-722; 005-687-613-330-965; 005-816-882-596-698; 006-363-181-231-829; 007-100-854-114-320; 011-505-245-313-789; 012-126-534-300-833; 013-078-023-106-994; 013-178-250-115-872; 013-979-490-258-16X; 014-271-672-899-294; 015-086-190-970-15X; 015-827-310-085-522; 015-838-559-521-063; 016-099-375-383-962; 016-299-163-967-17X; 016-374-033-674-210; 017-474-877-166-384; 018-307-748-292-382; 018-363-607-755-319; 021-881-860-469-197; 021-907-109-035-846; 022-728-761-159-156; 023-002-467-350-391; 024-462-007-648-764; 024-747-898-493-936; 024-991-285-884-613; 025-174-598-948-557; 027-236-681-772-058; 027-373-094-953-410; 027-867-193-555-207; 029-442-498-862-40X; 029-497-947-622-013; 030-158-445-802-179; 030-796-530-586-630; 030-941-905-275-731; 031-246-895-409-258; 031-367-601-624-210; 033-570-915-150-202; 037-235-313-120-10X; 037-925-131-862-91X; 038-226-244-060-87X; 038-514-552-468-638; 038-656-275-067-556; 039-884-799-440-279; 040-433-441-470-468; 042-397-095-646-412; 042-993-124-341-53X; 043-265-674-559-139; 044-173-816-556-215; 044-447-965-753-816; 046-378-241-778-07X; 047-060-149-224-361; 047-530-879-998-274; 048-898-632-409-898; 049-139-192-687-614; 050-229-167-950-702; 053-856-200-697-078; 055-723-835-627-296; 056-232-020-574-541; 058-979-001-887-575; 060-405-878-944-299; 060-537-568-782-41X; 062-463-499-411-837; 062-720-958-158-944; 063-381-030-371-53X; 063-479-381-311-497; 066-273-597-255-258; 067-049-698-952-298; 068-143-370-714-090; 070-105-833-645-023; 071-580-869-115-058; 072-622-058-961-962; 072-876-839-141-481; 073-202-781-475-889; 074-319-001-406-483; 077-415-312-899-392; 078-936-767-956-971; 079-241-618-494-65X; 080-233-431-633-598; 080-347-918-115-894; 080-584-108-523-879; 081-792-177-421-65X; 083-886-766-500-68X; 084-023-588-183-986; 084-714-377-888-612; 085-962-875-192-959; 089-346-747-625-584; 090-839-858-710-15X; 091-580-087-847-348; 091-870-421-612-989; 092-102-812-803-031; 097-705-090-089-247; 097-929-881-295-541; 100-199-377-793-212; 100-831-379-552-291; 101-267-886-591-06X; 102-121-840-293-811; 104-676-645-726-150; 106-999-366-521-119; 113-297-544-489-308; 116-467-125-631-160; 117-133-490-999-445; 119-025-636-425-669; 119-416-295-833-581; 122-587-751-462-61X; 125-147-859-566-189; 127-331-695-431-749; 130-848-499-106-500; 132-836-726-676-496; 133-286-916-663-621; 135-198-669-922-704; 135-500-965-194-873; 137-795-875-305-537; 142-354-841-018-30X; 147-524-608-920-568; 152-156-578-752-632; 158-576-166-416-519; 162-335-207-939-955; 163-808-214-737-853; 170-809-831-811-033; 173-671-386-840-150; 176-702-220-353-81X; 187-415-864-366-98X,0
014-837-978-840-500,Nanomaterials for cartilage tissue engineering,,2013,book chapter,Nanomaterials in Tissue Engineering,,Elsevier,,Eun Ji Chung; Nina Shah; Ramille N. Shah,"Abstract: This chapter discusses strategies that make use of nanomaterials for cartilage regeneration. In order to understand the necessary requirements for optimal tissue regeneration and design efficacious nanomaterials, cartilage structure and biology are first reviewed and an overview of current clinical strategies for cartilage repair is described. The chapter then discusses three emerging nanomaterials research areas including hydrogels, nanofibers, and nanocomposites. Particular emphasis is given to strategies that aim to regenerate articular cartilage.",,,301,334,Self-healing hydrogels; Nanomaterials; Regeneration (biology); Nanotechnology; Materials science; Cartilage; Cartilage tissue engineering; Cartilage repair; Research areas; Articular cartilage,,,,,https://www.sciencedirect.com/science/article/pii/B9780857095961500110 http://www.sciencedirect.com/science/article/pii/B9780857095961500110 https://www.scholars.northwestern.edu/en/publications/nanomaterials-for-cartilage-tissue-engineering,http://dx.doi.org/10.1533/9780857097231.2.301,,10.1533/9780857097231.2.301,45870004,,0,000-548-345-955-931; 000-684-995-093-145; 000-783-355-728-898; 001-255-126-380-899; 001-572-300-015-707; 003-317-504-525-092; 004-112-936-289-238; 004-562-336-307-381; 004-897-022-109-977; 005-469-707-109-676; 006-247-725-253-818; 006-290-961-581-69X; 006-380-210-759-775; 006-717-439-362-056; 006-770-084-212-763; 006-866-616-536-934; 007-427-337-722-840; 007-944-915-693-099; 009-504-272-342-802; 009-740-468-103-461; 009-846-861-587-779; 010-100-984-554-541; 010-324-817-422-173; 011-393-952-728-840; 011-497-100-942-413; 012-358-266-788-352; 013-727-786-179-208; 013-823-789-389-104; 015-873-959-887-893; 015-918-920-953-060; 016-209-932-780-229; 018-973-377-274-592; 019-210-732-786-455; 019-213-469-120-077; 019-638-323-214-189; 020-145-257-896-627; 020-185-937-196-671; 020-911-169-840-930; 021-147-019-317-218; 021-345-089-129-914; 021-523-565-892-857; 021-846-396-833-579; 022-422-058-941-11X; 022-852-605-409-158; 022-946-731-293-413; 022-962-623-483-615; 023-191-253-960-720; 023-492-955-332-218; 023-917-741-909-916; 024-529-277-792-620; 024-663-562-450-707; 025-470-655-160-149; 025-574-182-791-982; 026-114-357-229-430; 027-229-007-440-320; 028-999-848-882-956; 029-553-410-640-565; 029-777-643-857-805; 029-782-392-385-191; 030-679-888-036-534; 032-608-702-487-148; 033-240-559-750-057; 033-344-674-939-679; 033-449-157-365-671; 033-886-454-787-534; 034-153-671-990-844; 035-227-895-664-875; 035-468-719-667-492; 035-795-729-195-511; 035-875-509-465-946; 037-102-034-281-526; 039-395-889-872-852; 040-691-145-134-699; 040-811-851-761-546; 041-740-643-701-806; 043-659-133-703-929; 043-674-907-736-237; 045-265-499-150-768; 045-767-713-337-962; 047-431-402-280-878; 048-466-154-724-797; 049-058-558-177-80X; 049-376-871-788-053; 050-224-949-456-327; 050-229-564-961-464; 050-621-517-972-220; 050-948-313-143-468; 050-953-427-390-244; 051-000-386-003-044; 051-662-829-379-829; 052-407-311-109-507; 056-340-242-529-605; 056-713-324-712-066; 060-024-909-103-427; 060-909-081-721-492; 061-883-204-431-73X; 064-817-578-229-177; 066-463-204-807-646; 066-607-008-231-977; 068-333-867-366-615; 068-885-284-663-517; 069-368-181-697-002; 069-810-581-254-103; 069-862-695-626-723; 072-256-908-358-768; 072-497-976-765-418; 073-969-860-386-482; 074-017-344-602-108; 074-603-715-766-024; 076-597-070-505-373; 076-631-561-308-573; 077-678-629-346-504; 077-876-094-299-840; 078-090-309-950-701; 080-068-733-744-174; 081-013-195-095-40X; 081-527-827-516-275; 082-907-724-167-130; 083-905-841-919-191; 084-448-472-852-408; 085-288-663-884-88X; 087-577-193-765-600; 087-635-007-799-86X; 088-653-592-333-272; 089-449-380-851-922; 089-647-590-634-405; 089-663-728-774-41X; 090-730-781-641-897; 092-929-292-266-644; 094-308-913-371-895; 094-865-761-400-109; 096-697-617-737-447; 099-231-174-763-092; 099-621-824-840-488; 100-743-815-411-277; 100-928-933-005-553; 103-156-457-724-371; 105-265-232-782-04X; 106-471-493-201-040; 106-629-485-233-509; 107-549-566-557-114; 111-234-068-452-836; 111-586-307-063-723; 112-647-374-909-832; 113-542-385-996-754; 114-643-751-643-094; 114-756-589-524-345; 114-920-812-702-952; 115-540-394-331-256; 116-858-669-988-158; 116-987-998-961-037; 121-343-103-912-507; 130-277-330-035-034; 130-883-276-503-270; 132-682-215-714-359; 135-084-110-625-287; 138-449-497-449-019; 139-151-059-661-719; 140-584-259-502-527; 143-116-780-284-69X; 143-430-975-105-212; 145-083-334-024-999; 150-574-002-180-917; 151-546-314-781-197; 154-091-888-904-062; 155-826-108-872-751; 162-238-895-040-083; 169-304-297-154-176; 176-994-555-474-91X; 182-530-975-907-576; 187-470-076-110-766; 192-523-766-185-009; 193-495-621-757-96X; 198-877-721-569-240,1
014-853-096-133-281,Impact of Nanomaterials on Health and Environment,2012-10-13,2012,journal article,Arabian Journal for Science and Engineering,13198025; 21914281,Springer Science and Business Media LLC,Saudi Arabia,Selvin P. Thomas; Eid M. Al-Mutairi; S. K. De,"Humans have been exposed to airborne nanosized materials (<100 nm) throughout the millennia, but the extent of exposure has increased significantly since the industrial revolution with special reference to the combustion processes. The advent of nanotechnology in the last 2 decades has further increased the risk of exposure of nanomaterials through one of the following routes; inhalation, ingestion, dermal and drug delivery using engineered nanomaterials. Conversion from bulk state to nanosize imparts new properties to the nanomaterials in regard to mechanical, electrical, optical, catalytic activity, and lastly, but not the least, the biological activity. Toxicological effects of nanomaterials need to be examined during a product’s lifecycle including manufacture, use and disposal. The health hazards and safety considerations of nanomaterials need further attention and basic interdisciplinary research work is called for involving materials scientists, toxicologists, medical practitioners and environmental engineers.",38,3,457,477,Nanomaterials; Health impact of nanotechnology; Nanotechnology; Materials science; Human health; Engineered nanomaterials,,,,,https://link.springer.com/article/10.1007%2Fs13369-012-0324-0,http://dx.doi.org/10.1007/s13369-012-0324-0,,10.1007/s13369-012-0324-0,2044912539,,0,000-250-674-780-085; 001-333-784-631-793; 001-387-040-564-448; 002-246-110-683-600; 003-205-424-117-455; 003-279-613-890-828; 003-518-280-828-035; 003-655-028-070-040; 004-134-130-843-567; 005-442-422-007-844; 005-643-404-648-278; 006-793-716-614-966; 007-716-188-729-010; 007-782-656-416-177; 007-827-496-905-540; 007-839-970-402-288; 008-026-084-779-329; 008-163-738-795-688; 008-668-764-473-037; 008-946-003-442-794; 009-302-999-639-791; 009-551-348-198-985; 009-858-333-233-094; 010-544-724-684-160; 011-292-340-588-581; 011-344-587-439-539; 011-531-864-098-685; 012-063-997-033-393; 013-046-200-535-620; 013-088-915-642-089; 013-333-870-142-211; 013-355-683-940-901; 013-999-353-516-175; 014-670-058-130-002; 015-222-865-559-806; 016-084-358-875-760; 016-675-702-692-31X; 016-893-458-140-69X; 017-117-638-011-558; 017-428-507-694-908; 018-979-482-513-791; 019-829-208-968-841; 020-140-446-800-29X; 021-384-277-650-653; 021-722-932-907-355; 021-922-515-618-532; 022-289-295-001-578; 022-878-943-408-030; 023-939-293-077-462; 024-503-898-212-187; 025-489-829-451-836; 027-373-674-382-183; 028-393-725-789-800; 029-736-168-443-388; 030-517-471-364-311; 030-664-774-417-062; 030-862-619-503-216; 031-410-368-468-346; 031-633-185-596-546; 031-874-014-281-897; 032-773-907-065-634; 033-010-124-019-587; 033-427-841-712-900; 034-153-973-412-118; 034-710-371-999-985; 035-472-617-858-521; 035-883-712-822-136; 035-964-714-457-456; 035-967-457-420-41X; 036-134-994-588-277; 036-163-695-473-392; 037-936-041-485-683; 040-782-969-198-760; 041-485-307-271-581; 041-949-515-090-278; 042-543-444-551-351; 043-485-193-521-820; 043-696-090-653-951; 045-086-434-839-253; 045-109-673-802-465; 045-571-514-720-710; 047-857-180-956-040; 050-364-954-558-111; 050-666-528-694-851; 050-795-119-131-32X; 051-798-691-140-761; 052-664-112-898-248; 054-421-089-451-945; 054-632-913-767-13X; 054-865-268-428-246; 055-921-408-762-204; 057-043-079-025-284; 058-010-572-219-571; 059-138-746-563-444; 059-349-204-715-845; 061-160-864-596-143; 062-584-435-112-070; 062-690-270-267-750; 065-178-739-597-332; 065-330-154-967-506; 067-669-849-619-36X; 069-972-054-570-368; 072-232-249-974-463; 072-242-647-492-338; 073-548-790-294-826; 073-802-985-102-012; 073-814-474-169-74X; 075-748-860-169-30X; 075-774-440-937-666; 076-944-039-530-89X; 077-197-722-043-236; 077-599-990-663-732; 078-895-185-228-394; 079-142-354-376-006; 082-468-008-022-334; 083-026-550-466-902; 084-395-025-540-414; 084-778-286-968-118; 085-312-333-860-727; 087-562-353-901-279; 088-694-109-950-950; 089-088-402-059-979; 089-556-369-217-297; 089-620-652-656-643; 091-313-014-681-467; 091-935-872-852-708; 094-377-725-226-390; 096-987-221-456-011; 097-754-330-549-662; 098-327-629-083-887; 098-443-959-952-430; 099-392-943-523-665; 099-813-130-465-915; 100-402-378-886-542; 105-103-075-942-510; 105-561-738-840-135; 105-797-802-882-358; 106-079-664-323-67X; 106-568-076-764-492; 107-087-739-556-993; 107-687-984-927-611; 108-886-617-784-602; 110-897-665-338-346; 112-300-100-233-043; 113-206-721-948-530; 116-319-271-849-569; 116-390-294-041-601; 122-236-808-130-823; 122-893-645-100-653; 123-526-095-108-395; 124-792-866-298-114; 130-250-877-972-793; 140-710-991-078-637; 141-536-310-372-95X; 141-582-867-379-654; 144-633-281-409-971; 145-389-945-271-093; 146-463-377-130-020; 152-277-361-338-917; 160-761-269-195-348; 162-327-904-815-392; 162-569-135-580-761; 174-934-877-581-438; 175-179-504-652-029; 177-029-255-132-856; 177-427-412-089-892; 186-056-887-731-62X; 193-027-720-620-611; 196-703-314-113-841; 198-822-678-134-293,19
014-919-796-124-086,Advances in nanomaterials for treatment of hypoxic tumor,2020-07-08,2020,journal article,National Science Review,20955138; 2053714x,Oxford University Press (OUP),United Kingdom,Mei-Zhen Zou; Wen-Long Liu; Han-Shi Chen; Xue-Feng Bai; Fan Gao; Jing-Jie Ye; Han Cheng; Xian-Zheng Zhang,"The hypoxic tumor microenvironment is characterized by disordered vasculature and rapid proliferation of tumors, resulting from tumor invasion, progression and metastasis. The hypoxic conditions restrict efficiency of tumor therapies, such as chemotherapy, radiotherapy, phototherapy and immunotherapy, leading to serious results of tumor recurrence and high mortality. Recently, research has concentrated on developing functional nanomaterials to treat hypoxic tumors. In this review, we categorize such nanomaterials into (i) nanomaterials that elevate oxygen levels in tumors for enhanced oxygen-dependent tumor therapy and (ii) nanomaterials with diminished oxygen dependence for hypoxic tumor therapy. To elevate oxygen levels in tumors, oxygen-carrying nanomaterials, oxygen-generating nanomaterials and oxygen-economizing nanomaterials can be used. To diminish oxygen dependence of nanomaterials for hypoxic tumor therapy, therapeutic gas-generating nanomaterials and radical-generating nanomaterials can be used. The biocompatibility and therapeutic efficacy of these nanomaterials are discussed.",8,2,,,Nanomaterials; Chemotherapy; Immunotherapy; Metastasis; Tumor therapy; High mortality; Hypoxic tumor; Cancer research; Radiation therapy; Medicine,,,,National Natural Science Foundation of China; National Natural Science Foundation of China; National Natural Science Foundation of China; National Natural Science Foundation of China,https://academic.oup.com/nsr/article/8/2/nwaa160/5868788 https://www.sciengine.com/publisher/scp/journal/NSR/8/2/10.1093/nsr/nwaa160?slug=fulltext,http://dx.doi.org/10.1093/nsr/nwaa160,,10.1093/nsr/nwaa160,3041208438,,0,000-419-605-769-027; 000-833-383-585-639; 001-478-999-795-223; 001-591-424-472-460; 003-454-409-102-99X; 005-838-333-391-363; 006-499-235-549-385; 006-628-993-666-116; 007-738-025-993-447; 008-843-894-034-53X; 009-000-305-563-195; 009-493-855-216-313; 009-802-416-726-457; 010-342-417-481-069; 011-048-525-107-268; 011-391-084-605-787; 012-157-935-873-490; 012-312-909-403-695; 012-322-656-838-605; 012-382-220-822-797; 013-179-228-961-583; 013-779-949-902-291; 013-971-148-586-348; 013-973-158-972-479; 014-173-927-591-306; 014-850-859-557-004; 015-389-410-768-067; 015-398-607-007-581; 015-857-626-727-939; 015-884-353-491-345; 016-510-205-812-354; 017-672-076-943-283; 017-797-732-238-515; 018-041-202-885-383; 018-119-019-104-160; 018-250-090-176-056; 018-293-980-004-862; 019-892-125-646-216; 019-978-825-965-944; 020-249-711-205-862; 021-131-426-863-498; 021-190-126-971-040; 021-475-198-669-851; 021-929-265-808-772; 022-170-888-709-362; 023-312-305-375-805; 023-939-488-795-384; 023-961-400-547-150; 025-413-209-054-361; 026-166-577-478-812; 026-614-607-266-869; 029-305-418-685-693; 029-361-482-623-581; 029-714-345-035-549; 029-759-096-932-677; 030-314-770-285-998; 030-591-685-287-177; 030-901-563-487-358; 030-984-412-755-438; 031-086-770-207-062; 031-874-767-786-873; 032-956-524-973-530; 033-758-456-907-169; 034-221-877-521-703; 034-353-011-108-63X; 034-651-273-290-641; 035-540-364-544-373; 037-251-211-825-66X; 037-522-497-430-752; 037-805-966-478-792; 038-190-225-848-010; 038-690-114-453-084; 038-987-079-049-824; 039-124-468-658-458; 039-282-891-571-900; 039-659-759-219-755; 040-339-621-321-231; 040-857-460-300-201; 041-558-261-371-732; 042-247-547-979-733; 042-312-276-675-823; 042-476-852-284-961; 044-010-284-055-906; 045-048-157-209-490; 045-163-219-961-105; 045-468-904-243-408; 046-542-661-385-020; 047-141-640-031-230; 047-330-502-245-583; 048-422-110-333-490; 048-785-265-205-349; 048-881-391-777-372; 049-652-515-368-448; 049-698-398-829-383; 050-913-382-941-99X; 051-275-240-425-917; 051-768-403-310-096; 055-135-055-743-682; 056-229-123-172-468; 057-095-548-432-793; 057-217-831-563-29X; 058-868-573-822-804; 058-928-039-743-964; 059-226-960-616-340; 059-285-779-244-706; 060-163-211-485-443; 061-363-051-420-810; 062-177-592-298-085; 063-950-810-914-010; 065-109-399-073-401; 065-490-130-043-475; 065-923-266-259-882; 068-906-301-689-082; 069-591-303-363-302; 071-270-765-919-445; 071-632-611-204-645; 073-227-655-232-342; 082-280-133-855-859; 084-115-784-524-563; 084-205-540-462-836; 085-727-459-159-21X; 087-347-179-441-657; 088-868-017-258-550; 089-266-717-835-185; 096-893-157-800-502; 101-487-456-989-611; 103-668-754-470-792; 103-833-085-156-646; 104-851-820-273-749; 106-560-690-607-917; 107-316-161-800-756; 108-089-673-173-695; 109-684-600-668-796; 111-648-962-492-04X; 111-684-888-464-54X; 120-851-580-970-050; 122-972-140-748-476; 126-481-547-846-915; 134-627-210-862-652; 137-395-779-300-725; 138-185-878-351-748; 144-095-484-396-992; 144-819-315-028-014; 146-504-112-765-360; 149-391-960-767-722; 160-031-247-379-985; 173-050-719-708-616; 178-481-053-274-36X; 188-828-747-762-854,5
015-000-579-984-250,Research Progress of Nanomaterials-based Mercury Ions Sensors,,2011,journal article,Environment and Ecology in the Three Gorges,,,,LI Nian-bing,The development of nanomaterials-based mercury ions sensors is summarized in this paper.The introduction focuses on the applications of nanomaterials in mercury ions sensors as well as the construction and operation of the DNA-integrated nanomaterials mercury ion sensors.,,,,,Environmental chemistry; Nanomaterials; Ion; Nanotechnology; Materials science; Mercury (element),,,,,https://en.cnki.com.cn/Article_en/CJFDTOTAL-SXHS201103012.htm,https://en.cnki.com.cn/Article_en/CJFDTOTAL-SXHS201103012.htm,,,2361095557,,0,,0
015-134-970-930-689,Black titanium dioxide (TiO2) nanomaterials,2015-01-15,2015,journal article,Chemical Society reviews,14604744; 03060012,Royal Society of Chemistry,United Kingdom,Xiaobo Chen; Lei Liu; Fuqiang Huang,"In the past few decades, there has been a wide research interest in titanium dioxide (TiO2) nanomaterials due to their applications in photocatalytic hydrogen generation and environmental pollution removal. Improving the optical absorption properties of TiO2 nanomaterials has been successfully demonstrated to enhance their photocatalytic activities, especially in the report of black TiO2 nanoparticles. The recent progress in the investigation of black TiO2 nanomaterials has been reviewed here, and special emphasis has been given on their fabrication methods along with their various chemical/physical properties and applications.",44,7,1861,1885,Nanomaterials; Nanotechnology; Materials science; Hydrogen production; Titanium dioxide; Environmental pollution; Tio2 nanoparticles; Fabrication methods; Photocatalysis,,,,,https://pubmed.ncbi.nlm.nih.gov/25590565/ http://pubs.rsc.org/en/content/articlehtml/2015/cs/c4cs00330f http://xlink.rsc.org/?DOI=C4CS00330F https://www.ncbi.nlm.nih.gov/pubmed/25590565 http://pubs.rsc.org/en/content/articlelanding/2015/cs/c4cs00330f https://pubs.rsc.org/en/content/articlelanding/2015/cs/c4cs00330f,http://dx.doi.org/10.1039/c4cs00330f,25590565,10.1039/c4cs00330f,1992345514,,5,001-187-709-491-687; 001-741-686-210-680; 001-886-166-108-25X; 002-084-420-400-961; 002-279-365-643-88X; 002-948-566-071-828; 003-174-069-551-126; 003-208-418-214-607; 004-215-061-242-198; 005-272-024-554-405; 005-637-635-011-273; 005-816-256-214-592; 005-867-333-060-399; 006-319-830-670-55X; 006-363-181-231-829; 006-441-457-171-902; 008-057-351-297-829; 008-078-901-974-840; 008-257-571-835-103; 009-493-855-216-313; 010-173-592-439-648; 010-238-564-434-975; 010-287-198-072-492; 010-557-013-182-28X; 010-839-848-485-540; 012-019-048-216-640; 012-019-304-449-030; 012-728-030-226-092; 012-794-376-893-357; 012-882-772-047-566; 013-450-906-063-324; 013-527-879-904-281; 014-315-743-987-921; 014-336-377-538-570; 015-549-396-243-087; 017-512-535-048-390; 017-564-730-101-585; 017-572-955-350-179; 018-170-125-537-123; 018-792-060-664-16X; 018-806-768-738-915; 019-186-396-342-996; 019-290-096-142-642; 019-714-881-978-070; 020-931-114-322-755; 021-868-827-221-425; 022-178-741-343-26X; 023-144-567-721-675; 023-706-932-267-16X; 026-216-581-702-285; 026-292-987-779-05X; 026-471-991-683-492; 026-647-882-671-739; 026-982-051-071-896; 028-272-331-168-429; 028-538-195-622-206; 028-792-922-735-746; 029-050-858-297-713; 029-052-095-659-366; 029-107-195-608-545; 029-229-881-231-077; 029-382-851-729-449; 029-767-914-588-645; 030-502-076-371-464; 031-020-588-207-929; 031-106-862-151-719; 031-663-644-537-64X; 032-726-416-604-910; 032-873-970-032-702; 033-239-561-121-788; 034-158-598-091-457; 034-361-338-146-136; 035-430-006-617-061; 037-872-554-734-50X; 038-233-672-393-828; 038-596-664-916-759; 039-342-055-427-577; 039-399-609-605-900; 039-739-067-098-550; 041-686-516-701-171; 042-223-493-834-312; 042-224-997-570-87X; 042-467-590-401-894; 042-486-789-061-624; 043-067-611-669-923; 043-071-759-309-678; 043-531-155-617-092; 043-935-177-367-742; 045-438-571-357-214; 048-610-500-400-749; 049-673-821-601-458; 050-257-567-176-937; 050-669-368-026-953; 051-253-888-911-267; 051-320-002-282-340; 051-386-435-222-054; 052-032-846-962-813; 052-548-827-124-504; 052-810-698-768-143; 053-058-949-005-196; 053-586-544-770-614; 054-600-617-330-738; 055-432-110-238-373; 056-264-853-428-190; 056-752-377-876-875; 056-869-878-587-595; 058-062-165-168-556; 058-347-340-316-202; 058-546-968-903-13X; 060-959-843-499-011; 061-776-377-875-570; 062-285-706-631-682; 062-615-264-004-460; 062-629-221-073-543; 062-638-250-853-228; 063-737-843-582-830; 064-062-390-485-563; 064-257-056-523-819; 064-285-696-583-105; 065-292-902-900-645; 065-484-990-211-431; 066-389-375-980-82X; 066-983-313-915-864; 067-689-095-489-869; 067-990-130-468-303; 068-955-546-562-849; 071-790-184-394-651; 071-957-286-489-303; 071-974-729-302-988; 074-741-372-675-926; 075-664-557-457-415; 076-048-467-080-228; 078-021-398-784-776; 078-411-952-044-112; 078-935-690-642-135; 079-348-848-107-328; 080-919-456-723-916; 082-182-381-523-811; 082-713-418-797-171; 083-406-950-235-024; 085-289-080-078-75X; 085-878-705-370-204; 086-134-795-081-629; 086-357-898-689-352; 086-795-317-005-662; 088-301-495-115-717; 088-507-436-472-224; 089-762-458-514-928; 089-907-463-717-759; 090-528-161-647-64X; 090-924-554-269-306; 091-161-013-306-876; 091-689-186-592-028; 093-870-352-713-040; 093-938-824-670-105; 096-949-489-475-099; 100-522-029-628-656; 100-686-336-962-225; 102-056-467-980-446; 102-407-065-345-37X; 102-594-565-691-961; 102-770-613-336-017; 103-638-957-789-632; 104-172-407-780-54X; 104-394-877-549-768; 105-683-269-372-441; 106-092-664-249-867; 112-497-301-393-504; 113-240-447-833-253; 116-790-595-689-906; 117-163-040-672-557; 117-488-761-562-134; 118-072-407-338-858; 119-479-999-721-068; 120-819-543-178-080; 122-283-622-525-917; 122-461-854-495-98X; 122-653-194-933-230; 122-875-452-350-948; 124-554-586-263-079; 127-843-026-017-232; 134-455-374-279-14X; 136-568-998-097-946; 137-057-028-807-240; 138-599-281-259-463; 139-735-785-120-65X; 140-018-737-213-521; 140-273-439-335-692; 140-564-411-117-554; 141-172-315-399-700; 142-396-542-007-788; 157-491-833-099-141; 163-494-053-081-937; 165-455-013-380-597; 165-512-551-331-555; 167-832-384-125-96X; 171-260-558-263-419; 192-561-465-831-684; 193-260-166-951-384,880
015-145-309-566-312,The Role of Nanomaterials in Translational Medicine,2011-05-24,2011,journal article,ACS nano,1936086x; 19360851,American Chemical Society,United States,Erin B. Lavik; Horst A. von Recum,"There are a range of definitions for nanomaterials and a range of length scales that are considered nano, but one thing is consistent among fields: nanomaterials are small and special. Nanomaterials have the potential to have tremendous impact on medical treatments. In one example, nanomaterials are permitting the tracking of cells via magnetic resonance imaging (MRI) in clinical trials to assess the efficacy and safety of cellular therapies. In a second example, nanomaterials are acting as drug-delivery vehicles for the targeted delivery of therapies to increase efficacy and to reduce side effects. However, there are distinct challenges that must be considered in the development and application of these materials, including careful analysis of the distribution and clearance of nanomaterials and their potential off-target effects. By carefully assessing materials early in their development at the bench, one may be able to move successful approaches through to the clinic more rapidly, which is indeed the goal of the field. For far too many conditions and diseases, the tools we have are less than adequate, and nanomaterials have the potential to fill that void. To realize this potential, investigators must be willing to invest time and resources to develop and to translate these technologies to the point where the risk is low enough that they have real, commercial possibilities. Working collaboratively and leveraging resources and experience play important roles in moving technologies through preclinical and clinical testing. It requires incredible dedication of teams of researchers, but the result is new treatments and therapies.",5,5,3419,3424,Risk analysis (engineering); Nanomaterials; Nanomedicine; Translational medicine; Nanotechnology; Computer science,,Biomedical Research/trends; Nanomedicine/trends; Nanostructures/therapeutic use; Translational Medical Research/trends,,NIH HHS (DP2 OD007338) United States; NIH HHS (DP2 OD007338-01) United States,https://mdsoar.org/bitstream/11603/21202/1/nihms298993.pdf https://pubs.acs.org/doi/10.1021/nn201371a http://europepmc.org/articles/PMC3110679 https://pubs.acs.org/doi/abs/10.1021/nn201371a https://mdsoar.org/handle/11603/21202 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3110679/,http://dx.doi.org/10.1021/nn201371a,21604811,10.1021/nn201371a,2062007574,PMC3110679,0,004-396-127-200-528; 005-539-194-351-029; 009-214-731-191-72X; 012-385-213-958-585; 018-133-315-424-653; 021-246-163-054-33X; 023-000-764-832-275; 025-453-019-428-154; 039-372-990-350-715; 039-901-699-513-356; 042-839-536-917-990; 044-642-505-186-391; 045-250-542-705-705; 045-425-765-916-800; 046-033-220-590-234; 047-117-669-448-777; 049-767-907-303-803; 053-847-729-961-604; 056-935-906-239-268; 059-170-516-978-302; 063-523-585-352-624; 066-753-132-696-689; 068-208-623-552-806; 077-053-369-079-111; 091-453-660-163-052; 115-972-294-054-30X; 122-298-496-424-171; 137-388-057-905-524; 167-474-776-806-863; 179-272-349-770-018,61
015-258-258-729-45X,Assembly and Electronic Applications of Colloidal Nanomaterials.,2016-11-15,2016,journal article,"Advanced materials (Deerfield Beach, Fla.)",15214095; 09359648,Wiley-Blackwell,United States,Jian Zhu; Mark C. Hersam,"Artificial solids and thin films assembled from colloidal nanomaterials give rise to versatile properties that can be exploited in a range of technologies. In particular, solution-based processes allow for the large-scale and low-cost production of nanoelectronics on rigid or mechanically flexible substrates. To achieve this goal, several processing steps require careful consideration, including nanomaterial synthesis or exfoliation, purification, separation, assembly, hybrid integration, and device testing. Using a ubiquitous electronic device – the field-effect transistor – as a platform, colloidal nanomaterials in three electronic material categories are reviewed systematically: semiconductors, conductors, and dielectrics. The resulting comparative analysis reveals promising opportunities and remaining challenges for colloidal nanomaterials in electronic applications, thereby providing a roadmap for future research and development.",29,4,1603895,,Semiconductor; Exfoliation joint; Nanomaterials; Nanoelectronics; Field-effect transistor; Nanotechnology; Transistor; Thin film; Materials science; Colloid,field-effect transistors; monodisperse; nanocrystals; nanotubes; two-dimensional nanomaterials,,,Office of Naval Research; National Science Foundation,https://onlinelibrary.wiley.com/doi/full/10.1002/adma.201603895 http://europepmc.org/abstract/MED/27862354 https://www.scholars.northwestern.edu/en/publications/assembly-and-electronic-applications-of-colloidal-nanomaterials https://www.ncbi.nlm.nih.gov/pubmed/27862354,http://dx.doi.org/10.1002/adma.201603895,27862354,10.1002/adma.201603895,2553453500,,0,000-174-097-344-918; 000-406-021-816-157; 000-510-552-539-670; 000-553-915-162-578; 000-574-383-389-714; 000-667-994-866-164; 000-718-009-053-444; 000-757-933-741-164; 000-797-335-079-875; 000-964-004-269-880; 001-060-710-361-216; 001-173-749-418-487; 001-256-992-299-805; 001-377-612-017-767; 001-421-123-981-630; 001-534-881-716-669; 001-610-606-288-833; 001-973-748-052-175; 002-606-647-884-02X; 002-902-024-446-716; 003-041-233-978-385; 003-140-336-028-036; 003-261-336-925-520; 003-273-078-820-336; 003-373-714-203-426; 003-462-643-868-280; 003-864-123-836-842; 003-890-196-636-04X; 003-917-005-774-181; 003-982-367-587-042; 004-008-930-180-178; 004-042-741-062-956; 004-158-787-369-261; 004-358-046-841-334; 004-442-939-322-63X; 004-504-427-817-592; 004-693-881-315-280; 004-798-972-396-232; 004-805-168-985-67X; 004-812-897-697-569; 005-521-533-049-938; 005-535-942-080-511; 005-554-695-987-717; 005-898-453-634-491; 006-037-905-384-289; 006-167-254-418-195; 006-227-615-855-991; 006-282-928-363-834; 006-392-346-465-387; 006-457-845-920-967; 006-619-015-281-608; 006-894-777-313-000; 007-170-014-948-983; 007-870-720-616-254; 008-057-351-297-829; 008-115-474-342-354; 008-230-830-648-59X; 008-568-075-509-155; 008-915-553-825-78X; 009-137-691-809-76X; 009-154-526-605-362; 009-499-206-146-375; 009-553-123-523-272; 009-827-051-207-304; 009-878-816-869-538; 009-894-616-186-29X; 010-402-241-968-587; 010-492-957-428-238; 010-626-005-473-833; 010-855-011-797-809; 011-053-077-523-714; 011-335-770-945-451; 011-966-158-929-114; 012-202-991-289-045; 012-327-284-849-989; 012-479-220-677-041; 012-578-712-060-228; 013-333-042-042-40X; 013-335-607-244-455; 013-364-541-376-705; 013-434-875-807-73X; 013-998-774-419-889; 014-149-382-877-899; 014-252-888-384-35X; 014-320-911-510-054; 014-364-229-556-45X; 014-498-097-025-131; 014-706-541-105-095; 015-173-679-317-16X; 015-243-511-016-700; 015-497-519-614-65X; 015-868-315-148-941; 016-248-923-039-481; 016-262-330-602-022; 016-280-671-961-508; 016-377-336-113-828; 016-867-191-947-97X; 017-029-927-882-763; 017-123-366-122-211; 017-219-422-140-315; 017-257-041-150-699; 017-300-648-244-676; 017-425-362-098-895; 017-960-618-078-658; 018-060-646-031-569; 018-169-121-181-897; 018-346-276-248-35X; 018-464-772-284-090; 018-563-973-380-605; 018-885-841-830-67X; 018-919-337-623-930; 019-153-459-223-804; 019-422-723-824-821; 019-798-948-856-539; 019-862-701-211-732; 020-029-364-303-737; 020-360-638-764-347; 020-491-639-409-312; 021-035-769-752-765; 021-222-900-759-596; 021-241-462-996-391; 021-249-351-800-487; 021-868-098-966-936; 021-900-175-259-037; 021-934-508-257-140; 022-272-864-069-214; 022-502-454-040-620; 022-615-304-454-319; 022-688-732-592-934; 022-954-588-225-396; 023-442-195-728-547; 023-580-759-100-604; 023-599-172-482-156; 024-310-988-971-004; 024-312-623-798-375; 024-551-437-809-091; 024-586-021-229-704; 024-835-276-670-803; 025-352-206-174-45X; 025-481-790-372-586; 025-542-697-697-745; 025-599-356-337-351; 025-822-353-945-123; 025-844-533-183-397; 025-889-266-984-42X; 026-014-789-256-899; 026-212-638-729-529; 026-264-345-326-704; 026-372-051-103-386; 026-454-682-394-289; 026-740-006-286-239; 027-042-248-746-224; 027-190-106-516-655; 027-436-956-440-375; 027-475-703-267-027; 027-793-227-329-920; 028-632-911-689-729; 028-822-434-716-022; 028-998-134-148-130; 029-013-942-492-711; 029-195-502-857-086; 029-288-167-303-280; 029-378-113-770-325; 029-449-098-987-459; 029-829-025-098-268; 030-064-442-251-802; 030-120-325-751-297; 030-269-869-154-090; 030-392-638-957-586; 031-006-435-525-650; 031-091-135-199-602; 031-465-552-772-522; 031-470-812-058-154; 031-513-215-925-309; 032-094-463-411-094; 032-175-225-720-902; 032-178-375-442-833; 032-226-352-399-645; 032-248-811-381-549; 032-737-750-311-754; 032-910-816-986-911; 033-357-713-717-490; 033-760-398-037-881; 033-918-623-285-329; 033-978-247-926-878; 034-148-183-963-613; 034-589-298-812-616; 034-649-952-681-051; 034-693-598-673-427; 034-998-693-917-677; 035-035-585-238-401; 035-129-012-530-787; 035-632-564-919-924; 035-671-572-219-794; 036-397-375-774-198; 036-535-858-910-230; 036-865-241-624-72X; 037-473-241-376-918; 037-690-656-256-767; 038-195-855-304-141; 038-491-171-631-156; 038-618-341-315-240; 038-838-270-411-992; 039-360-752-095-167; 039-437-971-955-422; 039-712-366-806-684; 039-835-966-396-666; 039-978-439-064-772; 040-313-430-660-964; 040-318-900-161-047; 040-366-509-677-258; 040-453-056-699-205; 040-519-810-655-36X; 040-613-247-410-320; 040-755-735-970-160; 041-156-470-448-693; 041-189-569-342-777; 041-224-490-567-763; 041-375-796-082-054; 041-735-819-555-464; 042-158-030-404-027; 042-197-131-449-576; 042-887-250-266-981; 043-341-447-197-328; 043-468-055-795-300; 043-479-153-210-349; 043-556-024-442-967; 044-162-521-518-63X; 044-176-053-770-689; 044-692-426-069-934; 044-733-537-196-352; 045-401-588-761-61X; 045-471-693-947-006; 045-541-494-352-22X; 045-593-633-966-585; 045-660-169-220-807; 045-929-305-029-919; 046-336-852-243-239; 046-520-497-369-901; 046-962-968-182-683; 047-040-669-330-370; 047-738-977-996-857; 048-344-023-929-797; 048-718-326-981-756; 048-742-343-220-596; 048-853-533-106-980; 049-090-795-106-220; 049-177-253-233-067; 049-331-159-154-234; 049-420-447-887-066; 049-815-518-629-686; 050-148-129-952-200; 050-641-354-754-365; 050-694-637-397-600; 050-777-633-736-023; 050-792-641-519-956; 051-078-655-126-035; 051-593-910-005-73X; 051-692-251-511-383; 052-816-226-025-090; 053-078-703-397-853; 054-031-334-390-91X; 054-073-909-805-668; 054-780-525-372-296; 054-963-589-748-741; 055-355-309-374-245; 055-487-676-430-24X; 055-726-536-896-860; 055-865-704-840-015; 055-866-068-762-558; 056-352-961-176-701; 056-497-584-408-577; 056-929-855-122-893; 057-144-708-545-868; 057-685-341-909-769; 058-156-350-491-184; 058-247-772-053-92X; 059-212-942-333-622; 059-503-156-924-10X; 059-775-165-495-182; 060-243-108-520-597; 060-915-593-222-719; 060-980-574-071-776; 061-350-349-724-144; 061-351-432-804-975; 061-416-395-208-879; 061-694-270-866-413; 062-123-153-856-918; 062-163-992-563-442; 062-796-476-432-278; 063-258-073-696-98X; 063-478-379-874-771; 063-928-018-552-465; 064-038-542-242-385; 064-466-441-497-101; 064-499-188-620-663; 064-662-130-879-290; 064-767-531-529-989; 064-872-106-130-031; 065-218-442-381-163; 065-401-110-530-017; 065-572-568-012-488; 065-702-461-128-555; 066-183-882-083-935; 066-231-862-280-046; 066-500-329-156-12X; 066-687-475-036-225; 066-705-387-326-309; 066-791-472-645-033; 067-090-415-805-71X; 067-205-146-797-690; 067-349-525-439-554; 067-462-837-167-388; 067-637-802-763-720; 067-863-975-472-230; 067-973-627-564-021; 068-243-098-498-058; 068-472-575-365-063; 068-684-517-763-172; 069-858-791-370-631; 070-236-005-872-546; 070-739-131-825-34X; 071-067-578-792-641; 071-541-360-655-260; 073-094-075-683-36X; 073-861-878-251-872; 073-893-194-187-95X; 074-171-867-704-678; 074-195-565-366-446; 075-072-430-643-465; 075-154-772-701-636; 076-649-649-764-157; 077-268-589-985-157; 077-643-192-254-040; 077-895-573-756-192; 078-252-623-750-74X; 078-590-242-104-906; 079-378-574-786-85X; 079-824-764-381-025; 079-826-799-991-439; 080-387-276-483-949; 080-904-452-290-971; 081-935-395-402-057; 082-775-612-423-193; 084-291-773-742-461; 084-438-066-147-309; 084-910-483-441-45X; 085-600-789-323-571; 085-891-075-162-334; 086-110-380-575-022; 086-649-756-622-86X; 087-094-374-955-343; 087-293-688-252-781; 087-624-225-017-869; 088-160-696-865-403; 088-638-260-574-031; 090-731-241-564-872; 091-444-732-056-703; 092-288-111-887-525; 092-701-442-997-151; 093-721-120-430-720; 093-827-145-917-442; 093-904-725-685-058; 093-932-310-506-941; 093-951-913-186-303; 093-960-113-892-343; 094-570-291-422-670; 095-086-519-591-975; 095-550-894-327-638; 095-622-442-080-785; 095-723-165-632-272; 095-870-019-319-552; 096-589-387-351-937; 097-392-685-998-162; 097-547-369-236-098; 097-759-953-928-506; 097-915-416-111-308; 098-895-490-590-870; 099-099-699-933-589; 099-101-207-479-130; 099-542-063-302-267; 099-617-399-504-544; 100-406-370-911-561; 100-554-253-099-126; 101-125-220-069-917; 101-276-696-397-973; 101-925-267-566-967; 102-076-161-656-318; 103-730-607-766-280; 104-107-749-747-562; 105-337-012-626-977; 107-157-918-709-052; 107-380-508-495-313; 107-488-493-770-064; 107-803-301-643-691; 108-052-047-708-550; 108-380-239-497-500; 108-607-947-100-379; 109-456-025-349-929; 109-662-104-838-875; 111-087-026-503-650; 111-975-407-849-845; 112-733-337-597-527; 113-022-941-155-659; 114-521-259-059-739; 114-669-623-430-532; 115-026-206-537-619; 115-699-767-092-011; 116-350-760-208-282; 116-408-734-166-161; 118-335-480-415-233; 118-773-549-370-214; 118-936-060-893-822; 119-487-452-111-768; 119-893-073-195-766; 121-073-161-561-306; 121-253-227-619-127; 123-603-266-097-51X; 123-800-744-243-589; 123-806-133-009-889; 126-244-569-553-92X; 128-376-025-089-652; 130-230-002-221-972; 131-017-869-808-075; 131-695-559-254-022; 132-010-302-229-288; 132-425-547-020-17X; 133-118-206-289-089; 134-226-975-474-697; 134-536-232-047-727; 135-045-010-129-68X; 138-102-663-024-751; 139-980-077-675-776; 141-547-981-419-505; 144-831-013-278-677; 145-089-843-722-928; 145-903-981-208-816; 146-774-851-909-137; 148-758-566-882-695; 151-913-395-293-268; 153-058-171-059-382; 153-896-732-794-786; 156-039-012-016-196; 161-419-693-833-76X; 166-551-944-842-573; 170-133-084-279-698; 173-702-844-009-671; 174-562-878-708-934; 180-961-668-231-109; 183-107-532-838-32X; 183-176-754-472-852; 184-348-559-750-962; 184-556-267-836-103; 190-672-762-594-848; 191-304-715-950-229; 195-101-810-899-068,69
015-412-162-638-214,Application of nanomaterials in in-vitro diagnostics,,2014,journal article,Zhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation,16717104,Zhongguo yi liao qi xie za zhi bian ji bu,China,Sulin Zhang; Jiangbo Cai; Li Wu,"Nanomaterials appear to be promising for a number of applications in in-vitro diagnostics, mainly due to the biocompatibility, specific surface and conduction activity. The use of nanostructures as diagnostic tools has the advantage of very low limit of detection achievable, high sensitivity, strong selectivity and the possibility to fabricate point-of-care diagnostic devices. With the problems of nanotechnology solved, nanomaterials had already put a broad impact in the field of clinical medical examination.",38,2,118,121,Nanomaterials; Nanotechnology; Materials science; Biocompatibility; Diagnostic tools,,Nanostructures; Nanotechnology,,,https://europepmc.org/abstract/MED/24941776 http://europepmc.org/abstract/MED/24941776 https://pubmed.ncbi.nlm.nih.gov/24941776/ https://www.ncbi.nlm.nih.gov/pubmed/24941776,https://www.ncbi.nlm.nih.gov/pubmed/24941776,24941776,,2402413099,,0,,0
015-572-322-821-142,Nanomaterials for photoelectrochemical water splitting - review,,2018,journal article,International Journal of Hydrogen Energy,03603199,Elsevier BV,United Kingdom,Josny Joy; Jinu Mathew; Soney C. George,"Abstract Photoelectrochemical (PEC) water splitting using nanomaterials is one of the promising techniques to generate hydrogen in an easier, cheaper and sustainable way. By modifying a photocatalyst with a suitable band width material can improve the overall solar-to-hydrogen (STH) energy conversion efficiency. Nanomaterials can tune their band width by controlling its size and morphology. In many studies, the importance of nanostructured materials, their morphological and crystalline effects in water splitting is highlighted. Charge separation and transportation is the major concern in PEC water splitting. Nanomaterials are having high surface to volume ratio which facilitates charge separation and suppress electron-hole pair recombination. This review focuses on the recent developments in water splitting techniques using PEC based nanomaterials as well as different strategies to improve hydrogen evolution.",43,10,4804,4817,Nanomaterials; Surface-area-to-volume ratio; Nanotechnology; Materials science; Energy conversion efficiency; Band width; High surface; Water splitting; Hydrogen; Photocatalysis,,,,,https://www.cheric.org/research/tech/periodicals/view.php?seq=1624524 https://www.sciencedirect.com/science/article/pii/S0360319918301745,http://dx.doi.org/10.1016/j.ijhydene.2018.01.099,,10.1016/j.ijhydene.2018.01.099,2790064090,,0,000-823-734-863-399; 001-126-209-352-446; 001-191-581-553-341; 003-195-076-256-902; 004-715-412-466-021; 004-855-235-119-807; 005-739-169-932-186; 007-337-911-667-913; 007-531-436-744-842; 008-612-393-861-926; 009-147-726-901-849; 010-800-547-998-950; 012-614-668-005-429; 013-636-780-285-313; 014-920-049-402-837; 015-400-160-504-96X; 015-818-356-348-928; 015-967-884-428-517; 016-075-516-069-189; 016-340-873-730-195; 016-434-768-795-277; 016-874-170-980-696; 017-512-535-048-390; 017-579-602-736-326; 018-082-746-596-45X; 018-505-591-464-71X; 019-139-012-792-508; 019-257-154-782-548; 019-356-572-103-070; 020-075-509-925-850; 020-230-369-737-862; 020-240-571-128-728; 023-561-757-996-992; 024-218-832-097-136; 024-241-528-692-34X; 024-838-263-117-092; 025-105-139-744-855; 025-656-767-049-539; 027-784-733-703-028; 027-797-462-345-072; 028-611-964-012-516; 028-691-992-009-050; 029-064-168-620-330; 031-643-762-250-836; 031-726-758-699-220; 032-258-227-570-454; 032-987-425-189-566; 033-330-254-203-158; 034-067-469-643-207; 034-482-624-068-731; 034-536-332-206-443; 035-166-541-397-793; 037-196-436-615-584; 040-420-700-027-194; 043-017-723-501-433; 043-827-695-062-967; 044-737-153-259-658; 045-179-325-594-827; 045-558-275-927-506; 045-980-239-727-594; 046-135-802-668-828; 046-169-689-743-990; 046-931-196-405-434; 048-282-824-171-460; 048-671-521-400-376; 049-834-758-004-099; 050-047-988-233-068; 052-016-540-630-568; 052-236-306-545-044; 056-044-518-977-040; 057-120-290-524-579; 058-724-105-836-612; 059-632-529-758-863; 059-684-860-653-169; 059-807-212-930-153; 059-842-475-409-988; 059-892-341-589-739; 061-175-047-330-646; 062-024-707-029-735; 062-368-394-734-757; 063-875-965-122-07X; 064-183-574-365-591; 064-465-271-682-907; 065-134-487-313-561; 065-248-552-646-094; 065-574-634-466-840; 066-030-140-199-368; 069-842-123-951-24X; 069-854-018-520-585; 070-241-209-757-52X; 075-947-196-870-14X; 076-072-620-249-633; 077-878-442-143-607; 084-475-642-768-107; 085-626-678-401-966; 085-878-705-370-204; 086-934-827-974-719; 088-003-012-013-850; 088-057-109-120-920; 088-604-426-172-185; 088-854-151-885-101; 088-900-952-287-480; 089-385-200-365-768; 089-755-661-798-457; 090-721-797-565-353; 091-406-728-010-027; 091-692-063-706-133; 091-993-745-695-725; 092-612-526-293-923; 094-275-557-415-186; 094-867-952-445-798; 095-444-888-504-301; 095-828-997-500-628; 095-958-975-069-238; 097-472-622-616-171; 097-657-225-051-577; 104-670-017-936-053; 105-928-353-366-928; 106-060-487-497-467; 106-431-217-578-814; 106-757-650-193-544; 110-782-892-463-606; 113-502-991-432-40X; 117-092-687-745-088; 119-018-362-107-827; 122-123-182-289-910; 129-031-488-424-157; 137-629-419-444-45X; 138-250-146-876-205; 141-131-631-903-20X; 142-353-593-057-371; 145-678-310-458-760; 146-502-750-384-328; 146-524-216-233-463; 154-543-904-449-19X; 168-721-943-879-560; 176-540-062-545-541,202
015-600-342-486-172,Nanomaterials Safer‐by‐Design: An Environmental Safety Perspective,2018-02-13,2018,journal article,"Advanced materials (Deerfield Beach, Fla.)",15214095; 09359648,Wiley-Blackwell,United States,Sijie Lin; Tianyu Yu; Zhenyang Yu; Xialin Hu; Daqiang Yin,"Designing safer nanomaterials and nanostructures has gained increasing attention in the field of nanoscience and technology in recent years. Based on the body of experimental evidence contributed by environmental health and safety studies, materials scientists now have a better grasp on the relationships between the nanomaterials' physicochemical characteristics and their hazard/safety profiles. Therefore, it is expected that an integration of design synthesis and safety assessment will foster nanomaterials safer-by-design by considering both applications and implications. From the environmental safety perspective, the most recent advances that demonstrate effective nanomaterials safer-by-design are highlighted.",30,17,1705691,,Risk analysis (engineering); Nanomaterials; Materials science; Perspective (graphical); SAFER; Design synthesis; Safety studies; Environmental safety; Hazard,environmental safety; nanomaterials; safer-by-design,,,National Natural Science Foundation of China; National Natural Science Foundation of China; National Natural Science Foundation of China,https://pubmed.ncbi.nlm.nih.gov/29436017/ https://onlinelibrary.wiley.com/doi/abs/10.1002/adma.201705691 https://www.ncbi.nlm.nih.gov/pubmed/29436017,http://dx.doi.org/10.1002/adma.201705691,29436017,10.1002/adma.201705691,2791294307,,0,002-828-175-026-441; 004-274-784-842-760; 004-487-242-764-074; 005-280-875-905-816; 012-749-102-372-172; 013-294-433-904-880; 022-632-565-594-285; 026-309-662-578-629; 031-392-852-946-585; 031-605-714-350-448; 033-837-863-362-528; 037-525-270-477-971; 039-494-110-162-499; 043-163-703-492-838; 046-888-509-755-777; 049-937-086-872-644; 050-015-085-748-961; 050-129-154-992-200; 050-193-932-308-898; 050-526-374-865-405; 052-701-129-265-762; 053-825-362-767-444; 054-948-479-218-269; 059-455-513-985-055; 067-227-408-798-309; 067-734-580-615-531; 073-221-817-069-043; 074-091-274-331-757; 078-549-698-488-94X; 081-840-496-229-108; 095-768-078-536-775; 105-561-738-840-135; 136-094-861-747-811,36
015-844-842-428-113,Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment,2011-11-15,2011,journal article,Chemical Society reviews,14604744; 03060012,Royal Society of Chemistry,United Kingdom,Carl D. Walkey; Warren C. W. Chan,"Nanomaterials hold promise as multifunctional diagnostic and therapeutic agents. However, the effective application of nanomaterials is hampered by limited understanding and control over their interactions with complex biological systems. When a nanomaterial enters a physiological environment, it rapidly adsorbs proteins forming what is known as the protein ‘corona’. The protein corona alters the size and interfacial composition of a nanomaterial, giving it a biological identity that is distinct from its synthetic identity. The biological identity determines the physiological response including signalling, kinetics, transport, accumulation, and toxicity. The structure and composition of the protein corona depends on the synthetic identity of the nanomaterial (size, shape, and composition), the nature of the physiological environment (blood, interstitial fluid, cell cytoplasm, etc.), and the duration of exposure. In this critical review, we discuss the formation of the protein corona, its structure and composition, and its influence on the physiological response. We also present an ‘adsorbome’ of 125 plasma proteins that are known to associate with nanomaterials. We further describe how the protein corona is related to the synthetic identity of a nanomaterial, and highlight efforts to control protein–nanomaterial interactions. We conclude by discussing gaps in the understanding of protein–nanomaterial interactions along with strategies to fill them (167 references).",41,7,2780,2799,Nanomaterials; Nanotechnology; Chemistry; Protein Corona,,"Adsorption; Animals; Humans; Kinetics; Models, Biological; Nanoparticles/chemistry; Particle Size; Proteins/chemistry",Proteins,Canadian Institutes of Health Research Canada,https://pubs.rsc.org/en/content/articlelanding/2012/cs/c1cs15233e#! https://doi.org/10.1039%2FC1CS15233E http://pubs.rsc.org/en/content/articlelanding/2012/cs/c1cs15233e#!divAbstract https://www.ncbi.nlm.nih.gov/pubmed/22086677 http://xlink.rsc.org/?DOI=c1cs15233e https://pubag.nal.usda.gov/catalog/6613555,http://dx.doi.org/10.1039/c1cs15233e,22086677,10.1039/c1cs15233e,2050886209,,4,000-132-078-142-231; 000-224-461-175-800; 000-471-925-947-089; 000-553-508-084-023; 000-715-022-309-324; 000-874-519-292-87X; 001-304-645-444-442; 001-742-973-951-814; 002-061-573-976-214; 003-052-232-346-70X; 003-872-786-670-679; 004-180-759-795-555; 005-716-268-121-272; 006-147-233-354-964; 006-785-096-492-944; 007-204-606-505-484; 007-459-451-140-170; 008-256-970-272-833; 008-768-172-582-668; 008-817-677-488-333; 009-106-870-729-683; 010-503-779-736-430; 010-638-378-520-055; 011-601-557-929-224; 011-673-863-978-684; 013-142-325-765-745; 015-694-979-152-444; 016-641-316-259-950; 016-844-942-283-077; 017-027-907-392-709; 017-268-038-397-977; 019-130-926-675-323; 019-336-453-332-42X; 020-306-990-639-45X; 020-365-147-688-960; 020-365-582-702-931; 020-566-995-271-106; 020-633-449-318-525; 021-089-282-052-947; 021-780-101-365-407; 023-436-084-764-843; 025-022-953-748-873; 025-508-616-263-883; 026-102-898-190-657; 026-546-101-913-246; 026-632-799-863-500; 027-050-081-021-124; 027-344-707-657-09X; 028-168-027-803-328; 028-193-446-756-268; 029-495-623-050-689; 029-666-140-163-340; 029-866-185-254-20X; 029-912-105-134-705; 030-350-841-024-073; 031-247-988-493-350; 031-532-602-532-365; 031-918-819-474-508; 032-235-919-554-111; 032-479-737-087-779; 032-816-661-064-654; 034-051-222-827-171; 034-701-558-688-314; 035-292-759-304-534; 035-659-681-774-517; 035-919-228-575-462; 036-620-963-975-999; 037-216-600-139-264; 037-559-465-893-09X; 037-752-757-492-102; 038-191-311-786-359; 039-079-455-504-396; 039-388-964-528-811; 040-433-916-760-363; 041-035-136-949-23X; 041-965-129-219-168; 042-166-139-469-166; 042-600-866-340-093; 043-140-275-472-483; 043-384-185-100-935; 043-571-985-345-133; 043-935-364-521-207; 044-248-524-774-951; 044-953-015-533-694; 045-474-533-068-751; 045-907-679-001-411; 047-502-578-959-417; 047-631-147-989-324; 048-262-687-246-316; 049-007-776-873-416; 049-870-457-119-042; 050-011-101-462-472; 050-887-043-978-679; 051-000-386-003-044; 051-249-670-521-192; 051-425-605-501-021; 051-653-572-108-008; 052-540-475-374-801; 052-740-371-384-235; 053-131-153-925-884; 054-617-823-154-799; 055-451-113-665-868; 055-943-185-559-133; 056-093-280-784-070; 056-719-253-173-858; 057-027-778-306-27X; 058-646-060-582-290; 059-465-291-966-885; 059-521-816-259-803; 059-561-820-854-898; 060-178-460-559-150; 060-908-118-859-483; 061-503-419-440-011; 061-939-320-934-377; 063-925-992-412-681; 065-761-469-610-098; 065-908-792-536-653; 065-951-641-049-077; 066-119-715-310-321; 066-294-145-967-687; 067-316-634-966-352; 067-622-925-652-383; 067-989-927-278-824; 068-277-954-852-108; 069-888-527-803-167; 070-082-202-074-376; 070-458-576-001-65X; 071-323-835-781-549; 074-621-734-895-197; 074-660-736-899-10X; 074-820-440-272-893; 076-126-354-455-717; 077-056-114-808-419; 077-229-149-084-433; 077-579-356-134-675; 080-122-871-425-598; 080-529-414-550-363; 081-227-127-126-394; 083-801-572-639-274; 084-617-467-062-393; 084-799-188-253-031; 085-838-463-418-984; 087-660-571-517-426; 089-263-808-831-784; 089-423-508-333-636; 091-571-555-471-894; 092-947-029-208-737; 095-147-391-641-414; 095-286-510-023-484; 096-646-466-395-872; 099-894-243-069-406; 100-453-802-457-836; 102-609-914-867-785; 106-167-168-225-042; 108-358-584-225-927; 109-054-913-683-739; 116-305-745-084-880; 117-610-875-962-28X; 119-493-100-705-344; 120-465-281-190-868; 122-552-168-791-045; 124-966-582-909-507; 126-173-860-414-532; 130-695-534-667-30X; 139-800-181-799-92X; 143-319-808-788-84X; 143-396-598-191-576; 144-997-128-452-866; 148-591-547-330-391; 150-946-672-546-310; 152-484-863-701-829; 154-858-252-095-264; 160-159-756-365-015; 164-000-189-844-634; 164-331-223-018-931; 184-776-612-834-93X,1128
015-965-604-965-141,Biosafety Assessment of Silicon Nanomaterials,2014-04-03,2014,book chapter,SpringerBriefs in Molecular Science,21915407; 21915415,Springer Berlin Heidelberg,,Yao He; Yuanyuan Su,"Biosafety assessment of nanomaterials is of essential importance and regarded as a critical precondition for practical applications. Silicon nanomaterials have shown great promise for myriad biological and biomedical applications, including biosensing, bioimaging, cancer diagnosis and therapy, etc. It is worthwhile to point out that, while favorable biocompatibility is accredited to silicon, systematic and reliable biosafety assessment of silicon nanomaterials is required to be carried out for practical applications. Scientists have made pioneer work to investigate in vitro and in vivo behaviors (e.g., cellular viability, biodistribution, pharmacokinetics, etc.) of two typical kinds of silicon nanomaterials (i.e., silicon nanoparticles (SiNPs) and silicon nanowires (SiNWs)). These primary results suggest favorable biocompatibility of silicon nanomaterials in general; notwithstanding, potential safety concerns are also addressed by several studies, based on investigation of detectable in vitro and in vivo toxicity induced by silicon nanomaterials. This chapter intends to take SiNPs and SiNWs as models and discuss topics concerning silicon materials-related biosafety investigation, with the hope to outline these pioneer studies as the starting points for risk assessment of silicon nanostructures.",,,93,104,Nanomaterials; Nanotechnology; Materials science; Silicon nanowires; Silicon nanostructures; Cellular viability; In vivo toxicity; Biosafety; Silicon,,,,,https://rd.springer.com/chapter/10.1007/978-3-642-54668-6_6 https://link.springer.com/chapter/10.1007/978-3-642-54668-6_6,http://dx.doi.org/10.1007/978-3-642-54668-6_6,,10.1007/978-3-642-54668-6_6,77657148,,0,003-391-458-378-41X; 004-302-128-192-806; 004-550-992-914-392; 005-494-782-145-102; 005-793-761-223-773; 006-091-426-144-218; 007-957-582-184-642; 008-178-017-495-783; 012-041-998-587-251; 012-306-484-748-725; 013-289-802-134-089; 013-344-179-611-304; 014-351-395-869-90X; 021-016-237-801-323; 022-538-861-143-998; 023-639-410-550-286; 023-989-040-416-089; 024-802-475-139-061; 025-323-947-342-008; 025-583-308-710-987; 027-782-470-113-747; 029-741-523-820-771; 030-649-406-363-712; 032-590-323-372-831; 033-671-437-290-974; 035-472-617-858-521; 035-697-604-698-300; 039-540-927-725-510; 039-729-249-286-123; 040-295-877-674-645; 040-835-774-581-774; 041-819-761-845-247; 045-874-373-739-87X; 046-358-862-322-210; 046-815-044-085-613; 054-068-725-429-104; 055-664-907-721-218; 056-314-453-788-763; 058-714-110-751-18X; 064-219-436-255-134; 065-075-192-716-93X; 068-548-272-495-31X; 070-558-962-454-794; 071-606-629-495-357; 079-175-470-141-379; 082-493-227-153-267; 087-125-574-959-938; 091-060-027-975-621; 095-316-819-289-832; 098-785-008-701-548; 108-886-617-784-602; 110-370-689-398-211; 110-690-378-554-697; 113-478-931-314-383; 131-372-783-133-632; 133-858-050-717-975; 142-325-179-186-284; 144-679-510-790-934,1
015-977-559-815-133,Advances of Anti-Caries Nanomaterials.,2020-10-30,2020,journal article,"Molecules (Basel, Switzerland)",14203049,Multidisciplinary Digital Publishing Institute (MDPI),Switzerland,Hui Chen; Lisha Gu; Binyou Liao; Xuedong Zhou; Lei Cheng; Biao Ren,"Caries is the most common and extensive oral chronic disease. Due to the lack of anti-caries properties, traditional caries filling materials can easily cause secondary caries and lead to treatment failure. Nanomaterials can interfere with the bacteria metabolism, inhibit the formation of biofilm, reduce demineralization, and promote remineralization, which is expected to be an effective strategy for caries management. The nanotechnology in anti-caries materials, especially nano-adhesive and nano-composite resin, has developed fast in recent years. In this review, the antibacterial nanomaterials, remineralization nanomaterials, and nano-drug delivery systems are reviewed. We are aimed to provide a theoretical basis for the future development of anti-caries nanomaterials.",25,21,5047,,Nanomaterials; Nanotechnology; Demineralization; Chronic disease; Filling materials; Treatment failure; Caries management; Medicine,anti-caries; antibacterial; nanomaterials; nanotechnology; remineralization,Anti-Bacterial Agents/chemistry; Cariostatic Agents/chemistry; Dental Caries/drug therapy; Drug Delivery Systems; Humans; Nanocomposites/chemistry,Anti-Bacterial Agents; Cariostatic Agents,National Natural Science Foundation of China (81870778); National Natural Science Foundation of China (81600858); National Natural Science Foundation of China (81870759); National Natural Science Foundation of China (81870759); Applied Basic Research Programs of Sichuan Province (2020YJ0227),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662703 https://www.mdpi.com/1420-3049/25/21/5047 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662703 https://europepmc.org/article/MED/33143140 https://www.mdpi.com/1420-3049/25/21/5047/pdf https://pubmed.ncbi.nlm.nih.gov/33143140/,http://dx.doi.org/10.3390/molecules25215047,33143140,10.3390/molecules25215047,3095556843,PMC7662703,0,000-380-202-250-030; 000-636-984-534-260; 000-943-974-671-237; 001-366-452-628-660; 003-255-022-872-71X; 003-696-179-683-582; 003-820-113-973-910; 003-825-317-719-212; 003-933-390-824-009; 004-137-484-355-927; 004-235-769-864-484; 004-998-730-067-299; 005-263-650-556-85X; 005-516-351-394-427; 005-992-577-833-602; 008-240-929-973-48X; 009-610-750-741-04X; 009-758-846-671-649; 010-170-512-735-196; 010-868-722-690-429; 011-062-085-927-537; 011-110-917-072-951; 013-457-238-394-09X; 013-741-398-811-444; 014-458-685-553-081; 014-518-966-913-460; 014-990-959-310-433; 015-372-546-171-111; 015-727-990-758-082; 017-087-942-699-735; 017-636-163-434-550; 018-022-580-238-286; 018-450-829-088-385; 019-540-893-062-10X; 021-077-967-237-524; 021-658-982-066-538; 021-807-274-102-899; 022-640-735-040-593; 023-282-353-214-729; 023-825-713-371-444; 026-333-523-910-812; 026-702-403-737-171; 028-600-630-308-102; 029-094-224-855-298; 029-394-626-468-80X; 030-804-491-401-003; 030-843-316-104-185; 032-630-623-827-176; 033-248-357-232-16X; 033-554-628-765-490; 033-873-182-513-501; 035-544-759-980-901; 037-875-592-686-258; 040-472-510-540-178; 040-687-705-418-170; 042-390-627-413-766; 042-845-623-931-740; 045-731-824-177-987; 046-105-694-259-439; 047-496-905-927-693; 047-740-568-720-019; 048-072-620-106-880; 049-954-121-514-864; 050-047-505-082-550; 050-243-791-848-331; 050-411-787-604-975; 050-694-173-973-787; 053-122-139-638-833; 053-321-300-726-98X; 054-288-093-421-247; 054-329-803-433-153; 055-676-093-010-350; 056-483-295-797-687; 059-309-843-560-505; 059-468-934-217-217; 059-819-184-893-567; 067-183-828-805-497; 070-100-064-369-569; 070-412-552-719-583; 070-938-433-701-31X; 071-430-112-143-213; 072-062-969-020-650; 073-116-652-283-839; 075-343-441-241-287; 076-387-210-274-496; 077-043-364-513-207; 079-234-122-748-438; 081-494-440-023-304; 087-808-213-733-397; 089-077-316-195-188; 089-943-792-768-598; 090-543-305-976-991; 098-459-345-469-918; 098-522-874-269-38X; 099-253-216-640-451; 099-512-753-160-879; 103-433-638-275-109; 105-835-922-401-365; 110-938-934-940-73X; 111-832-677-399-436; 113-483-723-908-95X; 115-650-578-684-408; 115-829-829-678-062; 117-365-148-183-435; 118-952-526-094-337; 120-484-724-353-990; 120-780-651-952-963; 129-119-365-154-35X; 130-713-181-153-026; 131-743-134-537-661; 135-696-434-247-048; 138-831-229-213-496; 143-457-732-171-40X; 161-058-703-454-704; 163-403-311-297-700; 166-416-588-120-141; 178-856-368-719-181; 185-529-260-130-020,4
016-149-111-279-881,Polydopamine as a stable and functional nanomaterial.,2019-12-14,2019,journal article,"Colloids and surfaces. B, Biointerfaces",18734367; 09277765,Elsevier,Netherlands,Salima El Yakhlifi; Vincent Ball,"The mussel inspired chemistry of dopamine leading to versatile coatings on the surface of all kinds of materials in a one pot process was considered as the unique aspect of catecholamine for a long time. Only recently, research has been undertaken to valorize the simultaneous oxidation and colloid formation in dopamine solutions in the presence of an oxidant. This mini review summarizes the synthesis methods allowing to get controlled nanomaterials, either nanoparticles, hollow capsules or nanotubes and even chiral nanomaterials from dopamine solutions. Finally the applications of those nanomaterials will be described.",186,,110719,110719,Nanomaterials; Nanoparticle; Nanotechnology; Materials science; Synthesis methods; Mussel inspired; Mini review; Colloid,Biomimetic approaches; Nanomaterials; Polydopamine; Templates,Indoles/chemical synthesis; Molecular Structure; Nanostructures/chemistry; Particle Size; Polymers/chemical synthesis; Surface Properties,Indoles; Polymers; polydopamine,,https://www.ncbi.nlm.nih.gov/pubmed/31846893 https://www.sciencedirect.com/science/article/pii/S092777651930863X https://europepmc.org/article/MED/31846893 https://pubag.nal.usda.gov/catalog/6785833 https://pubmed.ncbi.nlm.nih.gov/31846893/,http://dx.doi.org/10.1016/j.colsurfb.2019.110719,31846893,10.1016/j.colsurfb.2019.110719,2995610908,,0,002-908-017-078-297; 003-689-072-274-249; 004-850-748-534-923; 004-943-402-979-784; 006-355-848-014-006; 006-909-293-782-408; 006-920-386-598-420; 007-300-462-503-155; 008-484-674-668-010; 009-257-769-101-195; 010-655-563-337-257; 013-425-950-134-906; 014-956-084-749-03X; 016-236-114-226-721; 017-236-495-705-457; 017-545-533-409-325; 017-685-334-889-009; 018-122-969-920-679; 018-180-312-688-110; 018-479-818-532-814; 018-517-107-592-33X; 019-078-864-483-354; 019-645-819-624-347; 021-685-640-474-818; 022-063-088-062-78X; 022-433-474-087-817; 023-066-310-096-615; 024-134-458-778-020; 024-476-885-776-353; 024-516-006-925-791; 024-873-177-998-763; 025-488-729-415-729; 029-788-978-011-346; 029-857-597-127-587; 031-099-476-555-974; 031-505-177-298-50X; 032-118-557-103-82X; 033-287-332-389-760; 034-640-017-567-062; 036-172-367-020-524; 036-415-432-063-55X; 038-665-437-742-628; 044-403-801-820-029; 044-907-126-289-99X; 047-377-043-734-879; 048-319-414-470-042; 048-928-292-968-830; 049-401-134-401-586; 050-043-883-718-001; 050-712-796-877-413; 052-171-389-936-731; 053-085-635-145-608; 053-501-509-980-442; 056-855-113-730-17X; 057-168-586-616-969; 058-347-951-335-509; 062-679-865-091-822; 066-286-469-558-329; 070-452-960-230-070; 072-337-123-899-577; 072-931-541-487-075; 074-506-625-744-441; 075-066-698-695-329; 075-769-655-859-750; 078-327-523-756-662; 080-489-679-202-707; 083-596-852-835-552; 084-148-040-928-662; 090-361-592-814-452; 093-192-357-379-432; 098-812-324-824-073; 109-038-521-747-959; 112-544-273-000-070; 114-745-128-457-668; 114-864-810-356-618; 131-269-090-914-975; 135-282-507-564-491; 135-412-367-496-265; 136-346-731-544-934; 146-684-411-512-313; 147-146-204-189-179; 152-561-211-592-168,18
016-265-470-695-578,Direct Synthesis of Nanomaterials: Building Bridges Between Metal Complexes and Nanomaterials,,2018,book chapter,Direct Synthesis of Metal Complexes,,Elsevier,,Luis Arturo García de la Rosa; Miguel A. Méndez-Rojas,"Abstract Nanochemistry is an emerging new field of chemistry, in particular of solid-state chemistry, which emphasizes the study and development of preparation methods of useful materials with nanometer-size dimensions (1–100 nm), as defined by Geoffry Ozin, a pioneer in the field. The direct synthesis of metal complexes and organometallic compounds from zerovalent metals is a known methodology that was well developed during the past 165 years, since the first preparation of Zn(CH 2 CH 3 ) 2 by Frankland from the direct reaction of metallic zinc powder and ethyl iodide. Although comparatively, the dimensions of the simplest and smaller nanoparticles are a thousand times larger than the most common coordination or organometallic compounds, there are several interesting characteristics that may serve as bridges to extrapolate several of the synthetic tools developed around the direct synthesis of metal complexes toward the preparation of inorganic nanomaterials. First of all, the surface of inorganic nanomaterials (metallic, metal oxides, or metal chalcogenides, among several others) is very reactive and unstable, unless a coordinating surfactant is used to coat the surface. It is relatively easy to understand that the surfactant behaves as a coordination ligand and that it may play an important role not only on stabilization, but also on the control of the structure and properties of the resulting nanomaterial. Here, we discuss several bridging concepts among coordination compounds and nanochemistry, and present direct synthesis as a novel and useful synthetic tool for the preparation of several useful and interesting inorganic nanomaterials.",,,317,337,Nanomaterials; Nanoparticle; Nanotechnology; Nanochemistry; Materials science; Ethyl iodide; Zinc; Metal; Coordination complex; Group 2 organometallic chemistry,,,,,https://www.sciencedirect.com/science/article/pii/B9780128110614000086,http://dx.doi.org/10.1016/b978-0-12-811061-4.00008-6,,10.1016/b978-0-12-811061-4.00008-6,2802178110,,0,000-252-760-429-151; 000-317-442-241-019; 001-355-954-524-358; 001-944-418-773-727; 003-791-105-344-313; 004-011-429-935-108; 004-109-454-064-696; 005-071-069-266-473; 005-649-256-371-752; 008-539-725-320-248; 009-755-766-606-237; 011-360-662-461-163; 015-129-305-287-930; 017-355-358-503-340; 018-573-157-304-128; 019-868-288-936-322; 022-913-128-226-151; 022-927-606-937-044; 024-909-924-507-932; 025-744-228-128-30X; 026-193-298-191-29X; 026-424-425-909-387; 029-757-730-182-406; 030-084-260-643-758; 032-040-052-804-068; 034-882-550-676-20X; 038-539-859-545-504; 040-359-429-291-94X; 043-415-058-112-078; 044-495-544-332-198; 046-475-428-067-539; 056-076-696-548-413; 058-101-946-907-314; 058-883-539-991-677; 062-460-797-248-608; 064-655-895-748-107; 066-793-673-614-056; 069-044-154-760-423; 071-080-329-745-306; 073-002-999-475-471; 075-875-555-571-513; 078-911-540-732-235; 082-740-095-186-184; 087-998-312-320-299; 096-439-274-571-681; 099-112-077-674-352; 102-407-659-040-514; 106-699-953-736-419; 107-793-569-908-922; 110-897-665-338-346; 118-466-469-886-763; 124-211-992-375-274; 136-962-222-623-182; 142-956-122-688-110; 147-289-713-356-615; 154-419-978-190-848; 157-000-913-722-280; 159-058-824-787-837; 159-977-381-737-351; 163-404-782-072-65X; 166-602-245-022-91X; 167-663-871-990-657; 168-682-452-151-912; 173-038-650-492-316; 175-059-651-717-631,1
016-394-570-954-515,Synthesis of nanomaterials for biomedical applications,2014-07-09,2014,dissertation,,,,,Selina Vi Yu Tang,"The field of nanotechnology is growing vastly, both as a field of research and in commercial applications. This rapid growth calls for synthesis methods which can produce high quality nanomaterials, while being scalable.; ; This thesis describes an investigation into the use of a continuous hydrothermal reactor for the synthesis of nanomaterials, with potential use in three different biomedical applications – bone scaffolds, fluorescent biomarkers, and MRI contrast agents.; ; The first chapter of this thesis provides an overview of nanotechnology: the advantages of nanoscale, the commercial industries which can benefit, and the predominant methods currently used to produce nanomaterials. Some advantages and drawbacks of each synthesis route are given, concluding with a description of the Nozzle reactor – the patented technology used for nanomaterial synthesis in this Thesis. Chapter 2 then focusses on the characterisation techniques used in this thesis, detailing the principles of how data is obtained, as well as highlighting the limitations of each method. ; ; With the background information in place, chapters 3, 4 and 5 describe more specific nanomaterials and how they can be applied to each of the aforementioned biomedical fields. These chapters provide the technical details of how various nanomaterials can be synthesised using the Nozzle reactor, and the structural data (crystallinity, particle size) obtained from these samples. Furthermore, the functional properties of these nanomaterials are tested and the results, along with a discussion of any trends, are presented.; ; Finally, this thesis concludes with a summary of the results described and emphasises the key areas where further work can be conducted.",,,,,Nanomaterials; Nanotechnology; Materials science; Background information; Synthesis methods; Field (computer science),,,,,http://eprints.nottingham.ac.uk/14101/ http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.632452,http://eprints.nottingham.ac.uk/14101/,,,1566713813,,0,,0
016-557-416-137-166,Design of Nanomaterials for Hydrogen Storage,2020-07-07,2020,journal article,Energies,19961073,MDPI AG,Switzerland,Luca Pasquini,"The interaction of hydrogen with solids and the mechanisms of hydride formation experience significant changes in nanomaterials due to a number of structural features. This review aims at illustrating the design principles that have recently inspired the development of new nanomaterials for hydrogen storage. After a general discussion about the influence of nanomaterials’ microstructure on their hydrogen sorption properties, several scientific cases and hot topics are illustrated surveying various classes of materials. These include bulk-like nanomaterials processed by mechanochemical routes, thin films and multilayers, nano-objects with composite architectures such as core–shell or composite nanoparticles, and nanoparticles on porous or graphene-like supports. Finally, selected examples of recent in situ studies of metal–hydride transformation mechanisms using microscopy and spectroscopy techniques are highlighted.",13,13,3503,,Composite number; Nanomaterials; Nanoparticle; Nanotechnology; Thin film; Materials science; Hydride; Hydrogen; Hydrogen storage; Microstructure,,,,,https://cris.unibo.it/handle/11585/797664 https://ideas.repec.org/a/gam/jeners/v13y2020i13p3503-d381266.html https://www.mdpi.com/1996-1073/13/13/3503/pdf https://www.mdpi.com/1996-1073/13/13/3503,http://dx.doi.org/10.3390/en13133503,,10.3390/en13133503,3039105698,,0,000-037-216-608-71X; 001-064-145-397-061; 001-403-949-779-536; 002-558-846-229-825; 003-361-878-133-753; 004-448-078-674-939; 004-814-136-962-216; 006-935-702-736-509; 007-726-472-549-884; 008-384-865-823-986; 009-289-420-255-657; 009-367-409-524-001; 009-524-472-735-991; 010-126-176-875-940; 010-754-181-008-566; 011-319-344-016-641; 011-374-973-162-790; 011-849-415-648-522; 012-058-286-962-093; 012-629-876-054-518; 013-964-082-135-898; 015-835-771-076-936; 016-783-641-857-659; 017-092-870-209-755; 017-880-031-353-075; 019-545-223-362-579; 021-049-466-822-137; 023-759-270-364-233; 024-245-096-457-511; 024-329-641-520-335; 024-981-691-916-634; 030-030-749-947-809; 032-521-063-500-198; 032-809-490-009-371; 035-120-630-392-333; 036-076-363-234-883; 037-015-843-229-984; 037-434-430-290-708; 037-911-374-352-239; 038-267-288-653-192; 038-269-701-430-849; 038-293-837-760-863; 040-256-803-674-51X; 040-768-281-990-265; 041-775-762-573-843; 044-326-424-880-993; 044-474-345-318-753; 045-791-280-708-43X; 046-046-297-829-779; 046-265-938-924-208; 047-011-323-185-37X; 047-341-407-652-926; 047-693-110-903-48X; 052-802-071-027-501; 054-587-458-064-239; 057-272-789-403-365; 057-808-027-368-738; 059-276-695-887-363; 059-500-917-522-663; 060-445-067-924-434; 060-591-231-072-17X; 060-953-730-354-150; 061-810-763-377-904; 065-183-271-583-125; 065-637-779-977-76X; 067-528-757-974-680; 069-408-610-859-713; 069-883-034-967-953; 074-124-733-915-865; 074-379-388-352-671; 075-610-507-740-868; 076-001-170-574-413; 076-354-743-208-634; 079-913-163-719-945; 081-560-611-861-277; 081-877-423-095-857; 084-090-408-348-916; 084-822-771-856-393; 087-496-275-333-487; 087-822-805-736-39X; 091-226-247-711-879; 091-660-218-395-645; 091-966-226-416-882; 092-200-870-982-567; 092-208-710-135-170; 093-418-090-012-04X; 096-016-883-806-568; 097-417-328-907-275; 097-961-600-031-495; 098-262-017-792-522; 099-814-636-189-051; 102-302-933-046-476; 104-698-277-828-344; 104-720-672-869-558; 105-790-621-178-634; 105-857-368-630-642; 111-781-809-209-183; 121-900-399-764-257; 123-143-501-670-634; 123-859-225-446-268; 124-440-536-122-037; 126-109-320-597-845; 126-928-609-492-189; 130-648-581-084-914; 139-359-000-042-115; 141-140-938-995-596; 143-421-814-783-042; 144-480-509-046-704; 149-180-832-358-262; 155-131-462-291-684; 158-104-269-481-553; 165-713-840-881-693; 165-981-465-601-506; 168-121-410-500-053; 171-936-186-383-387; 172-784-243-476-050; 173-146-296-531-068,4
016-650-729-777-275,Polydopamine Integrated Nanomaterials and Their Biomedical Applications.,2015-10-07,2015,journal article,Current pharmaceutical design,18734286; 13816128,Bentham Science Publishers B.V.,United Arab Emirates,Xiaoping Chen; Yongshun Huang; Gang Yang; Jiaxing Li; Tingting Wang; Olaf H. Schulz; Lisa K. Jennings,"In the past few decades, the applications of nanomaterials in biologic systems have become one of the most studied areas. Many novel syntheses and processing methods have been developed to generate nanomaterials to enhance biomedical applications. Among those methods, polydopamine (PDA) integrated nanomaterials have attracted considerable interest for various types of biomedical applications. This concise review outlines the basic chemistry and material science regarding PDA and discusses its successful applications in drug delivery, biosensing, antifouling and antimicrobial activities, as well as its interaction with cells.",21,29,4262,4275,Nanomaterials; Nanotechnology; Drug delivery; Processing methods,,Animals; Anti-Infective Agents/administration & dosage; Biofouling/prevention & control; Biosensing Techniques/methods; Drug Delivery Systems/methods; Humans; Indoles/administration & dosage; Nanostructures/administration & dosage; Polymers/administration & dosage,Anti-Infective Agents; Indoles; Polymers; polydopamine,,https://www.ncbi.nlm.nih.gov/pubmed/26323424 http://europepmc.org/abstract/MED/26323424 https://www.eurekaselect.com/134563/article,http://dx.doi.org/10.2174/1381612821666150901103418,26323424,10.2174/1381612821666150901103418,2198085887,,0,000-208-100-428-876; 002-419-217-462-341; 005-232-688-694-658; 006-233-567-466-414; 006-321-701-832-041; 007-488-262-432-871; 008-009-274-061-858; 008-540-603-771-604; 010-000-208-630-726; 010-861-585-922-550; 011-097-782-866-370; 013-109-061-744-611; 013-501-602-422-356; 013-791-825-364-462; 014-706-816-597-173; 014-793-080-653-248; 015-474-656-635-957; 015-915-786-684-678; 016-536-614-404-621; 017-734-388-138-33X; 021-580-397-302-176; 022-377-262-893-709; 025-641-591-227-060; 025-727-834-541-159; 028-125-333-722-307; 028-184-814-534-163; 028-347-234-780-038; 028-740-119-241-291; 030-708-072-860-029; 031-040-429-688-946; 031-944-223-111-051; 033-287-332-389-760; 033-872-745-254-992; 034-647-918-152-907; 037-308-239-613-022; 038-516-258-853-200; 041-913-107-744-645; 045-950-622-806-992; 046-424-358-785-825; 047-322-769-233-661; 049-218-913-180-190; 049-313-018-462-98X; 050-523-343-995-924; 051-662-338-155-855; 052-450-305-326-699; 053-085-635-145-608; 053-610-041-619-282; 054-223-092-364-167; 059-440-947-349-425; 059-886-890-017-986; 061-288-832-094-66X; 063-838-009-487-869; 065-007-031-726-091; 068-223-172-040-152; 068-342-308-227-736; 070-449-320-249-825; 071-668-415-352-485; 072-574-644-053-592; 074-506-625-744-441; 080-332-404-840-739; 081-382-002-107-456; 083-021-201-698-526; 083-293-894-288-042; 084-439-366-204-058; 086-266-388-876-680; 090-361-592-814-452; 093-210-856-587-486; 096-980-886-621-470; 100-466-426-171-078; 101-282-072-834-873; 102-012-820-468-925; 103-474-317-501-022; 103-888-467-439-332; 104-374-798-655-046; 114-511-287-648-662; 122-315-632-597-547; 135-090-643-334-280; 143-182-501-912-24X; 146-684-411-512-313; 153-122-914-316-372; 156-144-070-250-153; 161-550-171-413-227,28
016-707-104-843-919,Aptamer-conjugated nanomaterials and their applications,2011-10-14,2011,journal article,Advanced Drug Delivery Reviews,0169409x,Elsevier,Netherlands,Liu Yang; Xiao-Bing Zhang; Mao Ye; Jian-Hui Jiang; Ronghua Yang; Ting Fu; Yan Chen; Kemin Wang; Chen Liu; Weihong Tan,"The combination of aptamers with novel nanomaterials, including nanomaterial-based aptamer bioconjugates has attracted considerable interest and has led to a wide variety of applications. In this review, we discuss how a variety of nanomaterials, including gold, silica and magnetic nanoparticles, as well as carbon nanotubes, hydrogels, liposomes and micelles, have been used to functionalize aptamers for a variety of applications. These aptamer functionalized materials have led to advances in amplified biosensing, cancer cell-specific recognition, high-efficiency separation, and targeted drug delivery.",63,14,1361,1370,Self-healing hydrogels; Targeted drug delivery; Aptamer; Drug carrier; Nanomaterials; Nanoparticle; Nanotechnology; Chemistry; Drug delivery; Magnetic nanoparticles,,,,,https://europepmc.org/articles/PMC3245877 http://www.sciencedirect.com/science/article/pii/S0169409X11002699 https://pubmed.ncbi.nlm.nih.gov/22016112/ https://www.sciencedirect.com/science/article/pii/S0169409X11002699 https://www.ncbi.nlm.nih.gov/pubmed/22016112,https://europepmc.org/articles/PMC3245877,,,2034192753,,0,000-710-575-211-201; 003-246-300-580-887; 004-971-097-571-800; 005-735-709-482-510; 005-965-217-752-16X; 006-444-884-235-062; 007-012-366-867-219; 007-223-730-630-593; 008-192-604-996-436; 008-326-075-900-179; 008-671-654-880-202; 009-014-629-401-886; 009-779-307-526-584; 010-718-817-770-84X; 010-923-219-737-196; 011-045-019-433-913; 011-579-814-731-844; 013-481-621-630-761; 013-507-517-056-248; 013-685-064-979-219; 013-812-310-465-336; 013-915-316-150-695; 014-286-034-228-340; 015-238-417-406-132; 015-588-211-483-853; 016-467-614-097-442; 017-837-917-793-308; 018-833-245-044-598; 019-725-839-934-449; 020-602-627-935-162; 021-464-769-875-613; 022-014-288-979-09X; 023-089-689-795-921; 023-240-595-054-275; 023-984-448-649-000; 024-409-497-184-188; 026-121-905-810-222; 026-615-987-956-865; 026-734-765-037-582; 027-699-664-009-406; 028-742-235-175-091; 029-151-464-174-350; 029-256-048-391-453; 029-369-389-343-776; 030-523-382-663-783; 032-630-312-253-54X; 032-693-683-151-460; 033-706-550-617-534; 033-920-035-339-346; 035-325-234-491-590; 035-596-696-287-724; 038-153-814-636-507; 044-196-031-267-175; 045-781-110-960-916; 045-901-592-049-132; 046-047-789-005-201; 046-131-456-649-078; 047-242-547-988-743; 049-246-825-246-506; 052-699-328-351-233; 053-141-415-785-738; 054-837-264-126-947; 056-804-734-289-903; 056-898-961-750-552; 057-727-931-283-332; 058-037-613-716-76X; 058-593-864-916-181; 059-893-308-907-031; 063-481-792-726-155; 066-402-572-616-609; 066-492-667-986-401; 068-578-993-448-887; 069-491-101-248-295; 069-915-668-271-708; 070-183-548-156-283; 075-184-776-837-343; 075-949-839-628-664; 078-758-073-328-744; 078-758-663-297-298; 080-249-340-523-031; 080-374-043-392-752; 082-233-881-911-578; 084-698-045-156-768; 085-270-462-243-896; 087-847-633-661-475; 089-944-917-570-062; 091-239-537-536-661; 092-191-121-534-933; 093-528-479-497-935; 094-112-701-797-371; 094-889-351-758-69X; 097-817-411-645-82X; 101-968-907-991-428; 104-178-747-134-525; 108-419-725-001-684; 110-953-491-972-294; 112-431-361-238-07X; 116-558-512-221-624; 125-675-193-284-167; 143-245-149-594-62X; 166-490-170-000-025; 177-026-510-155-921; 199-696-310-483-382,147
016-753-866-032-132,Research on Effect of Adding Nanomaterial to Propellant on Gun Barrel,,2010,,,,,,Chen Yong-cai,"The barrel lifes of three small caliber rifles were tested by using the propellant with nanomaterial and the standard propellant respectively. The test results show that the service life increases observably due to adding nanomaterial to the propellant. Then, the influence of the nanomaterial on the tube was researched by splitting the two barrels tested and detecting their inner surfaces. It was found that the erosion of the barrel bore is reduced observably by using the propellant with nanomaterial. And it makes the volume and the size of the gun chamber change less. Therefore, the barrel life can be prolonged by adding the nanomaterial in the propellant.",,,,,Service life; Nanomaterials; Composite material; Nanotechnology; Barrel (horology); Materials science; Tube (fluid conveyance); Small caliber; Gun barrel; Propellant,,,,,http://en.cnki.com.cn/Article_en/CJFDTOTAL-BAXY201001011.htm,http://en.cnki.com.cn/Article_en/CJFDTOTAL-BAXY201001011.htm,,,2353327375,,0,,0
016-790-672-427-892,Redox-active nanomaterials for nanomedicine applications,2017-10-19,2017,journal article,Nanoscale,20403372; 20403364,Royal Society of Chemistry,United Kingdom,Christopher M. Sims; Shannon K. Hanna; Daniel A. Heller; Christopher P. Horoszko; Monique E. Johnson; Antonio R. Montoro Bustos; Vytas Reipa; Kathryn R. Riley; Bryant C. Nelson,"Nanomedicine utilizes the remarkable properties of nanomaterials for the diagnosis, treatment, and prevention of disease. Many of these nanomaterials have been shown to have robust antioxidative properties, potentially functioning as strong scavengers of reactive oxygen species. Conversely, several nanomaterials have also been shown to promote the generation of reactive oxygen species, which may precipitate the onset of oxidative stress, a state that is thought to contribute to the development of a variety of adverse conditions. As such, the impacts of nanomaterials on biological entities are often associated with and influenced by their specific redox properties. In this review, we overview several classes of nanomaterials that have been or projected to be used across a wide range of biomedical applications, with discussion focusing on their unique redox properties. Nanomaterials examined include iron, cerium, and titanium metal oxide nanoparticles, gold, silver, and selenium nanoparticles, and various nanoscale carbon allotropes such as graphene, carbon nanotubes, fullerenes, and their derivatives/variations. Principal topics of discussion include the chemical mechanisms by which the nanomaterials directly interact with biological entities and the biological cascades that are thus indirectly impacted. Selected case studies highlighting the redox properties of nanomaterials and how they affect biological responses are used to exemplify the biologically-relevant redox mechanisms for each of the described nanomaterials.",9,40,15226,15251,Nanomaterials; Nanomedicine; Nanoparticle; Nanotechnology; Materials science; Titanium metal; Graphene; Redox active; Carbon nanotube; Redox,,"Free Radical Scavengers/pharmacology; Graphite; Humans; Metal Nanoparticles; Nanomedicine; Nanostructures; Nanotubes, Carbon; Oxidation-Reduction; Reactive Oxygen Species/metabolism","Free Radical Scavengers; Nanotubes, Carbon; Reactive Oxygen Species; Graphite",Intramural NIST DOC (9999-NIST) United States; NICHD NIH HHS (DP2 HD075698) United States; NCI NIH HHS (P30 CA008748) United States; NCI NIH HHS (T32 CA062948) United States,http://xlink.rsc.org/?DOI=C7NR05429G http://pubs.rsc.org/en/content/articlelanding/2017/nr/c7nr05429g https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648636/ https://doi.org/10.1039/C7NR05429G https://pubs.rsc.org/en/content/articlelanding/2017/nr/c7nr05429g#! https://europepmc.org/articles/PMC5648636 https://works.swarthmore.edu/cgi/viewcontent.cgi?article=1235&context=fac-chemistry https://works.swarthmore.edu/fac-chemistry/235/ https://www.nist.gov/publications/redox-active-nanomaterials-nanomedicine-applications https://pubmed.ncbi.nlm.nih.gov/28991962/,http://dx.doi.org/10.1039/c7nr05429g,28991962,10.1039/c7nr05429g,2761727637,PMC5648636,0,000-691-215-121-295; 000-797-335-079-875; 001-367-744-510-896; 001-416-394-898-752; 001-525-110-413-075; 001-606-537-741-785; 002-795-443-912-231; 002-805-215-170-084; 002-901-082-448-846; 003-013-965-270-974; 003-257-973-825-520; 003-423-905-569-116; 003-549-831-540-735; 003-609-998-795-379; 003-690-799-276-921; 004-050-188-488-82X; 004-318-349-104-351; 004-771-251-135-331; 004-868-493-553-06X; 005-174-033-252-418; 005-426-084-330-656; 005-595-440-526-696; 005-650-379-718-988; 006-023-737-273-506; 006-058-153-129-738; 006-108-702-955-825; 006-154-168-715-713; 006-181-406-489-779; 006-709-334-483-388; 006-934-525-150-368; 006-962-542-514-811; 007-024-648-795-370; 007-099-081-909-90X; 007-396-972-527-770; 007-415-950-804-045; 007-439-929-106-898; 007-618-461-614-945; 007-635-139-002-46X; 007-893-389-064-104; 007-946-627-521-013; 008-232-203-699-071; 008-350-649-395-846; 008-520-053-984-710; 008-850-368-639-307; 009-253-514-797-671; 009-271-957-329-382; 009-826-583-611-258; 010-234-196-981-95X; 010-235-709-267-167; 010-295-470-583-591; 010-435-552-014-191; 010-689-134-279-082; 010-876-120-743-968; 010-948-927-915-206; 010-955-373-427-66X; 011-147-291-891-785; 011-281-401-733-276; 011-314-538-227-372; 011-837-711-681-53X; 012-098-578-526-628; 012-306-484-748-725; 012-335-365-251-057; 012-635-039-540-683; 012-662-045-658-075; 012-698-925-405-214; 012-861-561-256-752; 012-945-535-964-956; 012-947-123-352-100; 013-659-597-420-937; 013-826-937-878-350; 014-580-089-116-597; 014-680-520-015-098; 014-900-727-901-339; 014-917-460-092-456; 014-958-622-173-373; 014-996-119-607-821; 015-234-768-373-397; 015-343-603-330-172; 015-827-267-179-549; 016-042-871-088-228; 016-074-110-622-437; 016-104-997-595-226; 016-328-250-759-90X; 016-433-698-920-76X; 016-510-910-218-027; 016-542-926-548-078; 016-701-158-138-505; 016-788-628-539-165; 016-820-811-842-362; 017-392-926-121-723; 017-984-234-373-187; 018-094-933-135-067; 018-313-142-142-022; 018-429-417-842-971; 018-552-332-053-344; 018-866-566-036-813; 018-874-614-219-906; 018-943-760-688-248; 019-035-179-182-465; 019-134-486-294-68X; 019-178-552-018-160; 019-303-447-137-352; 019-551-796-375-984; 019-555-453-663-202; 019-805-760-308-859; 020-134-780-776-386; 020-168-271-624-494; 020-204-475-053-449; 020-462-188-501-28X; 020-783-866-554-75X; 020-791-427-103-113; 020-846-900-210-439; 021-307-243-034-36X; 021-963-260-910-347; 022-059-925-903-266; 022-229-432-812-605; 022-250-983-138-625; 022-383-525-308-761; 022-855-482-829-729; 022-878-943-408-030; 023-312-305-375-805; 023-421-524-663-279; 023-426-250-905-076; 023-624-099-591-779; 024-158-300-975-08X; 024-180-962-411-807; 024-544-010-764-765; 025-089-993-157-724; 025-327-496-012-402; 026-312-320-413-530; 026-408-921-191-001; 026-441-096-336-331; 026-501-702-320-498; 026-762-379-601-331; 026-886-949-077-696; 027-029-387-059-233; 027-393-328-794-116; 027-533-957-981-864; 027-704-197-163-095; 028-230-746-941-975; 028-447-169-539-026; 028-511-492-265-081; 028-546-126-419-693; 028-881-658-042-469; 029-208-228-271-858; 030-136-946-105-382; 030-422-535-272-773; 030-468-227-059-384; 030-649-798-531-905; 031-200-026-767-578; 031-216-862-428-914; 031-656-510-845-190; 032-340-610-287-873; 032-838-259-938-816; 033-063-087-329-402; 033-163-244-002-269; 033-795-419-348-09X; 034-036-444-403-715; 034-263-047-021-684; 034-591-735-254-900; 034-631-987-387-113; 034-682-907-658-64X; 034-857-729-043-213; 035-268-555-409-764; 035-317-710-194-635; 035-323-974-796-622; 035-573-757-962-139; 035-883-712-822-136; 036-070-574-589-601; 037-031-669-506-690; 037-136-664-179-353; 037-137-997-022-228; 037-183-415-678-954; 038-153-814-636-507; 038-690-114-453-084; 038-704-232-755-619; 038-976-166-359-165; 039-480-073-280-340; 039-563-070-650-899; 039-705-182-604-054; 039-929-743-725-79X; 040-095-080-227-518; 040-427-357-303-789; 040-428-293-873-102; 040-633-670-051-642; 040-648-595-553-555; 040-900-538-161-59X; 041-343-812-493-667; 041-715-459-777-814; 041-820-565-139-925; 041-892-508-715-730; 042-931-397-210-582; 042-948-848-995-632; 042-992-732-732-935; 043-104-856-236-237; 043-517-420-940-405; 043-704-391-376-879; 043-747-732-942-374; 044-376-761-094-411; 044-446-936-015-692; 044-731-553-254-920; 045-117-367-995-465; 045-265-838-695-130; 045-506-038-980-747; 046-105-694-259-439; 046-506-853-112-686; 046-758-963-544-712; 047-270-592-494-628; 047-766-459-104-677; 048-012-307-745-956; 048-297-936-703-961; 048-426-246-044-274; 049-193-775-512-098; 049-602-563-385-511; 049-993-010-037-681; 050-117-766-410-349; 050-359-510-075-390; 050-600-443-328-148; 051-318-058-983-274; 051-705-503-745-080; 052-106-167-069-037; 052-616-843-462-919; 053-356-082-675-730; 053-364-978-906-239; 053-871-566-238-592; 054-561-533-881-47X; 054-871-865-580-642; 057-155-571-491-224; 057-516-716-664-677; 057-625-716-139-218; 057-791-760-496-603; 057-923-619-704-479; 058-115-915-983-24X; 058-422-953-893-966; 058-573-335-467-191; 059-271-120-430-853; 060-257-998-730-330; 060-742-350-931-972; 061-051-955-535-220; 061-259-082-440-929; 061-317-727-464-956; 062-166-517-578-972; 062-528-868-652-498; 062-881-669-245-782; 063-089-930-326-912; 063-816-147-928-979; 064-484-493-988-497; 064-783-217-840-517; 065-207-409-006-907; 065-333-184-289-404; 065-482-927-919-673; 065-515-156-293-948; 066-208-946-417-85X; 066-835-600-902-455; 067-224-054-165-833; 067-722-152-008-913; 068-172-897-599-562; 068-225-346-368-000; 068-239-266-457-57X; 069-393-042-663-94X; 069-779-803-673-109; 069-863-420-222-257; 070-120-849-489-905; 070-137-372-494-125; 070-609-412-419-06X; 070-690-822-012-714; 070-778-695-069-414; 070-988-661-782-006; 071-274-805-480-384; 071-468-198-380-351; 071-714-269-884-620; 074-204-453-242-416; 074-290-525-210-290; 074-733-616-505-908; 075-187-550-699-914; 075-524-898-635-908; 075-752-483-470-35X; 075-791-240-771-408; 076-667-774-240-829; 077-761-656-567-318; 077-859-925-275-475; 078-317-742-066-275; 078-546-088-830-994; 079-360-877-274-40X; 079-438-750-077-895; 079-880-120-853-871; 080-404-292-985-019; 080-440-629-425-120; 080-455-685-979-648; 081-235-155-218-405; 081-319-425-377-819; 081-351-517-187-780; 081-370-742-024-48X; 082-380-205-077-047; 084-437-257-770-983; 084-665-365-744-795; 086-643-837-863-481; 087-027-109-711-612; 087-346-740-930-110; 088-114-253-617-673; 088-600-060-802-50X; 088-684-197-413-696; 089-410-808-618-091; 089-413-826-095-670; 089-794-106-148-406; 089-824-829-812-010; 091-097-928-632-123; 091-310-306-040-14X; 092-085-806-858-042; 092-093-241-317-723; 092-511-072-388-940; 092-831-392-556-504; 093-168-769-772-652; 093-455-690-325-499; 093-911-571-101-245; 094-192-525-368-246; 094-564-370-547-737; 094-714-604-015-911; 095-397-000-827-898; 095-471-903-740-876; 095-636-704-910-863; 095-939-588-824-076; 096-107-302-089-577; 096-531-052-600-696; 096-646-466-395-872; 097-626-142-433-527; 098-048-956-815-932; 098-805-784-735-906; 099-389-289-164-233; 100-001-105-736-891; 100-219-789-586-792; 100-433-160-317-744; 101-314-209-095-797; 102-169-488-368-791; 103-279-275-500-764; 104-656-008-334-05X; 106-917-125-677-188; 107-138-286-747-398; 110-219-421-363-665; 110-819-705-550-04X; 112-990-824-814-530; 113-067-537-464-053; 114-260-975-302-91X; 115-054-368-755-780; 115-951-932-051-603; 116-306-061-578-999; 116-632-045-463-730; 116-789-648-434-846; 118-348-669-995-326; 119-011-080-506-326; 120-752-472-905-506; 122-284-724-807-039; 122-894-523-432-486; 123-385-265-491-651; 124-365-195-886-938; 124-412-800-853-253; 126-208-277-044-48X; 127-394-365-961-710; 128-445-364-739-96X; 128-838-957-895-623; 129-104-058-613-286; 130-014-653-118-18X; 130-797-714-746-782; 133-018-699-436-72X; 133-415-611-433-452; 133-592-792-203-919; 134-427-681-929-642; 137-566-513-145-151; 137-591-258-367-412; 137-801-987-410-487; 138-864-236-210-50X; 140-590-133-484-651; 141-142-693-581-14X; 142-324-477-082-18X; 149-016-653-346-130; 150-454-803-116-687; 153-058-171-059-382; 158-797-211-913-637; 159-507-410-764-062; 160-347-536-298-170; 161-207-241-316-812; 177-913-091-898-309; 180-804-605-498-448; 181-622-489-163-497; 182-062-830-877-084; 187-530-310-554-843; 195-505-059-915-500,62
016-814-879-061-174,Nanomaterial-based cosmeceuticals,,2020,book chapter,Handbook of Functionalized Nanomaterials for Industrial Applications,,Elsevier,,Pravin Shende; Drashti Patel; Anjali Takke,"Abstract Cosmeceuticals are the latest addition to the healthcare industry. There are a number of topical cosmeceutical products used for various conditions related to the skin such as wrinkles, hyperpigmentation, and aging. Nanotechnology is one of the major advancements in the personal care industry and is considered as safe for targeted delivery of active medicaments. A significant number of novel formulations are used in personal care with consumer-perceptible benefits, resulting in economic benefits to the cosmetics industry. Nanomaterial-based cosmeceuticals are advantageous in a variety of products due to enhance penetration and increased bioavailability of active ingredients. This chapter outlines the different types of nanomaterials like liposomes, nanoemulsion, nanosponges, solid lipid nanoparticles, nanopigments, dendrimers, etc., along with their applications and also provides patent data and regulatory perspectives. Toxicity and safety of nanocosmeceuticals need to be kept in mind while exploring various nanomaterials for cosmetics.",,,775,791,Nanomaterials; Business; Nanotechnology; Solid lipid nanoparticle; Cosmetics; Cosmeceutical; Cosmeceuticals; Economic benefits; Personal care; Active ingredient,,,,,https://www.sciencedirect.com/science/article/pii/B9780128167878000247,http://dx.doi.org/10.1016/b978-0-12-816787-8.00024-7,,10.1016/b978-0-12-816787-8.00024-7,3020460037,,0,002-638-361-417-211; 004-349-697-007-701; 004-463-178-843-07X; 011-781-832-610-519; 013-058-481-938-191; 014-209-710-448-770; 017-618-166-470-945; 022-813-130-209-168; 023-042-805-467-098; 024-555-114-888-336; 025-120-101-843-562; 025-986-601-469-586; 030-248-535-603-121; 034-388-682-384-491; 035-220-425-705-562; 038-933-821-858-084; 042-815-531-934-760; 044-071-748-126-565; 044-555-739-096-174; 047-826-816-208-610; 050-497-759-678-74X; 055-921-408-762-204; 058-067-426-364-348; 061-087-595-532-45X; 066-616-082-115-493; 066-766-935-650-441; 068-438-157-357-096; 070-034-291-938-378; 075-015-724-349-199; 090-227-598-941-308; 103-169-335-109-576; 104-699-708-130-744; 113-348-721-085-185; 123-732-176-562-036; 137-281-424-053-977; 153-350-397-442-876; 161-266-169-984-794,1
017-137-370-104-769,Computational studies on the interactions of nanomaterials with proteins and their impacts,2015-12-10,2015,journal article,Chinese Physics B,16741056,IOP Publishing,China,Deyi An; Ji-Guo Su; Chun-Hua Li; Jingyuan Li,"Intensive concerns about the biosafety of nanomaterials demand the systematic study of the mechanisms about their biological effects. Many biological effects can be attributed to the interaction of nanomaterials with protein and their impacts on protein function. On the other hand, nanomaterials exhibit the potential in a variety of biomedical applications, many of which also involve the direct interaction with protein. In this paper, we review some recent computational studies about this subject, especially the interaction of carbon and gold nanomaterials. Besides the hydrophobic and {\pi}-stacking interactions, the interaction mode of carbon nanomaterials can be regulated by their functional groups. And the coating of gold nanomaterials also adjusts their interaction mode, in addition to the coordination interaction with cysteine's sulfur group and histidine's imidazole group. Moreover, nanomaterials can interact with multiple proteins and the impacts on protein activity are attributed to a wide spectrum of mechanisms. The findings about the mechanisms of nanomaterial-protein interaction can further guide the design and development of nanomaterial to realize the applications in disease diagnosis and treatment.",24,12,120504,,Nanomaterials; Nanotechnology; Chemistry; Biological effect; Nanomaterials; Nanotechnology; Chemistry; Protein activity; Protein function; Interaction mode; Carbon nanomaterials,,,,,http://iopscience.iop.org/article/10.1088/1674-1056/24/12/120504/meta https://ui.adsabs.harvard.edu/abs/2015ChPhB..24l0504A/abstract http://arxiv.org/abs/1509.05563,http://dx.doi.org/10.1088/1674-1056/24/12/120504,,10.1088/1674-1056/24/12/120504,3104213642; 2247933104,,0,001-304-645-444-442; 002-300-695-553-063; 004-077-510-195-014; 005-345-443-455-06X; 005-716-268-121-272; 005-942-907-329-981; 006-239-192-438-931; 006-743-480-927-089; 008-014-013-929-336; 008-200-021-266-156; 008-828-963-518-875; 008-941-374-652-544; 009-433-271-836-629; 010-366-384-518-30X; 011-857-355-228-971; 012-868-864-795-27X; 012-945-535-964-956; 013-141-678-329-389; 013-909-986-735-501; 014-158-495-095-505; 015-401-212-215-487; 015-894-367-387-636; 016-341-399-647-232; 016-657-169-678-421; 018-094-933-135-067; 018-158-541-634-414; 018-196-595-148-259; 018-255-414-893-346; 019-247-528-811-077; 020-147-078-269-74X; 020-684-711-955-889; 022-401-068-725-434; 022-660-316-942-849; 023-731-947-341-566; 025-446-816-962-768; 025-881-094-100-002; 027-079-212-688-949; 027-463-365-947-055; 029-125-973-870-697; 030-310-007-170-654; 030-495-218-463-717; 033-818-797-115-25X; 034-710-371-999-985; 035-172-740-397-076; 035-883-712-822-136; 036-349-407-037-760; 038-627-754-965-422; 038-769-623-672-180; 039-096-327-760-197; 040-661-765-954-084; 041-516-725-993-033; 042-297-923-122-991; 042-343-268-083-408; 043-642-084-107-758; 045-019-461-832-196; 047-168-943-866-454; 048-905-631-736-515; 048-968-852-895-358; 050-525-743-278-704; 051-163-831-394-335; 051-425-605-501-021; 051-484-510-377-347; 053-248-528-484-544; 053-352-618-432-158; 053-511-908-739-217; 054-113-129-198-59X; 055-433-282-311-949; 055-895-832-628-083; 055-921-408-762-204; 057-916-049-141-161; 058-061-553-108-163; 062-218-289-564-641; 063-790-900-485-811; 065-308-585-395-385; 065-961-036-598-560; 066-052-336-860-872; 066-242-570-932-202; 066-687-475-036-225; 067-518-984-257-017; 070-111-528-404-582; 071-447-753-479-252; 072-169-944-003-643; 073-172-693-865-778; 076-547-121-949-084; 078-620-439-904-506; 078-669-128-101-973; 079-127-336-147-394; 080-460-950-237-271; 081-370-742-024-48X; 081-813-382-213-497; 083-801-572-639-274; 087-429-539-195-55X; 088-334-626-180-529; 088-490-013-538-641; 089-436-359-677-453; 091-072-682-508-497; 093-045-522-589-602; 095-975-344-254-634; 096-829-372-257-737; 101-793-757-250-891; 103-223-481-581-187; 103-237-391-084-256; 103-385-703-685-662; 106-610-578-436-348; 110-702-433-794-550; 115-874-912-580-739; 118-008-330-751-866; 118-129-126-968-102; 118-300-105-620-26X; 121-361-783-695-401; 121-667-170-425-11X; 122-487-862-603-253; 123-357-419-165-229; 125-993-176-471-773; 128-428-212-315-098; 135-251-256-783-814; 136-167-198-203-360; 141-206-643-122-025; 144-359-718-606-523; 146-479-667-771-236; 149-016-653-346-130; 173-136-810-733-414; 176-724-587-481-129; 182-640-321-660-313; 185-065-202-124-316; 193-326-970-687-931,2
017-141-339-651-459,Impact the Metal Nanomaterials on Visual Facts of Polymers Mix,2020-07-30,2020,journal article,Solid State Technology,0038111x,,,Zaid A. Hasan,"The optical properties for (PMMA - PS) mix doped Cu nanomaterials , a polymers mix films is prepare by casting method to vary value of Cu nanomaterials, the visual facts for these samples studied. Take the optical absorption for these samples of ( 190 – 1100 nm) , found account the effect of Cu nanomaterials to some visual facts for polymers mix. This study explained change in the visual factsKeywords: Materials; polymers; physical properties; nanomaterial",63,1,1769,1774,Nanomaterials; Casting; Nanotechnology; Materials science; Polymer; Metal; Doping; Absorption (chemistry),,,,,,,,,3092790976,,0,,0
017-159-806-869-293,Recent Developments in the Application of Nanomaterials in Agroecosystems.,2020-12-02,2020,journal article,"Nanomaterials (Basel, Switzerland)",20794991,,Switzerland,Haleema Saleem; Syed Javaid Zaidi,"Nanotechnology implies the scientific research, development, and manufacture, along with processing, of materials and structures on a nano scale. Presently, the contamination of metalloids and metals in the soil has gained substantial attention. The consolidation of nanomaterials and plants in ecological management has received considerable research attention because certain nanomaterials could enhance plant seed germination and entire plant growth. Conversely, when the nanomaterial concentration is not properly controlled, toxicity will definitely develop. This paper discusses the role of nanomaterials as: (1) nano-pesticides (for improving the plant resistance against the biotic stress); and (2) nano-fertilizers (for promoting the plant growth by providing vital nutrients). This review analyzes the potential usages of nanomaterials in agroecosystem. In addition, the adverse effects of nanomaterials on soil organisms are discussed. We mostly examine the beneficial effects of nanomaterials such as nano-zerovalent iron, iron oxide, titanium dioxide, nano-hydroxyapatite, carbon nanotubes, and silver- and copper-based nanomaterials. Some nanomaterials can affect the growth, survival, and reproduction of soil organisms. A change from testing/using nanomaterials in plants for developing nanomaterials depending on agricultural requirements would be an important phase in the utilization of nanomaterials in sustainable agriculture. Conversely, the transport as well as ecological toxicity of nanomaterials should be seriously examined for guaranteeing its benign usage in agriculture.",10,12,2411,,Agriculture; Nanomaterials; Heavy metals; Plant growth; Beneficial effects; Environmental science; Environmental protection; Sustainable agriculture; Agroecosystem,environmental impact; heavy metals; nanomaterials; plants; soil pollution; toxicity,,,Qatar University (IRCC-2019-04),https://www.mdpi.com/2079-4991/10/12/2411/pdf https://www.scilit.net/article/7663d595d371cc2feeda7b68695a35eb https://www.mdpi.com/2079-4991/10/12/2411 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761570 https://pubmed.ncbi.nlm.nih.gov/33276643/,http://dx.doi.org/10.3390/nano10122411,33276643,10.3390/nano10122411,3109620614,PMC7761570,0,000-183-913-887-895; 000-329-230-459-620; 000-539-014-085-703; 000-842-504-699-419; 000-876-903-880-317; 001-087-056-492-886; 001-393-266-517-602; 001-854-874-419-490; 001-987-242-093-225; 002-552-463-355-974; 002-868-789-241-046; 003-265-954-049-829; 003-687-648-121-52X; 004-145-802-308-510; 004-327-760-003-918; 004-541-747-418-948; 004-763-742-206-878; 005-832-378-298-878; 006-786-840-667-832; 007-083-688-166-659; 007-138-904-926-276; 007-177-888-556-376; 007-558-696-671-184; 007-807-134-105-396; 007-856-778-233-159; 008-113-337-470-043; 008-438-580-329-125; 008-697-729-923-453; 009-859-702-090-530; 009-965-459-902-875; 010-868-432-680-548; 011-318-361-412-967; 011-872-862-217-009; 012-201-645-540-837; 012-292-971-110-513; 012-332-770-361-694; 013-131-647-824-53X; 013-150-008-128-304; 013-163-515-892-553; 014-516-434-166-303; 014-609-367-257-186; 015-252-134-886-800; 015-850-238-405-32X; 016-040-985-946-287; 016-405-835-199-983; 016-544-725-482-083; 016-581-093-393-252; 016-903-242-846-809; 016-904-358-053-071; 017-072-616-872-895; 017-375-481-056-425; 018-994-074-542-011; 019-104-637-957-712; 019-209-206-943-598; 019-568-790-067-404; 019-810-941-640-718; 020-329-861-078-336; 020-673-466-452-351; 020-737-627-377-146; 020-981-565-582-404; 021-264-783-746-408; 021-668-032-767-778; 021-726-607-212-275; 021-732-991-179-844; 022-204-172-961-039; 022-826-392-085-372; 023-224-819-752-014; 024-000-253-443-848; 024-502-570-892-516; 024-789-059-938-004; 025-262-454-465-214; 025-639-327-332-686; 025-691-782-289-622; 025-956-596-993-465; 026-064-417-622-400; 026-379-500-211-721; 026-487-181-843-243; 026-950-168-954-354; 027-112-916-800-099; 027-524-146-476-448; 027-808-447-413-234; 027-918-022-706-522; 028-054-895-960-301; 028-177-145-616-536; 028-752-631-172-182; 029-079-145-951-809; 029-247-932-480-532; 030-375-875-048-349; 031-328-893-446-409; 031-481-562-366-19X; 031-769-742-143-658; 031-977-991-106-133; 032-095-116-847-939; 033-841-319-011-494; 034-438-957-184-521; 034-929-473-865-669; 036-171-275-406-185; 036-379-151-794-086; 036-861-448-997-859; 038-952-376-754-597; 039-112-333-773-979; 039-133-898-896-872; 040-158-641-372-148; 041-188-883-818-281; 041-690-704-581-033; 041-815-749-327-764; 041-994-228-735-865; 042-441-233-916-747; 043-027-467-479-482; 044-080-573-794-653; 044-080-859-156-999; 044-503-046-121-15X; 045-318-647-580-601; 045-741-372-983-521; 045-957-428-834-545; 047-505-066-894-000; 048-111-131-817-146; 048-271-877-278-006; 048-904-847-089-21X; 049-320-293-878-846; 049-358-699-191-001; 049-410-482-839-01X; 049-646-235-250-76X; 049-697-173-975-596; 049-963-738-003-647; 051-228-077-835-470; 051-886-037-044-257; 052-008-156-876-280; 052-149-344-438-973; 052-315-135-861-880; 052-610-357-113-222; 052-830-296-618-941; 053-634-678-862-139; 054-371-832-902-691; 055-591-447-545-238; 056-440-543-158-391; 056-833-533-367-015; 057-302-922-897-523; 057-570-013-311-960; 058-203-028-247-406; 058-800-949-765-166; 060-204-085-176-129; 060-324-339-505-786; 060-355-522-082-736; 060-460-021-170-775; 060-471-764-154-999; 061-807-454-540-803; 061-852-952-126-640; 062-620-175-464-47X; 063-046-863-583-029; 063-289-135-822-964; 066-168-508-237-046; 068-256-061-501-519; 069-219-454-709-584; 070-000-701-284-579; 070-519-854-436-706; 070-567-654-034-098; 071-115-133-696-60X; 071-164-873-254-058; 072-668-954-432-659; 074-941-997-773-231; 077-268-511-103-038; 079-053-864-050-204; 081-654-955-778-044; 081-723-306-740-894; 081-785-496-056-797; 082-018-484-013-959; 082-179-356-583-17X; 082-520-014-085-804; 083-752-546-848-816; 084-015-347-682-805; 084-765-027-505-394; 085-584-727-771-38X; 088-401-561-228-460; 088-441-076-666-869; 089-859-939-650-198; 091-707-866-984-400; 092-006-113-897-470; 092-263-248-248-213; 093-432-725-479-999; 093-823-947-574-279; 095-315-502-289-143; 097-642-250-148-248; 098-116-080-102-533; 098-541-722-907-331; 098-737-868-614-683; 098-834-161-504-514; 102-190-772-291-687; 102-753-918-917-571; 103-305-301-058-970; 103-702-896-507-454; 105-468-180-423-255; 107-616-411-967-108; 107-626-493-292-536; 107-806-261-633-555; 107-848-636-288-766; 108-688-455-600-745; 109-569-776-273-989; 112-068-673-718-239; 115-206-985-342-631; 117-621-551-366-274; 119-318-595-841-138; 121-929-087-422-978; 122-768-698-182-530; 127-186-205-882-128; 127-570-399-057-770; 130-796-108-862-842; 130-884-451-129-015; 132-573-733-070-300; 132-859-952-506-155; 136-409-244-401-587; 136-793-972-426-351; 137-676-156-948-809; 140-232-293-500-411; 141-536-310-372-95X; 143-990-286-004-657; 147-650-140-055-368; 149-436-137-909-815; 150-699-180-693-300; 153-383-150-344-677; 158-097-564-663-680; 166-265-642-365-268; 170-278-757-697-833; 171-736-837-352-896; 174-368-126-005-292; 177-167-530-473-299; 197-223-209-540-706; 199-404-588-179-150,6
017-342-168-324-162,Chitin nanomaterials: preparation and surface modifications,,2020,book chapter,Handbook of Chitin and Chitosan,,Elsevier,,Abul K. Mallik; Nurus Sakib;  Shaharuzzaman; Papia Haque; Mohammed Mizanur Rahman,"Abstract This chapter is focused on various chitin-based nanomaterials, their preparation methods, and the surface modification processes for diversifying their applications. Chitin biopolymer has special properties, that is, nontoxicity, antibacterial activity, biodegradability, and biocompatibility. Moreover, chitin can be converted to different nanomaterials with enhanced properties, especially for use in biomedical applications. For example, it can be converted to chitin nanofiber, chitin nanowhisker, chitin nanocomposite, polymer/chitin bionanocomposite, chitin nanogel, etc. Various techniques have been used to prepare the chitin-based nanomaterials, like electrospinning for the preparation of nanofibers. Surface modification of chitin-based nanomaterials is another technique to improve the properties of the nanomaterials, as well as their applicability.",,,165,194,Surface modification; Nanogel; Nanomaterials; Electrospinning; Nanotechnology; Materials science; Biocompatibility; Chitin; Nanofiber; Nanocomposite,,,,,https://www.sciencedirect.com/science/article/pii/B9780128179703000067,http://dx.doi.org/10.1016/b978-0-12-817970-3.00006-7,,10.1016/b978-0-12-817970-3.00006-7,3037392659,,0,000-632-591-679-217; 001-695-451-337-228; 002-946-328-903-634; 003-163-459-041-582; 003-877-832-861-613; 004-280-474-211-26X; 005-607-729-460-03X; 005-709-728-214-168; 005-954-260-206-494; 007-312-830-882-59X; 008-461-105-647-592; 008-506-546-295-592; 009-697-761-924-92X; 010-575-955-271-437; 011-198-078-667-610; 011-748-759-457-217; 011-845-544-517-598; 011-989-960-432-385; 012-329-707-165-001; 013-269-865-915-626; 013-467-260-807-507; 013-601-430-337-11X; 013-726-796-394-660; 014-520-963-823-526; 016-402-444-150-556; 017-745-602-902-532; 018-766-346-359-049; 022-618-948-918-506; 024-880-081-557-141; 025-150-891-253-897; 025-491-153-614-131; 027-037-823-707-525; 027-097-179-007-783; 027-445-247-540-896; 029-397-180-653-974; 030-121-056-932-27X; 033-768-228-075-945; 034-242-426-179-93X; 034-676-904-746-571; 035-271-847-205-808; 039-906-324-908-223; 041-191-442-229-550; 041-310-718-306-991; 041-474-667-863-27X; 041-999-768-559-615; 044-314-112-213-982; 046-198-627-225-058; 048-888-463-367-543; 049-780-607-704-898; 051-156-650-995-259; 051-986-369-101-682; 057-770-477-454-552; 057-789-059-264-676; 059-405-100-403-891; 060-202-262-836-433; 063-579-945-402-799; 066-426-848-394-653; 066-942-408-545-850; 066-974-468-802-720; 067-354-510-399-648; 067-365-463-638-194; 069-640-497-887-080; 069-793-538-201-645; 069-925-429-709-61X; 070-545-494-356-890; 073-755-257-177-13X; 074-457-159-916-913; 075-249-417-300-477; 077-188-890-061-965; 077-212-831-792-714; 079-503-563-073-758; 079-630-261-667-915; 080-138-198-787-711; 080-957-549-052-653; 081-015-039-232-336; 084-748-472-598-731; 097-975-759-603-317; 098-139-664-393-954; 100-161-793-709-426; 103-526-478-535-102; 106-395-290-664-940; 115-285-221-460-599; 116-676-054-527-163; 119-805-788-642-168; 127-967-682-713-804; 130-489-186-768-886; 132-184-427-851-45X; 140-759-179-705-182; 143-816-854-877-197; 151-615-117-434-985; 161-186-767-433-933; 195-363-276-288-047,1
017-349-615-417-929,Importance of researches on chronic effects by manufactured nanomaterials,2011-02-01,2011,journal article,Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,00316903; 13475231,Pharmaceutical Society of Japan,Japan,Akihiko Hirose; Atsuya Takagi; Tetsuji Nishimura; Hiroyuki Tsuda; Yoshimitsu Sakamoto; Akio Ogata; Dai Nakae; Okio Hino; Jun Kanno,"Manufactured nanomaterials are the most important substances for the nanotechnology. The nanomaterials possess different physico-chemical properties from bulk materials. The new properties may lead to biologically beneficial effects and/or adverse effects. However, there are no standardized evaluation methods at present. Some domestic research projects and international OECD programs are ongoing, in order to share the health impact information of nanomaterials or to standardize the evaluation methods. From 2005, our institutes have been conducting the research on the establishment of health risk assessment methodology of manufactured nanomaterials. In the course of the research project, we revealed that the nanomaterials were competent to cause chronic effects, by analyzing the intraperitoneal administration studies and carcinogenic promotion studies. These studies suggested that even aggregated nanomaterials were crumbled into nanosized particles inside the body during the long-term, and the particles were transferred to other organs. Also investigations of the toxicokinetic properties of nanomaterials after exposure are important to predict the chronically targeted tissues. The long lasting particles/fibers in the particular tissues may cause chronic adverse effects. Therefore, focusing on the toxicological characterization of chronic effects was considered to be most appropriate approach for establishing the risk assessment methods of nanomaterials.",131,2,195,201,Nanotechnology; Health risk assessment; Long lasting; Health impact; Manufactured nanomaterials; Evaluation methods; Beneficial effects,,"Animals; Chemistry, Physical; Humans; Mice; Nanostructures/adverse effects; Nanotubes, Carbon/adverse effects; Particle Size; Risk Assessment/methods; Toxicity Tests, Chronic","Nanotubes, Carbon",,https://pubmed.ncbi.nlm.nih.gov/21297361/ https://www.ncbi.nlm.nih.gov/pubmed/21297361 http://europepmc.org/abstract/MED/21297361 http://joi.jlc.jst.go.jp/JST.JSTAGE/yakushi/131.195?from=CrossRef,http://dx.doi.org/10.1248/yakushi.131.195,21297361,10.1248/yakushi.131.195,2332448291,,0,000-408-372-382-839; 009-433-271-836-629; 020-989-973-784-343; 025-200-681-612-794; 035-172-740-397-076; 037-936-041-485-683; 045-021-941-569-086; 051-126-598-938-187; 057-699-070-202-215; 091-313-014-681-467; 098-834-452-705-754; 111-010-950-042-639,1
017-529-272-210-851,Biosensors Based on Advanced Sulfur-Containing Nanomaterials.,2020-06-19,2020,journal article,"Sensors (Basel, Switzerland)",14248220; 14243210,Multidisciplinary Digital Publishing Institute (MDPI),Switzerland,Chunmei Li; Yihan Wang; Hui Jiang; Xuemei Wang,"In recent years, sulfur-containing nanomaterials and their derivatives/composites have attracted much attention because of their important role in the field of biosensor, biolabeling, drug delivery and diagnostic imaging technology, which inspires us to compile this review. To focus on the relationships between advanced biomaterials and biosensors, this review describes the applications of various types of sulfur-containing nanomaterials in biosensors. We bring two types of sulfur-containing nanomaterials including metallic sulfide nanomaterials and sulfur-containing quantum dots, to discuss and summarize the possibility and application as biosensors based on the sulfur-containing nanomaterials. Finally, future perspective and challenges of biosensors based on sulfur-containing nanomaterials are briefly rendered.",20,12,3488,,Engineering; Nanomaterials; Biosensor; Nanotechnology; Metallic sulfide; Sulfur containing; Future perspective,biosensors; metallic sulfide nanomaterials; sulfur-containing nanomaterials; sulfur-containing quantum dots,Biosensing Techniques; Nanostructures; Quantum Dots; Sulfur,Sulfur,National Key Research and Development Program of China (2017YFA0205300); National Natural Science Foundation of China (21675023); National Natural Science Foundation of China (91753106); Postgraduate Research & Practice Innovation Program of Jiangsu Province (KYCX19_0109),https://www.mdpi.com/1424-8220/20/12/3488 https://dblp.uni-trier.de/db/journals/sensors/sensors20.html#LiWJW20 https://www.mdpi.com/1424-8220/20/12/3488/pdf https://pubmed.ncbi.nlm.nih.gov/32575665/ https://doi.org/10.3390/s20123488 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349518,http://dx.doi.org/10.3390/s20123488,32575665,10.3390/s20123488,3036287597,PMC7349518,0,000-120-526-103-175; 000-592-741-331-133; 000-656-621-667-425; 002-597-788-039-602; 002-934-827-945-216; 003-015-761-210-020; 003-156-336-119-276; 003-475-213-772-345; 003-816-189-380-749; 004-196-883-628-451; 004-290-573-605-941; 004-411-084-073-508; 005-304-319-165-849; 006-084-123-368-374; 006-224-254-107-117; 006-287-744-590-293; 006-638-869-161-128; 006-674-860-505-594; 008-746-587-739-56X; 010-285-590-285-952; 010-905-013-296-63X; 011-028-649-128-986; 011-427-005-291-41X; 011-781-351-573-075; 012-134-035-149-200; 012-671-360-553-171; 013-693-822-427-30X; 013-790-048-311-651; 014-061-109-468-748; 014-445-455-730-772; 018-023-383-048-381; 018-554-470-199-498; 019-493-383-430-217; 020-061-798-635-405; 020-461-560-729-623; 020-562-343-198-531; 021-573-616-538-811; 022-219-312-064-80X; 023-534-751-370-012; 024-139-624-481-090; 024-275-456-056-381; 024-547-490-319-129; 025-068-592-444-615; 025-205-812-886-828; 025-419-684-935-640; 025-566-180-857-917; 025-938-732-258-31X; 027-276-642-355-32X; 028-420-258-743-651; 028-515-775-002-052; 029-731-917-699-338; 029-750-904-853-176; 030-539-316-839-898; 030-745-589-138-998; 031-192-123-987-858; 034-194-594-492-163; 034-788-830-871-826; 035-230-391-323-572; 035-622-461-917-88X; 035-844-126-266-972; 037-015-962-480-098; 037-728-737-110-218; 038-210-980-877-865; 039-240-788-675-167; 040-149-007-886-067; 040-246-342-809-901; 040-511-614-201-292; 040-512-872-382-422; 040-805-305-639-067; 041-077-426-628-309; 041-142-374-444-310; 041-375-682-656-515; 042-603-804-181-465; 042-791-458-391-347; 044-066-682-118-039; 044-561-487-259-651; 044-619-712-643-203; 044-660-553-227-425; 044-726-439-939-444; 045-068-275-092-295; 045-509-199-019-096; 049-587-574-285-564; 049-662-600-844-268; 050-310-922-134-978; 051-359-193-603-212; 051-487-076-881-287; 051-698-085-409-291; 051-769-747-819-560; 052-152-620-240-080; 052-213-710-818-305; 052-403-572-783-825; 052-652-642-666-083; 053-274-322-538-980; 054-259-517-472-054; 054-420-025-679-815; 054-960-792-844-102; 055-139-456-667-420; 057-040-275-093-344; 057-933-832-083-092; 058-741-410-898-320; 058-748-315-825-723; 062-338-410-457-175; 067-579-879-258-770; 069-785-932-227-632; 069-969-584-892-359; 070-130-043-835-388; 070-254-107-465-406; 070-498-170-340-551; 070-987-932-074-040; 072-010-492-279-993; 075-314-194-556-640; 075-684-636-985-038; 078-018-154-347-812; 080-891-029-820-402; 081-073-736-366-685; 081-913-828-213-378; 082-354-416-447-782; 082-537-506-715-13X; 083-984-889-339-776; 085-028-290-548-419; 087-510-082-531-522; 087-592-077-208-87X; 088-104-444-200-046; 089-020-440-800-114; 089-294-976-659-321; 089-853-917-557-358; 090-763-751-648-60X; 092-496-884-613-629; 094-097-141-249-007; 094-517-118-969-389; 095-841-584-626-093; 095-991-124-582-96X; 097-610-662-661-754; 097-697-244-289-827; 099-077-256-747-536; 100-903-628-483-830; 102-716-060-844-46X; 102-758-854-017-306; 103-298-580-451-712; 105-586-410-116-689; 107-888-172-495-930; 109-591-917-125-236; 111-215-059-030-486; 112-247-483-323-256; 112-526-767-012-822; 114-100-454-559-864; 116-566-483-640-976; 117-172-729-408-670; 117-794-422-477-934; 122-400-827-193-880; 122-602-986-448-76X; 123-228-736-529-865; 125-192-871-240-061; 125-955-883-368-997; 129-159-176-081-346; 130-775-519-888-411; 136-696-267-723-102; 138-830-977-103-335; 139-579-239-246-309; 142-691-465-674-537; 144-364-316-449-509; 146-015-394-177-470; 146-384-847-994-486; 148-898-181-525-659; 162-501-666-396-858; 163-419-117-154-200; 163-729-037-422-168; 178-812-885-607-538,1
